⚠️ Important: This reference is for estimation only. Always verify with prescribing information and a qualified healthcare provider. Doses may vary based on condition, renal/hepatic function, and other factors.
Quick Dose Reference by Weight
Scroll down for detailed drug information. Select your child's weight category:
Paracetamol
Acetaminophen
💊 Fever, pain
Formulation
Syrup
120mg/5ml
Dose Range
10–15 mg/kg
Max Daily
60 mg/kg
Frequency
Every 4-6 hours
Max Single
1000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–75 mg | 2.1–3.1 ml | ≤ 300 mg |
| 6 kg | 60–90 mg | 2.5–3.8 ml | ≤ 360 mg |
| 7 kg | 70–105 mg | 2.9–4.4 ml | ≤ 420 mg |
| 8 kg | 80–120 mg | 3.3–5.0 ml | ≤ 480 mg |
| 9 kg | 90–135 mg | 3.8–5.6 ml | ≤ 540 mg |
| 10 kg | 100–150 mg | 4.2–6.3 ml | ≤ 600 mg |
| 12 kg | 120–180 mg | 5.0–7.5 ml | ≤ 720 mg |
| 15 kg | 150–225 mg | 6.3–9.4 ml | ≤ 900 mg |
| 18 kg | 180–270 mg | 7.5–11.3 ml | ≤ 1080 mg |
| 20 kg | 200–300 mg | 8.3–12.5 ml | ≤ 1200 mg |
| 25 kg | 250–375 mg | 10.4–15.6 ml | ≤ 1500 mg |
| 30 kg | 300–450 mg | 12.5–18.8 ml | ≤ 1800 mg |
⚠️ Warnings
- • Do not exceed 4g/day in children
- • Avoid in liver disease
- • Monitor liver function if used long-term
Ibuprofen
Ibuprofen
💊 Fever, pain, inflammation
Formulation
Syrup
100mg/5ml
Dose Range
5–10 mg/kg
Max Daily
40 mg/kg
Frequency
Every 6-8 hours
Max Single
400 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 25–50 mg | 1.3–2.5 ml | ≤ 200 mg |
| 6 kg | 30–60 mg | 1.5–3.0 ml | ≤ 240 mg |
| 7 kg | 35–70 mg | 1.8–3.5 ml | ≤ 280 mg |
| 8 kg | 40–80 mg | 2.0–4.0 ml | ≤ 320 mg |
| 9 kg | 45–90 mg | 2.3–4.5 ml | ≤ 360 mg |
| 10 kg | 50–100 mg | 2.5–5.0 ml | ≤ 400 mg |
| 12 kg | 60–120 mg | 3.0–6.0 ml | ≤ 480 mg |
| 15 kg | 75–150 mg | 3.8–7.5 ml | ≤ 600 mg |
| 18 kg | 90–180 mg | 4.5–9.0 ml | ≤ 720 mg |
| 20 kg | 100–200 mg | 5.0–10.0 ml | ≤ 800 mg |
| 25 kg | 125–250 mg | 6.3–12.5 ml | ≤ 1000 mg |
| 30 kg | 150–300 mg | 7.5–15.0 ml | ≤ 1200 mg |
⚠️ Warnings
- • Take with food to reduce GI upset
- • Avoid in renal impairment
- • May cause GI bleeding
Amoxicillin
Amoxicillin
💊 Respiratory infections, ear infections, UTIs
Formulation
Syrup
250mg/5ml
Dose Range
20–40 mg/kg
Max Daily
90 mg/kg
Frequency
Every 8 hours (3 times daily)
Max Single
1000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 100–200 mg | 2.0–4.0 ml | ≤ 450 mg |
| 6 kg | 120–240 mg | 2.4–4.8 ml | ≤ 540 mg |
| 7 kg | 140–280 mg | 2.8–5.6 ml | ≤ 630 mg |
| 8 kg | 160–320 mg | 3.2–6.4 ml | ≤ 720 mg |
| 9 kg | 180–360 mg | 3.6–7.2 ml | ≤ 810 mg |
| 10 kg | 200–400 mg | 4.0–8.0 ml | ≤ 900 mg |
| 12 kg | 240–480 mg | 4.8–9.6 ml | ≤ 1080 mg |
| 15 kg | 300–600 mg | 6.0–12.0 ml | ≤ 1350 mg |
| 18 kg | 360–720 mg | 7.2–14.4 ml | ≤ 1620 mg |
| 20 kg | 400–800 mg | 8.0–16.0 ml | ≤ 1800 mg |
| 25 kg | 500–1000 mg | 10.0–20.0 ml | ≤ 2250 mg |
| 30 kg | 600–1200 mg | 12.0–24.0 ml | ≤ 2700 mg |
⚠️ Warnings
- • Monitor for allergic reactions
- • Complete full course of treatment
- • May cause diarrhea
Cefixime
Cefixime
💊 UTIs, respiratory infections, otitis media
Formulation
Syrup
100mg/5ml
Dose Range
8–12 mg/kg
Max Daily
12 mg/kg
Frequency
Every 12 hours (twice daily)
Max Single
400 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 40–60 mg | 2.0–3.0 ml | ≤ 60 mg |
| 6 kg | 48–72 mg | 2.4–3.6 ml | ≤ 72 mg |
| 7 kg | 56–84 mg | 2.8–4.2 ml | ≤ 84 mg |
| 8 kg | 64–96 mg | 3.2–4.8 ml | ≤ 96 mg |
| 9 kg | 72–108 mg | 3.6–5.4 ml | ≤ 108 mg |
| 10 kg | 80–120 mg | 4.0–6.0 ml | ≤ 120 mg |
| 12 kg | 96–144 mg | 4.8–7.2 ml | ≤ 144 mg |
| 15 kg | 120–180 mg | 6.0–9.0 ml | ≤ 180 mg |
| 18 kg | 144–216 mg | 7.2–10.8 ml | ≤ 216 mg |
| 20 kg | 160–240 mg | 8.0–12.0 ml | ≤ 240 mg |
| 25 kg | 200–300 mg | 10.0–15.0 ml | ≤ 300 mg |
| 30 kg | 240–360 mg | 12.0–18.0 ml | ≤ 360 mg |
⚠️ Warnings
- • Monitor for allergic reactions
- • Complete full course
- • May cause diarrhea
Azithromycin
Azithromycin
💊 Respiratory infections, skin infections
Formulation
Syrup
200mg/5ml
Dose Range
10–10 mg/kg
Max Daily
10 mg/kg
Frequency
Once daily
Max Single
500 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–50 mg | 1.3–1.3 ml | ≤ 50 mg |
| 6 kg | 60–60 mg | 1.5–1.5 ml | ≤ 60 mg |
| 7 kg | 70–70 mg | 1.8–1.8 ml | ≤ 70 mg |
| 8 kg | 80–80 mg | 2.0–2.0 ml | ≤ 80 mg |
| 9 kg | 90–90 mg | 2.3–2.3 ml | ≤ 90 mg |
| 10 kg | 100–100 mg | 2.5–2.5 ml | ≤ 100 mg |
| 12 kg | 120–120 mg | 3.0–3.0 ml | ≤ 120 mg |
| 15 kg | 150–150 mg | 3.8–3.8 ml | ≤ 150 mg |
| 18 kg | 180–180 mg | 4.5–4.5 ml | ≤ 180 mg |
| 20 kg | 200–200 mg | 5.0–5.0 ml | ≤ 200 mg |
| 25 kg | 250–250 mg | 6.3–6.3 ml | ≤ 250 mg |
| 30 kg | 300–300 mg | 7.5–7.5 ml | ≤ 300 mg |
⚠️ Warnings
- • Complete full course
- • May cause GI upset
- • Monitor for cardiac effects
Ondansetron
Ondansetron
💊 Nausea, vomiting
Formulation
Syrup
2mg/5ml
Dose Range
0.1–0.15 mg/kg
Max Daily
0.6 mg/kg
Frequency
Every 8 hours as needed
Max Single
8 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–1 mg | 1.3–1.9 ml | ≤ 3 mg |
| 6 kg | 1–1 mg | 1.5–2.2 ml | ≤ 4 mg |
| 7 kg | 1–1 mg | 1.8–2.6 ml | ≤ 4 mg |
| 8 kg | 1–1 mg | 2.0–3.0 ml | ≤ 5 mg |
| 9 kg | 1–1 mg | 2.3–3.4 ml | ≤ 5 mg |
| 10 kg | 1–2 mg | 2.5–3.8 ml | ≤ 6 mg |
| 12 kg | 1–2 mg | 3.0–4.5 ml | ≤ 7 mg |
| 15 kg | 2–2 mg | 3.8–5.6 ml | ≤ 9 mg |
| 18 kg | 2–3 mg | 4.5–6.7 ml | ≤ 11 mg |
| 20 kg | 2–3 mg | 5.0–7.5 ml | ≤ 12 mg |
| 25 kg | 3–4 mg | 6.3–9.4 ml | ≤ 15 mg |
| 30 kg | 3–5 mg | 7.5–11.3 ml | ≤ 18 mg |
⚠️ Warnings
- • Monitor for QT prolongation
- • May cause headache
- • Avoid in patients with pheochromocytoma
Metronidazole
Metronidazole
💊 Anaerobic infections, giardiasis, amebiasis
Formulation
Suspension
200mg/5ml
Dose Range
7.5–10 mg/kg
Max Daily
40 mg/kg
Frequency
Every 8 hours
Max Single
500 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 38–50 mg | 0.9–1.3 ml | ≤ 200 mg |
| 6 kg | 45–60 mg | 1.1–1.5 ml | ≤ 240 mg |
| 7 kg | 53–70 mg | 1.3–1.8 ml | ≤ 280 mg |
| 8 kg | 60–80 mg | 1.5–2.0 ml | ≤ 320 mg |
| 9 kg | 68–90 mg | 1.7–2.3 ml | ≤ 360 mg |
| 10 kg | 75–100 mg | 1.9–2.5 ml | ≤ 400 mg |
| 12 kg | 90–120 mg | 2.3–3.0 ml | ≤ 480 mg |
| 15 kg | 113–150 mg | 2.8–3.8 ml | ≤ 600 mg |
| 18 kg | 135–180 mg | 3.4–4.5 ml | ≤ 720 mg |
| 20 kg | 150–200 mg | 3.8–5.0 ml | ≤ 800 mg |
| 25 kg | 188–250 mg | 4.7–6.3 ml | ≤ 1000 mg |
| 30 kg | 225–300 mg | 5.6–7.5 ml | ≤ 1200 mg |
⚠️ Warnings
- • Complete full course
- • Avoid alcohol during treatment
- • May cause metallic taste
Salbutamol
Albuterol
💊 Asthma, bronchospasm
Formulation
Syrup
2mg/5ml
Dose Range
0.1–0.2 mg/kg
Max Daily
1.2 mg/kg
Frequency
Every 4-6 hours as needed
Max Single
10 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–1 mg | 1.3–2.5 ml | ≤ 6 mg |
| 6 kg | 1–1 mg | 1.5–3.0 ml | ≤ 7 mg |
| 7 kg | 1–1 mg | 1.8–3.5 ml | ≤ 8 mg |
| 8 kg | 1–2 mg | 2.0–4.0 ml | ≤ 10 mg |
| 9 kg | 1–2 mg | 2.3–4.5 ml | ≤ 11 mg |
| 10 kg | 1–2 mg | 2.5–5.0 ml | ≤ 12 mg |
| 12 kg | 1–2 mg | 3.0–6.0 ml | ≤ 14 mg |
| 15 kg | 2–3 mg | 3.8–7.5 ml | ≤ 18 mg |
| 18 kg | 2–4 mg | 4.5–9.0 ml | ≤ 22 mg |
| 20 kg | 2–4 mg | 5.0–10.0 ml | ≤ 24 mg |
| 25 kg | 3–5 mg | 6.3–12.5 ml | ≤ 30 mg |
| 30 kg | 3–6 mg | 7.5–15.0 ml | ≤ 36 mg |
⚠️ Warnings
- • Monitor heart rate
- • May cause tremors
- • Not for regular use if not needed
Prednisolone
Prednisolone
💊 Asthma exacerbations, allergic reactions, inflammatory conditions
Formulation
Syrup
5mg/5ml
Dose Range
1–2 mg/kg
Max Daily
60 mg/kg
Frequency
Once daily or divided doses
Max Single
60 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 5–10 mg | 5.0–10.0 ml | ≤ 300 mg |
| 6 kg | 6–12 mg | 6.0–12.0 ml | ≤ 360 mg |
| 7 kg | 7–14 mg | 7.0–14.0 ml | ≤ 420 mg |
| 8 kg | 8–16 mg | 8.0–16.0 ml | ≤ 480 mg |
| 9 kg | 9–18 mg | 9.0–18.0 ml | ≤ 540 mg |
| 10 kg | 10–20 mg | 10.0–20.0 ml | ≤ 600 mg |
| 12 kg | 12–24 mg | 12.0–24.0 ml | ≤ 720 mg |
| 15 kg | 15–30 mg | 15.0–30.0 ml | ≤ 900 mg |
| 18 kg | 18–36 mg | 18.0–36.0 ml | ≤ 1080 mg |
| 20 kg | 20–40 mg | 20.0–40.0 ml | ≤ 1200 mg |
| 25 kg | 25–50 mg | 25.0–50.0 ml | ≤ 1500 mg |
| 30 kg | 30–60 mg | 30.0–60.0 ml | ≤ 1800 mg |
⚠️ Warnings
- • Do not stop abruptly after prolonged use
- • Monitor for signs of infection
- • May cause increased appetite
Dexamethasone
Dexamethasone
💊 Croup, asthma exacerbations, allergic reactions
Formulation
Injection
4mg/ml
Dose Range
0.15–0.6 mg/kg
Max Daily
1.2 mg/kg
Frequency
Once daily
Max Single
20 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–3 mg | 0.2–0.8 ml | ≤ 6 mg |
| 6 kg | 1–4 mg | 0.2–0.9 ml | ≤ 7 mg |
| 7 kg | 1–4 mg | 0.3–1.1 ml | ≤ 8 mg |
| 8 kg | 1–5 mg | 0.3–1.2 ml | ≤ 10 mg |
| 9 kg | 1–5 mg | 0.3–1.3 ml | ≤ 11 mg |
| 10 kg | 2–6 mg | 0.4–1.5 ml | ≤ 12 mg |
| 12 kg | 2–7 mg | 0.4–1.8 ml | ≤ 14 mg |
| 15 kg | 2–9 mg | 0.6–2.3 ml | ≤ 18 mg |
| 18 kg | 3–11 mg | 0.7–2.7 ml | ≤ 22 mg |
| 20 kg | 3–12 mg | 0.8–3.0 ml | ≤ 24 mg |
| 25 kg | 4–15 mg | 0.9–3.8 ml | ≤ 30 mg |
| 30 kg | 5–18 mg | 1.1–4.5 ml | ≤ 36 mg |
⚠️ Warnings
- • Do not stop abruptly after prolonged use
- • Monitor blood glucose
- • May mask signs of infection
Ciprofloxacin
Ciprofloxacin
💊 UTIs, respiratory infections, bone and joint infections
Formulation
Suspension
250mg/5ml
Dose Range
10–20 mg/kg
Max Daily
40 mg/kg
Frequency
Every 12 hours
Max Single
750 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–100 mg | 1.0–2.0 ml | ≤ 200 mg |
| 6 kg | 60–120 mg | 1.2–2.4 ml | ≤ 240 mg |
| 7 kg | 70–140 mg | 1.4–2.8 ml | ≤ 280 mg |
| 8 kg | 80–160 mg | 1.6–3.2 ml | ≤ 320 mg |
| 9 kg | 90–180 mg | 1.8–3.6 ml | ≤ 360 mg |
| 10 kg | 100–200 mg | 2.0–4.0 ml | ≤ 400 mg |
| 12 kg | 120–240 mg | 2.4–4.8 ml | ≤ 480 mg |
| 15 kg | 150–300 mg | 3.0–6.0 ml | ≤ 600 mg |
| 18 kg | 180–360 mg | 3.6–7.2 ml | ≤ 720 mg |
| 20 kg | 200–400 mg | 4.0–8.0 ml | ≤ 800 mg |
| 25 kg | 250–500 mg | 5.0–10.0 ml | ≤ 1000 mg |
| 30 kg | 300–600 mg | 6.0–12.0 ml | ≤ 1200 mg |
⚠️ Warnings
- • Not recommended in children <18 unless no alternatives
- • May cause tendon damage
- • Take with adequate fluids
Cotrimoxazole
Trimethoprim-Sulfamethoxazole
💊 UTIs, PCP prophylaxis, otitis media
Formulation
Suspension
200mg SMX/40mg TMP per 5ml
Dose Range
2–4 mg/kg
Max Daily
16 mg/kg
Frequency
Every 12 hours
Max Single
160 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 10–20 mg | 0.3–0.5 ml | ≤ 80 mg |
| 6 kg | 12–24 mg | 0.3–0.6 ml | ≤ 96 mg |
| 7 kg | 14–28 mg | 0.3–0.7 ml | ≤ 112 mg |
| 8 kg | 16–32 mg | 0.4–0.8 ml | ≤ 128 mg |
| 9 kg | 18–36 mg | 0.5–0.9 ml | ≤ 144 mg |
| 10 kg | 20–40 mg | 0.5–1.0 ml | ≤ 160 mg |
| 12 kg | 24–48 mg | 0.6–1.2 ml | ≤ 192 mg |
| 15 kg | 30–60 mg | 0.8–1.5 ml | ≤ 240 mg |
| 18 kg | 36–72 mg | 0.9–1.8 ml | ≤ 288 mg |
| 20 kg | 40–80 mg | 1.0–2.0 ml | ≤ 320 mg |
| 25 kg | 50–100 mg | 1.3–2.5 ml | ≤ 400 mg |
| 30 kg | 60–120 mg | 1.5–3.0 ml | ≤ 480 mg |
⚠️ Warnings
- • Monitor for rash
- • Check for G6PD deficiency
- • May cause photosensitivity
Vancomycin
Vancomycin
💊 MRSA, serious gram-positive infections
Formulation
Injection
500mg/100ml
Dose Range
10–15 mg/kg
Max Daily
60 mg/kg
Frequency
Every 6 hours
Max Single
1000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–75 mg | 10.0–15.0 ml | ≤ 300 mg |
| 6 kg | 60–90 mg | 12.0–18.0 ml | ≤ 360 mg |
| 7 kg | 70–105 mg | 14.0–21.0 ml | ≤ 420 mg |
| 8 kg | 80–120 mg | 16.0–24.0 ml | ≤ 480 mg |
| 9 kg | 90–135 mg | 18.0–27.0 ml | ≤ 540 mg |
| 10 kg | 100–150 mg | 20.0–30.0 ml | ≤ 600 mg |
| 12 kg | 120–180 mg | 24.0–36.0 ml | ≤ 720 mg |
| 15 kg | 150–225 mg | 30.0–45.0 ml | ≤ 900 mg |
| 18 kg | 180–270 mg | 36.0–54.0 ml | ≤ 1080 mg |
| 20 kg | 200–300 mg | 40.0–60.0 ml | ≤ 1200 mg |
| 25 kg | 250–375 mg | 50.0–75.0 ml | ≤ 1500 mg |
| 30 kg | 300–450 mg | 60.0–90.0 ml | ≤ 1800 mg |
⚠️ Warnings
- • Must be given IV - not for IM use
- • Monitor serum levels
- • Infuse slowly to avoid Red Man Syndrome
Gentamicin
Gentamicin
💊 Serious gram-negative infections, neonatal sepsis
Formulation
Injection
20mg/ml
Dose Range
5–7.5 mg/kg
Max Daily
7.5 mg/kg
Frequency
Once daily
Max Single
240 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 25–38 mg | 2.5–3.8 ml | ≤ 38 mg |
| 6 kg | 30–45 mg | 3.0–4.5 ml | ≤ 45 mg |
| 7 kg | 35–53 mg | 3.5–5.3 ml | ≤ 53 mg |
| 8 kg | 40–60 mg | 4.0–6.0 ml | ≤ 60 mg |
| 9 kg | 45–68 mg | 4.5–6.8 ml | ≤ 68 mg |
| 10 kg | 50–75 mg | 5.0–7.5 ml | ≤ 75 mg |
| 12 kg | 60–90 mg | 6.0–9.0 ml | ≤ 90 mg |
| 15 kg | 75–113 mg | 7.5–11.3 ml | ≤ 113 mg |
| 18 kg | 90–135 mg | 9.0–13.5 ml | ≤ 135 mg |
| 20 kg | 100–150 mg | 10.0–15.0 ml | ≤ 150 mg |
| 25 kg | 125–188 mg | 12.5–18.8 ml | ≤ 188 mg |
| 30 kg | 150–225 mg | 15.0–22.5 ml | ≤ 225 mg |
⚠️ Warnings
- • Monitor renal function
- • Monitor serum levels
- • May cause ototoxicity and nephrotoxicity
Meropenem
Meropenem
💊 Serious gram-negative and anaerobic infections, meningitis
Formulation
Injection
500mg/20ml
Dose Range
20–40 mg/kg
Max Daily
120 mg/kg
Frequency
Every 8 hours
Max Single
2000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 100–200 mg | 5.0–10.0 ml | ≤ 600 mg |
| 6 kg | 120–240 mg | 6.0–12.0 ml | ≤ 720 mg |
| 7 kg | 140–280 mg | 7.0–14.0 ml | ≤ 840 mg |
| 8 kg | 160–320 mg | 8.0–16.0 ml | ≤ 960 mg |
| 9 kg | 180–360 mg | 9.0–18.0 ml | ≤ 1080 mg |
| 10 kg | 200–400 mg | 10.0–20.0 ml | ≤ 1200 mg |
| 12 kg | 240–480 mg | 12.0–24.0 ml | ≤ 1440 mg |
| 15 kg | 300–600 mg | 15.0–30.0 ml | ≤ 1800 mg |
| 18 kg | 360–720 mg | 18.0–36.0 ml | ≤ 2160 mg |
| 20 kg | 400–800 mg | 20.0–40.0 ml | ≤ 2400 mg |
| 25 kg | 500–1000 mg | 25.0–50.0 ml | ≤ 3000 mg |
| 30 kg | 600–1200 mg | 30.0–60.0 ml | ≤ 3600 mg |
⚠️ Warnings
- • Monitor for seizures
- • Adjust dose in renal impairment
- • Complete full course
Acyclovir
Acyclovir
💊 Herpes simplex, varicella-zoster
Formulation
Suspension
200mg/5ml
Dose Range
15–30 mg/kg
Max Daily
60 mg/kg
Frequency
Every 8 hours (3 times daily)
Max Single
800 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 75–150 mg | 1.9–3.8 ml | ≤ 300 mg |
| 6 kg | 90–180 mg | 2.3–4.5 ml | ≤ 360 mg |
| 7 kg | 105–210 mg | 2.6–5.3 ml | ≤ 420 mg |
| 8 kg | 120–240 mg | 3.0–6.0 ml | ≤ 480 mg |
| 9 kg | 135–270 mg | 3.4–6.8 ml | ≤ 540 mg |
| 10 kg | 150–300 mg | 3.8–7.5 ml | ≤ 600 mg |
| 12 kg | 180–360 mg | 4.5–9.0 ml | ≤ 720 mg |
| 15 kg | 225–450 mg | 5.6–11.3 ml | ≤ 900 mg |
| 18 kg | 270–540 mg | 6.8–13.5 ml | ≤ 1080 mg |
| 20 kg | 300–600 mg | 7.5–15.0 ml | ≤ 1200 mg |
| 25 kg | 375–750 mg | 9.4–18.8 ml | ≤ 1500 mg |
| 30 kg | 450–900 mg | 11.3–22.5 ml | ≤ 1800 mg |
⚠️ Warnings
- • Start early in disease course
- • Adequate hydration required
- • Monitor renal function
Clonazepam
Clonazepam
💊 Seizures, panic disorder, anxiety
Formulation
Drops
0.5mg/5ml
Dose Range
0.01–0.05 mg/kg
Max Daily
0.2 mg/kg
Frequency
Every 8-12 hours
Max Single
2 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 0–0 mg | 0.5–2.5 ml | ≤ 1 mg |
| 6 kg | 0–0 mg | 0.6–3.0 ml | ≤ 1 mg |
| 7 kg | 0–0 mg | 0.7–3.5 ml | ≤ 1 mg |
| 8 kg | 0–0 mg | 0.8–4.0 ml | ≤ 2 mg |
| 9 kg | 0–0 mg | 0.9–4.5 ml | ≤ 2 mg |
| 10 kg | 0–1 mg | 1.0–5.0 ml | ≤ 2 mg |
| 12 kg | 0–1 mg | 1.2–6.0 ml | ≤ 2 mg |
| 15 kg | 0–1 mg | 1.5–7.5 ml | ≤ 3 mg |
| 18 kg | 0–1 mg | 1.8–9.0 ml | ≤ 4 mg |
| 20 kg | 0–1 mg | 2.0–10.0 ml | ≤ 4 mg |
| 25 kg | 0–1 mg | 2.5–12.5 ml | ≤ 5 mg |
| 30 kg | 0–2 mg | 3.0–15.0 ml | ≤ 6 mg |
⚠️ Warnings
- • May cause drowsiness
- • Risk of dependence with prolonged use
- • Do not stop abruptly
Domperidone
Domperidone
💊 Nausea, vomiting, gastroparesis
Formulation
Suspension
5mg/5ml
Dose Range
0.2–0.4 mg/kg
Max Daily
1.6 mg/kg
Frequency
Every 8 hours
Max Single
20 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–2 mg | 1.0–2.0 ml | ≤ 8 mg |
| 6 kg | 1–2 mg | 1.2–2.4 ml | ≤ 10 mg |
| 7 kg | 1–3 mg | 1.4–2.8 ml | ≤ 11 mg |
| 8 kg | 2–3 mg | 1.6–3.2 ml | ≤ 13 mg |
| 9 kg | 2–4 mg | 1.8–3.6 ml | ≤ 14 mg |
| 10 kg | 2–4 mg | 2.0–4.0 ml | ≤ 16 mg |
| 12 kg | 2–5 mg | 2.4–4.8 ml | ≤ 19 mg |
| 15 kg | 3–6 mg | 3.0–6.0 ml | ≤ 24 mg |
| 18 kg | 4–7 mg | 3.6–7.2 ml | ≤ 29 mg |
| 20 kg | 4–8 mg | 4.0–8.0 ml | ≤ 32 mg |
| 25 kg | 5–10 mg | 5.0–10.0 ml | ≤ 40 mg |
| 30 kg | 6–12 mg | 6.0–12.0 ml | ≤ 48 mg |
⚠️ Warnings
- • May cause cardiac effects
- • Not for use in patients with cardiac conditions
- • Use lowest effective dose
Ranitidine
Ranitidine
💊 GERD, peptic ulcer disease
Formulation
Syrup
75mg/5ml
Dose Range
2–4 mg/kg
Max Daily
8 mg/kg
Frequency
Every 12 hours
Max Single
150 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 10–20 mg | 0.7–1.3 ml | ≤ 40 mg |
| 6 kg | 12–24 mg | 0.8–1.6 ml | ≤ 48 mg |
| 7 kg | 14–28 mg | 0.9–1.9 ml | ≤ 56 mg |
| 8 kg | 16–32 mg | 1.1–2.1 ml | ≤ 64 mg |
| 9 kg | 18–36 mg | 1.2–2.4 ml | ≤ 72 mg |
| 10 kg | 20–40 mg | 1.3–2.7 ml | ≤ 80 mg |
| 12 kg | 24–48 mg | 1.6–3.2 ml | ≤ 96 mg |
| 15 kg | 30–60 mg | 2.0–4.0 ml | ≤ 120 mg |
| 18 kg | 36–72 mg | 2.4–4.8 ml | ≤ 144 mg |
| 20 kg | 40–80 mg | 2.7–5.3 ml | ≤ 160 mg |
| 25 kg | 50–100 mg | 3.3–6.7 ml | ≤ 200 mg |
| 30 kg | 60–120 mg | 4.0–8.0 ml | ≤ 240 mg |
⚠️ Warnings
- • Consider safer alternatives
- • Monitor for confusional symptoms
- • May mask gastric cancer symptoms
Cetirizine
Cetirizine
💊 Allergic rhinitis, urticaria
Formulation
Syrup
5mg/5ml
Dose Range
0.25–0.25 mg/kg
Max Daily
0.25 mg/kg
Frequency
Once daily
Max Single
10 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–1 mg | 1.3–1.3 ml | ≤ 1 mg |
| 6 kg | 2–2 mg | 1.5–1.5 ml | ≤ 2 mg |
| 7 kg | 2–2 mg | 1.8–1.8 ml | ≤ 2 mg |
| 8 kg | 2–2 mg | 2.0–2.0 ml | ≤ 2 mg |
| 9 kg | 2–2 mg | 2.3–2.3 ml | ≤ 2 mg |
| 10 kg | 3–3 mg | 2.5–2.5 ml | ≤ 3 mg |
| 12 kg | 3–3 mg | 3.0–3.0 ml | ≤ 3 mg |
| 15 kg | 4–4 mg | 3.8–3.8 ml | ≤ 4 mg |
| 18 kg | 5–5 mg | 4.5–4.5 ml | ≤ 5 mg |
| 20 kg | 5–5 mg | 5.0–5.0 ml | ≤ 5 mg |
| 25 kg | 6–6 mg | 6.3–6.3 ml | ≤ 6 mg |
| 30 kg | 8–8 mg | 7.5–7.5 ml | ≤ 8 mg |
⚠️ Warnings
- • May cause drowsiness
- • Avoid in renal impairment
- • Use with caution in children
Loratadine
Loratadine
💊 Allergic rhinitis, urticaria
Formulation
Syrup
5mg/5ml
Dose Range
0.5–0.5 mg/kg
Max Daily
0.5 mg/kg
Frequency
Once daily
Max Single
10 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 3–3 mg | 2.5–2.5 ml | ≤ 3 mg |
| 6 kg | 3–3 mg | 3.0–3.0 ml | ≤ 3 mg |
| 7 kg | 4–4 mg | 3.5–3.5 ml | ≤ 4 mg |
| 8 kg | 4–4 mg | 4.0–4.0 ml | ≤ 4 mg |
| 9 kg | 5–5 mg | 4.5–4.5 ml | ≤ 5 mg |
| 10 kg | 5–5 mg | 5.0–5.0 ml | ≤ 5 mg |
| 12 kg | 6–6 mg | 6.0–6.0 ml | ≤ 6 mg |
| 15 kg | 8–8 mg | 7.5–7.5 ml | ≤ 8 mg |
| 18 kg | 9–9 mg | 9.0–9.0 ml | ≤ 9 mg |
| 20 kg | 10–10 mg | 10.0–10.0 ml | ≤ 10 mg |
| 25 kg | 13–13 mg | 12.5–12.5 ml | ≤ 13 mg |
| 30 kg | 15–15 mg | 15.0–15.0 ml | ≤ 15 mg |
⚠️ Warnings
- • Non-drowsy formulation
- • Avoid in severe liver impairment
- • May cause headache
Promethazine
Promethazine
💊 Nausea, vomiting, allergic reactions, motion sickness
Formulation
Syrup
5mg/5ml
Dose Range
0.5–1 mg/kg
Max Daily
4 mg/kg
Frequency
Every 6 hours as needed
Max Single
25 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 3–5 mg | 2.5–5.0 ml | ≤ 20 mg |
| 6 kg | 3–6 mg | 3.0–6.0 ml | ≤ 24 mg |
| 7 kg | 4–7 mg | 3.5–7.0 ml | ≤ 28 mg |
| 8 kg | 4–8 mg | 4.0–8.0 ml | ≤ 32 mg |
| 9 kg | 5–9 mg | 4.5–9.0 ml | ≤ 36 mg |
| 10 kg | 5–10 mg | 5.0–10.0 ml | ≤ 40 mg |
| 12 kg | 6–12 mg | 6.0–12.0 ml | ≤ 48 mg |
| 15 kg | 8–15 mg | 7.5–15.0 ml | ≤ 60 mg |
| 18 kg | 9–18 mg | 9.0–18.0 ml | ≤ 72 mg |
| 20 kg | 10–20 mg | 10.0–20.0 ml | ≤ 80 mg |
| 25 kg | 13–25 mg | 12.5–25.0 ml | ≤ 100 mg |
| 30 kg | 15–30 mg | 15.0–30.0 ml | ≤ 120 mg |
⚠️ Warnings
- • May cause severe sedation
- • Not for children <2 years due to respiratory depression risk
- • Monitor for paradoxical excitement
ORS Solution
Oral Rehydration Solution
💊 Diarrhea, dehydration prevention
Formulation
Solution
WHO ORS sachet dissolved in 1L water
Dose Range
50–100 mg/kg
Max Daily
200 mg/kg
Frequency
Frequent small amounts
Max Single
10000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 250–500 mg | 277.8–555.6 ml | ≤ 1000 mg |
| 6 kg | 300–600 mg | 333.3–666.7 ml | ≤ 1200 mg |
| 7 kg | 350–700 mg | 388.9–777.8 ml | ≤ 1400 mg |
| 8 kg | 400–800 mg | 444.4–888.9 ml | ≤ 1600 mg |
| 9 kg | 450–900 mg | 500.0–1000.0 ml | ≤ 1800 mg |
| 10 kg | 500–1000 mg | 555.6–1111.1 ml | ≤ 2000 mg |
| 12 kg | 600–1200 mg | 666.7–1333.3 ml | ≤ 2400 mg |
| 15 kg | 750–1500 mg | 833.3–1666.7 ml | ≤ 3000 mg |
| 18 kg | 900–1800 mg | 1000.0–2000.0 ml | ≤ 3600 mg |
| 20 kg | 1000–2000 mg | 1111.1–2222.2 ml | ≤ 4000 mg |
| 25 kg | 1250–2500 mg | 1388.9–2777.8 ml | ≤ 5000 mg |
| 30 kg | 1500–3000 mg | 1666.7–3333.3 ml | ≤ 6000 mg |
⚠️ Warnings
- • Must be prepared correctly
- • Do not boil after preparation
- • Use within 24 hours
Zinc Sulfate
Zinc Sulfate
💊 Diarrhea (adjunct to ORS), zinc deficiency
Formulation
Syrup
20mg/5ml
Dose Range
0.5–1 mg/kg
Max Daily
1 mg/kg
Frequency
Once daily for 10-14 days
Max Single
20 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 3–5 mg | 0.6–1.3 ml | ≤ 5 mg |
| 6 kg | 3–6 mg | 0.8–1.5 ml | ≤ 6 mg |
| 7 kg | 4–7 mg | 0.9–1.8 ml | ≤ 7 mg |
| 8 kg | 4–8 mg | 1.0–2.0 ml | ≤ 8 mg |
| 9 kg | 5–9 mg | 1.1–2.3 ml | ≤ 9 mg |
| 10 kg | 5–10 mg | 1.3–2.5 ml | ≤ 10 mg |
| 12 kg | 6–12 mg | 1.5–3.0 ml | ≤ 12 mg |
| 15 kg | 8–15 mg | 1.9–3.8 ml | ≤ 15 mg |
| 18 kg | 9–18 mg | 2.3–4.5 ml | ≤ 18 mg |
| 20 kg | 10–20 mg | 2.5–5.0 ml | ≤ 20 mg |
| 25 kg | 13–25 mg | 3.1–6.3 ml | ≤ 25 mg |
| 30 kg | 15–30 mg | 3.8–7.5 ml | ≤ 30 mg |
⚠️ Warnings
- • Give 1-2 hours before or after meals
- • May cause GI upset
- • Complete full course
Diethylcarbamazine Citrate
Diethylcarbamazine
💊 Filariasis, tropical eosinophilia, visceral larva migrans
Formulation
Tablet
50mg, 100mg tablets
Dose Range
6–15 mg/kg
Max Daily
30 mg/kg
Frequency
Every 8 hours
Max Single
400 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 30–75 mg | 0.6–1.5 ml | ≤ 150 mg |
| 6 kg | 36–90 mg | 0.7–1.8 ml | ≤ 180 mg |
| 7 kg | 42–105 mg | 0.8–2.1 ml | ≤ 210 mg |
| 8 kg | 48–120 mg | 1.0–2.4 ml | ≤ 240 mg |
| 9 kg | 54–135 mg | 1.1–2.7 ml | ≤ 270 mg |
| 10 kg | 60–150 mg | 1.2–3.0 ml | ≤ 300 mg |
| 12 kg | 72–180 mg | 1.4–3.6 ml | ≤ 360 mg |
| 15 kg | 90–225 mg | 1.8–4.5 ml | ≤ 450 mg |
| 18 kg | 108–270 mg | 2.2–5.4 ml | ≤ 540 mg |
| 20 kg | 120–300 mg | 2.4–6.0 ml | ≤ 600 mg |
| 25 kg | 150–375 mg | 3.0–7.5 ml | ≤ 750 mg |
| 30 kg | 180–450 mg | 3.6–9.0 ml | ≤ 900 mg |
⚠️ Warnings
- • Complete full course
- • May cause GI upset
- • Monitor for allergic reactions
Ivermectin
Ivermectin
💊 Scabies, strongyloidiasis, onchocerciasis, filariasis
Formulation
Tablet
3mg, 6mg, 12mg tablets
Dose Range
0.2–0.2 mg/kg
Max Daily
0.2 mg/kg
Frequency
Once daily, may repeat after 2 weeks
Max Single
12 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–1 mg | 0.3–0.3 ml | ≤ 1 mg |
| 6 kg | 1–1 mg | 0.4–0.4 ml | ≤ 1 mg |
| 7 kg | 1–1 mg | 0.5–0.5 ml | ≤ 1 mg |
| 8 kg | 2–2 mg | 0.5–0.5 ml | ≤ 2 mg |
| 9 kg | 2–2 mg | 0.6–0.6 ml | ≤ 2 mg |
| 10 kg | 2–2 mg | 0.7–0.7 ml | ≤ 2 mg |
| 12 kg | 2–2 mg | 0.8–0.8 ml | ≤ 2 mg |
| 15 kg | 3–3 mg | 1.0–1.0 ml | ≤ 3 mg |
| 18 kg | 4–4 mg | 1.2–1.2 ml | ≤ 4 mg |
| 20 kg | 4–4 mg | 1.3–1.3 ml | ≤ 4 mg |
| 25 kg | 5–5 mg | 1.7–1.7 ml | ≤ 5 mg |
| 30 kg | 6–6 mg | 2.0–2.0 ml | ≤ 6 mg |
⚠️ Warnings
- • Avoid below 15kg (<5 yr)
- • May cause dizziness
Albendazole
Albendazole
💊 Roundworms, hookworms, whipworms, giardiasis, neurocysticercosis, hydatid disease
Formulation
Suspension
200mg/5ml
Dose Range
10–15 mg/kg
Max Daily
30 mg/kg
Frequency
Once or twice daily based on indication
Max Single
400 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–75 mg | 1.3–1.9 ml | ≤ 150 mg |
| 6 kg | 60–90 mg | 1.5–2.3 ml | ≤ 180 mg |
| 7 kg | 70–105 mg | 1.8–2.6 ml | ≤ 210 mg |
| 8 kg | 80–120 mg | 2.0–3.0 ml | ≤ 240 mg |
| 9 kg | 90–135 mg | 2.3–3.4 ml | ≤ 270 mg |
| 10 kg | 100–150 mg | 2.5–3.8 ml | ≤ 300 mg |
| 12 kg | 120–180 mg | 3.0–4.5 ml | ≤ 360 mg |
| 15 kg | 150–225 mg | 3.8–5.6 ml | ≤ 450 mg |
| 18 kg | 180–270 mg | 4.5–6.8 ml | ≤ 540 mg |
| 20 kg | 200–300 mg | 5.0–7.5 ml | ≤ 600 mg |
| 25 kg | 250–375 mg | 6.3–9.4 ml | ≤ 750 mg |
| 30 kg | 300–450 mg | 7.5–11.3 ml | ≤ 900 mg |
⚠️ Warnings
- • Take with fatty meals for better absorption
- • Monitor liver function
- • Contraindicated in ocular cysticercosis
Levamisole
Levamisole
💊 Ascariasis, hookworm, immunopotentiating agent
Formulation
Syrup
50mg/5ml
Dose Range
2–5 mg/kg
Max Daily
10 mg/kg
Frequency
Single dose, may repeat after 7 days
Max Single
150 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 10–25 mg | 1.0–2.5 ml | ≤ 50 mg |
| 6 kg | 12–30 mg | 1.2–3.0 ml | ≤ 60 mg |
| 7 kg | 14–35 mg | 1.4–3.5 ml | ≤ 70 mg |
| 8 kg | 16–40 mg | 1.6–4.0 ml | ≤ 80 mg |
| 9 kg | 18–45 mg | 1.8–4.5 ml | ≤ 90 mg |
| 10 kg | 20–50 mg | 2.0–5.0 ml | ≤ 100 mg |
| 12 kg | 24–60 mg | 2.4–6.0 ml | ≤ 120 mg |
| 15 kg | 30–75 mg | 3.0–7.5 ml | ≤ 150 mg |
| 18 kg | 36–90 mg | 3.6–9.0 ml | ≤ 180 mg |
| 20 kg | 40–100 mg | 4.0–10.0 ml | ≤ 200 mg |
| 25 kg | 50–125 mg | 5.0–12.5 ml | ≤ 250 mg |
| 30 kg | 60–150 mg | 6.0–15.0 ml | ≤ 300 mg |
⚠️ Warnings
- • Avoid in hepatic or renal insufficiency
- • Monitor blood counts
Mebendazole
Mebendazole
💊 Roundworms, pinworms, whipworms, hookworms, tapeworms
Formulation
Suspension
100mg/5ml
Dose Range
15–30 mg/kg
Max Daily
30 mg/kg
Frequency
100mg twice daily for 3 days or single dose
Max Single
200 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 75–150 mg | 3.8–7.5 ml | ≤ 150 mg |
| 6 kg | 90–180 mg | 4.5–9.0 ml | ≤ 180 mg |
| 7 kg | 105–210 mg | 5.3–10.5 ml | ≤ 210 mg |
| 8 kg | 120–240 mg | 6.0–12.0 ml | ≤ 240 mg |
| 9 kg | 135–270 mg | 6.8–13.5 ml | ≤ 270 mg |
| 10 kg | 150–300 mg | 7.5–15.0 ml | ≤ 300 mg |
| 12 kg | 180–360 mg | 9.0–18.0 ml | ≤ 360 mg |
| 15 kg | 225–450 mg | 11.3–22.5 ml | ≤ 450 mg |
| 18 kg | 270–540 mg | 13.5–27.0 ml | ≤ 540 mg |
| 20 kg | 300–600 mg | 15.0–30.0 ml | ≤ 600 mg |
| 25 kg | 375–750 mg | 18.8–37.5 ml | ≤ 750 mg |
| 30 kg | 450–900 mg | 22.5–45.0 ml | ≤ 900 mg |
⚠️ Warnings
- • May cause abdominal pain
- • Avoid in liver dysfunction
Praziquantel
Praziquantel
💊 Schistosomiasis, tapeworms, neurocysticercosis, liver fluke
Formulation
Tablet
500mg tablets
Dose Range
5–60 mg/kg
Max Daily
150 mg/kg
Frequency
Varies by indication (single dose to 15 days)
Max Single
600 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 25–300 mg | 0.1–0.6 ml | ≤ 750 mg |
| 6 kg | 30–360 mg | 0.1–0.7 ml | ≤ 900 mg |
| 7 kg | 35–420 mg | 0.1–0.8 ml | ≤ 1050 mg |
| 8 kg | 40–480 mg | 0.1–1.0 ml | ≤ 1200 mg |
| 9 kg | 45–540 mg | 0.1–1.1 ml | ≤ 1350 mg |
| 10 kg | 50–600 mg | 0.1–1.2 ml | ≤ 1500 mg |
| 12 kg | 60–720 mg | 0.1–1.4 ml | ≤ 1800 mg |
| 15 kg | 75–900 mg | 0.1–1.8 ml | ≤ 2250 mg |
| 18 kg | 90–1080 mg | 0.2–2.2 ml | ≤ 2700 mg |
| 20 kg | 100–1200 mg | 0.2–2.4 ml | ≤ 3000 mg |
| 25 kg | 125–1500 mg | 0.3–3.0 ml | ≤ 3750 mg |
| 30 kg | 150–1800 mg | 0.3–3.6 ml | ≤ 4500 mg |
⚠️ Warnings
- • Give with food
- • Avoid in ocular cysticercosis
- • May cause neurological effects in neurocysticercosis
Niclosamide
Niclosamide
💊 Taenia saginata, Taenia solium, Diphyllobothrium latum, Hymenolepis nana
Formulation
Tablet
500mg tablets
Dose Range
20–25 mg/kg
Max Daily
50 mg/kg
Frequency
Empty stomach, repeat after 1 hour
Max Single
1000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 100–125 mg | 0.2–0.3 ml | ≤ 250 mg |
| 6 kg | 120–150 mg | 0.2–0.3 ml | ≤ 300 mg |
| 7 kg | 140–175 mg | 0.3–0.3 ml | ≤ 350 mg |
| 8 kg | 160–200 mg | 0.3–0.4 ml | ≤ 400 mg |
| 9 kg | 180–225 mg | 0.4–0.5 ml | ≤ 450 mg |
| 10 kg | 200–250 mg | 0.4–0.5 ml | ≤ 500 mg |
| 12 kg | 240–300 mg | 0.5–0.6 ml | ≤ 600 mg |
| 15 kg | 300–375 mg | 0.6–0.8 ml | ≤ 750 mg |
| 18 kg | 360–450 mg | 0.7–0.9 ml | ≤ 900 mg |
| 20 kg | 400–500 mg | 0.8–1.0 ml | ≤ 1000 mg |
| 25 kg | 500–625 mg | 1.0–1.3 ml | ≤ 1250 mg |
| 30 kg | 600–750 mg | 1.2–1.5 ml | ≤ 1500 mg |
⚠️ Warnings
- • Give on empty stomach
- • Give purgative 2 hours after last dose
Nitazoxanide
Nitazoxanide
💊 Giardiasis, amebiasis, cryptosporidiosis
Formulation
Syrup
100mg/5ml
Dose Range
10–20 mg/kg
Max Daily
40 mg/kg
Frequency
Twice daily for 3 days
Max Single
500 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–100 mg | 2.5–5.0 ml | ≤ 200 mg |
| 6 kg | 60–120 mg | 3.0–6.0 ml | ≤ 240 mg |
| 7 kg | 70–140 mg | 3.5–7.0 ml | ≤ 280 mg |
| 8 kg | 80–160 mg | 4.0–8.0 ml | ≤ 320 mg |
| 9 kg | 90–180 mg | 4.5–9.0 ml | ≤ 360 mg |
| 10 kg | 100–200 mg | 5.0–10.0 ml | ≤ 400 mg |
| 12 kg | 120–240 mg | 6.0–12.0 ml | ≤ 480 mg |
| 15 kg | 150–300 mg | 7.5–15.0 ml | ≤ 600 mg |
| 18 kg | 180–360 mg | 9.0–18.0 ml | ≤ 720 mg |
| 20 kg | 200–400 mg | 10.0–20.0 ml | ≤ 800 mg |
| 25 kg | 250–500 mg | 12.5–25.0 ml | ≤ 1000 mg |
| 30 kg | 300–600 mg | 15.0–30.0 ml | ≤ 1200 mg |
⚠️ Warnings
- • Give with food
- • Avoid in diabetics
Paromomycin Sulfate
Paromomycin
💊 Amebiasis, giardiasis, cryptosporidiosis, tapeworms, visceral leishmaniasis
Formulation
Capsule
250mg capsules
Dose Range
10–45 mg/kg
Max Daily
75 mg/kg
Frequency
Varies by indication
Max Single
500 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–225 mg | 0.2–0.9 ml | ≤ 375 mg |
| 6 kg | 60–270 mg | 0.2–1.1 ml | ≤ 450 mg |
| 7 kg | 70–315 mg | 0.3–1.3 ml | ≤ 525 mg |
| 8 kg | 80–360 mg | 0.3–1.4 ml | ≤ 600 mg |
| 9 kg | 90–405 mg | 0.4–1.6 ml | ≤ 675 mg |
| 10 kg | 100–450 mg | 0.4–1.8 ml | ≤ 750 mg |
| 12 kg | 120–540 mg | 0.5–2.2 ml | ≤ 900 mg |
| 15 kg | 150–675 mg | 0.6–2.7 ml | ≤ 1125 mg |
| 18 kg | 180–810 mg | 0.7–3.2 ml | ≤ 1350 mg |
| 20 kg | 200–900 mg | 0.8–3.6 ml | ≤ 1500 mg |
| 25 kg | 250–1125 mg | 1.0–4.5 ml | ≤ 1875 mg |
| 30 kg | 300–1350 mg | 1.2–5.4 ml | ≤ 2250 mg |
⚠️ Warnings
- • Safe in pregnancy and lactation
- • Monitor renal function with prolonged use
Pyrantel Pamoate
Pyrantel Pamoate
💊 Pinworms, hookworms, roundworms, Strongyloides
Formulation
Suspension
250mg/5ml
Dose Range
10–11 mg/kg
Max Daily
11 mg/kg
Frequency
Single dose, repeat after 2 weeks
Max Single
1000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–55 mg | 1.0–1.1 ml | ≤ 55 mg |
| 6 kg | 60–66 mg | 1.2–1.3 ml | ≤ 66 mg |
| 7 kg | 70–77 mg | 1.4–1.5 ml | ≤ 77 mg |
| 8 kg | 80–88 mg | 1.6–1.8 ml | ≤ 88 mg |
| 9 kg | 90–99 mg | 1.8–2.0 ml | ≤ 99 mg |
| 10 kg | 100–110 mg | 2.0–2.2 ml | ≤ 110 mg |
| 12 kg | 120–132 mg | 2.4–2.6 ml | ≤ 132 mg |
| 15 kg | 150–165 mg | 3.0–3.3 ml | ≤ 165 mg |
| 18 kg | 180–198 mg | 3.6–4.0 ml | ≤ 198 mg |
| 20 kg | 200–220 mg | 4.0–4.4 ml | ≤ 220 mg |
| 25 kg | 250–275 mg | 5.0–5.5 ml | ≤ 275 mg |
| 30 kg | 300–330 mg | 6.0–6.6 ml | ≤ 330 mg |
⚠️ Warnings
- • May cause liver dysfunction
- • Give with or without food
Amiodarone
Amiodarone
💊 Ventricular tachycardia, fibrillation, arrhythmias
Formulation
Tablet
200mg tablets
Dose Range
10–20 mg/kg
Max Daily
20 mg/kg
Frequency
Twice daily initially, then once daily
Max Single
1000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–100 mg | 0.3–0.5 ml | ≤ 100 mg |
| 6 kg | 60–120 mg | 0.3–0.6 ml | ≤ 120 mg |
| 7 kg | 70–140 mg | 0.3–0.7 ml | ≤ 140 mg |
| 8 kg | 80–160 mg | 0.4–0.8 ml | ≤ 160 mg |
| 9 kg | 90–180 mg | 0.5–0.9 ml | ≤ 180 mg |
| 10 kg | 100–200 mg | 0.5–1.0 ml | ≤ 200 mg |
| 12 kg | 120–240 mg | 0.6–1.2 ml | ≤ 240 mg |
| 15 kg | 150–300 mg | 0.8–1.5 ml | ≤ 300 mg |
| 18 kg | 180–360 mg | 0.9–1.8 ml | ≤ 360 mg |
| 20 kg | 200–400 mg | 1.0–2.0 ml | ≤ 400 mg |
| 25 kg | 250–500 mg | 1.3–2.5 ml | ≤ 500 mg |
| 30 kg | 300–600 mg | 1.5–3.0 ml | ≤ 600 mg |
⚠️ Warnings
- • Multiple serious adverse effects
- • Monitor thyroid, liver, lung function
- • IV only in hospital
Atropine Sulfate
Atropine
💊 Bradycardia, heart block, preanesthetic medication, anticholinergic
Formulation
Injection
0.6mg/ml
Dose Range
0.01–0.03 mg/kg
Max Daily
0.12 mg/kg
Frequency
Every 4-6 hours as needed
Max Single
1 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 0–0 mg | 0.1–0.3 ml | ≤ 1 mg |
| 6 kg | 0–0 mg | 0.1–0.3 ml | ≤ 1 mg |
| 7 kg | 0–0 mg | 0.1–0.3 ml | ≤ 1 mg |
| 8 kg | 0–0 mg | 0.1–0.4 ml | ≤ 1 mg |
| 9 kg | 0–0 mg | 0.1–0.5 ml | ≤ 1 mg |
| 10 kg | 0–0 mg | 0.2–0.5 ml | ≤ 1 mg |
| 12 kg | 0–0 mg | 0.2–0.6 ml | ≤ 1 mg |
| 15 kg | 0–0 mg | 0.3–0.8 ml | ≤ 2 mg |
| 18 kg | 0–1 mg | 0.3–0.9 ml | ≤ 2 mg |
| 20 kg | 0–1 mg | 0.3–1.0 ml | ≤ 2 mg |
| 25 kg | 0–1 mg | 0.4–1.3 ml | ≤ 3 mg |
| 30 kg | 0–1 mg | 0.5–1.5 ml | ≤ 4 mg |
⚠️ Warnings
- • May cause tachycardia
- • Use with caution in children
- • Monitor for paradoxical excitement
Disopyramide Phosphate
Disopyramide
💊 Prevention of ventricular arrhythmias
Formulation
Capsule
100mg, 150mg capsules
Dose Range
10–30 mg/kg
Max Daily
60 mg/kg
Frequency
Every 6-12 hours
Max Single
200 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–150 mg | 0.5–1.5 ml | ≤ 300 mg |
| 6 kg | 60–180 mg | 0.6–1.8 ml | ≤ 360 mg |
| 7 kg | 70–210 mg | 0.7–2.1 ml | ≤ 420 mg |
| 8 kg | 80–240 mg | 0.8–2.4 ml | ≤ 480 mg |
| 9 kg | 90–270 mg | 0.9–2.7 ml | ≤ 540 mg |
| 10 kg | 100–300 mg | 1.0–3.0 ml | ≤ 600 mg |
| 12 kg | 120–360 mg | 1.2–3.6 ml | ≤ 720 mg |
| 15 kg | 150–450 mg | 1.5–4.5 ml | ≤ 900 mg |
| 18 kg | 180–540 mg | 1.8–5.4 ml | ≤ 1080 mg |
| 20 kg | 200–600 mg | 2.0–6.0 ml | ≤ 1200 mg |
| 25 kg | 250–750 mg | 2.5–7.5 ml | ≤ 1500 mg |
| 30 kg | 300–900 mg | 3.0–9.0 ml | ≤ 1800 mg |
⚠️ Warnings
- • May cause hypotension
- • Use with caution in heart failure
- • Monitor ECG
Lignocaine Hydrochloride
Lidocaine
💊 Ventricular arrhythmias, local anesthesia
Formulation
Injection
2% solution 50ml vial
Dose Range
1–5 mg/kg
Max Daily
5 mg/kg
Frequency
IV bolus every 5 min, then infusion
Max Single
100 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 5–25 mg | 0.2–1.2 ml | ≤ 25 mg |
| 6 kg | 6–30 mg | 0.3–1.4 ml | ≤ 30 mg |
| 7 kg | 7–35 mg | 0.3–1.7 ml | ≤ 35 mg |
| 8 kg | 8–40 mg | 0.4–1.9 ml | ≤ 40 mg |
| 9 kg | 9–45 mg | 0.4–2.1 ml | ≤ 45 mg |
| 10 kg | 10–50 mg | 0.5–2.4 ml | ≤ 50 mg |
| 12 kg | 12–60 mg | 0.6–2.9 ml | ≤ 60 mg |
| 15 kg | 15–75 mg | 0.7–3.6 ml | ≤ 75 mg |
| 18 kg | 18–90 mg | 0.9–4.3 ml | ≤ 90 mg |
| 20 kg | 20–100 mg | 1.0–4.8 ml | ≤ 100 mg |
| 25 kg | 25–125 mg | 1.2–6.0 ml | ≤ 125 mg |
| 30 kg | 30–150 mg | 1.4–7.1 ml | ≤ 150 mg |
⚠️ Warnings
- • Monitor cardiac function
- • Have resuscitation equipment ready
- • Correct electrolyte imbalances
Quinidine Sulfate
Quinidine
💊 Atrial tachycardia, flutter, fibrillation, ventricular tachyarrhythmias
Formulation
Tablet
200mg tablets
Dose Range
2–30 mg/kg
Max Daily
30 mg/kg
Frequency
Every 6-8 hours
Max Single
400 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 10–150 mg | 0.1–0.8 ml | ≤ 150 mg |
| 6 kg | 12–180 mg | 0.1–0.9 ml | ≤ 180 mg |
| 7 kg | 14–210 mg | 0.1–1.1 ml | ≤ 210 mg |
| 8 kg | 16–240 mg | 0.1–1.2 ml | ≤ 240 mg |
| 9 kg | 18–270 mg | 0.1–1.4 ml | ≤ 270 mg |
| 10 kg | 20–300 mg | 0.1–1.5 ml | ≤ 300 mg |
| 12 kg | 24–360 mg | 0.1–1.8 ml | ≤ 360 mg |
| 15 kg | 30–450 mg | 0.1–2.3 ml | ≤ 450 mg |
| 18 kg | 36–540 mg | 0.2–2.7 ml | ≤ 540 mg |
| 20 kg | 40–600 mg | 0.2–3.0 ml | ≤ 600 mg |
| 25 kg | 50–750 mg | 0.3–3.8 ml | ≤ 750 mg |
| 30 kg | 60–900 mg | 0.3–4.5 ml | ≤ 900 mg |
⚠️ Warnings
- • Monitor ECG for QT prolongation
- • Monitor for blood disorders
- • Multiple drug interactions
Verapamil
Verapamil
💊 Control of ventricular rate in PSVT, atrial fibrillation and flutter
Formulation
Tablet
40mg, 80mg tablets
Dose Range
0.1–0.3 mg/kg
Max Daily
8 mg/kg
Frequency
Every 8 hours oral, IV over 2 minutes
Max Single
10 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–2 mg | 0.0–0.0 ml | ≤ 40 mg |
| 6 kg | 1–2 mg | 0.0–0.0 ml | ≤ 48 mg |
| 7 kg | 1–2 mg | 0.0–0.1 ml | ≤ 56 mg |
| 8 kg | 1–2 mg | 0.0–0.1 ml | ≤ 64 mg |
| 9 kg | 1–3 mg | 0.0–0.1 ml | ≤ 72 mg |
| 10 kg | 1–3 mg | 0.0–0.1 ml | ≤ 80 mg |
| 12 kg | 1–4 mg | 0.0–0.1 ml | ≤ 96 mg |
| 15 kg | 2–5 mg | 0.0–0.1 ml | ≤ 120 mg |
| 18 kg | 2–5 mg | 0.0–0.1 ml | ≤ 144 mg |
| 20 kg | 2–6 mg | 0.1–0.1 ml | ≤ 160 mg |
| 25 kg | 3–8 mg | 0.1–0.2 ml | ≤ 200 mg |
| 30 kg | 3–9 mg | 0.1–0.2 ml | ≤ 240 mg |
⚠️ Warnings
- • Contraindicated in cardiogenic shock and heart block
- • Avoid IV in infants with hypotension
Procainamide Hydrochloride
Procainamide
💊 Atrial flutter, fibrillation, paroxysmal atrial tachycardia, ventricular ectopics
Formulation
Tablet
250mg tablets
Dose Range
50–60 mg/kg
Max Daily
60 mg/kg
Frequency
Every 3-6 hours
Max Single
1000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 250–300 mg | 1.0–1.2 ml | ≤ 300 mg |
| 6 kg | 300–360 mg | 1.2–1.4 ml | ≤ 360 mg |
| 7 kg | 350–420 mg | 1.4–1.7 ml | ≤ 420 mg |
| 8 kg | 400–480 mg | 1.6–1.9 ml | ≤ 480 mg |
| 9 kg | 450–540 mg | 1.8–2.2 ml | ≤ 540 mg |
| 10 kg | 500–600 mg | 2.0–2.4 ml | ≤ 600 mg |
| 12 kg | 600–720 mg | 2.4–2.9 ml | ≤ 720 mg |
| 15 kg | 750–900 mg | 3.0–3.6 ml | ≤ 900 mg |
| 18 kg | 900–1080 mg | 3.6–4.3 ml | ≤ 1080 mg |
| 20 kg | 1000–1200 mg | 4.0–4.8 ml | ≤ 1200 mg |
| 25 kg | 1250–1500 mg | 5.0–6.0 ml | ≤ 1500 mg |
| 30 kg | 1500–1800 mg | 6.0–7.2 ml | ≤ 1800 mg |
⚠️ Warnings
- • Monitor for blood dyscrasias
- • May cause lupus-like syndrome
- • Monitor ECG
Propranolol Hydrochloride
Propranolol
💊 Tachyarrhythmias, hypertension, migraine prophylaxis
Formulation
Tablet
10mg, 40mg, 80mg tablets
Dose Range
0.5–1 mg/kg
Max Daily
4 mg/kg
Frequency
Every 6-8 hours oral, IV repeat in 15 min
Max Single
20 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 3–5 mg | 0.3–0.5 ml | ≤ 20 mg |
| 6 kg | 3–6 mg | 0.3–0.6 ml | ≤ 24 mg |
| 7 kg | 4–7 mg | 0.3–0.7 ml | ≤ 28 mg |
| 8 kg | 4–8 mg | 0.4–0.8 ml | ≤ 32 mg |
| 9 kg | 5–9 mg | 0.5–0.9 ml | ≤ 36 mg |
| 10 kg | 5–10 mg | 0.5–1.0 ml | ≤ 40 mg |
| 12 kg | 6–12 mg | 0.6–1.2 ml | ≤ 48 mg |
| 15 kg | 8–15 mg | 0.8–1.5 ml | ≤ 60 mg |
| 18 kg | 9–18 mg | 0.9–1.8 ml | ≤ 72 mg |
| 20 kg | 10–20 mg | 1.0–2.0 ml | ≤ 80 mg |
| 25 kg | 13–25 mg | 1.3–2.5 ml | ≤ 100 mg |
| 30 kg | 15–30 mg | 1.5–3.0 ml | ≤ 120 mg |
⚠️ Warnings
- • Monitor for bronchospasm
- • Use with caution in asthma
- • May mask hypoglycemic symptoms
Phenytoin Sodium
Phenytoin
💊 Ventricular arrhythmias, seizures
Formulation
Injection
50mg/ml in 2ml ampoule
Dose Range
5–10 mg/kg
Max Daily
10 mg/kg
Frequency
Every 12 hours
Max Single
1500 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 25–50 mg | 0.5–1.0 ml | ≤ 50 mg |
| 6 kg | 30–60 mg | 0.6–1.2 ml | ≤ 60 mg |
| 7 kg | 35–70 mg | 0.7–1.4 ml | ≤ 70 mg |
| 8 kg | 40–80 mg | 0.8–1.6 ml | ≤ 80 mg |
| 9 kg | 45–90 mg | 0.9–1.8 ml | ≤ 90 mg |
| 10 kg | 50–100 mg | 1.0–2.0 ml | ≤ 100 mg |
| 12 kg | 60–120 mg | 1.2–2.4 ml | ≤ 120 mg |
| 15 kg | 75–150 mg | 1.5–3.0 ml | ≤ 150 mg |
| 18 kg | 90–180 mg | 1.8–3.6 ml | ≤ 180 mg |
| 20 kg | 100–200 mg | 2.0–4.0 ml | ≤ 200 mg |
| 25 kg | 125–250 mg | 2.5–5.0 ml | ≤ 250 mg |
| 30 kg | 150–300 mg | 3.0–6.0 ml | ≤ 300 mg |
⚠️ Warnings
- • Monitor serum levels
- • Avoid rapid IV injection
- • Monitor for hypotension during IV
Adenosine
Adenosine
💊 Paroxysmal supraventricular tachycardia (PSVT)
Formulation
Injection
6mg/2ml ampoule
Dose Range
0.1–0.3 mg/kg
Max Daily
0.3 mg/kg
Frequency
Rapid IV bolus, may repeat
Max Single
12 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–2 mg | 0.2–0.5 ml | ≤ 2 mg |
| 6 kg | 1–2 mg | 0.2–0.6 ml | ≤ 2 mg |
| 7 kg | 1–2 mg | 0.2–0.7 ml | ≤ 2 mg |
| 8 kg | 1–2 mg | 0.3–0.8 ml | ≤ 2 mg |
| 9 kg | 1–3 mg | 0.3–0.9 ml | ≤ 3 mg |
| 10 kg | 1–3 mg | 0.3–1.0 ml | ≤ 3 mg |
| 12 kg | 1–4 mg | 0.4–1.2 ml | ≤ 4 mg |
| 15 kg | 2–5 mg | 0.5–1.5 ml | ≤ 5 mg |
| 18 kg | 2–5 mg | 0.6–1.8 ml | ≤ 5 mg |
| 20 kg | 2–6 mg | 0.7–2.0 ml | ≤ 6 mg |
| 25 kg | 3–8 mg | 0.8–2.5 ml | ≤ 8 mg |
| 30 kg | 3–9 mg | 1.0–3.0 ml | ≤ 9 mg |
⚠️ Warnings
- • Use with defibrillator support
- • Must be given as rapid bolus
- • Monitor ECG
Amikacin Sulfate
Amikacin
💊 Serious gram-negative infections, MDR tuberculosis
Formulation
Injection
100mg, 250mg, 500mg vials
Dose Range
15–20 mg/kg
Max Daily
20 mg/kg
Frequency
Every 8-12 hours IV/IM
Max Single
1500 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 75–100 mg | 1.5–2.0 ml | ≤ 100 mg |
| 6 kg | 90–120 mg | 1.8–2.4 ml | ≤ 120 mg |
| 7 kg | 105–140 mg | 2.1–2.8 ml | ≤ 140 mg |
| 8 kg | 120–160 mg | 2.4–3.2 ml | ≤ 160 mg |
| 9 kg | 135–180 mg | 2.7–3.6 ml | ≤ 180 mg |
| 10 kg | 150–200 mg | 3.0–4.0 ml | ≤ 200 mg |
| 12 kg | 180–240 mg | 3.6–4.8 ml | ≤ 240 mg |
| 15 kg | 225–300 mg | 4.5–6.0 ml | ≤ 300 mg |
| 18 kg | 270–360 mg | 5.4–7.2 ml | ≤ 360 mg |
| 20 kg | 300–400 mg | 6.0–8.0 ml | ≤ 400 mg |
| 25 kg | 375–500 mg | 7.5–10.0 ml | ≤ 500 mg |
| 30 kg | 450–600 mg | 9.0–12.0 ml | ≤ 600 mg |
⚠️ Warnings
- • Monitor serum levels
- • Monitor renal function
- • Monitor for ototoxicity and nephrotoxicity
Kanamycin Sulfate
Kanamycin
💊 Serious gram-negative infections, MDR tuberculosis
Formulation
Injection
500mg, 1gm vials
Dose Range
15–30 mg/kg
Max Daily
30 mg/kg
Frequency
Every 8-12 hours IV/IM
Max Single
1000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 75–150 mg | 0.1–0.3 ml | ≤ 150 mg |
| 6 kg | 90–180 mg | 0.2–0.4 ml | ≤ 180 mg |
| 7 kg | 105–210 mg | 0.2–0.4 ml | ≤ 210 mg |
| 8 kg | 120–240 mg | 0.2–0.5 ml | ≤ 240 mg |
| 9 kg | 135–270 mg | 0.3–0.5 ml | ≤ 270 mg |
| 10 kg | 150–300 mg | 0.3–0.6 ml | ≤ 300 mg |
| 12 kg | 180–360 mg | 0.4–0.7 ml | ≤ 360 mg |
| 15 kg | 225–450 mg | 0.5–0.9 ml | ≤ 450 mg |
| 18 kg | 270–540 mg | 0.5–1.1 ml | ≤ 540 mg |
| 20 kg | 300–600 mg | 0.6–1.2 ml | ≤ 600 mg |
| 25 kg | 375–750 mg | 0.8–1.5 ml | ≤ 750 mg |
| 30 kg | 450–900 mg | 0.9–1.8 ml | ≤ 900 mg |
⚠️ Warnings
- • Monitor serum levels
- • Monitor renal and auditory function
- • Use with caution in renal impairment
Netilmicin Sulfate
Netilmicin
💊 Serious gram-negative infections
Formulation
Injection
10mg, 25mg, 50mg, 100mg/ml
Dose Range
5–10 mg/kg
Max Daily
10 mg/kg
Frequency
Every 8-12 hours IV/IM
Max Single
200 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 25–50 mg | 0.5–1.0 ml | ≤ 50 mg |
| 6 kg | 30–60 mg | 0.6–1.2 ml | ≤ 60 mg |
| 7 kg | 35–70 mg | 0.7–1.4 ml | ≤ 70 mg |
| 8 kg | 40–80 mg | 0.8–1.6 ml | ≤ 80 mg |
| 9 kg | 45–90 mg | 0.9–1.8 ml | ≤ 90 mg |
| 10 kg | 50–100 mg | 1.0–2.0 ml | ≤ 100 mg |
| 12 kg | 60–120 mg | 1.2–2.4 ml | ≤ 120 mg |
| 15 kg | 75–150 mg | 1.5–3.0 ml | ≤ 150 mg |
| 18 kg | 90–180 mg | 1.8–3.6 ml | ≤ 180 mg |
| 20 kg | 100–200 mg | 2.0–4.0 ml | ≤ 200 mg |
| 25 kg | 125–250 mg | 2.5–5.0 ml | ≤ 250 mg |
| 30 kg | 150–300 mg | 3.0–6.0 ml | ≤ 300 mg |
⚠️ Warnings
- • Monitor serum levels
- • Monitor renal function
- • Adjust dose in renal impairment
Streptomycin Sulphate
Streptomycin
💊 Tuberculosis, tularemia, plague, brucellosis
Formulation
Injection
0.75gm, 1gm vials
Dose Range
20–40 mg/kg
Max Daily
40 mg/kg
Frequency
Every 12 hours or single daily dose IM
Max Single
1000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 100–200 mg | 0.1–0.3 ml | ≤ 200 mg |
| 6 kg | 120–240 mg | 0.2–0.3 ml | ≤ 240 mg |
| 7 kg | 140–280 mg | 0.2–0.4 ml | ≤ 280 mg |
| 8 kg | 160–320 mg | 0.2–0.4 ml | ≤ 320 mg |
| 9 kg | 180–360 mg | 0.2–0.5 ml | ≤ 360 mg |
| 10 kg | 200–400 mg | 0.3–0.5 ml | ≤ 400 mg |
| 12 kg | 240–480 mg | 0.3–0.6 ml | ≤ 480 mg |
| 15 kg | 300–600 mg | 0.4–0.8 ml | ≤ 600 mg |
| 18 kg | 360–720 mg | 0.5–1.0 ml | ≤ 720 mg |
| 20 kg | 400–800 mg | 0.5–1.1 ml | ≤ 800 mg |
| 25 kg | 500–1000 mg | 0.7–1.3 ml | ≤ 1000 mg |
| 30 kg | 600–1200 mg | 0.8–1.6 ml | ≤ 1200 mg |
⚠️ Warnings
- • Monitor auditory function
- • Monitor renal function
- • Use with caution in renal impairment
Tobramycin
Tobramycin
💊 Serious gram-negative infections, Pseudomonas infections, cystic fibrosis
Formulation
Injection
20mg, 40mg, 80mg in 2ml vials
Dose Range
6–7.5 mg/kg
Max Daily
7.5 mg/kg
Frequency
Every 8-12 hours IV/IM
Max Single
240 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 30–38 mg | 0.8–0.9 ml | ≤ 38 mg |
| 6 kg | 36–45 mg | 0.9–1.1 ml | ≤ 45 mg |
| 7 kg | 42–53 mg | 1.1–1.3 ml | ≤ 53 mg |
| 8 kg | 48–60 mg | 1.2–1.5 ml | ≤ 60 mg |
| 9 kg | 54–68 mg | 1.4–1.7 ml | ≤ 68 mg |
| 10 kg | 60–75 mg | 1.5–1.9 ml | ≤ 75 mg |
| 12 kg | 72–90 mg | 1.8–2.3 ml | ≤ 90 mg |
| 15 kg | 90–113 mg | 2.3–2.8 ml | ≤ 113 mg |
| 18 kg | 108–135 mg | 2.7–3.4 ml | ≤ 135 mg |
| 20 kg | 120–150 mg | 3.0–3.8 ml | ≤ 150 mg |
| 25 kg | 150–188 mg | 3.8–4.7 ml | ≤ 188 mg |
| 30 kg | 180–225 mg | 4.5–5.6 ml | ≤ 225 mg |
⚠️ Warnings
- • Monitor serum levels
- • Monitor renal function
- • Monitor for ototoxicity
Cefaclor
Cefaclor
💊 Respiratory infections, otitis media, skin infections, UTIs
Formulation
Suspension
125mg, 187mg per 5ml
Dose Range
20–40 mg/kg
Max Daily
40 mg/kg
Frequency
Every 8 hours
Max Single
500 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 100–200 mg | 4.0–8.0 ml | ≤ 200 mg |
| 6 kg | 120–240 mg | 4.8–9.6 ml | ≤ 240 mg |
| 7 kg | 140–280 mg | 5.6–11.2 ml | ≤ 280 mg |
| 8 kg | 160–320 mg | 6.4–12.8 ml | ≤ 320 mg |
| 9 kg | 180–360 mg | 7.2–14.4 ml | ≤ 360 mg |
| 10 kg | 200–400 mg | 8.0–16.0 ml | ≤ 400 mg |
| 12 kg | 240–480 mg | 9.6–19.2 ml | ≤ 480 mg |
| 15 kg | 300–600 mg | 12.0–24.0 ml | ≤ 600 mg |
| 18 kg | 360–720 mg | 14.4–28.8 ml | ≤ 720 mg |
| 20 kg | 400–800 mg | 16.0–32.0 ml | ≤ 800 mg |
| 25 kg | 500–1000 mg | 20.0–40.0 ml | ≤ 1000 mg |
| 30 kg | 600–1200 mg | 24.0–48.0 ml | ≤ 1200 mg |
⚠️ Warnings
- • Monitor for allergic reactions
- • May cause diarrhea
- • Complete full course
Cefadroxil
Cefadroxil
💊 Skin infections, pharyngitis, UTIs
Formulation
Suspension
125mg, 250mg per 5ml
Dose Range
30–30 mg/kg
Max Daily
30 mg/kg
Frequency
Every 12 hours
Max Single
1000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 150–150 mg | 6.0–6.0 ml | ≤ 150 mg |
| 6 kg | 180–180 mg | 7.2–7.2 ml | ≤ 180 mg |
| 7 kg | 210–210 mg | 8.4–8.4 ml | ≤ 210 mg |
| 8 kg | 240–240 mg | 9.6–9.6 ml | ≤ 240 mg |
| 9 kg | 270–270 mg | 10.8–10.8 ml | ≤ 270 mg |
| 10 kg | 300–300 mg | 12.0–12.0 ml | ≤ 300 mg |
| 12 kg | 360–360 mg | 14.4–14.4 ml | ≤ 360 mg |
| 15 kg | 450–450 mg | 18.0–18.0 ml | ≤ 450 mg |
| 18 kg | 540–540 mg | 21.6–21.6 ml | ≤ 540 mg |
| 20 kg | 600–600 mg | 24.0–24.0 ml | ≤ 600 mg |
| 25 kg | 750–750 mg | 30.0–30.0 ml | ≤ 750 mg |
| 30 kg | 900–900 mg | 36.0–36.0 ml | ≤ 900 mg |
⚠️ Warnings
- • Monitor for allergic reactions
- • Use with caution in penicillin allergy
Cefazolin Sodium
Cefazolin
💊 Surgical prophylaxis, respiratory infections, bone infections
Formulation
Injection
250mg, 500mg, 1gm vials
Dose Range
50–100 mg/kg
Max Daily
100 mg/kg
Frequency
Every 6 hours IV/IM
Max Single
1000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 250–500 mg | 0.5–1.0 ml | ≤ 500 mg |
| 6 kg | 300–600 mg | 0.6–1.2 ml | ≤ 600 mg |
| 7 kg | 350–700 mg | 0.7–1.4 ml | ≤ 700 mg |
| 8 kg | 400–800 mg | 0.8–1.6 ml | ≤ 800 mg |
| 9 kg | 450–900 mg | 0.9–1.8 ml | ≤ 900 mg |
| 10 kg | 500–1000 mg | 1.0–2.0 ml | ≤ 1000 mg |
| 12 kg | 600–1200 mg | 1.2–2.4 ml | ≤ 1200 mg |
| 15 kg | 750–1500 mg | 1.5–3.0 ml | ≤ 1500 mg |
| 18 kg | 900–1800 mg | 1.8–3.6 ml | ≤ 1800 mg |
| 20 kg | 1000–2000 mg | 2.0–4.0 ml | ≤ 2000 mg |
| 25 kg | 1250–2500 mg | 2.5–5.0 ml | ≤ 2500 mg |
| 30 kg | 1500–3000 mg | 3.0–6.0 ml | ≤ 3000 mg |
⚠️ Warnings
- • Safety not established in newborns
- • Monitor for allergic reactions
Cefdinir
Cefdinir
💊 Respiratory infections, otitis media, skin infections
Formulation
Suspension
125mg/5ml
Dose Range
14–14 mg/kg
Max Daily
14 mg/kg
Frequency
Once or twice daily
Max Single
600 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 70–70 mg | 2.8–2.8 ml | ≤ 70 mg |
| 6 kg | 84–84 mg | 3.4–3.4 ml | ≤ 84 mg |
| 7 kg | 98–98 mg | 3.9–3.9 ml | ≤ 98 mg |
| 8 kg | 112–112 mg | 4.5–4.5 ml | ≤ 112 mg |
| 9 kg | 126–126 mg | 5.0–5.0 ml | ≤ 126 mg |
| 10 kg | 140–140 mg | 5.6–5.6 ml | ≤ 140 mg |
| 12 kg | 168–168 mg | 6.7–6.7 ml | ≤ 168 mg |
| 15 kg | 210–210 mg | 8.4–8.4 ml | ≤ 210 mg |
| 18 kg | 252–252 mg | 10.1–10.1 ml | ≤ 252 mg |
| 20 kg | 280–280 mg | 11.2–11.2 ml | ≤ 280 mg |
| 25 kg | 350–350 mg | 14.0–14.0 ml | ≤ 350 mg |
| 30 kg | 420–420 mg | 16.8–16.8 ml | ≤ 420 mg |
⚠️ Warnings
- • Monitor for allergic reactions
- • May cause false positive Coombs test
Cefditoren Pivoxil
Cefditoren
💊 Group A Streptococcus, respiratory infections, skin infections
Formulation
Tablet
30mg, 50mg DT tablets
Dose Range
3–3 mg/kg
Max Daily
9 mg/kg
Frequency
Every 8 hours for 5 days
Max Single
200 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 15–15 mg | 0.5–0.5 ml | ≤ 45 mg |
| 6 kg | 18–18 mg | 0.6–0.6 ml | ≤ 54 mg |
| 7 kg | 21–21 mg | 0.7–0.7 ml | ≤ 63 mg |
| 8 kg | 24–24 mg | 0.8–0.8 ml | ≤ 72 mg |
| 9 kg | 27–27 mg | 0.9–0.9 ml | ≤ 81 mg |
| 10 kg | 30–30 mg | 1.0–1.0 ml | ≤ 90 mg |
| 12 kg | 36–36 mg | 1.2–1.2 ml | ≤ 108 mg |
| 15 kg | 45–45 mg | 1.5–1.5 ml | ≤ 135 mg |
| 18 kg | 54–54 mg | 1.8–1.8 ml | ≤ 162 mg |
| 20 kg | 60–60 mg | 2.0–2.0 ml | ≤ 180 mg |
| 25 kg | 75–75 mg | 2.5–2.5 ml | ≤ 225 mg |
| 30 kg | 90–90 mg | 3.0–3.0 ml | ≤ 270 mg |
⚠️ Warnings
- • Monitor for allergic reactions
- • May cause GI disturbances
Cefepime
Cefepime
💊 Pneumonia, febrile neutropenia, serious infections, meningitis
Formulation
Injection
250mg, 500mg, 1gm vials
Dose Range
100–150 mg/kg
Max Daily
150 mg/kg
Frequency
Every 12 hours IV
Max Single
2000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 500–750 mg | 1.0–1.5 ml | ≤ 750 mg |
| 6 kg | 600–900 mg | 1.2–1.8 ml | ≤ 900 mg |
| 7 kg | 700–1050 mg | 1.4–2.1 ml | ≤ 1050 mg |
| 8 kg | 800–1200 mg | 1.6–2.4 ml | ≤ 1200 mg |
| 9 kg | 900–1350 mg | 1.8–2.7 ml | ≤ 1350 mg |
| 10 kg | 1000–1500 mg | 2.0–3.0 ml | ≤ 1500 mg |
| 12 kg | 1200–1800 mg | 2.4–3.6 ml | ≤ 1800 mg |
| 15 kg | 1500–2250 mg | 3.0–4.5 ml | ≤ 2250 mg |
| 18 kg | 1800–2700 mg | 3.6–5.4 ml | ≤ 2700 mg |
| 20 kg | 2000–3000 mg | 4.0–6.0 ml | ≤ 3000 mg |
| 25 kg | 2500–3750 mg | 5.0–7.5 ml | ≤ 3750 mg |
| 30 kg | 3000–4500 mg | 6.0–9.0 ml | ≤ 4500 mg |
⚠️ Warnings
- • Monitor for neurotoxicity
- • Monitor renal function
- • Use with caution in penicillin allergy
Cefoperazone
Cefoperazone
💊 Serious gram-negative and anaerobic infections, ESBL organisms
Formulation
Injection
1gm, 2gm vials
Dose Range
100–150 mg/kg
Max Daily
150 mg/kg
Frequency
Every 8-12 hours IV
Max Single
4000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 500–750 mg | 0.5–0.8 ml | ≤ 750 mg |
| 6 kg | 600–900 mg | 0.6–0.9 ml | ≤ 900 mg |
| 7 kg | 700–1050 mg | 0.7–1.1 ml | ≤ 1050 mg |
| 8 kg | 800–1200 mg | 0.8–1.2 ml | ≤ 1200 mg |
| 9 kg | 900–1350 mg | 0.9–1.4 ml | ≤ 1350 mg |
| 10 kg | 1000–1500 mg | 1.0–1.5 ml | ≤ 1500 mg |
| 12 kg | 1200–1800 mg | 1.2–1.8 ml | ≤ 1800 mg |
| 15 kg | 1500–2250 mg | 1.5–2.3 ml | ≤ 2250 mg |
| 18 kg | 1800–2700 mg | 1.8–2.7 ml | ≤ 2700 mg |
| 20 kg | 2000–3000 mg | 2.0–3.0 ml | ≤ 3000 mg |
| 25 kg | 2500–3750 mg | 2.5–3.8 ml | ≤ 3750 mg |
| 30 kg | 3000–4500 mg | 3.0–4.5 ml | ≤ 4500 mg |
⚠️ Warnings
- • Does not cross blood-brain barrier
- • Monitor for bleeding
- • May cause disulfiram-like reaction with alcohol
Cefoperazone with Sulbactam
Cefoperazone/Sulbactam
💊 ESBL organisms, serious gram-negative and anaerobic infections
Formulation
Injection
1gm/0.5gm, 2gm/1gm vials
Dose Range
40–160 mg/kg
Max Daily
160 mg/kg
Frequency
Every 6-12 hours IV
Max Single
4000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 200–800 mg | 0.2–0.8 ml | ≤ 800 mg |
| 6 kg | 240–960 mg | 0.2–1.0 ml | ≤ 960 mg |
| 7 kg | 280–1120 mg | 0.3–1.1 ml | ≤ 1120 mg |
| 8 kg | 320–1280 mg | 0.3–1.3 ml | ≤ 1280 mg |
| 9 kg | 360–1440 mg | 0.4–1.4 ml | ≤ 1440 mg |
| 10 kg | 400–1600 mg | 0.4–1.6 ml | ≤ 1600 mg |
| 12 kg | 480–1920 mg | 0.5–1.9 ml | ≤ 1920 mg |
| 15 kg | 600–2400 mg | 0.6–2.4 ml | ≤ 2400 mg |
| 18 kg | 720–2880 mg | 0.7–2.9 ml | ≤ 2880 mg |
| 20 kg | 800–3200 mg | 0.8–3.2 ml | ≤ 3200 mg |
| 25 kg | 1000–4000 mg | 1.0–4.0 ml | ≤ 4000 mg |
| 30 kg | 1200–4800 mg | 1.2–4.8 ml | ≤ 4800 mg |
⚠️ Warnings
- • Monitor for bleeding
- • Sulbactam max 80mg/kg/day
- • Monitor liver function
Cefotaxime Sodium
Cefotaxime
💊 Meningitis, serious infections, gonorrhea
Formulation
Injection
250mg, 500mg, 1gm vials
Dose Range
100–200 mg/kg
Max Daily
200 mg/kg
Frequency
Every 6-8 hours IV/IM
Max Single
2000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 500–1000 mg | 1.0–2.0 ml | ≤ 1000 mg |
| 6 kg | 600–1200 mg | 1.2–2.4 ml | ≤ 1200 mg |
| 7 kg | 700–1400 mg | 1.4–2.8 ml | ≤ 1400 mg |
| 8 kg | 800–1600 mg | 1.6–3.2 ml | ≤ 1600 mg |
| 9 kg | 900–1800 mg | 1.8–3.6 ml | ≤ 1800 mg |
| 10 kg | 1000–2000 mg | 2.0–4.0 ml | ≤ 2000 mg |
| 12 kg | 1200–2400 mg | 2.4–4.8 ml | ≤ 2400 mg |
| 15 kg | 1500–3000 mg | 3.0–6.0 ml | ≤ 3000 mg |
| 18 kg | 1800–3600 mg | 3.6–7.2 ml | ≤ 3600 mg |
| 20 kg | 2000–4000 mg | 4.0–8.0 ml | ≤ 4000 mg |
| 25 kg | 2500–5000 mg | 5.0–10.0 ml | ≤ 5000 mg |
| 30 kg | 3000–6000 mg | 6.0–12.0 ml | ≤ 6000 mg |
⚠️ Warnings
- • Crosses blood-brain barrier
- • Monitor for allergic reactions
Cefpirome
Cefpirome
💊 Sepsis, skin infections, immunocompromised infections, severe pneumonia
Formulation
Injection
1gm, 2gm vials
Dose Range
30–60 mg/kg
Max Daily
60 mg/kg
Frequency
Every 12 hours IV
Max Single
2000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 150–300 mg | 0.1–0.3 ml | ≤ 300 mg |
| 6 kg | 180–360 mg | 0.2–0.4 ml | ≤ 360 mg |
| 7 kg | 210–420 mg | 0.2–0.4 ml | ≤ 420 mg |
| 8 kg | 240–480 mg | 0.2–0.5 ml | ≤ 480 mg |
| 9 kg | 270–540 mg | 0.3–0.5 ml | ≤ 540 mg |
| 10 kg | 300–600 mg | 0.3–0.6 ml | ≤ 600 mg |
| 12 kg | 360–720 mg | 0.4–0.7 ml | ≤ 720 mg |
| 15 kg | 450–900 mg | 0.5–0.9 ml | ≤ 900 mg |
| 18 kg | 540–1080 mg | 0.5–1.1 ml | ≤ 1080 mg |
| 20 kg | 600–1200 mg | 0.6–1.2 ml | ≤ 1200 mg |
| 25 kg | 750–1500 mg | 0.8–1.5 ml | ≤ 1500 mg |
| 30 kg | 900–1800 mg | 0.9–1.8 ml | ≤ 1800 mg |
⚠️ Warnings
- • Monitor for superinfection
- • Use with caution in renal impairment
Cefpodoxime Proxetil
Cefpodoxime
💊 Respiratory infections, otitis media, skin infections, UTIs, enteric fever
Formulation
Suspension
50mg, 100mg per 5ml
Dose Range
10–10 mg/kg
Max Daily
10 mg/kg
Frequency
Every 12 hours with food
Max Single
400 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–50 mg | 2.5–2.5 ml | ≤ 50 mg |
| 6 kg | 60–60 mg | 3.0–3.0 ml | ≤ 60 mg |
| 7 kg | 70–70 mg | 3.5–3.5 ml | ≤ 70 mg |
| 8 kg | 80–80 mg | 4.0–4.0 ml | ≤ 80 mg |
| 9 kg | 90–90 mg | 4.5–4.5 ml | ≤ 90 mg |
| 10 kg | 100–100 mg | 5.0–5.0 ml | ≤ 100 mg |
| 12 kg | 120–120 mg | 6.0–6.0 ml | ≤ 120 mg |
| 15 kg | 150–150 mg | 7.5–7.5 ml | ≤ 150 mg |
| 18 kg | 180–180 mg | 9.0–9.0 ml | ≤ 180 mg |
| 20 kg | 200–200 mg | 10.0–10.0 ml | ≤ 200 mg |
| 25 kg | 250–250 mg | 12.5–12.5 ml | ≤ 250 mg |
| 30 kg | 300–300 mg | 15.0–15.0 ml | ≤ 300 mg |
⚠️ Warnings
- • Give with food for better absorption
- • Monitor for allergic reactions
Cefprozil
Cefprozil
💊 Respiratory infections, otitis media, skin infections
Formulation
Suspension
125mg, 250mg per 5ml
Dose Range
15–30 mg/kg
Max Daily
30 mg/kg
Frequency
Every 12 hours
Max Single
500 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 75–150 mg | 3.0–6.0 ml | ≤ 150 mg |
| 6 kg | 90–180 mg | 3.6–7.2 ml | ≤ 180 mg |
| 7 kg | 105–210 mg | 4.2–8.4 ml | ≤ 210 mg |
| 8 kg | 120–240 mg | 4.8–9.6 ml | ≤ 240 mg |
| 9 kg | 135–270 mg | 5.4–10.8 ml | ≤ 270 mg |
| 10 kg | 150–300 mg | 6.0–12.0 ml | ≤ 300 mg |
| 12 kg | 180–360 mg | 7.2–14.4 ml | ≤ 360 mg |
| 15 kg | 225–450 mg | 9.0–18.0 ml | ≤ 450 mg |
| 18 kg | 270–540 mg | 10.8–21.6 ml | ≤ 540 mg |
| 20 kg | 300–600 mg | 12.0–24.0 ml | ≤ 600 mg |
| 25 kg | 375–750 mg | 15.0–30.0 ml | ≤ 750 mg |
| 30 kg | 450–900 mg | 18.0–36.0 ml | ≤ 900 mg |
⚠️ Warnings
- • Avoid below 6 months
- • Monitor for allergic reactions
Ceftazidime
Ceftazidime
💊 Pseudomonas infections, meningitis, serious gram-negative infections
Formulation
Injection
250mg, 500mg, 1gm vials
Dose Range
100–150 mg/kg
Max Daily
150 mg/kg
Frequency
Every 8 hours IV/IM
Max Single
2000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 500–750 mg | 1.0–1.5 ml | ≤ 750 mg |
| 6 kg | 600–900 mg | 1.2–1.8 ml | ≤ 900 mg |
| 7 kg | 700–1050 mg | 1.4–2.1 ml | ≤ 1050 mg |
| 8 kg | 800–1200 mg | 1.6–2.4 ml | ≤ 1200 mg |
| 9 kg | 900–1350 mg | 1.8–2.7 ml | ≤ 1350 mg |
| 10 kg | 1000–1500 mg | 2.0–3.0 ml | ≤ 1500 mg |
| 12 kg | 1200–1800 mg | 2.4–3.6 ml | ≤ 1800 mg |
| 15 kg | 1500–2250 mg | 3.0–4.5 ml | ≤ 2250 mg |
| 18 kg | 1800–2700 mg | 3.6–5.4 ml | ≤ 2700 mg |
| 20 kg | 2000–3000 mg | 4.0–6.0 ml | ≤ 3000 mg |
| 25 kg | 2500–3750 mg | 5.0–7.5 ml | ≤ 3750 mg |
| 30 kg | 3000–4500 mg | 6.0–9.0 ml | ≤ 4500 mg |
⚠️ Warnings
- • Specific for Pseudomonas aeruginosa
- • Monitor renal function
Ceftibuten
Ceftibuten
💊 Respiratory infections, otitis media, UTIs
Formulation
Capsule
400mg capsules
Dose Range
9–9 mg/kg
Max Daily
9 mg/kg
Frequency
Once daily
Max Single
400 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 45–45 mg | 0.1–0.1 ml | ≤ 45 mg |
| 6 kg | 54–54 mg | 0.1–0.1 ml | ≤ 54 mg |
| 7 kg | 63–63 mg | 0.2–0.2 ml | ≤ 63 mg |
| 8 kg | 72–72 mg | 0.2–0.2 ml | ≤ 72 mg |
| 9 kg | 81–81 mg | 0.2–0.2 ml | ≤ 81 mg |
| 10 kg | 90–90 mg | 0.2–0.2 ml | ≤ 90 mg |
| 12 kg | 108–108 mg | 0.3–0.3 ml | ≤ 108 mg |
| 15 kg | 135–135 mg | 0.3–0.3 ml | ≤ 135 mg |
| 18 kg | 162–162 mg | 0.4–0.4 ml | ≤ 162 mg |
| 20 kg | 180–180 mg | 0.5–0.5 ml | ≤ 180 mg |
| 25 kg | 225–225 mg | 0.6–0.6 ml | ≤ 225 mg |
| 30 kg | 270–270 mg | 0.7–0.7 ml | ≤ 270 mg |
⚠️ Warnings
- • Monitor for allergic reactions
- • Use with caution in penicillin allergy
Ceftizoxime
Ceftizoxime
💊 Serious infections, respiratory infections, UTIs, meningitis
Formulation
Injection
250mg, 1gm vials
Dose Range
100–200 mg/kg
Max Daily
200 mg/kg
Frequency
Every 6-8 hours IV/IM
Max Single
2000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 500–1000 mg | 1.0–2.0 ml | ≤ 1000 mg |
| 6 kg | 600–1200 mg | 1.2–2.4 ml | ≤ 1200 mg |
| 7 kg | 700–1400 mg | 1.4–2.8 ml | ≤ 1400 mg |
| 8 kg | 800–1600 mg | 1.6–3.2 ml | ≤ 1600 mg |
| 9 kg | 900–1800 mg | 1.8–3.6 ml | ≤ 1800 mg |
| 10 kg | 1000–2000 mg | 2.0–4.0 ml | ≤ 2000 mg |
| 12 kg | 1200–2400 mg | 2.4–4.8 ml | ≤ 2400 mg |
| 15 kg | 1500–3000 mg | 3.0–6.0 ml | ≤ 3000 mg |
| 18 kg | 1800–3600 mg | 3.6–7.2 ml | ≤ 3600 mg |
| 20 kg | 2000–4000 mg | 4.0–8.0 ml | ≤ 4000 mg |
| 25 kg | 2500–5000 mg | 5.0–10.0 ml | ≤ 5000 mg |
| 30 kg | 3000–6000 mg | 6.0–12.0 ml | ≤ 6000 mg |
⚠️ Warnings
- • Monitor for allergic reactions
- • Use with caution in renal impairment
Ceftriaxone Sodium
Ceftriaxone
💊 Meningitis, gonorrhea, serious infections, surgical prophylaxis
Formulation
Injection
125mg, 250mg, 500mg, 1gm vials
Dose Range
50–100 mg/kg
Max Daily
100 mg/kg
Frequency
Once or twice daily IV/IM
Max Single
4000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 250–500 mg | 1.0–2.0 ml | ≤ 500 mg |
| 6 kg | 300–600 mg | 1.2–2.4 ml | ≤ 600 mg |
| 7 kg | 350–700 mg | 1.4–2.8 ml | ≤ 700 mg |
| 8 kg | 400–800 mg | 1.6–3.2 ml | ≤ 800 mg |
| 9 kg | 450–900 mg | 1.8–3.6 ml | ≤ 900 mg |
| 10 kg | 500–1000 mg | 2.0–4.0 ml | ≤ 1000 mg |
| 12 kg | 600–1200 mg | 2.4–4.8 ml | ≤ 1200 mg |
| 15 kg | 750–1500 mg | 3.0–6.0 ml | ≤ 1500 mg |
| 18 kg | 900–1800 mg | 3.6–7.2 ml | ≤ 1800 mg |
| 20 kg | 1000–2000 mg | 4.0–8.0 ml | ≤ 2000 mg |
| 25 kg | 1250–2500 mg | 5.0–10.0 ml | ≤ 2500 mg |
| 30 kg | 1500–3000 mg | 6.0–12.0 ml | ≤ 3000 mg |
⚠️ Warnings
- • Crosses blood-brain barrier
- • Monitor for biliary sludge
- • IM injection painful
Ceftriaxone with Sulbactam
Ceftriaxone/Sulbactam
💊 Serious infections, ESBL organisms, respiratory infections
Formulation
Injection
1000mg/500mg, 500mg/250mg vials
Dose Range
75–150 mg/kg
Max Daily
150 mg/kg
Frequency
Every 12 hours IV
Max Single
1500 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 375–750 mg | 0.3–0.5 ml | ≤ 750 mg |
| 6 kg | 450–900 mg | 0.3–0.6 ml | ≤ 900 mg |
| 7 kg | 525–1050 mg | 0.3–0.7 ml | ≤ 1050 mg |
| 8 kg | 600–1200 mg | 0.4–0.8 ml | ≤ 1200 mg |
| 9 kg | 675–1350 mg | 0.5–0.9 ml | ≤ 1350 mg |
| 10 kg | 750–1500 mg | 0.5–1.0 ml | ≤ 1500 mg |
| 12 kg | 900–1800 mg | 0.6–1.2 ml | ≤ 1800 mg |
| 15 kg | 1125–2250 mg | 0.8–1.5 ml | ≤ 2250 mg |
| 18 kg | 1350–2700 mg | 0.9–1.8 ml | ≤ 2700 mg |
| 20 kg | 1500–3000 mg | 1.0–2.0 ml | ≤ 3000 mg |
| 25 kg | 1875–3750 mg | 1.3–2.5 ml | ≤ 3750 mg |
| 30 kg | 2250–4500 mg | 1.5–3.0 ml | ≤ 4500 mg |
⚠️ Warnings
- • Monitor for bleeding
- • Monitor liver function
Cefuroxime Axetil
Cefuroxime
💊 Respiratory infections, meningitis, UTIs, skin infections, enteric fever
Formulation
Suspension
125mg per 5ml
Dose Range
20–40 mg/kg
Max Daily
150 mg/kg
Frequency
Every 6-8 hours IV/IM, every 12 hours oral
Max Single
1500 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 100–200 mg | 4.0–8.0 ml | ≤ 750 mg |
| 6 kg | 120–240 mg | 4.8–9.6 ml | ≤ 900 mg |
| 7 kg | 140–280 mg | 5.6–11.2 ml | ≤ 1050 mg |
| 8 kg | 160–320 mg | 6.4–12.8 ml | ≤ 1200 mg |
| 9 kg | 180–360 mg | 7.2–14.4 ml | ≤ 1350 mg |
| 10 kg | 200–400 mg | 8.0–16.0 ml | ≤ 1500 mg |
| 12 kg | 240–480 mg | 9.6–19.2 ml | ≤ 1800 mg |
| 15 kg | 300–600 mg | 12.0–24.0 ml | ≤ 2250 mg |
| 18 kg | 360–720 mg | 14.4–28.8 ml | ≤ 2700 mg |
| 20 kg | 400–800 mg | 16.0–32.0 ml | ≤ 3000 mg |
| 25 kg | 500–1000 mg | 20.0–40.0 ml | ≤ 3750 mg |
| 30 kg | 600–1200 mg | 24.0–48.0 ml | ≤ 4500 mg |
⚠️ Warnings
- • Oral form: give with or after food
- • Monitor for allergic reactions
Cephalexin
Cephalexin
💊 Skin infections, pharyngitis, otitis media, respiratory infections, UTIs
Formulation
Suspension
125mg, 250mg per 5ml
Dose Range
25–100 mg/kg
Max Daily
100 mg/kg
Frequency
Every 6-8 hours
Max Single
500 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 125–500 mg | 5.0–20.0 ml | ≤ 500 mg |
| 6 kg | 150–600 mg | 6.0–24.0 ml | ≤ 600 mg |
| 7 kg | 175–700 mg | 7.0–28.0 ml | ≤ 700 mg |
| 8 kg | 200–800 mg | 8.0–32.0 ml | ≤ 800 mg |
| 9 kg | 225–900 mg | 9.0–36.0 ml | ≤ 900 mg |
| 10 kg | 250–1000 mg | 10.0–40.0 ml | ≤ 1000 mg |
| 12 kg | 300–1200 mg | 12.0–48.0 ml | ≤ 1200 mg |
| 15 kg | 375–1500 mg | 15.0–60.0 ml | ≤ 1500 mg |
| 18 kg | 450–1800 mg | 18.0–72.0 ml | ≤ 1800 mg |
| 20 kg | 500–2000 mg | 20.0–80.0 ml | ≤ 2000 mg |
| 25 kg | 625–2500 mg | 25.0–100.0 ml | ≤ 2500 mg |
| 30 kg | 750–3000 mg | 30.0–120.0 ml | ≤ 3000 mg |
⚠️ Warnings
- • Monitor for allergic reactions
- • May cause false positive Coombs test
Norfloxacin
Norfloxacin
💊 UTI
Formulation
Tablet
Standard tablet
Dose Range
10–15 mg/kg
Max Daily
N/A
Frequency
Every 12 hours
Max Single
400 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–75 mg | 50.0–75.0 ml | — |
| 6 kg | 60–90 mg | 60.0–90.0 ml | — |
| 7 kg | 70–105 mg | 70.0–105.0 ml | — |
| 8 kg | 80–120 mg | 80.0–120.0 ml | — |
| 9 kg | 90–135 mg | 90.0–135.0 ml | — |
| 10 kg | 100–150 mg | 100.0–150.0 ml | — |
| 12 kg | 120–180 mg | 120.0–180.0 ml | — |
| 15 kg | 150–225 mg | 150.0–225.0 ml | — |
| 18 kg | 180–270 mg | 180.0–270.0 ml | — |
| 20 kg | 200–300 mg | 200.0–300.0 ml | — |
| 25 kg | 250–375 mg | 250.0–375.0 ml | — |
| 30 kg | 300–450 mg | 300.0–450.0 ml | — |
⚠️ Warnings
- • Avoid in children with history of seizures, G-6-PD deficiency. May produce pseudotumor cerebri. C/I: Epilepsy, porphyria, age <3 months.
Ofloxacin
Ofloxacin
💊 Gram-positive, Gram-negative infections including S. aureus and S. typhi
Formulation
Tablet
Standard tablet
Dose Range
15–15 mg/kg
Max Daily
N/A
Frequency
Every 12 hours (oral); 12 hr for 5-10mg/kg
Max Single
400 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 75–75 mg | 75.0–75.0 ml | — |
| 6 kg | 90–90 mg | 90.0–90.0 ml | — |
| 7 kg | 105–105 mg | 105.0–105.0 ml | — |
| 8 kg | 120–120 mg | 120.0–120.0 ml | — |
| 9 kg | 135–135 mg | 135.0–135.0 ml | — |
| 10 kg | 150–150 mg | 150.0–150.0 ml | — |
| 12 kg | 180–180 mg | 180.0–180.0 ml | — |
| 15 kg | 225–225 mg | 225.0–225.0 ml | — |
| 18 kg | 270–270 mg | 270.0–270.0 ml | — |
| 20 kg | 300–300 mg | 300.0–300.0 ml | — |
| 25 kg | 375–375 mg | 375.0–375.0 ml | — |
| 30 kg | 450–450 mg | 450.0–450.0 ml | — |
⚠️ Warnings
- • Effective coverage including S. aureus and S. typhi.
Levofloxacin
Levofloxacin
💊 Gram-positive and Gram-negative infections, MDR TB. No coverage against Pseudomonas aeruginosa.
Formulation
Tablet
Standard tablet
Dose Range
10–10 mg/kg
Max Daily
N/A
Frequency
Once daily
Max Single
500 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–50 mg | 50.0–50.0 ml | — |
| 6 kg | 60–60 mg | 60.0–60.0 ml | — |
| 7 kg | 70–70 mg | 70.0–70.0 ml | — |
| 8 kg | 80–80 mg | 80.0–80.0 ml | — |
| 9 kg | 90–90 mg | 90.0–90.0 ml | — |
| 10 kg | 100–100 mg | 100.0–100.0 ml | — |
| 12 kg | 120–120 mg | 120.0–120.0 ml | — |
| 15 kg | 150–150 mg | 150.0–150.0 ml | — |
| 18 kg | 180–180 mg | 180.0–180.0 ml | — |
| 20 kg | 200–200 mg | 200.0–200.0 ml | — |
| 25 kg | 250–250 mg | 250.0–250.0 ml | — |
| 30 kg | 300–300 mg | 300.0–300.0 ml | — |
⚠️ Warnings
- • Avoid concurrent use of antacids.
Nalidixic Acid
Nalidixic acid
💊 UTI
Formulation
Tablet
Standard tablet
Dose Range
50–50 mg/kg
Max Daily
N/A
Frequency
Every 6-8 hours
Max Single
1000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 250–250 mg | 250.0–250.0 ml | — |
| 6 kg | 300–300 mg | 300.0–300.0 ml | — |
| 7 kg | 350–350 mg | 350.0–350.0 ml | — |
| 8 kg | 400–400 mg | 400.0–400.0 ml | — |
| 9 kg | 450–450 mg | 450.0–450.0 ml | — |
| 10 kg | 500–500 mg | 500.0–500.0 ml | — |
| 12 kg | 600–600 mg | 600.0–600.0 ml | — |
| 15 kg | 750–750 mg | 750.0–750.0 ml | — |
| 18 kg | 900–900 mg | 900.0–900.0 ml | — |
| 20 kg | 1000–1000 mg | 1000.0–1000.0 ml | — |
| 25 kg | 1250–1250 mg | 1250.0–1250.0 ml | — |
| 30 kg | 1500–1500 mg | 1500.0–1500.0 ml | — |
⚠️ Warnings
- • Not recommended in infants below 3 months. UTI prophylaxis: 30 mg/kg/day q 12 hr.
Sparfloxacin
Sparfloxacin
💊 Gram-positive and Gram-negative organisms
Formulation
Tablet
Standard tablet
Dose Range
4–4 mg/kg
Max Daily
N/A
Frequency
Once daily
Max Single
200 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 20–20 mg | 20.0–20.0 ml | — |
| 6 kg | 24–24 mg | 24.0–24.0 ml | — |
| 7 kg | 28–28 mg | 28.0–28.0 ml | — |
| 8 kg | 32–32 mg | 32.0–32.0 ml | — |
| 9 kg | 36–36 mg | 36.0–36.0 ml | — |
| 10 kg | 40–40 mg | 40.0–40.0 ml | — |
| 12 kg | 48–48 mg | 48.0–48.0 ml | — |
| 15 kg | 60–60 mg | 60.0–60.0 ml | — |
| 18 kg | 72–72 mg | 72.0–72.0 ml | — |
| 20 kg | 80–80 mg | 80.0–80.0 ml | — |
| 25 kg | 100–100 mg | 100.0–100.0 ml | — |
| 30 kg | 120–120 mg | 120.0–120.0 ml | — |
⚠️ Warnings
- •
Pefloxacin
Pefloxacin
💊 Effective coverage against most Gram-negative and Gram-positive including S. aureus and S. typhi
Formulation
Tablet
Standard tablet
Dose Range
10–20 mg/kg
Max Daily
N/A
Frequency
Every 12 hours
Max Single
400 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–100 mg | 50.0–100.0 ml | — |
| 6 kg | 60–120 mg | 60.0–120.0 ml | — |
| 7 kg | 70–140 mg | 70.0–140.0 ml | — |
| 8 kg | 80–160 mg | 80.0–160.0 ml | — |
| 9 kg | 90–180 mg | 90.0–180.0 ml | — |
| 10 kg | 100–200 mg | 100.0–200.0 ml | — |
| 12 kg | 120–240 mg | 120.0–240.0 ml | — |
| 15 kg | 150–300 mg | 150.0–300.0 ml | — |
| 18 kg | 180–360 mg | 180.0–360.0 ml | — |
| 20 kg | 200–400 mg | 200.0–400.0 ml | — |
| 25 kg | 250–500 mg | 250.0–500.0 ml | — |
| 30 kg | 300–600 mg | 300.0–600.0 ml | — |
⚠️ Warnings
- • Adjust dose in hepatic insufficiency.
Clindamycin
Clindamycin hydrochloride
💊 MRSA, anaerobic infections, P. carinii pneumonia, toxoplasma encephalitis
Formulation
Tablet
Standard tablet
Dose Range
20–40 mg/kg
Max Daily
N/A
Frequency
Every 6-8 hours (oral); 6-8 hr (IV)
Max Single
600 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 100–200 mg | 100.0–200.0 ml | — |
| 6 kg | 120–240 mg | 120.0–240.0 ml | — |
| 7 kg | 140–280 mg | 140.0–280.0 ml | — |
| 8 kg | 160–320 mg | 160.0–320.0 ml | — |
| 9 kg | 180–360 mg | 180.0–360.0 ml | — |
| 10 kg | 200–400 mg | 200.0–400.0 ml | — |
| 12 kg | 240–480 mg | 240.0–480.0 ml | — |
| 15 kg | 300–600 mg | 300.0–600.0 ml | — |
| 18 kg | 360–720 mg | 360.0–720.0 ml | — |
| 20 kg | 400–800 mg | 400.0–800.0 ml | — |
| 25 kg | 500–1000 mg | 500.0–1000.0 ml | — |
| 30 kg | 600–1200 mg | 600.0–1200.0 ml | — |
⚠️ Warnings
- • Pseudomembranous colitis. Avoid coadministration with erythromycin.
Lincomycin
Lincomycin
💊 Gram-positive infections
Formulation
Tablet
Standard tablet
Dose Range
30–60 mg/kg
Max Daily
N/A
Frequency
Every 8 hours (oral); 8-12 hr (IM/IV)
Max Single
600 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 150–300 mg | 150.0–300.0 ml | — |
| 6 kg | 180–360 mg | 180.0–360.0 ml | — |
| 7 kg | 210–420 mg | 210.0–420.0 ml | — |
| 8 kg | 240–480 mg | 240.0–480.0 ml | — |
| 9 kg | 270–540 mg | 270.0–540.0 ml | — |
| 10 kg | 300–600 mg | 300.0–600.0 ml | — |
| 12 kg | 360–720 mg | 360.0–720.0 ml | — |
| 15 kg | 450–900 mg | 450.0–900.0 ml | — |
| 18 kg | 540–1080 mg | 540.0–1080.0 ml | — |
| 20 kg | 600–1200 mg | 600.0–1200.0 ml | — |
| 25 kg | 750–1500 mg | 750.0–1500.0 ml | — |
| 30 kg | 900–1800 mg | 900.0–1800.0 ml | — |
⚠️ Warnings
- • Pseudomembranous colitis.
Clarithromycin
Clarithromycin
💊 H. pylori, chlamydiae, mycoplasma, atypical mycobacteria, M. marinum infection
Formulation
Tablet
Standard tablet
Dose Range
15–15 mg/kg
Max Daily
N/A
Frequency
Every 12 hours
Max Single
500 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 75–75 mg | 75.0–75.0 ml | — |
| 6 kg | 90–90 mg | 90.0–90.0 ml | — |
| 7 kg | 105–105 mg | 105.0–105.0 ml | — |
| 8 kg | 120–120 mg | 120.0–120.0 ml | — |
| 9 kg | 135–135 mg | 135.0–135.0 ml | — |
| 10 kg | 150–150 mg | 150.0–150.0 ml | — |
| 12 kg | 180–180 mg | 180.0–180.0 ml | — |
| 15 kg | 225–225 mg | 225.0–225.0 ml | — |
| 18 kg | 270–270 mg | 270.0–270.0 ml | — |
| 20 kg | 300–300 mg | 300.0–300.0 ml | — |
| 25 kg | 375–375 mg | 375.0–375.0 ml | — |
| 30 kg | 450–450 mg | 450.0–450.0 ml | — |
⚠️ Warnings
- • Efficacy and safety in infants below 6 months not evaluated.
Erythromycin
Erythromycin
💊 Gram-positive infections, Arcanobacterium haemolyticum
Formulation
Tablet
Standard tablet
Dose Range
30–50 mg/kg
Max Daily
N/A
Frequency
Every 6 hours (oral); IV over 6-8 hr
Max Single
500 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 150–250 mg | 150.0–250.0 ml | — |
| 6 kg | 180–300 mg | 180.0–300.0 ml | — |
| 7 kg | 210–350 mg | 210.0–350.0 ml | — |
| 8 kg | 240–400 mg | 240.0–400.0 ml | — |
| 9 kg | 270–450 mg | 270.0–450.0 ml | — |
| 10 kg | 300–500 mg | 300.0–500.0 ml | — |
| 12 kg | 360–600 mg | 360.0–600.0 ml | — |
| 15 kg | 450–750 mg | 450.0–750.0 ml | — |
| 18 kg | 540–900 mg | 540.0–900.0 ml | — |
| 20 kg | 600–1000 mg | 600.0–1000.0 ml | — |
| 25 kg | 750–1250 mg | 750.0–1250.0 ml | — |
| 30 kg | 900–1500 mg | 900.0–1500.0 ml | — |
⚠️ Warnings
- •
Roxithromycin
Roxithromycin
💊 Gram-positive infections
Formulation
Tablet
Standard tablet
Dose Range
5–8 mg/kg
Max Daily
N/A
Frequency
Every 12 hours
Max Single
150 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 25–40 mg | 25.0–40.0 ml | — |
| 6 kg | 30–48 mg | 30.0–48.0 ml | — |
| 7 kg | 35–56 mg | 35.0–56.0 ml | — |
| 8 kg | 40–64 mg | 40.0–64.0 ml | — |
| 9 kg | 45–72 mg | 45.0–72.0 ml | — |
| 10 kg | 50–80 mg | 50.0–80.0 ml | — |
| 12 kg | 60–96 mg | 60.0–96.0 ml | — |
| 15 kg | 75–120 mg | 75.0–120.0 ml | — |
| 18 kg | 90–144 mg | 90.0–144.0 ml | — |
| 20 kg | 100–160 mg | 100.0–160.0 ml | — |
| 25 kg | 125–200 mg | 125.0–200.0 ml | — |
| 30 kg | 150–240 mg | 150.0–240.0 ml | — |
⚠️ Warnings
- • Avoid concomitant use with ergotamine alkaloids.
Penicillin G Benzathine
Penicillin G benzathine
💊 Secondary prophylaxis against rheumatic fever
Formulation
Injection
0.6 mega units (<6 yrs), 1.2 mega units (≥6 yrs)
Dose Range
50000–100000 mg/kg
Max Daily
N/A
Frequency
IM every 3 weeks
Max Single
N/A
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 250000–500000 mg | 250000.0–500000.0 ml | — |
| 6 kg | 300000–600000 mg | 300000.0–600000.0 ml | — |
| 7 kg | 350000–700000 mg | 350000.0–700000.0 ml | — |
| 8 kg | 400000–800000 mg | 400000.0–800000.0 ml | — |
| 9 kg | 450000–900000 mg | 450000.0–900000.0 ml | — |
| 10 kg | 500000–1000000 mg | 500000.0–1000000.0 ml | — |
| 12 kg | 600000–1200000 mg | 600000.0–1200000.0 ml | — |
| 15 kg | 750000–1500000 mg | 750000.0–1500000.0 ml | — |
| 18 kg | 900000–1800000 mg | 900000.0–1800000.0 ml | — |
| 20 kg | 1000000–2000000 mg | 1000000.0–2000000.0 ml | — |
| 25 kg | 1250000–2500000 mg | 1250000.0–2500000.0 ml | — |
| 30 kg | 1500000–3000000 mg | 1500000.0–3000000.0 ml | — |
⚠️ Warnings
- • C/I: Penicillin hypersensitivity.
Penicillin V
Phenoxymethyl Penicillin
💊 Rheumatic prophylaxis 250 mg BD
Formulation
Tablet
Standard tablet
Dose Range
10–25 mg/kg
Max Daily
N/A
Frequency
Every 6 hours (30 min before or 2 hr after food)
Max Single
500 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–125 mg | 50.0–125.0 ml | — |
| 6 kg | 60–150 mg | 60.0–150.0 ml | — |
| 7 kg | 70–175 mg | 70.0–175.0 ml | — |
| 8 kg | 80–200 mg | 80.0–200.0 ml | — |
| 9 kg | 90–225 mg | 90.0–225.0 ml | — |
| 10 kg | 100–250 mg | 100.0–250.0 ml | — |
| 12 kg | 120–300 mg | 120.0–300.0 ml | — |
| 15 kg | 150–375 mg | 150.0–375.0 ml | — |
| 18 kg | 180–450 mg | 180.0–450.0 ml | — |
| 20 kg | 200–500 mg | 200.0–500.0 ml | — |
| 25 kg | 250–625 mg | 250.0–625.0 ml | — |
| 30 kg | 300–750 mg | 300.0–750.0 ml | — |
⚠️ Warnings
- • For rheumatic prophylaxis 250 mg orally twice daily.
Piperacillin
Piperacillin
💊 Gram-negative and Gram-positive infections
Formulation
Tablet
Standard tablet
Dose Range
200–300 mg/kg
Max Daily
N/A
Frequency
Every 4-6 hours
Max Single
4000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1000–1500 mg | 1000.0–1500.0 ml | — |
| 6 kg | 1200–1800 mg | 1200.0–1800.0 ml | — |
| 7 kg | 1400–2100 mg | 1400.0–2100.0 ml | — |
| 8 kg | 1600–2400 mg | 1600.0–2400.0 ml | — |
| 9 kg | 1800–2700 mg | 1800.0–2700.0 ml | — |
| 10 kg | 2000–3000 mg | 2000.0–3000.0 ml | — |
| 12 kg | 2400–3600 mg | 2400.0–3600.0 ml | — |
| 15 kg | 3000–4500 mg | 3000.0–4500.0 ml | — |
| 18 kg | 3600–5400 mg | 3600.0–5400.0 ml | — |
| 20 kg | 4000–6000 mg | 4000.0–6000.0 ml | — |
| 25 kg | 5000–7500 mg | 5000.0–7500.0 ml | — |
| 30 kg | 6000–9000 mg | 6000.0–9000.0 ml | — |
⚠️ Warnings
- • C/I: Infectious mononucleosis; penicillin or cephalosporin allergy.
Piperacillin with Tazobactam
Piperacillin/tazobactam
💊 Broad spectrum Gram-positive and Gram-negative aerobic and anaerobic bacteria
Formulation
Tablet
Standard tablet
Dose Range
300–400 mg/kg
Max Daily
N/A
Frequency
Every 6-8 hours
Max Single
4000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1500–2000 mg | 1500.0–2000.0 ml | — |
| 6 kg | 1800–2400 mg | 1800.0–2400.0 ml | — |
| 7 kg | 2100–2800 mg | 2100.0–2800.0 ml | — |
| 8 kg | 2400–3200 mg | 2400.0–3200.0 ml | — |
| 9 kg | 2700–3600 mg | 2700.0–3600.0 ml | — |
| 10 kg | 3000–4000 mg | 3000.0–4000.0 ml | — |
| 12 kg | 3600–4800 mg | 3600.0–4800.0 ml | — |
| 15 kg | 4500–6000 mg | 4500.0–6000.0 ml | — |
| 18 kg | 5400–7200 mg | 5400.0–7200.0 ml | — |
| 20 kg | 6000–8000 mg | 6000.0–8000.0 ml | — |
| 25 kg | 7500–10000 mg | 7500.0–10000.0 ml | — |
| 30 kg | 9000–12000 mg | 9000.0–12000.0 ml | — |
⚠️ Warnings
- •
Ticarcillin with Clavulanic Acid
Ticarcillin/clavulanic acid
💊 Beta-lactamase producing enterobacteriaceae
Formulation
Tablet
Standard tablet
Dose Range
200–300 mg/kg
Max Daily
N/A
Frequency
Every 6-8 hours
Max Single
3100 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1000–1500 mg | 1000.0–1500.0 ml | — |
| 6 kg | 1200–1800 mg | 1200.0–1800.0 ml | — |
| 7 kg | 1400–2100 mg | 1400.0–2100.0 ml | — |
| 8 kg | 1600–2400 mg | 1600.0–2400.0 ml | — |
| 9 kg | 1800–2700 mg | 1800.0–2700.0 ml | — |
| 10 kg | 2000–3000 mg | 2000.0–3000.0 ml | — |
| 12 kg | 2400–3600 mg | 2400.0–3600.0 ml | — |
| 15 kg | 3000–4500 mg | 3000.0–4500.0 ml | — |
| 18 kg | 3600–5400 mg | 3600.0–5400.0 ml | — |
| 20 kg | 4000–6000 mg | 4000.0–6000.0 ml | — |
| 25 kg | 5000–7500 mg | 5000.0–7500.0 ml | — |
| 30 kg | 6000–9000 mg | 6000.0–9000.0 ml | — |
⚠️ Warnings
- • Sodium and potassium content is significant.
Imipenem/Cilastatin
Imipenem/cilastatin
💊 Broad spectrum Gram-positive and Gram-negative aerobic and anaerobic bacteria including ESBL producers
Formulation
Tablet
Standard tablet
Dose Range
60–100 mg/kg
Max Daily
N/A
Frequency
Every 6 hours
Max Single
2000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 300–500 mg | 300.0–500.0 ml | — |
| 6 kg | 360–600 mg | 360.0–600.0 ml | — |
| 7 kg | 420–700 mg | 420.0–700.0 ml | — |
| 8 kg | 480–800 mg | 480.0–800.0 ml | — |
| 9 kg | 540–900 mg | 540.0–900.0 ml | — |
| 10 kg | 600–1000 mg | 600.0–1000.0 ml | — |
| 12 kg | 720–1200 mg | 720.0–1200.0 ml | — |
| 15 kg | 900–1500 mg | 900.0–1500.0 ml | — |
| 18 kg | 1080–1800 mg | 1080.0–1800.0 ml | — |
| 20 kg | 1200–2000 mg | 1200.0–2000.0 ml | — |
| 25 kg | 1500–2500 mg | 1500.0–2500.0 ml | — |
| 30 kg | 1800–3000 mg | 1800.0–3000.0 ml | — |
⚠️ Warnings
- • Use with caution in children with epilepsy.
Co-trimoxazole
Sulfamethoxazole/Trimethoprim
💊 Typhoid fever, Pneumocystis carinii infection, UTI prophylaxis
Formulation
Tablet
Standard tablet
Dose Range
5–8 mg/kg
Max Daily
N/A
Frequency
Every 12 hours (TMP component)
Max Single
160 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 25–40 mg | 25.0–40.0 ml | — |
| 6 kg | 30–48 mg | 30.0–48.0 ml | — |
| 7 kg | 35–56 mg | 35.0–56.0 ml | — |
| 8 kg | 40–64 mg | 40.0–64.0 ml | — |
| 9 kg | 45–72 mg | 45.0–72.0 ml | — |
| 10 kg | 50–80 mg | 50.0–80.0 ml | — |
| 12 kg | 60–96 mg | 60.0–96.0 ml | — |
| 15 kg | 75–120 mg | 75.0–120.0 ml | — |
| 18 kg | 90–144 mg | 90.0–144.0 ml | — |
| 20 kg | 100–160 mg | 100.0–160.0 ml | — |
| 25 kg | 125–200 mg | 125.0–200.0 ml | — |
| 30 kg | 150–240 mg | 150.0–240.0 ml | — |
⚠️ Warnings
- • C/I: Infants <1 month, G-6-PD deficiency.
Aztreonam
Aztreonam
💊 Enterobacteriaceae and Pseudomonas aeruginosa. Beta-lactamase stable. Crosses BBB. No oto or nephrotoxicity.
Formulation
Tablet
Standard tablet
Dose Range
90–120 mg/kg
Max Daily
N/A
Frequency
Every 6-8 hours
Max Single
2000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 450–600 mg | 450.0–600.0 ml | — |
| 6 kg | 540–720 mg | 540.0–720.0 ml | — |
| 7 kg | 630–840 mg | 630.0–840.0 ml | — |
| 8 kg | 720–960 mg | 720.0–960.0 ml | — |
| 9 kg | 810–1080 mg | 810.0–1080.0 ml | — |
| 10 kg | 900–1200 mg | 900.0–1200.0 ml | — |
| 12 kg | 1080–1440 mg | 1080.0–1440.0 ml | — |
| 15 kg | 1350–1800 mg | 1350.0–1800.0 ml | — |
| 18 kg | 1620–2160 mg | 1620.0–2160.0 ml | — |
| 20 kg | 1800–2400 mg | 1800.0–2400.0 ml | — |
| 25 kg | 2250–3000 mg | 2250.0–3000.0 ml | — |
| 30 kg | 2700–3600 mg | 2700.0–3600.0 ml | — |
⚠️ Warnings
- • Not recommended <1 week age.
Chlorophenicol
Chloramphenicol
💊 Serious bacterial infections
Formulation
Tablet
Standard tablet
Dose Range
50–100 mg/kg
Max Daily
N/A
Frequency
Every 8 hours
Max Single
1000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 250–500 mg | 250.0–500.0 ml | — |
| 6 kg | 300–600 mg | 300.0–600.0 ml | — |
| 7 kg | 350–700 mg | 350.0–700.0 ml | — |
| 8 kg | 400–800 mg | 400.0–800.0 ml | — |
| 9 kg | 450–900 mg | 450.0–900.0 ml | — |
| 10 kg | 500–1000 mg | 500.0–1000.0 ml | — |
| 12 kg | 600–1200 mg | 600.0–1200.0 ml | — |
| 15 kg | 750–1500 mg | 750.0–1500.0 ml | — |
| 18 kg | 900–1800 mg | 900.0–1800.0 ml | — |
| 20 kg | 1000–2000 mg | 1000.0–2000.0 ml | — |
| 25 kg | 1250–2500 mg | 1250.0–2500.0 ml | — |
| 30 kg | 1500–3000 mg | 1500.0–3000.0 ml | — |
⚠️ Warnings
- • Monitor blood levels (15-30 μg/ml). Grey baby syndrome in neonates. C/I: Blood dyscrasias, premature infants <14 days, porphyria.
Furazolidone
Furazolidone
💊 Bacterial and protozoal infections
Formulation
Tablet
Standard tablet
Dose Range
6–6 mg/kg
Max Daily
N/A
Frequency
Every 6-8 hours
Max Single
100 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 30–30 mg | 30.0–30.0 ml | — |
| 6 kg | 36–36 mg | 36.0–36.0 ml | — |
| 7 kg | 42–42 mg | 42.0–42.0 ml | — |
| 8 kg | 48–48 mg | 48.0–48.0 ml | — |
| 9 kg | 54–54 mg | 54.0–54.0 ml | — |
| 10 kg | 60–60 mg | 60.0–60.0 ml | — |
| 12 kg | 72–72 mg | 72.0–72.0 ml | — |
| 15 kg | 90–90 mg | 90.0–90.0 ml | — |
| 18 kg | 108–108 mg | 108.0–108.0 ml | — |
| 20 kg | 120–120 mg | 120.0–120.0 ml | — |
| 25 kg | 150–150 mg | 150.0–150.0 ml | — |
| 30 kg | 180–180 mg | 180.0–180.0 ml | — |
⚠️ Warnings
- • Carcinogenic and mutagenic. C/I: Infants <1 month, G-6-PD deficiency.
Linezolid
Linezolid
💊 Vancomycin resistant enterococci, MRSA
Formulation
Tablet
Standard tablet
Dose Range
20–20 mg/kg
Max Daily
N/A
Frequency
Every 12 hours
Max Single
600 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 100–100 mg | 100.0–100.0 ml | — |
| 6 kg | 120–120 mg | 120.0–120.0 ml | — |
| 7 kg | 140–140 mg | 140.0–140.0 ml | — |
| 8 kg | 160–160 mg | 160.0–160.0 ml | — |
| 9 kg | 180–180 mg | 180.0–180.0 ml | — |
| 10 kg | 200–200 mg | 200.0–200.0 ml | — |
| 12 kg | 240–240 mg | 240.0–240.0 ml | — |
| 15 kg | 300–300 mg | 300.0–300.0 ml | — |
| 18 kg | 360–360 mg | 360.0–360.0 ml | — |
| 20 kg | 400–400 mg | 400.0–400.0 ml | — |
| 25 kg | 500–500 mg | 500.0–500.0 ml | — |
| 30 kg | 600–600 mg | 600.0–600.0 ml | — |
⚠️ Warnings
- • Give IV over 30-120 min. SE: lactic acidosis, seizures, hepatic/renal dysfunction, bone marrow suppression.
Colistin Sulfate
Colistin sulfate (Oral)
💊 Gram-negative infections
Formulation
Tablet
Standard tablet
Dose Range
5–15 mg/kg
Max Daily
N/A
Frequency
Every 6-8 hours
Max Single
150 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 25–75 mg | 25.0–75.0 ml | — |
| 6 kg | 30–90 mg | 30.0–90.0 ml | — |
| 7 kg | 35–105 mg | 35.0–105.0 ml | — |
| 8 kg | 40–120 mg | 40.0–120.0 ml | — |
| 9 kg | 45–135 mg | 45.0–135.0 ml | — |
| 10 kg | 50–150 mg | 50.0–150.0 ml | — |
| 12 kg | 60–180 mg | 60.0–180.0 ml | — |
| 15 kg | 75–225 mg | 75.0–225.0 ml | — |
| 18 kg | 90–270 mg | 90.0–270.0 ml | — |
| 20 kg | 100–300 mg | 100.0–300.0 ml | — |
| 25 kg | 125–375 mg | 125.0–375.0 ml | — |
| 30 kg | 150–450 mg | 150.0–450.0 ml | — |
⚠️ Warnings
- • Nephrotoxicity and neurotoxicity.
Doxycycline
Doxycycline
💊 Chronic bronchitis, brucellosis, chlamydia, mycoplasma, rickettsia, ehrlichiosis, cholera, acne. Tick borne rickettsia 2.2 mg/kg q12hr.
Formulation
Tablet
Standard tablet
Dose Range
2–5 mg/kg
Max Daily
N/A
Frequency
Every 12 hours
Max Single
100 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 10–25 mg | 10.0–25.0 ml | — |
| 6 kg | 12–30 mg | 12.0–30.0 ml | — |
| 7 kg | 14–35 mg | 14.0–35.0 ml | — |
| 8 kg | 16–40 mg | 16.0–40.0 ml | — |
| 9 kg | 18–45 mg | 18.0–45.0 ml | — |
| 10 kg | 20–50 mg | 20.0–50.0 ml | — |
| 12 kg | 24–60 mg | 24.0–60.0 ml | — |
| 15 kg | 30–75 mg | 30.0–75.0 ml | — |
| 18 kg | 36–90 mg | 36.0–90.0 ml | — |
| 20 kg | 40–100 mg | 40.0–100.0 ml | — |
| 25 kg | 50–125 mg | 50.0–125.0 ml | — |
| 30 kg | 60–150 mg | 60.0–150.0 ml | — |
⚠️ Warnings
- • Avoid in children below 8 years due to risk of teeth staining and growth retardation.
Minocycline
Minocycline
💊 Bacterial infections
Formulation
Tablet
Standard tablet
Dose Range
4–8 mg/kg
Max Daily
N/A
Frequency
Once then q 12 hours
Max Single
200 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 20–40 mg | 20.0–40.0 ml | — |
| 6 kg | 24–48 mg | 24.0–48.0 ml | — |
| 7 kg | 28–56 mg | 28.0–56.0 ml | — |
| 8 kg | 32–64 mg | 32.0–64.0 ml | — |
| 9 kg | 36–72 mg | 36.0–72.0 ml | — |
| 10 kg | 40–80 mg | 40.0–80.0 ml | — |
| 12 kg | 48–96 mg | 48.0–96.0 ml | — |
| 15 kg | 60–120 mg | 60.0–120.0 ml | — |
| 18 kg | 72–144 mg | 72.0–144.0 ml | — |
| 20 kg | 80–160 mg | 80.0–160.0 ml | — |
| 25 kg | 100–200 mg | 100.0–200.0 ml | — |
| 30 kg | 120–240 mg | 120.0–240.0 ml | — |
⚠️ Warnings
- • Avoid in children below 8 years. C/I: Renal failure.
Nitrofurantoin
Nitrofurantoin
💊 UTI. Prophylaxis 1-2 mg/kg at bedtime.
Formulation
Tablet
Standard tablet
Dose Range
5–7 mg/kg
Max Daily
N/A
Frequency
Every 6 hours with meals
Max Single
100 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 25–35 mg | 25.0–35.0 ml | — |
| 6 kg | 30–42 mg | 30.0–42.0 ml | — |
| 7 kg | 35–49 mg | 35.0–49.0 ml | — |
| 8 kg | 40–56 mg | 40.0–56.0 ml | — |
| 9 kg | 45–63 mg | 45.0–63.0 ml | — |
| 10 kg | 50–70 mg | 50.0–70.0 ml | — |
| 12 kg | 60–84 mg | 60.0–84.0 ml | — |
| 15 kg | 75–105 mg | 75.0–105.0 ml | — |
| 18 kg | 90–126 mg | 90.0–126.0 ml | — |
| 20 kg | 100–140 mg | 100.0–140.0 ml | — |
| 25 kg | 125–175 mg | 125.0–175.0 ml | — |
| 30 kg | 150–210 mg | 150.0–210.0 ml | — |
⚠️ Warnings
- • C/I: Impaired renal function, G-6-PD deficiency, age <1 month.
Teicoplanin
Teicoplanin
💊 Gram-positive cocci including MRSA. Crosses BBB.
Formulation
Tablet
Standard tablet
Dose Range
10–10 mg/kg
Max Daily
N/A
Frequency
q 12 hr x 3 doses then q 24 hr
Max Single
400 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–50 mg | 50.0–50.0 ml | — |
| 6 kg | 60–60 mg | 60.0–60.0 ml | — |
| 7 kg | 70–70 mg | 70.0–70.0 ml | — |
| 8 kg | 80–80 mg | 80.0–80.0 ml | — |
| 9 kg | 90–90 mg | 90.0–90.0 ml | — |
| 10 kg | 100–100 mg | 100.0–100.0 ml | — |
| 12 kg | 120–120 mg | 120.0–120.0 ml | — |
| 15 kg | 150–150 mg | 150.0–150.0 ml | — |
| 18 kg | 180–180 mg | 180.0–180.0 ml | — |
| 20 kg | 200–200 mg | 200.0–200.0 ml | — |
| 25 kg | 250–250 mg | 250.0–250.0 ml | — |
| 30 kg | 300–300 mg | 300.0–300.0 ml | — |
⚠️ Warnings
- • Decrease dose from day 4 in renal failure.
Tigecycline
Tigecycline
💊 MRSA, Gram-negative MDR, Acinetobacter ESBL, carbapenem-resistant S. aureus
Formulation
Tablet
Standard tablet
Dose Range
1–1.5 mg/kg
Max Daily
N/A
Frequency
Loading then maintenance
Max Single
100 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 5–8 mg | 5.0–7.5 ml | — |
| 6 kg | 6–9 mg | 6.0–9.0 ml | — |
| 7 kg | 7–11 mg | 7.0–10.5 ml | — |
| 8 kg | 8–12 mg | 8.0–12.0 ml | — |
| 9 kg | 9–14 mg | 9.0–13.5 ml | — |
| 10 kg | 10–15 mg | 10.0–15.0 ml | — |
| 12 kg | 12–18 mg | 12.0–18.0 ml | — |
| 15 kg | 15–23 mg | 15.0–22.5 ml | — |
| 18 kg | 18–27 mg | 18.0–27.0 ml | — |
| 20 kg | 20–30 mg | 20.0–30.0 ml | — |
| 25 kg | 25–38 mg | 25.0–37.5 ml | — |
| 30 kg | 30–45 mg | 30.0–45.0 ml | — |
⚠️ Warnings
- • Hepatotoxicity.
Tetracycline
Tetracycline hydrochloride
💊 Broad spectrum bacterial infections
Formulation
Tablet
Standard tablet
Dose Range
25–50 mg/kg
Max Daily
N/A
Frequency
Every 6 hours
Max Single
500 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 125–250 mg | 125.0–250.0 ml | — |
| 6 kg | 150–300 mg | 150.0–300.0 ml | — |
| 7 kg | 175–350 mg | 175.0–350.0 ml | — |
| 8 kg | 200–400 mg | 200.0–400.0 ml | — |
| 9 kg | 225–450 mg | 225.0–450.0 ml | — |
| 10 kg | 250–500 mg | 250.0–500.0 ml | — |
| 12 kg | 300–600 mg | 300.0–600.0 ml | — |
| 15 kg | 375–750 mg | 375.0–750.0 ml | — |
| 18 kg | 450–900 mg | 450.0–900.0 ml | — |
| 20 kg | 500–1000 mg | 500.0–1000.0 ml | — |
| 25 kg | 625–1250 mg | 625.0–1250.0 ml | — |
| 30 kg | 750–1500 mg | 750.0–1500.0 ml | — |
⚠️ Warnings
- • Avoid in children below 8 years. C/I: <8 yr, SLE, hypersensitivity. SE: GI disturbances, C. difficile diarrhea.
Acenocoumarol
Acenocoumarol
💊 Anticoagulation
Formulation
Tablet
Standard tablet
Dose Range
0.05–0.2 mg/kg
Max Daily
N/A
Frequency
Once daily
Max Single
4 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 0–1 mg | 0.3–1.0 ml | — |
| 6 kg | 0–1 mg | 0.3–1.2 ml | — |
| 7 kg | 0–1 mg | 0.4–1.4 ml | — |
| 8 kg | 0–2 mg | 0.4–1.6 ml | — |
| 9 kg | 0–2 mg | 0.5–1.8 ml | — |
| 10 kg | 1–2 mg | 0.5–2.0 ml | — |
| 12 kg | 1–2 mg | 0.6–2.4 ml | — |
| 15 kg | 1–3 mg | 0.8–3.0 ml | — |
| 18 kg | 1–4 mg | 0.9–3.6 ml | — |
| 20 kg | 1–4 mg | 1.0–4.0 ml | — |
| 25 kg | 1–5 mg | 1.3–5.0 ml | — |
| 30 kg | 2–6 mg | 1.5–6.0 ml | — |
⚠️ Warnings
- • Maintain prothrombin time 1.5x normal.
Phenindione
Phenindione
💊 Thromboembolism
Formulation
Tablet
Standard tablet
Dose Range
0.5–4 mg/kg
Max Daily
N/A
Frequency
Every 12 hours
Max Single
N/A
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 3–20 mg | 2.5–20.0 ml | — |
| 6 kg | 3–24 mg | 3.0–24.0 ml | — |
| 7 kg | 4–28 mg | 3.5–28.0 ml | — |
| 8 kg | 4–32 mg | 4.0–32.0 ml | — |
| 9 kg | 5–36 mg | 4.5–36.0 ml | — |
| 10 kg | 5–40 mg | 5.0–40.0 ml | — |
| 12 kg | 6–48 mg | 6.0–48.0 ml | — |
| 15 kg | 8–60 mg | 7.5–60.0 ml | — |
| 18 kg | 9–72 mg | 9.0–72.0 ml | — |
| 20 kg | 10–80 mg | 10.0–80.0 ml | — |
| 25 kg | 13–100 mg | 12.5–100.0 ml | — |
| 30 kg | 15–120 mg | 15.0–120.0 ml | — |
⚠️ Warnings
- •
Wararfarin
Warfarin
💊 Anticoagulation, DVT prophylaxis
Formulation
Tablet
Standard tablet
Dose Range
0.05–0.34 mg/kg
Max Daily
N/A
Frequency
Once daily (adjust to maintain PT 2-3 INR)
Max Single
N/A
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 0–2 mg | 0.3–1.7 ml | — |
| 6 kg | 0–2 mg | 0.3–2.0 ml | — |
| 7 kg | 0–2 mg | 0.4–2.4 ml | — |
| 8 kg | 0–3 mg | 0.4–2.7 ml | — |
| 9 kg | 0–3 mg | 0.5–3.1 ml | — |
| 10 kg | 1–3 mg | 0.5–3.4 ml | — |
| 12 kg | 1–4 mg | 0.6–4.1 ml | — |
| 15 kg | 1–5 mg | 0.8–5.1 ml | — |
| 18 kg | 1–6 mg | 0.9–6.1 ml | — |
| 20 kg | 1–7 mg | 1.0–6.8 ml | — |
| 25 kg | 1–9 mg | 1.3–8.5 ml | — |
| 30 kg | 2–10 mg | 1.5–10.2 ml | — |
⚠️ Warnings
- • Adjust dose to maintain desired prothrombin time.
Clobazam
Clobazam
💊 Complex partial, generalized tonic-clonic seizures, absence attacks, myoclonic seizures, Lennox-Gestaut syndrome, febrile seizure prophylaxis
Formulation
Tablet
Standard tablet
Dose Range
0.1–1 mg/kg
Max Daily
N/A
Frequency
Once or twice daily
Max Single
60 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–5 mg | 0.5–5.0 ml | — |
| 6 kg | 1–6 mg | 0.6–6.0 ml | — |
| 7 kg | 1–7 mg | 0.7–7.0 ml | — |
| 8 kg | 1–8 mg | 0.8–8.0 ml | — |
| 9 kg | 1–9 mg | 0.9–9.0 ml | — |
| 10 kg | 1–10 mg | 1.0–10.0 ml | — |
| 12 kg | 1–12 mg | 1.2–12.0 ml | — |
| 15 kg | 2–15 mg | 1.5–15.0 ml | — |
| 18 kg | 2–18 mg | 1.8–18.0 ml | — |
| 20 kg | 2–20 mg | 2.0–20.0 ml | — |
| 25 kg | 3–25 mg | 2.5–25.0 ml | — |
| 30 kg | 3–30 mg | 3.0–30.0 ml | — |
⚠️ Warnings
- • C/I: Myasthenia gravis, benzodiazepine hypersensitivity. Max 1 mg/kg/day for febrile seizure prophylaxis.
Diazepam
Diazepam
💊 Status epilepticus, muscle spasms due to tetanus, febrile seizures, anxiety. Neonatal tetanus: 0.5-5.0 mg/kg q2-4hr.
Formulation
Tablet
Standard tablet
Dose Range
0.2–0.5 mg/kg
Max Daily
N/A
Frequency
Status epilepticus: repeat q 3-5 min (max <5yr: 5mg, >5yr: 10mg total)
Max Single
10 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–3 mg | 1.0–2.5 ml | — |
| 6 kg | 1–3 mg | 1.2–3.0 ml | — |
| 7 kg | 1–4 mg | 1.4–3.5 ml | — |
| 8 kg | 2–4 mg | 1.6–4.0 ml | — |
| 9 kg | 2–5 mg | 1.8–4.5 ml | — |
| 10 kg | 2–5 mg | 2.0–5.0 ml | — |
| 12 kg | 2–6 mg | 2.4–6.0 ml | — |
| 15 kg | 3–8 mg | 3.0–7.5 ml | — |
| 18 kg | 4–9 mg | 3.6–9.0 ml | — |
| 20 kg | 4–10 mg | 4.0–10.0 ml | — |
| 25 kg | 5–13 mg | 5.0–12.5 ml | — |
| 30 kg | 6–15 mg | 6.0–15.0 ml | — |
⚠️ Warnings
- • Rapid IV bolus may cause apnea. C/I: Porphyria.
Ethosuximide
Ethosuximide
💊 Absence attacks
Formulation
Tablet
Standard tablet
Dose Range
15–15 mg/kg
Max Daily
N/A
Frequency
Every 12 hours
Max Single
1500 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 75–75 mg | 75.0–75.0 ml | — |
| 6 kg | 90–90 mg | 90.0–90.0 ml | — |
| 7 kg | 105–105 mg | 105.0–105.0 ml | — |
| 8 kg | 120–120 mg | 120.0–120.0 ml | — |
| 9 kg | 135–135 mg | 135.0–135.0 ml | — |
| 10 kg | 150–150 mg | 150.0–150.0 ml | — |
| 12 kg | 180–180 mg | 180.0–180.0 ml | — |
| 15 kg | 225–225 mg | 225.0–225.0 ml | — |
| 18 kg | 270–270 mg | 270.0–270.0 ml | — |
| 20 kg | 300–300 mg | 300.0–300.0 ml | — |
| 25 kg | 375–375 mg | 375.0–375.0 ml | — |
| 30 kg | 450–450 mg | 450.0–450.0 ml | — |
⚠️ Warnings
- • <6 yr max 500 mg/day; >6 yr max 1500 mg/day.
Fosphenytoin
Fosphenytoin sodium
💊 Status epilepticus, tonic-clonic seizures, partial seizures
Formulation
Tablet
Standard tablet
Dose Range
4–6 mg/kg
Max Daily
N/A
Frequency
q 6-8 hr IV/IM; loading 15-20 mg/kg IV
Max Single
150 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 20–30 mg | 20.0–30.0 ml | — |
| 6 kg | 24–36 mg | 24.0–36.0 ml | — |
| 7 kg | 28–42 mg | 28.0–42.0 ml | — |
| 8 kg | 32–48 mg | 32.0–48.0 ml | — |
| 9 kg | 36–54 mg | 36.0–54.0 ml | — |
| 10 kg | 40–60 mg | 40.0–60.0 ml | — |
| 12 kg | 48–72 mg | 48.0–72.0 ml | — |
| 15 kg | 60–90 mg | 60.0–90.0 ml | — |
| 18 kg | 72–108 mg | 72.0–108.0 ml | — |
| 20 kg | 80–120 mg | 80.0–120.0 ml | — |
| 25 kg | 100–150 mg | 100.0–150.0 ml | — |
| 30 kg | 120–180 mg | 120.0–180.0 ml | — |
⚠️ Warnings
- • Water soluble prodrug of phenytoin. Max IV infusion 3 mg/kg/min.
Gabapentin
Gabapentin
💊 Partial seizures, diabetic neuropathy, postherpetic neuralgia
Formulation
Tablet
Standard tablet
Dose Range
15–60 mg/kg
Max Daily
N/A
Frequency
Every 8 hours
Max Single
800 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 75–300 mg | 75.0–300.0 ml | — |
| 6 kg | 90–360 mg | 90.0–360.0 ml | — |
| 7 kg | 105–420 mg | 105.0–420.0 ml | — |
| 8 kg | 120–480 mg | 120.0–480.0 ml | — |
| 9 kg | 135–540 mg | 135.0–540.0 ml | — |
| 10 kg | 150–600 mg | 150.0–600.0 ml | — |
| 12 kg | 180–720 mg | 180.0–720.0 ml | — |
| 15 kg | 225–900 mg | 225.0–900.0 ml | — |
| 18 kg | 270–1080 mg | 270.0–1080.0 ml | — |
| 20 kg | 300–1200 mg | 300.0–1200.0 ml | — |
| 25 kg | 375–1500 mg | 375.0–1500.0 ml | — |
| 30 kg | 450–1800 mg | 450.0–1800.0 ml | — |
⚠️ Warnings
- • Avoid below 2 years.
Lacosamide
Lacosamide
💊 Refractory partial-onset seizures, diabetic neuropathy
Formulation
Tablet
Standard tablet
Dose Range
1–12 mg/kg
Max Daily
N/A
Frequency
Every 12 hours
Max Single
400 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 5–60 mg | 5.0–60.0 ml | — |
| 6 kg | 6–72 mg | 6.0–72.0 ml | — |
| 7 kg | 7–84 mg | 7.0–84.0 ml | — |
| 8 kg | 8–96 mg | 8.0–96.0 ml | — |
| 9 kg | 9–108 mg | 9.0–108.0 ml | — |
| 10 kg | 10–120 mg | 10.0–120.0 ml | — |
| 12 kg | 12–144 mg | 12.0–144.0 ml | — |
| 15 kg | 15–180 mg | 15.0–180.0 ml | — |
| 18 kg | 18–216 mg | 18.0–216.0 ml | — |
| 20 kg | 20–240 mg | 20.0–240.0 ml | — |
| 25 kg | 25–300 mg | 25.0–300.0 ml | — |
| 30 kg | 30–360 mg | 30.0–360.0 ml | — |
⚠️ Warnings
- •
Lamotrigine
Lamotrigine
💊 Partial seizures, Lennox-Gastaut syndrome, generalized seizures, atypical absence, atonic, myoclonic seizures. First-line for absence seizures.
Formulation
Tablet
Standard tablet
Dose Range
5–15 mg/kg
Max Daily
N/A
Frequency
Every 12 hours (slow titration)
Max Single
400 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 25–75 mg | 25.0–75.0 ml | — |
| 6 kg | 30–90 mg | 30.0–90.0 ml | — |
| 7 kg | 35–105 mg | 35.0–105.0 ml | — |
| 8 kg | 40–120 mg | 40.0–120.0 ml | — |
| 9 kg | 45–135 mg | 45.0–135.0 ml | — |
| 10 kg | 50–150 mg | 50.0–150.0 ml | — |
| 12 kg | 60–180 mg | 60.0–180.0 ml | — |
| 15 kg | 75–225 mg | 75.0–225.0 ml | — |
| 18 kg | 90–270 mg | 90.0–270.0 ml | — |
| 20 kg | 100–300 mg | 100.0–300.0 ml | — |
| 25 kg | 125–375 mg | 125.0–375.0 ml | — |
| 30 kg | 150–450 mg | 150.0–450.0 ml | — |
⚠️ Warnings
- • Life-threatening skin rash risk. C/I: Significant hepatic disease.
Levetiracetam
Levetiracetam
💊 Refractory partial seizures, generalized tonic-clonic seizures, absence attacks, astatic myoclonic seizures (LGS). Can be given to newborns.
Formulation
Tablet
Standard tablet
Dose Range
10–60 mg/kg
Max Daily
N/A
Frequency
Every 12 hours (increase 10 mg/kg every 2 weeks)
Max Single
1500 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–300 mg | 50.0–300.0 ml | — |
| 6 kg | 60–360 mg | 60.0–360.0 ml | — |
| 7 kg | 70–420 mg | 70.0–420.0 ml | — |
| 8 kg | 80–480 mg | 80.0–480.0 ml | — |
| 9 kg | 90–540 mg | 90.0–540.0 ml | — |
| 10 kg | 100–600 mg | 100.0–600.0 ml | — |
| 12 kg | 120–720 mg | 120.0–720.0 ml | — |
| 15 kg | 150–900 mg | 150.0–900.0 ml | — |
| 18 kg | 180–1080 mg | 180.0–1080.0 ml | — |
| 20 kg | 200–1200 mg | 200.0–1200.0 ml | — |
| 25 kg | 250–1500 mg | 250.0–1500.0 ml | — |
| 30 kg | 300–1800 mg | 300.0–1800.0 ml | — |
⚠️ Warnings
- •
Lorazepam
Lorazepam
💊 Status epilepticus, myoclonus, partial epilepsy, infantile spasms, insomnia
Formulation
Tablet
Standard tablet
Dose Range
0.05–0.1 mg/kg
Max Daily
N/A
Frequency
q 4-8 hr (sedation); max 4 mg/dose IV
Max Single
4 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 0–1 mg | 0.3–0.5 ml | — |
| 6 kg | 0–1 mg | 0.3–0.6 ml | — |
| 7 kg | 0–1 mg | 0.4–0.7 ml | — |
| 8 kg | 0–1 mg | 0.4–0.8 ml | — |
| 9 kg | 0–1 mg | 0.5–0.9 ml | — |
| 10 kg | 1–1 mg | 0.5–1.0 ml | — |
| 12 kg | 1–1 mg | 0.6–1.2 ml | — |
| 15 kg | 1–2 mg | 0.8–1.5 ml | — |
| 18 kg | 1–2 mg | 0.9–1.8 ml | — |
| 20 kg | 1–2 mg | 1.0–2.0 ml | — |
| 25 kg | 1–3 mg | 1.3–2.5 ml | — |
| 30 kg | 2–3 mg | 1.5–3.0 ml | — |
⚠️ Warnings
- • Low risk of hypotension and respiratory depression. Longer duration vs diazepam.
Midazolam
Midazolam
💊 Status epilepticus, sedation during mechanical ventilation, acute seizure control
Formulation
Tablet
Standard tablet
Dose Range
0.2–0.2 mg/kg
Max Daily
N/A
Frequency
Status epilepticus: bolus then 0.1-0.2 mg/kg/hr infusion
Max Single
5 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–1 mg | 1.0–1.0 ml | — |
| 6 kg | 1–1 mg | 1.2–1.2 ml | — |
| 7 kg | 1–1 mg | 1.4–1.4 ml | — |
| 8 kg | 2–2 mg | 1.6–1.6 ml | — |
| 9 kg | 2–2 mg | 1.8–1.8 ml | — |
| 10 kg | 2–2 mg | 2.0–2.0 ml | — |
| 12 kg | 2–2 mg | 2.4–2.4 ml | — |
| 15 kg | 3–3 mg | 3.0–3.0 ml | — |
| 18 kg | 4–4 mg | 3.6–3.6 ml | — |
| 20 kg | 4–4 mg | 4.0–4.0 ml | — |
| 25 kg | 5–5 mg | 5.0–5.0 ml | — |
| 30 kg | 6–6 mg | 6.0–6.0 ml | — |
⚠️ Warnings
- • Avoid with erythromycin. Intranasal 0.3 mg/kg, buccal 0.3 mg/kg for acute seizure control.
Nitrazepam
Nitrazepam
💊 Myoclonus, partial epilepsy, infantile spasms, insomnia
Formulation
Tablet
Standard tablet
Dose Range
0.3–1 mg/kg
Max Daily
N/A
Frequency
Every 12 hours or single dose at night
Max Single
10 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 2–5 mg | 1.5–5.0 ml | — |
| 6 kg | 2–6 mg | 1.8–6.0 ml | — |
| 7 kg | 2–7 mg | 2.1–7.0 ml | — |
| 8 kg | 2–8 mg | 2.4–8.0 ml | — |
| 9 kg | 3–9 mg | 2.7–9.0 ml | — |
| 10 kg | 3–10 mg | 3.0–10.0 ml | — |
| 12 kg | 4–12 mg | 3.6–12.0 ml | — |
| 15 kg | 5–15 mg | 4.5–15.0 ml | — |
| 18 kg | 5–18 mg | 5.4–18.0 ml | — |
| 20 kg | 6–20 mg | 6.0–20.0 ml | — |
| 25 kg | 8–25 mg | 7.5–25.0 ml | — |
| 30 kg | 9–30 mg | 9.0–30.0 ml | — |
⚠️ Warnings
- • Therapeutic level 15-40 mg/l.
Paraldehyde
Paraldehyde
💊 Uncontrolled status epilepticus
Formulation
Tablet
Standard tablet
Dose Range
0.1–0.3 mg/kg
Max Daily
N/A
Frequency
q 4-6 hours (deep IM or PR with coconut oil)
Max Single
8 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–2 mg | 0.5–1.5 ml | — |
| 6 kg | 1–2 mg | 0.6–1.8 ml | — |
| 7 kg | 1–2 mg | 0.7–2.1 ml | — |
| 8 kg | 1–2 mg | 0.8–2.4 ml | — |
| 9 kg | 1–3 mg | 0.9–2.7 ml | — |
| 10 kg | 1–3 mg | 1.0–3.0 ml | — |
| 12 kg | 1–4 mg | 1.2–3.6 ml | — |
| 15 kg | 2–5 mg | 1.5–4.5 ml | — |
| 18 kg | 2–5 mg | 1.8–5.4 ml | — |
| 20 kg | 2–6 mg | 2.0–6.0 ml | — |
| 25 kg | 3–8 mg | 2.5–7.5 ml | — |
| 30 kg | 3–9 mg | 3.0–9.0 ml | — |
⚠️ Warnings
- • Proctitis and abscess at injection site. Use glass syringe. C/I: Pulmonary and hepatic disease.
Phenobarbitone
Phenobarbitone sodium
💊 Neonatal seizures, tonic-clonic, partial seizures, status epilepticus, febrile convulsions prophylaxis
Formulation
Tablet
Standard tablet
Dose Range
15–20 mg/kg
Max Daily
N/A
Frequency
Loading 15-20 mg/kg IV over 15-20 min; maintenance 3-5 mg/kg/day q 12 hr or single dose
Max Single
200 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 75–100 mg | 75.0–100.0 ml | — |
| 6 kg | 90–120 mg | 90.0–120.0 ml | — |
| 7 kg | 105–140 mg | 105.0–140.0 ml | — |
| 8 kg | 120–160 mg | 120.0–160.0 ml | — |
| 9 kg | 135–180 mg | 135.0–180.0 ml | — |
| 10 kg | 150–200 mg | 150.0–200.0 ml | — |
| 12 kg | 180–240 mg | 180.0–240.0 ml | — |
| 15 kg | 225–300 mg | 225.0–300.0 ml | — |
| 18 kg | 270–360 mg | 270.0–360.0 ml | — |
| 20 kg | 300–400 mg | 300.0–400.0 ml | — |
| 25 kg | 375–500 mg | 375.0–500.0 ml | — |
| 30 kg | 450–600 mg | 450.0–600.0 ml | — |
⚠️ Warnings
- • Therapeutic level 15-40 mg/l. C/I: Porphyria, hepatic and renal disease, severe asthma.
Primidone
Primidone
💊 Partial and tonic clonic seizures
Formulation
Tablet
Standard tablet
Dose Range
10–25 mg/kg
Max Daily
N/A
Frequency
Every 8-12 hours
Max Single
750 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–125 mg | 50.0–125.0 ml | — |
| 6 kg | 60–150 mg | 60.0–150.0 ml | — |
| 7 kg | 70–175 mg | 70.0–175.0 ml | — |
| 8 kg | 80–200 mg | 80.0–200.0 ml | — |
| 9 kg | 90–225 mg | 90.0–225.0 ml | — |
| 10 kg | 100–250 mg | 100.0–250.0 ml | — |
| 12 kg | 120–300 mg | 120.0–300.0 ml | — |
| 15 kg | 150–375 mg | 150.0–375.0 ml | — |
| 18 kg | 180–450 mg | 180.0–450.0 ml | — |
| 20 kg | 200–500 mg | 200.0–500.0 ml | — |
| 25 kg | 250–625 mg | 250.0–625.0 ml | — |
| 30 kg | 300–750 mg | 300.0–750.0 ml | — |
⚠️ Warnings
- • Start at 1/3 to 1/2 of initial dose. Newborn: 12-20 mg/kg/day q 6-12 hr.
Pyridoxine
Pyridoxine
💊 Pyridoxine dependent seizures
Formulation
Tablet
Standard tablet
Dose Range
50–100 mg/kg
Max Daily
N/A
Frequency
Once daily (maintenance)
Max Single
200 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 250–500 mg | 250.0–500.0 ml | — |
| 6 kg | 300–600 mg | 300.0–600.0 ml | — |
| 7 kg | 350–700 mg | 350.0–700.0 ml | — |
| 8 kg | 400–800 mg | 400.0–800.0 ml | — |
| 9 kg | 450–900 mg | 450.0–900.0 ml | — |
| 10 kg | 500–1000 mg | 500.0–1000.0 ml | — |
| 12 kg | 600–1200 mg | 600.0–1200.0 ml | — |
| 15 kg | 750–1500 mg | 750.0–1500.0 ml | — |
| 18 kg | 900–1800 mg | 900.0–1800.0 ml | — |
| 20 kg | 1000–2000 mg | 1000.0–2000.0 ml | — |
| 25 kg | 1250–2500 mg | 1250.0–2500.0 ml | — |
| 30 kg | 1500–3000 mg | 1500.0–3000.0 ml | — |
⚠️ Warnings
- • Give 50-100 mg/dose IM or rapid IV under EEG control.
Thiopental
Thiopental
💊 Uncontrolled status epilepticus (requires mechanical ventilation)
Formulation
Tablet
Standard tablet
Dose Range
5–10 mg/kg
Max Daily
N/A
Frequency
Loading then 2-10 mg/kg/hr continuous infusion
Max Single
200 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 25–50 mg | 25.0–50.0 ml | — |
| 6 kg | 30–60 mg | 30.0–60.0 ml | — |
| 7 kg | 35–70 mg | 35.0–70.0 ml | — |
| 8 kg | 40–80 mg | 40.0–80.0 ml | — |
| 9 kg | 45–90 mg | 45.0–90.0 ml | — |
| 10 kg | 50–100 mg | 50.0–100.0 ml | — |
| 12 kg | 60–120 mg | 60.0–120.0 ml | — |
| 15 kg | 75–150 mg | 75.0–150.0 ml | — |
| 18 kg | 90–180 mg | 90.0–180.0 ml | — |
| 20 kg | 100–200 mg | 100.0–200.0 ml | — |
| 25 kg | 125–250 mg | 125.0–250.0 ml | — |
| 30 kg | 150–300 mg | 150.0–300.0 ml | — |
⚠️ Warnings
- •
Topiramate
Topiramate
💊 Refractory partial seizures, primary generalized tonic-clonic seizures, absence seizures, Lennox-Gastaut, West syndrome, migraine prophylaxis
Formulation
Tablet
Standard tablet
Dose Range
1–8 mg/kg
Max Daily
N/A
Frequency
Once daily (gradually increased over 2 weeks)
Max Single
400 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 5–40 mg | 5.0–40.0 ml | — |
| 6 kg | 6–48 mg | 6.0–48.0 ml | — |
| 7 kg | 7–56 mg | 7.0–56.0 ml | — |
| 8 kg | 8–64 mg | 8.0–64.0 ml | — |
| 9 kg | 9–72 mg | 9.0–72.0 ml | — |
| 10 kg | 10–80 mg | 10.0–80.0 ml | — |
| 12 kg | 12–96 mg | 12.0–96.0 ml | — |
| 15 kg | 15–120 mg | 15.0–120.0 ml | — |
| 18 kg | 18–144 mg | 18.0–144.0 ml | — |
| 20 kg | 20–160 mg | 20.0–160.0 ml | — |
| 25 kg | 25–200 mg | 25.0–200.0 ml | — |
| 30 kg | 30–240 mg | 30.0–240.0 ml | — |
⚠️ Warnings
- • SE: anorexia, weight loss, dizziness, glaucoma, metabolic acidosis, ataxia, renal calculi.
Valproate Sodium
Valproate sodium
💊 Broad spectrum: generalized tonic-clonic, partial seizures, absence attacks, myoclonic, atonic, frequent febrile seizures, Lennox-Gestaut, West syndrome, juvenile myoclonic epilepsy
Formulation
Tablet
Standard tablet
Dose Range
10–60 mg/kg
Max Daily
N/A
Frequency
Every 8 hours (start 10-15 mg/kg/day, max 60 mg/kg/day)
Max Single
1000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–300 mg | 50.0–300.0 ml | — |
| 6 kg | 60–360 mg | 60.0–360.0 ml | — |
| 7 kg | 70–420 mg | 70.0–420.0 ml | — |
| 8 kg | 80–480 mg | 80.0–480.0 ml | — |
| 9 kg | 90–540 mg | 90.0–540.0 ml | — |
| 10 kg | 100–600 mg | 100.0–600.0 ml | — |
| 12 kg | 120–720 mg | 120.0–720.0 ml | — |
| 15 kg | 150–900 mg | 150.0–900.0 ml | — |
| 18 kg | 180–1080 mg | 180.0–1080.0 ml | — |
| 20 kg | 200–1200 mg | 200.0–1200.0 ml | — |
| 25 kg | 250–1500 mg | 250.0–1500.0 ml | — |
| 30 kg | 300–1800 mg | 300.0–1800.0 ml | — |
⚠️ Warnings
- • C/I: Active liver disease, urea cycle disorders. SE: hepatic/renal dysfunction, Reye-like syndrome, bleeding, alopecia.
Vigabatrin
Vigabatrin
💊 Resistant partial seizures, infantile spasms (especially tuberous sclerosis), Lennox-Gastaut syndrome. First-line for infantile spasms with steroids.
Formulation
Tablet
Standard tablet
Dose Range
50–150 mg/kg
Max Daily
N/A
Frequency
Every 12 hours (gradually increase by 30 mg/kg every 5 days)
Max Single
2000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 250–750 mg | 250.0–750.0 ml | — |
| 6 kg | 300–900 mg | 300.0–900.0 ml | — |
| 7 kg | 350–1050 mg | 350.0–1050.0 ml | — |
| 8 kg | 400–1200 mg | 400.0–1200.0 ml | — |
| 9 kg | 450–1350 mg | 450.0–1350.0 ml | — |
| 10 kg | 500–1500 mg | 500.0–1500.0 ml | — |
| 12 kg | 600–1800 mg | 600.0–1800.0 ml | — |
| 15 kg | 750–2250 mg | 750.0–2250.0 ml | — |
| 18 kg | 900–2700 mg | 900.0–2700.0 ml | — |
| 20 kg | 1000–3000 mg | 1000.0–3000.0 ml | — |
| 25 kg | 1250–3750 mg | 1250.0–3750.0 ml | — |
| 30 kg | 1500–4500 mg | 1500.0–4500.0 ml | — |
⚠️ Warnings
- • Stop if no response in 2 weeks. SE: weight gain, hyperkinesia, visual field defects, retinopathy.
Zonisamide
Zonisamide
💊 Partial and tonic-clonic seizures, atypical absences, Lennox-Gastaut syndrome, juvenile myoclonic epilepsy
Formulation
Tablet
Standard tablet
Dose Range
4–8 mg/kg
Max Daily
N/A
Frequency
Every 12 hours
Max Single
400 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 20–40 mg | 20.0–40.0 ml | — |
| 6 kg | 24–48 mg | 24.0–48.0 ml | — |
| 7 kg | 28–56 mg | 28.0–56.0 ml | — |
| 8 kg | 32–64 mg | 32.0–64.0 ml | — |
| 9 kg | 36–72 mg | 36.0–72.0 ml | — |
| 10 kg | 40–80 mg | 40.0–80.0 ml | — |
| 12 kg | 48–96 mg | 48.0–96.0 ml | — |
| 15 kg | 60–120 mg | 60.0–120.0 ml | — |
| 18 kg | 72–144 mg | 72.0–144.0 ml | — |
| 20 kg | 80–160 mg | 80.0–160.0 ml | — |
| 25 kg | 100–200 mg | 100.0–200.0 ml | — |
| 30 kg | 120–240 mg | 120.0–240.0 ml | — |
⚠️ Warnings
- • Avoid below 16 years.
Lorazepam (Status)
Lorazepam
💊 Uncontrolled status epilepticus
Formulation
Tablet
Standard tablet
Dose Range
0.05–0.1 mg/kg
Max Daily
N/A
Frequency
0.05-0.1 mg/kg/dose IV over 2-5 min; may repeat after 10-15 min
Max Single
4 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 0–1 mg | 0.3–0.5 ml | — |
| 6 kg | 0–1 mg | 0.3–0.6 ml | — |
| 7 kg | 0–1 mg | 0.4–0.7 ml | — |
| 8 kg | 0–1 mg | 0.4–0.8 ml | — |
| 9 kg | 0–1 mg | 0.5–0.9 ml | — |
| 10 kg | 1–1 mg | 0.5–1.0 ml | — |
| 12 kg | 1–1 mg | 0.6–1.2 ml | — |
| 15 kg | 1–2 mg | 0.8–1.5 ml | — |
| 18 kg | 1–2 mg | 0.9–1.8 ml | — |
| 20 kg | 1–2 mg | 1.0–2.0 ml | — |
| 25 kg | 1–3 mg | 1.3–2.5 ml | — |
| 30 kg | 2–3 mg | 1.5–3.0 ml | — |
⚠️ Warnings
- • Risk of hypotension and respiratory depression is low.
Chlorpromazine (Antiemetic)
Chlorpromazine
💊 Intractable hiccups, agitation, chorea
Formulation
Tablet
Standard tablet
Dose Range
0.5–0.5 mg/kg
Max Daily
N/A
Frequency
Every 4-6 hours
Max Single
75 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 3–3 mg | 2.5–2.5 ml | — |
| 6 kg | 3–3 mg | 3.0–3.0 ml | — |
| 7 kg | 4–4 mg | 3.5–3.5 ml | — |
| 8 kg | 4–4 mg | 4.0–4.0 ml | — |
| 9 kg | 5–5 mg | 4.5–4.5 ml | — |
| 10 kg | 5–5 mg | 5.0–5.0 ml | — |
| 12 kg | 6–6 mg | 6.0–6.0 ml | — |
| 15 kg | 8–8 mg | 7.5–7.5 ml | — |
| 18 kg | 9–9 mg | 9.0–9.0 ml | — |
| 20 kg | 10–10 mg | 10.0–10.0 ml | — |
| 25 kg | 13–13 mg | 12.5–12.5 ml | — |
| 30 kg | 15–15 mg | 15.0–15.0 ml | — |
⚠️ Warnings
- • Avoid in children below 1 year. Max <5yr: 40 mg/day, >5yr: 75 mg/day.
Dimenhydrinate
Dimenhydrinate
💊 Motion sickness, vertigo, radiation or chemotherapy induced nausea
Formulation
Tablet
Standard tablet
Dose Range
5–5 mg/kg
Max Daily
N/A
Frequency
Every 6 hours
Max Single
150 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 25–25 mg | 25.0–25.0 ml | — |
| 6 kg | 30–30 mg | 30.0–30.0 ml | — |
| 7 kg | 35–35 mg | 35.0–35.0 ml | — |
| 8 kg | 40–40 mg | 40.0–40.0 ml | — |
| 9 kg | 45–45 mg | 45.0–45.0 ml | — |
| 10 kg | 50–50 mg | 50.0–50.0 ml | — |
| 12 kg | 60–60 mg | 60.0–60.0 ml | — |
| 15 kg | 75–75 mg | 75.0–75.0 ml | — |
| 18 kg | 90–90 mg | 90.0–90.0 ml | — |
| 20 kg | 100–100 mg | 100.0–100.0 ml | — |
| 25 kg | 125–125 mg | 125.0–125.0 ml | — |
| 30 kg | 150–150 mg | 150.0–150.0 ml | — |
⚠️ Warnings
- • Avoid in children below 2 years. Max 2-6yr: 75 mg/day, 6-12yr: 150 mg/day.
Granisetron
Granisetron
💊 Chemotherapy induced emesis (10-15x more potent than ondansetron)
Formulation
Tablet
Standard tablet
Dose Range
10–20 mg/kg
Max Daily
N/A
Frequency
q 15-30 min before chemotherapy or single 40 μg/kg/dose
Max Single
2 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–100 mg | 50.0–100.0 ml | — |
| 6 kg | 60–120 mg | 60.0–120.0 ml | — |
| 7 kg | 70–140 mg | 70.0–140.0 ml | — |
| 8 kg | 80–160 mg | 80.0–160.0 ml | — |
| 9 kg | 90–180 mg | 90.0–180.0 ml | — |
| 10 kg | 100–200 mg | 100.0–200.0 ml | — |
| 12 kg | 120–240 mg | 120.0–240.0 ml | — |
| 15 kg | 150–300 mg | 150.0–300.0 ml | — |
| 18 kg | 180–360 mg | 180.0–360.0 ml | — |
| 20 kg | 200–400 mg | 200.0–400.0 ml | — |
| 25 kg | 250–500 mg | 250.0–500.0 ml | — |
| 30 kg | 300–600 mg | 300.0–600.0 ml | — |
⚠️ Warnings
- •
Metoclopramide
Metoclopramide hydrochloride
💊 GERD, GI dysmotility, galactagogue. Chemotherapy induced emesis 2-3 mg/kg/dose.
Formulation
Tablet
Standard tablet
Dose Range
0.1–0.8 mg/kg
Max Daily
N/A
Frequency
Every 6-8 hours
Max Single
20 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–4 mg | 0.5–4.0 ml | — |
| 6 kg | 1–5 mg | 0.6–4.8 ml | — |
| 7 kg | 1–6 mg | 0.7–5.6 ml | — |
| 8 kg | 1–6 mg | 0.8–6.4 ml | — |
| 9 kg | 1–7 mg | 0.9–7.2 ml | — |
| 10 kg | 1–8 mg | 1.0–8.0 ml | — |
| 12 kg | 1–10 mg | 1.2–9.6 ml | — |
| 15 kg | 2–12 mg | 1.5–12.0 ml | — |
| 18 kg | 2–14 mg | 1.8–14.4 ml | — |
| 20 kg | 2–16 mg | 2.0–16.0 ml | — |
| 25 kg | 3–20 mg | 2.5–20.0 ml | — |
| 30 kg | 3–24 mg | 3.0–24.0 ml | — |
⚠️ Warnings
- • Risk of extrapyramidal side effects. C/I: Epilepsy, pheochromocytoma. Avoid below 18 years.
Palonosetron
Palonosetron
💊 Nausea and vomiting associated with cancer chemotherapy, post-operative
Formulation
Tablet
Standard tablet
Dose Range
0.005–0.01 mg/kg
Max Daily
N/A
Frequency
Single dose (250 μg for chemo, 75 μg post-op)
Max Single
1.5 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 0–0 mg | 0.0–0.1 ml | — |
| 6 kg | 0–0 mg | 0.0–0.1 ml | — |
| 7 kg | 0–0 mg | 0.0–0.1 ml | — |
| 8 kg | 0–0 mg | 0.0–0.1 ml | — |
| 9 kg | 0–0 mg | 0.0–0.1 ml | — |
| 10 kg | 0–0 mg | 0.1–0.1 ml | — |
| 12 kg | 0–0 mg | 0.1–0.1 ml | — |
| 15 kg | 0–0 mg | 0.1–0.1 ml | — |
| 18 kg | 0–0 mg | 0.1–0.2 ml | — |
| 20 kg | 0–0 mg | 0.1–0.2 ml | — |
| 25 kg | 0–0 mg | 0.1–0.3 ml | — |
| 30 kg | 0–0 mg | 0.1–0.3 ml | — |
⚠️ Warnings
- • C/I: Intestinal obstruction or ileus.
Prochlorperazine
Prochlorperazine
💊 Nausea and vomiting
Formulation
Tablet
Standard tablet
Dose Range
0.4–0.4 mg/kg
Max Daily
N/A
Frequency
Every 6-8 hours
Max Single
25 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 2–2 mg | 2.0–2.0 ml | — |
| 6 kg | 2–2 mg | 2.4–2.4 ml | — |
| 7 kg | 3–3 mg | 2.8–2.8 ml | — |
| 8 kg | 3–3 mg | 3.2–3.2 ml | — |
| 9 kg | 4–4 mg | 3.6–3.6 ml | — |
| 10 kg | 4–4 mg | 4.0–4.0 ml | — |
| 12 kg | 5–5 mg | 4.8–4.8 ml | — |
| 15 kg | 6–6 mg | 6.0–6.0 ml | — |
| 18 kg | 7–7 mg | 7.2–7.2 ml | — |
| 20 kg | 8–8 mg | 8.0–8.0 ml | — |
| 25 kg | 10–10 mg | 10.0–10.0 ml | — |
| 30 kg | 12–12 mg | 12.0–12.0 ml | — |
⚠️ Warnings
- • SE: Extrapyramidal symptoms or orthostatic hypotension can occur.
Promethazine (Antiemetic)
Promethazine theoclate
💊 Motion sickness
Formulation
Tablet
Standard tablet
Dose Range
0.5–0.5 mg/kg
Max Daily
N/A
Frequency
Every 8-12 hours
Max Single
25 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 3–3 mg | 2.5–2.5 ml | — |
| 6 kg | 3–3 mg | 3.0–3.0 ml | — |
| 7 kg | 4–4 mg | 3.5–3.5 ml | — |
| 8 kg | 4–4 mg | 4.0–4.0 ml | — |
| 9 kg | 5–5 mg | 4.5–4.5 ml | — |
| 10 kg | 5–5 mg | 5.0–5.0 ml | — |
| 12 kg | 6–6 mg | 6.0–6.0 ml | — |
| 15 kg | 8–8 mg | 7.5–7.5 ml | — |
| 18 kg | 9–9 mg | 9.0–9.0 ml | — |
| 20 kg | 10–10 mg | 10.0–10.0 ml | — |
| 25 kg | 13–13 mg | 12.5–12.5 ml | — |
| 30 kg | 15–15 mg | 15.0–15.0 ml | — |
⚠️ Warnings
- • Administer first dose 1-2 hr before travel. C/I: Children <2 yr, asthma, sleep apnea.
Trifluoperazine
Trifluoperazine
💊 Nausea and vomiting due to radiation sickness and chemotherapy
Formulation
Tablet
Standard tablet
Dose Range
0.5–0.5 mg/kg
Max Daily
N/A
Frequency
Every 8 hours
Max Single
10 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 3–3 mg | 2.5–2.5 ml | — |
| 6 kg | 3–3 mg | 3.0–3.0 ml | — |
| 7 kg | 4–4 mg | 3.5–3.5 ml | — |
| 8 kg | 4–4 mg | 4.0–4.0 ml | — |
| 9 kg | 5–5 mg | 4.5–4.5 ml | — |
| 10 kg | 5–5 mg | 5.0–5.0 ml | — |
| 12 kg | 6–6 mg | 6.0–6.0 ml | — |
| 15 kg | 8–8 mg | 7.5–7.5 ml | — |
| 18 kg | 9–9 mg | 9.0–9.0 ml | — |
| 20 kg | 10–10 mg | 10.0–10.0 ml | — |
| 25 kg | 13–13 mg | 12.5–12.5 ml | — |
| 30 kg | 15–15 mg | 15.0–15.0 ml | — |
⚠️ Warnings
- • Extrapyramidal symptoms common. C/I: Comatose state, hepatic damage, children <3 yr, bone marrow depression.
Amphotericin B
Amphotericin B
💊 Candidemia, aspergillosis, blastomycosis, coccidioidomycosis, cryptococcosis, histoplasmosis, leishmaniasis, fungal endocarditis
Formulation
Tablet
Standard tablet
Dose Range
0.25–1 mg/kg
Max Daily
N/A
Frequency
Once daily IV infusion over 4-6 hr
Max Single
N/A
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–5 mg | 1.3–5.0 ml | — |
| 6 kg | 2–6 mg | 1.5–6.0 ml | — |
| 7 kg | 2–7 mg | 1.8–7.0 ml | — |
| 8 kg | 2–8 mg | 2.0–8.0 ml | — |
| 9 kg | 2–9 mg | 2.3–9.0 ml | — |
| 10 kg | 3–10 mg | 2.5–10.0 ml | — |
| 12 kg | 3–12 mg | 3.0–12.0 ml | — |
| 15 kg | 4–15 mg | 3.8–15.0 ml | — |
| 18 kg | 5–18 mg | 4.5–18.0 ml | — |
| 20 kg | 5–20 mg | 5.0–20.0 ml | — |
| 25 kg | 6–25 mg | 6.3–25.0 ml | — |
| 30 kg | 8–30 mg | 7.5–30.0 ml | — |
⚠️ Warnings
- • Monitor serum potassium, hepatic and renal toxicity. Change IV site frequently to prevent phlebitis. Liposomal 1-5 mg/kg/day.
Caspofungin
Caspofungin
💊 Invasive candidiasis, aspergillosis resistant/intolerant to amphotericin B, empirical therapy in febrile neutropenic patients
Formulation
Tablet
Standard tablet
Dose Range
1–2 mg/kg
Max Daily
N/A
Frequency
Once daily (70 mg/m² on day 1, then 50 mg/m²/day, max 70 mg/day)
Max Single
70 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 5–10 mg | 5.0–10.0 ml | — |
| 6 kg | 6–12 mg | 6.0–12.0 ml | — |
| 7 kg | 7–14 mg | 7.0–14.0 ml | — |
| 8 kg | 8–16 mg | 8.0–16.0 ml | — |
| 9 kg | 9–18 mg | 9.0–18.0 ml | — |
| 10 kg | 10–20 mg | 10.0–20.0 ml | — |
| 12 kg | 12–24 mg | 12.0–24.0 ml | — |
| 15 kg | 15–30 mg | 15.0–30.0 ml | — |
| 18 kg | 18–36 mg | 18.0–36.0 ml | — |
| 20 kg | 20–40 mg | 20.0–40.0 ml | — |
| 25 kg | 25–50 mg | 25.0–50.0 ml | — |
| 30 kg | 30–60 mg | 30.0–60.0 ml | — |
⚠️ Warnings
- • SE: nausea, vomiting, dysphagia, thrombophlebitis, dystonia.
Clotrimazole
Clotrimazole
💊 Oral and vaginal candidiasis, ringworm infections
Formulation
Tablet
Standard tablet
Dose Range
3–6 mg/kg
Max Daily
N/A
Frequency
Topical application
Max Single
200 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 15–30 mg | 15.0–30.0 ml | — |
| 6 kg | 18–36 mg | 18.0–36.0 ml | — |
| 7 kg | 21–42 mg | 21.0–42.0 ml | — |
| 8 kg | 24–48 mg | 24.0–48.0 ml | — |
| 9 kg | 27–54 mg | 27.0–54.0 ml | — |
| 10 kg | 30–60 mg | 30.0–60.0 ml | — |
| 12 kg | 36–72 mg | 36.0–72.0 ml | — |
| 15 kg | 45–90 mg | 45.0–90.0 ml | — |
| 18 kg | 54–108 mg | 54.0–108.0 ml | — |
| 20 kg | 60–120 mg | 60.0–120.0 ml | — |
| 25 kg | 75–150 mg | 75.0–150.0 ml | — |
| 30 kg | 90–180 mg | 90.0–180.0 ml | — |
⚠️ Warnings
- •
Fluconazole
Fluconazole
💊 Candidiasis, cryptococcal meningitis, prophylaxis in immunocompromised. Invasive systemic candidiasis 6-12 mg/kg/day.
Formulation
Tablet
Standard tablet
Dose Range
3–12 mg/kg
Max Daily
N/A
Frequency
Once daily
Max Single
400 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 15–60 mg | 15.0–60.0 ml | — |
| 6 kg | 18–72 mg | 18.0–72.0 ml | — |
| 7 kg | 21–84 mg | 21.0–84.0 ml | — |
| 8 kg | 24–96 mg | 24.0–96.0 ml | — |
| 9 kg | 27–108 mg | 27.0–108.0 ml | — |
| 10 kg | 30–120 mg | 30.0–120.0 ml | — |
| 12 kg | 36–144 mg | 36.0–144.0 ml | — |
| 15 kg | 45–180 mg | 45.0–180.0 ml | — |
| 18 kg | 54–216 mg | 54.0–216.0 ml | — |
| 20 kg | 60–240 mg | 60.0–240.0 ml | — |
| 25 kg | 75–300 mg | 75.0–300.0 ml | — |
| 30 kg | 90–360 mg | 90.0–360.0 ml | — |
⚠️ Warnings
- • SE: dizziness, skin rash, abdominal pain, hepatic dysfunction.
Flucytosine
Flucytosine
💊 Systemic yeast infections (Candida, Cryptococcus) - always combine with amphotericin B
Formulation
Tablet
Standard tablet
Dose Range
50–150 mg/kg
Max Daily
N/A
Frequency
Every 6-8 hours
Max Single
8000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 250–750 mg | 250.0–750.0 ml | — |
| 6 kg | 300–900 mg | 300.0–900.0 ml | — |
| 7 kg | 350–1050 mg | 350.0–1050.0 ml | — |
| 8 kg | 400–1200 mg | 400.0–1200.0 ml | — |
| 9 kg | 450–1350 mg | 450.0–1350.0 ml | — |
| 10 kg | 500–1500 mg | 500.0–1500.0 ml | — |
| 12 kg | 600–1800 mg | 600.0–1800.0 ml | — |
| 15 kg | 750–2250 mg | 750.0–2250.0 ml | — |
| 18 kg | 900–2700 mg | 900.0–2700.0 ml | — |
| 20 kg | 1000–3000 mg | 1000.0–3000.0 ml | — |
| 25 kg | 1250–3750 mg | 1250.0–3750.0 ml | — |
| 30 kg | 1500–4500 mg | 1500.0–4500.0 ml | — |
⚠️ Warnings
- • Adjust dose in renal dysfunction. Do not use as single agent. Max 8 gm/day.
Griseofulvin
Griseofulvin
💊 Dermatophyte infections (skin, hair, nails). Double dose in onychomycosis.
Formulation
Tablet
Standard tablet
Dose Range
5–15 mg/kg
Max Daily
N/A
Frequency
Every 6-12 hours
Max Single
500 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 25–75 mg | 25.0–75.0 ml | — |
| 6 kg | 30–90 mg | 30.0–90.0 ml | — |
| 7 kg | 35–105 mg | 35.0–105.0 ml | — |
| 8 kg | 40–120 mg | 40.0–120.0 ml | — |
| 9 kg | 45–135 mg | 45.0–135.0 ml | — |
| 10 kg | 50–150 mg | 50.0–150.0 ml | — |
| 12 kg | 60–180 mg | 60.0–180.0 ml | — |
| 15 kg | 75–225 mg | 75.0–225.0 ml | — |
| 18 kg | 90–270 mg | 90.0–270.0 ml | — |
| 20 kg | 100–300 mg | 100.0–300.0 ml | — |
| 25 kg | 125–375 mg | 125.0–375.0 ml | — |
| 30 kg | 150–450 mg | 150.0–450.0 ml | — |
⚠️ Warnings
- • Take with meals. For nails 6-12 weeks minimum.
Hamycin
Hamycin
💊 Oral thrush
Formulation
Tablet
Standard tablet
Dose Range
1–2 mg/kg
Max Daily
N/A
Frequency
Local application after each feed
Max Single
100 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 5–10 mg | 5.0–10.0 ml | — |
| 6 kg | 6–12 mg | 6.0–12.0 ml | — |
| 7 kg | 7–14 mg | 7.0–14.0 ml | — |
| 8 kg | 8–16 mg | 8.0–16.0 ml | — |
| 9 kg | 9–18 mg | 9.0–18.0 ml | — |
| 10 kg | 10–20 mg | 10.0–20.0 ml | — |
| 12 kg | 12–24 mg | 12.0–24.0 ml | — |
| 15 kg | 15–30 mg | 15.0–30.0 ml | — |
| 18 kg | 18–36 mg | 18.0–36.0 ml | — |
| 20 kg | 20–40 mg | 20.0–40.0 ml | — |
| 25 kg | 25–50 mg | 25.0–50.0 ml | — |
| 30 kg | 30–60 mg | 30.0–60.0 ml | — |
⚠️ Warnings
- •
Itraconazole
Itraconazole
💊 Blastomycosis, histoplasmosis, aspergillosis
Formulation
Tablet
Standard tablet
Dose Range
5–10 mg/kg
Max Daily
N/A
Frequency
Once or twice daily
Max Single
200 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 25–50 mg | 25.0–50.0 ml | — |
| 6 kg | 30–60 mg | 30.0–60.0 ml | — |
| 7 kg | 35–70 mg | 35.0–70.0 ml | — |
| 8 kg | 40–80 mg | 40.0–80.0 ml | — |
| 9 kg | 45–90 mg | 45.0–90.0 ml | — |
| 10 kg | 50–100 mg | 50.0–100.0 ml | — |
| 12 kg | 60–120 mg | 60.0–120.0 ml | — |
| 15 kg | 75–150 mg | 75.0–150.0 ml | — |
| 18 kg | 90–180 mg | 90.0–180.0 ml | — |
| 20 kg | 100–200 mg | 100.0–200.0 ml | — |
| 25 kg | 125–250 mg | 125.0–250.0 ml | — |
| 30 kg | 150–300 mg | 150.0–300.0 ml | — |
⚠️ Warnings
- • Not recommended in children below 12 years. SE: nonspecific GI side effects, raised liver enzymes, hypokalemia. Avoid with midazolam, cisapride, quinidine.
Ketoconazole
Ketoconazole
💊 Systemic fungal infections, cutaneous dermatophytes
Formulation
Tablet
Standard tablet
Dose Range
3.3–6.6 mg/kg
Max Daily
N/A
Frequency
Once daily after meals
Max Single
400 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 17–33 mg | 16.5–33.0 ml | — |
| 6 kg | 20–40 mg | 19.8–39.6 ml | — |
| 7 kg | 23–46 mg | 23.1–46.2 ml | — |
| 8 kg | 26–53 mg | 26.4–52.8 ml | — |
| 9 kg | 30–59 mg | 29.7–59.4 ml | — |
| 10 kg | 33–66 mg | 33.0–66.0 ml | — |
| 12 kg | 40–79 mg | 39.6–79.2 ml | — |
| 15 kg | 50–99 mg | 49.5–99.0 ml | — |
| 18 kg | 59–119 mg | 59.4–118.8 ml | — |
| 20 kg | 66–132 mg | 66.0–132.0 ml | — |
| 25 kg | 83–165 mg | 82.5–165.0 ml | — |
| 30 kg | 99–198 mg | 99.0–198.0 ml | — |
⚠️ Warnings
- • Monitor liver function tests. SE: suppression of testosterone and glucocorticoid secretion. C/I: hepatic impairment.
Miconazole
Miconazole
💊 Systemic yeast infections (Candida, Cryptococcus)
Formulation
Tablet
Standard tablet
Dose Range
20–40 mg/kg
Max Daily
N/A
Frequency
Every 8 hours (IV); 2.5-5 ml BD-TDS (oral)
Max Single
3600 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 100–200 mg | 100.0–200.0 ml | — |
| 6 kg | 120–240 mg | 120.0–240.0 ml | — |
| 7 kg | 140–280 mg | 140.0–280.0 ml | — |
| 8 kg | 160–320 mg | 160.0–320.0 ml | — |
| 9 kg | 180–360 mg | 180.0–360.0 ml | — |
| 10 kg | 200–400 mg | 200.0–400.0 ml | — |
| 12 kg | 240–480 mg | 240.0–480.0 ml | — |
| 15 kg | 300–600 mg | 300.0–600.0 ml | — |
| 18 kg | 360–720 mg | 360.0–720.0 ml | — |
| 20 kg | 400–800 mg | 400.0–800.0 ml | — |
| 25 kg | 500–1000 mg | 500.0–1000.0 ml | — |
| 30 kg | 600–1200 mg | 600.0–1200.0 ml | — |
⚠️ Warnings
- • IV dose diluted with isotonic saline or 5% dextrose over 30-60 min. Local phlebitis common.
Terbinafine
Terbinafine hydrochloride
💊 Fungal infections of skin, nails and hair
Formulation
Tablet
Standard tablet
Dose Range
5–8 mg/kg
Max Daily
N/A
Frequency
Once daily
Max Single
250 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 25–40 mg | 25.0–40.0 ml | — |
| 6 kg | 30–48 mg | 30.0–48.0 ml | — |
| 7 kg | 35–56 mg | 35.0–56.0 ml | — |
| 8 kg | 40–64 mg | 40.0–64.0 ml | — |
| 9 kg | 45–72 mg | 45.0–72.0 ml | — |
| 10 kg | 50–80 mg | 50.0–80.0 ml | — |
| 12 kg | 60–96 mg | 60.0–96.0 ml | — |
| 15 kg | 75–120 mg | 75.0–120.0 ml | — |
| 18 kg | 90–144 mg | 90.0–144.0 ml | — |
| 20 kg | 100–160 mg | 100.0–160.0 ml | — |
| 25 kg | 125–200 mg | 125.0–200.0 ml | — |
| 30 kg | 150–240 mg | 150.0–240.0 ml | — |
⚠️ Warnings
- • Avoid below 2 years. SE: diarrhea, nausea, skin irritation, leucopenia.
Voriconazole
Voriconazole
💊 Invasive aspergillosis, candidemia in non-neutropenic patients, fluconazole resistant Candida infections
Formulation
Tablet
Standard tablet
Dose Range
4–8 mg/kg
Max Daily
N/A
Frequency
Every 12 hours (loading 6 mg/kg q 12 hr x 24 hr)
Max Single
300 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 20–40 mg | 20.0–40.0 ml | — |
| 6 kg | 24–48 mg | 24.0–48.0 ml | — |
| 7 kg | 28–56 mg | 28.0–56.0 ml | — |
| 8 kg | 32–64 mg | 32.0–64.0 ml | — |
| 9 kg | 36–72 mg | 36.0–72.0 ml | — |
| 10 kg | 40–80 mg | 40.0–80.0 ml | — |
| 12 kg | 48–96 mg | 48.0–96.0 ml | — |
| 15 kg | 60–120 mg | 60.0–120.0 ml | — |
| 18 kg | 72–144 mg | 72.0–144.0 ml | — |
| 20 kg | 80–160 mg | 80.0–160.0 ml | — |
| 25 kg | 100–200 mg | 100.0–200.0 ml | — |
| 30 kg | 120–240 mg | 120.0–240.0 ml | — |
⚠️ Warnings
- • SE: skin rash, hepatotoxicity, photosensitivity.
Astemizole
Astemizole
💊 Allergic rhinitis, allergic skin conditions
Formulation
Tablet
Standard tablet
Dose Range
0.2–0.2 mg/kg
Max Daily
N/A
Frequency
Once daily on empty stomach
Max Single
30 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–1 mg | 1.0–1.0 ml | — |
| 6 kg | 1–1 mg | 1.2–1.2 ml | — |
| 7 kg | 1–1 mg | 1.4–1.4 ml | — |
| 8 kg | 2–2 mg | 1.6–1.6 ml | — |
| 9 kg | 2–2 mg | 1.8–1.8 ml | — |
| 10 kg | 2–2 mg | 2.0–2.0 ml | — |
| 12 kg | 2–2 mg | 2.4–2.4 ml | — |
| 15 kg | 3–3 mg | 3.0–3.0 ml | — |
| 18 kg | 4–4 mg | 3.6–3.6 ml | — |
| 20 kg | 4–4 mg | 4.0–4.0 ml | — |
| 25 kg | 5–5 mg | 5.0–5.0 ml | — |
| 30 kg | 6–6 mg | 6.0–6.0 ml | — |
⚠️ Warnings
- • C/I: Porphyria, long QT syndromes, epilepsy.
Azatadine
Azatadine maleate
💊 Allergic conditions
Formulation
Tablet
Standard tablet
Dose Range
0.05–0.1 mg/kg
Max Daily
N/A
Frequency
Twice daily
Max Single
2 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 0–1 mg | 0.3–0.5 ml | — |
| 6 kg | 0–1 mg | 0.3–0.6 ml | — |
| 7 kg | 0–1 mg | 0.4–0.7 ml | — |
| 8 kg | 0–1 mg | 0.4–0.8 ml | — |
| 9 kg | 0–1 mg | 0.5–0.9 ml | — |
| 10 kg | 1–1 mg | 0.5–1.0 ml | — |
| 12 kg | 1–1 mg | 0.6–1.2 ml | — |
| 15 kg | 1–2 mg | 0.8–1.5 ml | — |
| 18 kg | 1–2 mg | 0.9–1.8 ml | — |
| 20 kg | 1–2 mg | 1.0–2.0 ml | — |
| 25 kg | 1–3 mg | 1.3–2.5 ml | — |
| 30 kg | 2–3 mg | 1.5–3.0 ml | — |
⚠️ Warnings
- •
Chlorpheniramine
Chlorpheniramine maleate
💊 Allergic conditions, anaphylactic shock adjunct (0.8 mg/kg SC/IM/IV up to 4 times/day)
Formulation
Tablet
Standard tablet
Dose Range
0.35–0.35 mg/kg
Max Daily
N/A
Frequency
Every 4-6 hours
Max Single
40 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 2–2 mg | 1.8–1.8 ml | — |
| 6 kg | 2–2 mg | 2.1–2.1 ml | — |
| 7 kg | 2–2 mg | 2.4–2.4 ml | — |
| 8 kg | 3–3 mg | 2.8–2.8 ml | — |
| 9 kg | 3–3 mg | 3.1–3.1 ml | — |
| 10 kg | 4–4 mg | 3.5–3.5 ml | — |
| 12 kg | 4–4 mg | 4.2–4.2 ml | — |
| 15 kg | 5–5 mg | 5.3–5.3 ml | — |
| 18 kg | 6–6 mg | 6.3–6.3 ml | — |
| 20 kg | 7–7 mg | 7.0–7.0 ml | — |
| 25 kg | 9–9 mg | 8.8–8.8 ml | — |
| 30 kg | 11–11 mg | 10.5–10.5 ml | — |
⚠️ Warnings
- • Max 40 mg/day.
Clemastine
Clemastine fumarate
💊 Allergic rhinitis, skin allergy, conjunctivitis
Formulation
Tablet
Standard tablet
Dose Range
0.05–0.1 mg/kg
Max Daily
N/A
Frequency
Twice daily
Max Single
2 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 0–1 mg | 0.3–0.5 ml | — |
| 6 kg | 0–1 mg | 0.3–0.6 ml | — |
| 7 kg | 0–1 mg | 0.4–0.7 ml | — |
| 8 kg | 0–1 mg | 0.4–0.8 ml | — |
| 9 kg | 0–1 mg | 0.5–0.9 ml | — |
| 10 kg | 1–1 mg | 0.5–1.0 ml | — |
| 12 kg | 1–1 mg | 0.6–1.2 ml | — |
| 15 kg | 1–2 mg | 0.8–1.5 ml | — |
| 18 kg | 1–2 mg | 0.9–1.8 ml | — |
| 20 kg | 1–2 mg | 1.0–2.0 ml | — |
| 25 kg | 1–3 mg | 1.3–2.5 ml | — |
| 30 kg | 2–3 mg | 1.5–3.0 ml | — |
⚠️ Warnings
- • Avoid below 1 year. C/I: Narrow angle glaucoma.
Cyproheptadine
Cyproheptadine hydrochloride
💊 Appetite stimulant, skin allergy, migraine prophylaxis
Formulation
Tablet
Standard tablet
Dose Range
0.25–0.5 mg/kg
Max Daily
N/A
Frequency
Every 8-12 hours
Max Single
32 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–3 mg | 1.3–2.5 ml | — |
| 6 kg | 2–3 mg | 1.5–3.0 ml | — |
| 7 kg | 2–4 mg | 1.8–3.5 ml | — |
| 8 kg | 2–4 mg | 2.0–4.0 ml | — |
| 9 kg | 2–5 mg | 2.3–4.5 ml | — |
| 10 kg | 3–5 mg | 2.5–5.0 ml | — |
| 12 kg | 3–6 mg | 3.0–6.0 ml | — |
| 15 kg | 4–8 mg | 3.8–7.5 ml | — |
| 18 kg | 5–9 mg | 4.5–9.0 ml | — |
| 20 kg | 5–10 mg | 5.0–10.0 ml | — |
| 25 kg | 6–13 mg | 6.3–12.5 ml | — |
| 30 kg | 8–15 mg | 7.5–15.0 ml | — |
⚠️ Warnings
- • Max 2-6yr: 12 mg/day, 7-14yr: 16 mg/day. C/I: Glaucoma, urinary retention, asthma, MAOI therapy.
Desloratadine
Desloratadine
💊 Allergic rhinitis, allergic skin conditions
Formulation
Tablet
Standard tablet
Dose Range
1–5 mg/kg
Max Daily
N/A
Frequency
Once daily
Max Single
5 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 5–25 mg | 5.0–25.0 ml | — |
| 6 kg | 6–30 mg | 6.0–30.0 ml | — |
| 7 kg | 7–35 mg | 7.0–35.0 ml | — |
| 8 kg | 8–40 mg | 8.0–40.0 ml | — |
| 9 kg | 9–45 mg | 9.0–45.0 ml | — |
| 10 kg | 10–50 mg | 10.0–50.0 ml | — |
| 12 kg | 12–60 mg | 12.0–60.0 ml | — |
| 15 kg | 15–75 mg | 15.0–75.0 ml | — |
| 18 kg | 18–90 mg | 18.0–90.0 ml | — |
| 20 kg | 20–100 mg | 20.0–100.0 ml | — |
| 25 kg | 25–125 mg | 25.0–125.0 ml | — |
| 30 kg | 30–150 mg | 30.0–150.0 ml | — |
⚠️ Warnings
- • Avoid in children below 1 year.
Dimethindene
Dimethindene maleate
💊 Urticaria, angioedema, rhinitis
Formulation
Tablet
Standard tablet
Dose Range
0.05–0.1 mg/kg
Max Daily
N/A
Frequency
Every 8 hours or SR twice daily
Max Single
2 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 0–1 mg | 0.3–0.5 ml | — |
| 6 kg | 0–1 mg | 0.3–0.6 ml | — |
| 7 kg | 0–1 mg | 0.4–0.7 ml | — |
| 8 kg | 0–1 mg | 0.4–0.8 ml | — |
| 9 kg | 0–1 mg | 0.5–0.9 ml | — |
| 10 kg | 1–1 mg | 0.5–1.0 ml | — |
| 12 kg | 1–1 mg | 0.6–1.2 ml | — |
| 15 kg | 1–2 mg | 0.8–1.5 ml | — |
| 18 kg | 1–2 mg | 0.9–1.8 ml | — |
| 20 kg | 1–2 mg | 1.0–2.0 ml | — |
| 25 kg | 1–3 mg | 1.3–2.5 ml | — |
| 30 kg | 2–3 mg | 1.5–3.0 ml | — |
⚠️ Warnings
- • C/I: Epilepsy, urinary retention.
Diphenhydramine
Diphenhydramine hydrochloride
💊 Allergic conditions, anaphylaxis, phenothiazine overdose (1-2 mg/kg IV slowly)
Formulation
Tablet
Standard tablet
Dose Range
5–5 mg/kg
Max Daily
N/A
Frequency
Every 6 hours
Max Single
400 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 25–25 mg | 25.0–25.0 ml | — |
| 6 kg | 30–30 mg | 30.0–30.0 ml | — |
| 7 kg | 35–35 mg | 35.0–35.0 ml | — |
| 8 kg | 40–40 mg | 40.0–40.0 ml | — |
| 9 kg | 45–45 mg | 45.0–45.0 ml | — |
| 10 kg | 50–50 mg | 50.0–50.0 ml | — |
| 12 kg | 60–60 mg | 60.0–60.0 ml | — |
| 15 kg | 75–75 mg | 75.0–75.0 ml | — |
| 18 kg | 90–90 mg | 90.0–90.0 ml | — |
| 20 kg | 100–100 mg | 100.0–100.0 ml | — |
| 25 kg | 125–125 mg | 125.0–125.0 ml | — |
| 30 kg | 150–150 mg | 150.0–150.0 ml | — |
⚠️ Warnings
- • C/I: With MAOIs, asthma, narrow angle glaucoma, urinary retention. Max 300 mg/24 hr.
Ebastine
Ebastine
💊 Allergic rhinitis, allergic skin conditions
Formulation
Tablet
Standard tablet
Dose Range
0.2–0.2 mg/kg
Max Daily
N/A
Frequency
Once daily
Max Single
10 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–1 mg | 1.0–1.0 ml | — |
| 6 kg | 1–1 mg | 1.2–1.2 ml | — |
| 7 kg | 1–1 mg | 1.4–1.4 ml | — |
| 8 kg | 2–2 mg | 1.6–1.6 ml | — |
| 9 kg | 2–2 mg | 1.8–1.8 ml | — |
| 10 kg | 2–2 mg | 2.0–2.0 ml | — |
| 12 kg | 2–2 mg | 2.4–2.4 ml | — |
| 15 kg | 3–3 mg | 3.0–3.0 ml | — |
| 18 kg | 4–4 mg | 3.6–3.6 ml | — |
| 20 kg | 4–4 mg | 4.0–4.0 ml | — |
| 25 kg | 5–5 mg | 5.0–5.0 ml | — |
| 30 kg | 6–6 mg | 6.0–6.0 ml | — |
⚠️ Warnings
- • C/I: Cardiac arrhythmias.
Fexofenadine
Fexofenadine hydrochloride
💊 Allergic rhinitis, allergic skin conditions (chronic idiopathic urticaria)
Formulation
Tablet
Standard tablet
Dose Range
15–60 mg/kg
Max Daily
N/A
Frequency
Every 12 hours
Max Single
120 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 75–300 mg | 75.0–300.0 ml | — |
| 6 kg | 90–360 mg | 90.0–360.0 ml | — |
| 7 kg | 105–420 mg | 105.0–420.0 ml | — |
| 8 kg | 120–480 mg | 120.0–480.0 ml | — |
| 9 kg | 135–540 mg | 135.0–540.0 ml | — |
| 10 kg | 150–600 mg | 150.0–600.0 ml | — |
| 12 kg | 180–720 mg | 180.0–720.0 ml | — |
| 15 kg | 225–900 mg | 225.0–900.0 ml | — |
| 18 kg | 270–1080 mg | 270.0–1080.0 ml | — |
| 20 kg | 300–1200 mg | 300.0–1200.0 ml | — |
| 25 kg | 375–1500 mg | 375.0–1500.0 ml | — |
| 30 kg | 450–1800 mg | 450.0–1800.0 ml | — |
⚠️ Warnings
- • C/I: Flu-like symptoms, dizziness, drowsiness, dry mouth.
Hydroxyzine
Hydroxyzine hydrochloride
💊 Anxiety, pruritis, urticaria, sedation
Formulation
Tablet
Standard tablet
Dose Range
2–2 mg/kg
Max Daily
N/A
Frequency
Every 6 hours (oral); 0.5-1 mg/kg/dose q 4-6 hr IM
Max Single
25 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 10–10 mg | 10.0–10.0 ml | — |
| 6 kg | 12–12 mg | 12.0–12.0 ml | — |
| 7 kg | 14–14 mg | 14.0–14.0 ml | — |
| 8 kg | 16–16 mg | 16.0–16.0 ml | — |
| 9 kg | 18–18 mg | 18.0–18.0 ml | — |
| 10 kg | 20–20 mg | 20.0–20.0 ml | — |
| 12 kg | 24–24 mg | 24.0–24.0 ml | — |
| 15 kg | 30–30 mg | 30.0–30.0 ml | — |
| 18 kg | 36–36 mg | 36.0–36.0 ml | — |
| 20 kg | 40–40 mg | 40.0–40.0 ml | — |
| 25 kg | 50–50 mg | 50.0–50.0 ml | — |
| 30 kg | 60–60 mg | 60.0–60.0 ml | — |
⚠️ Warnings
- • Not recommended in infants below 6 months, acute porphyria, ECG changes.
Ketotifen
Ketotifen
💊 Prophylaxis of bronchial asthma, allergic rhinitis, allergic conjunctivitis
Formulation
Tablet
Standard tablet
Dose Range
0.5–1 mg/kg
Max Daily
N/A
Frequency
Twice daily
Max Single
2 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 3–5 mg | 2.5–5.0 ml | — |
| 6 kg | 3–6 mg | 3.0–6.0 ml | — |
| 7 kg | 4–7 mg | 3.5–7.0 ml | — |
| 8 kg | 4–8 mg | 4.0–8.0 ml | — |
| 9 kg | 5–9 mg | 4.5–9.0 ml | — |
| 10 kg | 5–10 mg | 5.0–10.0 ml | — |
| 12 kg | 6–12 mg | 6.0–12.0 ml | — |
| 15 kg | 8–15 mg | 7.5–15.0 ml | — |
| 18 kg | 9–18 mg | 9.0–18.0 ml | — |
| 20 kg | 10–20 mg | 10.0–20.0 ml | — |
| 25 kg | 13–25 mg | 12.5–25.0 ml | — |
| 30 kg | 15–30 mg | 15.0–30.0 ml | — |
⚠️ Warnings
- • Start at low dose and increase to max 1 mg BD.
Levocetirizine
Levocetirizine
💊 Allergic rhinitis, allergic skin conditions
Formulation
Tablet
Standard tablet
Dose Range
0.125–2.5 mg/kg
Max Daily
N/A
Frequency
Once or twice daily
Max Single
5 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–13 mg | 0.6–12.5 ml | — |
| 6 kg | 1–15 mg | 0.8–15.0 ml | — |
| 7 kg | 1–18 mg | 0.9–17.5 ml | — |
| 8 kg | 1–20 mg | 1.0–20.0 ml | — |
| 9 kg | 1–23 mg | 1.1–22.5 ml | — |
| 10 kg | 1–25 mg | 1.3–25.0 ml | — |
| 12 kg | 2–30 mg | 1.5–30.0 ml | — |
| 15 kg | 2–38 mg | 1.9–37.5 ml | — |
| 18 kg | 2–45 mg | 2.3–45.0 ml | — |
| 20 kg | 3–50 mg | 2.5–50.0 ml | — |
| 25 kg | 3–63 mg | 3.1–62.5 ml | — |
| 30 kg | 4–75 mg | 3.8–75.0 ml | — |
⚠️ Warnings
- • Avoid below 2 years.
Methdilazine
Methdilazine hydrochloride
💊 Pruritis, neurodermatitis
Formulation
Tablet
Standard tablet
Dose Range
0.1–0.2 mg/kg
Max Daily
N/A
Frequency
Every 12 hours
Max Single
5 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–1 mg | 0.5–1.0 ml | — |
| 6 kg | 1–1 mg | 0.6–1.2 ml | — |
| 7 kg | 1–1 mg | 0.7–1.4 ml | — |
| 8 kg | 1–2 mg | 0.8–1.6 ml | — |
| 9 kg | 1–2 mg | 0.9–1.8 ml | — |
| 10 kg | 1–2 mg | 1.0–2.0 ml | — |
| 12 kg | 1–2 mg | 1.2–2.4 ml | — |
| 15 kg | 2–3 mg | 1.5–3.0 ml | — |
| 18 kg | 2–4 mg | 1.8–3.6 ml | — |
| 20 kg | 2–4 mg | 2.0–4.0 ml | — |
| 25 kg | 3–5 mg | 2.5–5.0 ml | — |
| 30 kg | 3–6 mg | 3.0–6.0 ml | — |
⚠️ Warnings
- • Above 3 years only. C/I: Coma, jaundice with levodopa, bone marrow depression.
Mizolastine
Mizolastine
💊 Allergic rhinitis, allergic skin conditions
Formulation
Tablet
Standard tablet
Dose Range
10–10 mg/kg
Max Daily
N/A
Frequency
Once daily
Max Single
20 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–50 mg | 50.0–50.0 ml | — |
| 6 kg | 60–60 mg | 60.0–60.0 ml | — |
| 7 kg | 70–70 mg | 70.0–70.0 ml | — |
| 8 kg | 80–80 mg | 80.0–80.0 ml | — |
| 9 kg | 90–90 mg | 90.0–90.0 ml | — |
| 10 kg | 100–100 mg | 100.0–100.0 ml | — |
| 12 kg | 120–120 mg | 120.0–120.0 ml | — |
| 15 kg | 150–150 mg | 150.0–150.0 ml | — |
| 18 kg | 180–180 mg | 180.0–180.0 ml | — |
| 20 kg | 200–200 mg | 200.0–200.0 ml | — |
| 25 kg | 250–250 mg | 250.0–250.0 ml | — |
| 30 kg | 300–300 mg | 300.0–300.0 ml | — |
⚠️ Warnings
- • C/I: Hypokalemia, long QT, significant bradycardia.
Pheniramine
Pheniramine maleate
💊 Allergic conditions
Formulation
Tablet
Standard tablet
Dose Range
0.5–0.5 mg/kg
Max Daily
N/A
Frequency
Every 8 hours
Max Single
25 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 3–3 mg | 2.5–2.5 ml | — |
| 6 kg | 3–3 mg | 3.0–3.0 ml | — |
| 7 kg | 4–4 mg | 3.5–3.5 ml | — |
| 8 kg | 4–4 mg | 4.0–4.0 ml | — |
| 9 kg | 5–5 mg | 4.5–4.5 ml | — |
| 10 kg | 5–5 mg | 5.0–5.0 ml | — |
| 12 kg | 6–6 mg | 6.0–6.0 ml | — |
| 15 kg | 8–8 mg | 7.5–7.5 ml | — |
| 18 kg | 9–9 mg | 9.0–9.0 ml | — |
| 20 kg | 10–10 mg | 10.0–10.0 ml | — |
| 25 kg | 13–13 mg | 12.5–12.5 ml | — |
| 30 kg | 15–15 mg | 15.0–15.0 ml | — |
⚠️ Warnings
- • C/I: Epilepsy, asthma, neonates.
Pseudoephedrine
Pseudoephedrine
💊 Nasal decongestion
Formulation
Tablet
Standard tablet
Dose Range
4–4 mg/kg
Max Daily
N/A
Frequency
Every 6-8 hours
Max Single
240 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 20–20 mg | 20.0–20.0 ml | — |
| 6 kg | 24–24 mg | 24.0–24.0 ml | — |
| 7 kg | 28–28 mg | 28.0–28.0 ml | — |
| 8 kg | 32–32 mg | 32.0–32.0 ml | — |
| 9 kg | 36–36 mg | 36.0–36.0 ml | — |
| 10 kg | 40–40 mg | 40.0–40.0 ml | — |
| 12 kg | 48–48 mg | 48.0–48.0 ml | — |
| 15 kg | 60–60 mg | 60.0–60.0 ml | — |
| 18 kg | 72–72 mg | 72.0–72.0 ml | — |
| 20 kg | 80–80 mg | 80.0–80.0 ml | — |
| 25 kg | 100–100 mg | 100.0–100.0 ml | — |
| 30 kg | 120–120 mg | 120.0–120.0 ml | — |
⚠️ Warnings
- • Max 240 mg/day.
Triprolidine
Triprolidine hydrochloride
💊 Allergic rhinitis, allergic skin conditions
Formulation
Tablet
Standard tablet
Dose Range
0.3–1.25 mg/kg
Max Daily
N/A
Frequency
Every 4-6 hours
Max Single
2.5 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 2–6 mg | 1.5–6.3 ml | — |
| 6 kg | 2–8 mg | 1.8–7.5 ml | — |
| 7 kg | 2–9 mg | 2.1–8.8 ml | — |
| 8 kg | 2–10 mg | 2.4–10.0 ml | — |
| 9 kg | 3–11 mg | 2.7–11.3 ml | — |
| 10 kg | 3–13 mg | 3.0–12.5 ml | — |
| 12 kg | 4–15 mg | 3.6–15.0 ml | — |
| 15 kg | 5–19 mg | 4.5–18.8 ml | — |
| 18 kg | 5–23 mg | 5.4–22.5 ml | — |
| 20 kg | 6–25 mg | 6.0–25.0 ml | — |
| 25 kg | 8–31 mg | 7.5–31.3 ml | — |
| 30 kg | 9–38 mg | 9.0–37.5 ml | — |
⚠️ Warnings
- • Max depends on age group. Below 2 yr: max 1.25 mg/day; 2-4 yr: 2.5 mg/day; 4-6 yr: 3.75 mg/day; 6-12 yr: 10 mg/day.
Amiloride
Amiloride
💊 Hypertension (often with thiazide or loop diuretic)
Formulation
Tablet
Standard tablet
Dose Range
0.4–0.6 mg/kg
Max Daily
N/A
Frequency
Every 12-24 hours
Max Single
20 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 2–3 mg | 2.0–3.0 ml | — |
| 6 kg | 2–4 mg | 2.4–3.6 ml | — |
| 7 kg | 3–4 mg | 2.8–4.2 ml | — |
| 8 kg | 3–5 mg | 3.2–4.8 ml | — |
| 9 kg | 4–5 mg | 3.6–5.4 ml | — |
| 10 kg | 4–6 mg | 4.0–6.0 ml | — |
| 12 kg | 5–7 mg | 4.8–7.2 ml | — |
| 15 kg | 6–9 mg | 6.0–9.0 ml | — |
| 18 kg | 7–11 mg | 7.2–10.8 ml | — |
| 20 kg | 8–12 mg | 8.0–12.0 ml | — |
| 25 kg | 10–15 mg | 10.0–15.0 ml | — |
| 30 kg | 12–18 mg | 12.0–18.0 ml | — |
⚠️ Warnings
- • C/I: Hyperkalemia, impaired renal function.
Amlodipine
Amlodipine
💊 Hypertension
Formulation
Tablet
Standard tablet
Dose Range
0.05–0.5 mg/kg
Max Daily
N/A
Frequency
Every 12-24 hours
Max Single
10 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 0–3 mg | 0.3–2.5 ml | — |
| 6 kg | 0–3 mg | 0.3–3.0 ml | — |
| 7 kg | 0–4 mg | 0.4–3.5 ml | — |
| 8 kg | 0–4 mg | 0.4–4.0 ml | — |
| 9 kg | 0–5 mg | 0.5–4.5 ml | — |
| 10 kg | 1–5 mg | 0.5–5.0 ml | — |
| 12 kg | 1–6 mg | 0.6–6.0 ml | — |
| 15 kg | 1–8 mg | 0.8–7.5 ml | — |
| 18 kg | 1–9 mg | 0.9–9.0 ml | — |
| 20 kg | 1–10 mg | 1.0–10.0 ml | — |
| 25 kg | 1–13 mg | 1.3–12.5 ml | — |
| 30 kg | 2–15 mg | 1.5–15.0 ml | — |
⚠️ Warnings
- •
Atenolol
Atenolol
💊 Hypertension
Formulation
Tablet
Standard tablet
Dose Range
0.5–2 mg/kg
Max Daily
N/A
Frequency
Once daily
Max Single
50 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 3–10 mg | 2.5–10.0 ml | — |
| 6 kg | 3–12 mg | 3.0–12.0 ml | — |
| 7 kg | 4–14 mg | 3.5–14.0 ml | — |
| 8 kg | 4–16 mg | 4.0–16.0 ml | — |
| 9 kg | 5–18 mg | 4.5–18.0 ml | — |
| 10 kg | 5–20 mg | 5.0–20.0 ml | — |
| 12 kg | 6–24 mg | 6.0–24.0 ml | — |
| 15 kg | 8–30 mg | 7.5–30.0 ml | — |
| 18 kg | 9–36 mg | 9.0–36.0 ml | — |
| 20 kg | 10–40 mg | 10.0–40.0 ml | — |
| 25 kg | 13–50 mg | 12.5–50.0 ml | — |
| 30 kg | 15–60 mg | 15.0–60.0 ml | — |
⚠️ Warnings
- • C/I: Bradycardia, heart block, congestive cardiac failure, bronchial asthma, peripheral arterial disease.
Captopril
Captopril
💊 High renin hypertension, congestive heart failure
Formulation
Tablet
Standard tablet
Dose Range
0.5–6 mg/kg
Max Daily
N/A
Frequency
Every 8-12 hours (1 hr before meals)
Max Single
50 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 3–30 mg | 2.5–30.0 ml | — |
| 6 kg | 3–36 mg | 3.0–36.0 ml | — |
| 7 kg | 4–42 mg | 3.5–42.0 ml | — |
| 8 kg | 4–48 mg | 4.0–48.0 ml | — |
| 9 kg | 5–54 mg | 4.5–54.0 ml | — |
| 10 kg | 5–60 mg | 5.0–60.0 ml | — |
| 12 kg | 6–72 mg | 6.0–72.0 ml | — |
| 15 kg | 8–90 mg | 7.5–90.0 ml | — |
| 18 kg | 9–108 mg | 9.0–108.0 ml | — |
| 20 kg | 10–120 mg | 10.0–120.0 ml | — |
| 25 kg | 13–150 mg | 12.5–150.0 ml | — |
| 30 kg | 15–180 mg | 15.0–180.0 ml | — |
⚠️ Warnings
- • Use with diuretic and/or beta blocker. Monitor WBC and renal functions. C/I: Aortic stenosis, renal failure, porphyria, bilateral renal artery stenosis.
Carvedilol
Carvedilol
💊 Hypertension, left ventricular dysfunction, heart failure
Formulation
Tablet
Standard tablet
Dose Range
0.5–1 mg/kg
Max Daily
N/A
Frequency
Twice daily (start 6.25 mg BD, max 50 mg/day)
Max Single
25 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 3–5 mg | 2.5–5.0 ml | — |
| 6 kg | 3–6 mg | 3.0–6.0 ml | — |
| 7 kg | 4–7 mg | 3.5–7.0 ml | — |
| 8 kg | 4–8 mg | 4.0–8.0 ml | — |
| 9 kg | 5–9 mg | 4.5–9.0 ml | — |
| 10 kg | 5–10 mg | 5.0–10.0 ml | — |
| 12 kg | 6–12 mg | 6.0–12.0 ml | — |
| 15 kg | 8–15 mg | 7.5–15.0 ml | — |
| 18 kg | 9–18 mg | 9.0–18.0 ml | — |
| 20 kg | 10–20 mg | 10.0–20.0 ml | — |
| 25 kg | 13–25 mg | 12.5–25.0 ml | — |
| 30 kg | 15–30 mg | 15.0–30.0 ml | — |
⚠️ Warnings
- • C/I: Asthma, sinus bradycardia, heart block, sick-sinus syndrome, severe liver disease.
Clonidine
Clonidine hydrochloride
💊 Hypertension, ADHD, migraine prophylaxis, narcotic withdrawal
Formulation
Tablet
Standard tablet
Dose Range
15–25 mg/kg
Max Daily
N/A
Frequency
Every 6-8 hours (taper gradually to avoid rebound hypertension)
Max Single
0.3 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 75–125 mg | 75.0–125.0 ml | — |
| 6 kg | 90–150 mg | 90.0–150.0 ml | — |
| 7 kg | 105–175 mg | 105.0–175.0 ml | — |
| 8 kg | 120–200 mg | 120.0–200.0 ml | — |
| 9 kg | 135–225 mg | 135.0–225.0 ml | — |
| 10 kg | 150–250 mg | 150.0–250.0 ml | — |
| 12 kg | 180–300 mg | 180.0–300.0 ml | — |
| 15 kg | 225–375 mg | 225.0–375.0 ml | — |
| 18 kg | 270–450 mg | 270.0–450.0 ml | — |
| 20 kg | 300–500 mg | 300.0–500.0 ml | — |
| 25 kg | 375–625 mg | 375.0–625.0 ml | — |
| 30 kg | 450–750 mg | 450.0–750.0 ml | — |
⚠️ Warnings
- • Rebound hypertension if abruptly stopped. SE: dry mouth, dizziness, drowsiness, constipation, fatigue.
Diazoxide
Diazoxide
💊 Hypertensive crisis, intractable neonatal hypoglycaemia
Formulation
Tablet
Standard tablet
Dose Range
3–15 mg/kg
Max Daily
N/A
Frequency
PO q 8-12 hr; IV: repeat in 20 min if needed
Max Single
150 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 15–75 mg | 15.0–75.0 ml | — |
| 6 kg | 18–90 mg | 18.0–90.0 ml | — |
| 7 kg | 21–105 mg | 21.0–105.0 ml | — |
| 8 kg | 24–120 mg | 24.0–120.0 ml | — |
| 9 kg | 27–135 mg | 27.0–135.0 ml | — |
| 10 kg | 30–150 mg | 30.0–150.0 ml | — |
| 12 kg | 36–180 mg | 36.0–180.0 ml | — |
| 15 kg | 45–225 mg | 45.0–225.0 ml | — |
| 18 kg | 54–270 mg | 54.0–270.0 ml | — |
| 20 kg | 60–300 mg | 60.0–300.0 ml | — |
| 25 kg | 75–375 mg | 75.0–375.0 ml | — |
| 30 kg | 90–450 mg | 90.0–450.0 ml | — |
⚠️ Warnings
- • IV for hypertensive crisis: 1-3 mg/kg IV up to 150 mg; repeat q 5-15 min.
Enalapril
Enalapril maleate
💊 Hypertension
Formulation
Tablet
Standard tablet
Dose Range
0.1–1 mg/kg
Max Daily
N/A
Frequency
Every 12-24 hours
Max Single
40 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–5 mg | 0.5–5.0 ml | — |
| 6 kg | 1–6 mg | 0.6–6.0 ml | — |
| 7 kg | 1–7 mg | 0.7–7.0 ml | — |
| 8 kg | 1–8 mg | 0.8–8.0 ml | — |
| 9 kg | 1–9 mg | 0.9–9.0 ml | — |
| 10 kg | 1–10 mg | 1.0–10.0 ml | — |
| 12 kg | 1–12 mg | 1.2–12.0 ml | — |
| 15 kg | 2–15 mg | 1.5–15.0 ml | — |
| 18 kg | 2–18 mg | 1.8–18.0 ml | — |
| 20 kg | 2–20 mg | 2.0–20.0 ml | — |
| 25 kg | 3–25 mg | 2.5–25.0 ml | — |
| 30 kg | 3–30 mg | 3.0–30.0 ml | — |
⚠️ Warnings
- • SE: fatigue, hypotension, cough, hyperkalemia, angioedema. C/I: Aortic stenosis, bilateral renal artery stenosis, GFR <30 ml/min.
Hydralazine
Hydralazine hydrochloride
💊 Hypertension especially with renal involvement
Formulation
Tablet
Standard tablet
Dose Range
0.5–7 mg/kg
Max Daily
N/A
Frequency
Every 6-8 hours (oral); q 6 hr IV/IM for crisis (max 2 mg/kg/dose)
Max Single
20 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 3–35 mg | 2.5–35.0 ml | — |
| 6 kg | 3–42 mg | 3.0–42.0 ml | — |
| 7 kg | 4–49 mg | 3.5–49.0 ml | — |
| 8 kg | 4–56 mg | 4.0–56.0 ml | — |
| 9 kg | 5–63 mg | 4.5–63.0 ml | — |
| 10 kg | 5–70 mg | 5.0–70.0 ml | — |
| 12 kg | 6–84 mg | 6.0–84.0 ml | — |
| 15 kg | 8–105 mg | 7.5–105.0 ml | — |
| 18 kg | 9–126 mg | 9.0–126.0 ml | — |
| 20 kg | 10–140 mg | 10.0–140.0 ml | — |
| 25 kg | 13–175 mg | 12.5–175.0 ml | — |
| 30 kg | 15–210 mg | 15.0–210.0 ml | — |
⚠️ Warnings
- • C/I: Liver disease, pheochromocytoma, depression, MAOI use.
Labetalol
Labetalol
💊 Hypertension, hypertensive crisis
Formulation
Tablet
Standard tablet
Dose Range
1–3 mg/kg
Max Daily
N/A
Frequency
Every 12 hours (oral); IV crisis: 0.25-1 mg/kg over 2 min
Max Single
200 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 5–15 mg | 5.0–15.0 ml | — |
| 6 kg | 6–18 mg | 6.0–18.0 ml | — |
| 7 kg | 7–21 mg | 7.0–21.0 ml | — |
| 8 kg | 8–24 mg | 8.0–24.0 ml | — |
| 9 kg | 9–27 mg | 9.0–27.0 ml | — |
| 10 kg | 10–30 mg | 10.0–30.0 ml | — |
| 12 kg | 12–36 mg | 12.0–36.0 ml | — |
| 15 kg | 15–45 mg | 15.0–45.0 ml | — |
| 18 kg | 18–54 mg | 18.0–54.0 ml | — |
| 20 kg | 20–60 mg | 20.0–60.0 ml | — |
| 25 kg | 25–75 mg | 25.0–75.0 ml | — |
| 30 kg | 30–90 mg | 30.0–90.0 ml | — |
⚠️ Warnings
- • C/I: Asthmatics, heart failure, hypoglycemic states.
Lisinopril
Lisinopril
💊 Hypertension
Formulation
Tablet
Standard tablet
Dose Range
0.07–0.07 mg/kg
Max Daily
N/A
Frequency
Once daily
Max Single
5 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 0–0 mg | 0.4–0.4 ml | — |
| 6 kg | 0–0 mg | 0.4–0.4 ml | — |
| 7 kg | 0–0 mg | 0.5–0.5 ml | — |
| 8 kg | 1–1 mg | 0.6–0.6 ml | — |
| 9 kg | 1–1 mg | 0.6–0.6 ml | — |
| 10 kg | 1–1 mg | 0.7–0.7 ml | — |
| 12 kg | 1–1 mg | 0.8–0.8 ml | — |
| 15 kg | 1–1 mg | 1.1–1.1 ml | — |
| 18 kg | 1–1 mg | 1.3–1.3 ml | — |
| 20 kg | 1–1 mg | 1.4–1.4 ml | — |
| 25 kg | 2–2 mg | 1.8–1.8 ml | — |
| 30 kg | 2–2 mg | 2.1–2.1 ml | — |
⚠️ Warnings
- • C/I: Aortic and renal artery stenosis, renal dysfunction, collagen vascular disease, hyperkalemia.
Losartan
Losartan
💊 Hypertension (>6 yrs)
Formulation
Tablet
Standard tablet
Dose Range
0.7–1.4 mg/kg
Max Daily
N/A
Frequency
Once daily
Max Single
50 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 4–7 mg | 3.5–7.0 ml | — |
| 6 kg | 4–8 mg | 4.2–8.4 ml | — |
| 7 kg | 5–10 mg | 4.9–9.8 ml | — |
| 8 kg | 6–11 mg | 5.6–11.2 ml | — |
| 9 kg | 6–13 mg | 6.3–12.6 ml | — |
| 10 kg | 7–14 mg | 7.0–14.0 ml | — |
| 12 kg | 8–17 mg | 8.4–16.8 ml | — |
| 15 kg | 11–21 mg | 10.5–21.0 ml | — |
| 18 kg | 13–25 mg | 12.6–25.2 ml | — |
| 20 kg | 14–28 mg | 14.0–28.0 ml | — |
| 25 kg | 18–35 mg | 17.5–35.0 ml | — |
| 30 kg | 21–42 mg | 21.0–42.0 ml | — |
⚠️ Warnings
- •
Methyldopa
Methyldopa
💊 Hypertension (especially in pregnancy)
Formulation
Tablet
Standard tablet
Dose Range
5–40 mg/kg
Max Daily
N/A
Frequency
Every 6-8 hours
Max Single
500 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 25–200 mg | 25.0–200.0 ml | — |
| 6 kg | 30–240 mg | 30.0–240.0 ml | — |
| 7 kg | 35–280 mg | 35.0–280.0 ml | — |
| 8 kg | 40–320 mg | 40.0–320.0 ml | — |
| 9 kg | 45–360 mg | 45.0–360.0 ml | — |
| 10 kg | 50–400 mg | 50.0–400.0 ml | — |
| 12 kg | 60–480 mg | 60.0–480.0 ml | — |
| 15 kg | 75–600 mg | 75.0–600.0 ml | — |
| 18 kg | 90–720 mg | 90.0–720.0 ml | — |
| 20 kg | 100–800 mg | 100.0–800.0 ml | — |
| 25 kg | 125–1000 mg | 125.0–1000.0 ml | — |
| 30 kg | 150–1200 mg | 150.0–1200.0 ml | — |
⚠️ Warnings
- • C/I: Liver disease, pheochromocytoma, depression, MAOI use.
Metoprolol
Metoprolol
💊 Hypertension, cyanotic spells (0.1 mg/kg over 2-5 min q 5-10 min)
Formulation
Tablet
Standard tablet
Dose Range
1–4 mg/kg
Max Daily
N/A
Frequency
Every 8-12 hours (for cyanotic spells 0.1 mg/kg over 2-5 min)
Max Single
400 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 5–20 mg | 5.0–20.0 ml | — |
| 6 kg | 6–24 mg | 6.0–24.0 ml | — |
| 7 kg | 7–28 mg | 7.0–28.0 ml | — |
| 8 kg | 8–32 mg | 8.0–32.0 ml | — |
| 9 kg | 9–36 mg | 9.0–36.0 ml | — |
| 10 kg | 10–40 mg | 10.0–40.0 ml | — |
| 12 kg | 12–48 mg | 12.0–48.0 ml | — |
| 15 kg | 15–60 mg | 15.0–60.0 ml | — |
| 18 kg | 18–72 mg | 18.0–72.0 ml | — |
| 20 kg | 20–80 mg | 20.0–80.0 ml | — |
| 25 kg | 25–100 mg | 25.0–100.0 ml | — |
| 30 kg | 30–120 mg | 30.0–120.0 ml | — |
⚠️ Warnings
- • C/I: Sinus bradycardia, heart block, sick-sinus syndrome, pheochromocytoma, congestive cardiac failure.
Minoxidil
Minoxidil
💊 Severe hypertension (refractory)
Formulation
Tablet
Standard tablet
Dose Range
0.2–0.25 mg/kg
Max Daily
N/A
Frequency
Once daily (increase stepwise every 24 hr)
Max Single
100 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–1 mg | 1.0–1.3 ml | — |
| 6 kg | 1–2 mg | 1.2–1.5 ml | — |
| 7 kg | 1–2 mg | 1.4–1.8 ml | — |
| 8 kg | 2–2 mg | 1.6–2.0 ml | — |
| 9 kg | 2–2 mg | 1.8–2.3 ml | — |
| 10 kg | 2–3 mg | 2.0–2.5 ml | — |
| 12 kg | 2–3 mg | 2.4–3.0 ml | — |
| 15 kg | 3–4 mg | 3.0–3.8 ml | — |
| 18 kg | 4–5 mg | 3.6–4.5 ml | — |
| 20 kg | 4–5 mg | 4.0–5.0 ml | — |
| 25 kg | 5–6 mg | 5.0–6.3 ml | — |
| 30 kg | 6–8 mg | 6.0–7.5 ml | — |
⚠️ Warnings
- • SE: Hypertrichosis, pericardial effusion.
Prazosin
Prazosin
💊 Hypertension
Formulation
Tablet
Standard tablet
Dose Range
0.05–0.1 mg/kg
Max Daily
N/A
Frequency
Once daily (start 2.5 mg, increase up to 5-10 mg, max 20 mg)
Max Single
5 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 0–1 mg | 0.3–0.5 ml | — |
| 6 kg | 0–1 mg | 0.3–0.6 ml | — |
| 7 kg | 0–1 mg | 0.4–0.7 ml | — |
| 8 kg | 0–1 mg | 0.4–0.8 ml | — |
| 9 kg | 0–1 mg | 0.5–0.9 ml | — |
| 10 kg | 1–1 mg | 0.5–1.0 ml | — |
| 12 kg | 1–1 mg | 0.6–1.2 ml | — |
| 15 kg | 1–2 mg | 0.8–1.5 ml | — |
| 18 kg | 1–2 mg | 0.9–1.8 ml | — |
| 20 kg | 1–2 mg | 1.0–2.0 ml | — |
| 25 kg | 1–3 mg | 1.3–2.5 ml | — |
| 30 kg | 2–3 mg | 1.5–3.0 ml | — |
⚠️ Warnings
- • Not recommended for children.
Phentolamine
Phentolamine
💊 Hypertensive crisis during pheochromocytoma surgery
Formulation
Tablet
Standard tablet
Dose Range
0.05–0.1 mg/kg
Max Daily
N/A
Frequency
As needed for hypertensive crisis during pheochromocytoma surgery
Max Single
5 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 0–1 mg | 0.3–0.5 ml | — |
| 6 kg | 0–1 mg | 0.3–0.6 ml | — |
| 7 kg | 0–1 mg | 0.4–0.7 ml | — |
| 8 kg | 0–1 mg | 0.4–0.8 ml | — |
| 9 kg | 0–1 mg | 0.5–0.9 ml | — |
| 10 kg | 1–1 mg | 0.5–1.0 ml | — |
| 12 kg | 1–1 mg | 0.6–1.2 ml | — |
| 15 kg | 1–2 mg | 0.8–1.5 ml | — |
| 18 kg | 1–2 mg | 0.9–1.8 ml | — |
| 20 kg | 1–2 mg | 1.0–2.0 ml | — |
| 25 kg | 1–3 mg | 1.3–2.5 ml | — |
| 30 kg | 2–3 mg | 1.5–3.0 ml | — |
⚠️ Warnings
- •
Propranolol (Antihypertensive)
Propranolol
💊 Hypertension, tachyarrhythmias, essential tremors, anxiety, migraine prophylaxis, portal hypertension, capillary hemangioma
Formulation
Tablet
Standard tablet
Dose Range
0.5–4 mg/kg
Max Daily
N/A
Frequency
Every 6-12 hours (hypertension); 2-6 mg/kg/day q 6-8 hr (arrhythmia/cyanotic spells)
Max Single
40 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 3–20 mg | 2.5–20.0 ml | — |
| 6 kg | 3–24 mg | 3.0–24.0 ml | — |
| 7 kg | 4–28 mg | 3.5–28.0 ml | — |
| 8 kg | 4–32 mg | 4.0–32.0 ml | — |
| 9 kg | 5–36 mg | 4.5–36.0 ml | — |
| 10 kg | 5–40 mg | 5.0–40.0 ml | — |
| 12 kg | 6–48 mg | 6.0–48.0 ml | — |
| 15 kg | 8–60 mg | 7.5–60.0 ml | — |
| 18 kg | 9–72 mg | 9.0–72.0 ml | — |
| 20 kg | 10–80 mg | 10.0–80.0 ml | — |
| 25 kg | 13–100 mg | 12.5–100.0 ml | — |
| 30 kg | 15–120 mg | 15.0–120.0 ml | — |
⚠️ Warnings
- • C/I: Bronchial asthma, congestive heart failure, heart block.
Ramipril
Ramipril
💊 Hypertension
Formulation
Tablet
Standard tablet
Dose Range
0.05–0.6 mg/kg
Max Daily
N/A
Frequency
Once daily (start 1.25-6.25 mg/day, increase up to 20 mg/day)
Max Single
20 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 0–3 mg | 0.3–3.0 ml | — |
| 6 kg | 0–4 mg | 0.3–3.6 ml | — |
| 7 kg | 0–4 mg | 0.4–4.2 ml | — |
| 8 kg | 0–5 mg | 0.4–4.8 ml | — |
| 9 kg | 0–5 mg | 0.5–5.4 ml | — |
| 10 kg | 1–6 mg | 0.5–6.0 ml | — |
| 12 kg | 1–7 mg | 0.6–7.2 ml | — |
| 15 kg | 1–9 mg | 0.8–9.0 ml | — |
| 18 kg | 1–11 mg | 0.9–10.8 ml | — |
| 20 kg | 1–12 mg | 1.0–12.0 ml | — |
| 25 kg | 1–15 mg | 1.3–15.0 ml | — |
| 30 kg | 2–18 mg | 1.5–18.0 ml | — |
⚠️ Warnings
- • C/I: Hypersensitivity with any ACE inhibitor.
Reserpine
Reserpine
💊 Hypertension, hypertensive encephalopathy
Formulation
Tablet
Standard tablet
Dose Range
0.02–0.07 mg/kg
Max Daily
N/A
Frequency
Every 8-12 hours; hypertensive encephalopathy 0.07 mg/kg IM (max 1 mg)
Max Single
0.25 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 0–0 mg | 0.1–0.4 ml | — |
| 6 kg | 0–0 mg | 0.1–0.4 ml | — |
| 7 kg | 0–0 mg | 0.1–0.5 ml | — |
| 8 kg | 0–1 mg | 0.2–0.6 ml | — |
| 9 kg | 0–1 mg | 0.2–0.6 ml | — |
| 10 kg | 0–1 mg | 0.2–0.7 ml | — |
| 12 kg | 0–1 mg | 0.2–0.8 ml | — |
| 15 kg | 0–1 mg | 0.3–1.1 ml | — |
| 18 kg | 0–1 mg | 0.4–1.3 ml | — |
| 20 kg | 0–1 mg | 0.4–1.4 ml | — |
| 25 kg | 1–2 mg | 0.5–1.8 ml | — |
| 30 kg | 1–2 mg | 0.6–2.1 ml | — |
⚠️ Warnings
- • C/I: Depression, active peptic ulcer, ulcerative colitis.
Sodium Nitroprusside
Sodium nitroprusside
💊 Hypertensive crisis
Formulation
Tablet
Standard tablet
Dose Range
0.3–8 mg/kg
Max Daily
N/A
Frequency
Continuous IV infusion (0.3-8 μg/kg/min)
Max Single
N/A
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 2–40 mg | 1.5–40.0 ml | — |
| 6 kg | 2–48 mg | 1.8–48.0 ml | — |
| 7 kg | 2–56 mg | 2.1–56.0 ml | — |
| 8 kg | 2–64 mg | 2.4–64.0 ml | — |
| 9 kg | 3–72 mg | 2.7–72.0 ml | — |
| 10 kg | 3–80 mg | 3.0–80.0 ml | — |
| 12 kg | 4–96 mg | 3.6–96.0 ml | — |
| 15 kg | 5–120 mg | 4.5–120.0 ml | — |
| 18 kg | 5–144 mg | 5.4–144.0 ml | — |
| 20 kg | 6–160 mg | 6.0–160.0 ml | — |
| 25 kg | 8–200 mg | 7.5–200.0 ml | — |
| 30 kg | 9–240 mg | 9.0–240.0 ml | — |
⚠️ Warnings
- • Cyanide toxicity. C/I: Increased intracranial pressure, severe hepatic impairment.
Artemether
Artemether
💊 Severe falciparum malaria (when other alternatives unavailable)
Formulation
Tablet
Standard tablet
Dose Range
1.6–3.2 mg/kg
Max Daily
N/A
Frequency
Once daily IM (3.2 mg/kg on day 1, then 1.6 mg/kg daily for 4 days)
Max Single
80 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 8–16 mg | 8.0–16.0 ml | — |
| 6 kg | 10–19 mg | 9.6–19.2 ml | — |
| 7 kg | 11–22 mg | 11.2–22.4 ml | — |
| 8 kg | 13–26 mg | 12.8–25.6 ml | — |
| 9 kg | 14–29 mg | 14.4–28.8 ml | — |
| 10 kg | 16–32 mg | 16.0–32.0 ml | — |
| 12 kg | 19–38 mg | 19.2–38.4 ml | — |
| 15 kg | 24–48 mg | 24.0–48.0 ml | — |
| 18 kg | 29–58 mg | 28.8–57.6 ml | — |
| 20 kg | 32–64 mg | 32.0–64.0 ml | — |
| 25 kg | 40–80 mg | 40.0–80.0 ml | — |
| 30 kg | 48–96 mg | 48.0–96.0 ml | — |
⚠️ Warnings
- • C/I: G-6-PD deficiency, immunocompromised patients. Shift to oral as soon as feasible.
Artesunate
Artesunate
💊 Severe falciparum malaria
Formulation
Tablet
Standard tablet
Dose Range
2.4–2.4 mg/kg
Max Daily
N/A
Frequency
2.4 mg/kg at 0, 12, 24 hr then once daily for 7 days
Max Single
120 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 12–12 mg | 12.0–12.0 ml | — |
| 6 kg | 14–14 mg | 14.4–14.4 ml | — |
| 7 kg | 17–17 mg | 16.8–16.8 ml | — |
| 8 kg | 19–19 mg | 19.2–19.2 ml | — |
| 9 kg | 22–22 mg | 21.6–21.6 ml | — |
| 10 kg | 24–24 mg | 24.0–24.0 ml | — |
| 12 kg | 29–29 mg | 28.8–28.8 ml | — |
| 15 kg | 36–36 mg | 36.0–36.0 ml | — |
| 18 kg | 43–43 mg | 43.2–43.2 ml | — |
| 20 kg | 48–48 mg | 48.0–48.0 ml | — |
| 25 kg | 60–60 mg | 60.0–60.0 ml | — |
| 30 kg | 72–72 mg | 72.0–72.0 ml | — |
⚠️ Warnings
- •
Clofazimine
Clofazimine
💊 Leprosy (MDT: multi-bacillary and pauci-bacillary)
Formulation
Tablet
Standard tablet
Dose Range
1–6 mg/kg
Max Daily
N/A
Frequency
1 mg/kg/day; 4-6 mg/kg once a month; Lepra reaction 100 mg BD-TDS for 21 days
Max Single
N/A
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 5–30 mg | 5.0–30.0 ml | — |
| 6 kg | 6–36 mg | 6.0–36.0 ml | — |
| 7 kg | 7–42 mg | 7.0–42.0 ml | — |
| 8 kg | 8–48 mg | 8.0–48.0 ml | — |
| 9 kg | 9–54 mg | 9.0–54.0 ml | — |
| 10 kg | 10–60 mg | 10.0–60.0 ml | — |
| 12 kg | 12–72 mg | 12.0–72.0 ml | — |
| 15 kg | 15–90 mg | 15.0–90.0 ml | — |
| 18 kg | 18–108 mg | 18.0–108.0 ml | — |
| 20 kg | 20–120 mg | 20.0–120.0 ml | — |
| 25 kg | 25–150 mg | 25.0–150.0 ml | — |
| 30 kg | 30–180 mg | 30.0–180.0 ml | — |
⚠️ Warnings
- • May cause skin pigmentation which may resolve after stopping.
Dapsone
Dapsone
💊 Leprosy (MDT)
Formulation
Tablet
Standard tablet
Dose Range
1–2 mg/kg
Max Daily
N/A
Frequency
Once daily (start low dose, increase weekly; 50 mg twice weekly for adults)
Max Single
N/A
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 5–10 mg | 5.0–10.0 ml | — |
| 6 kg | 6–12 mg | 6.0–12.0 ml | — |
| 7 kg | 7–14 mg | 7.0–14.0 ml | — |
| 8 kg | 8–16 mg | 8.0–16.0 ml | — |
| 9 kg | 9–18 mg | 9.0–18.0 ml | — |
| 10 kg | 10–20 mg | 10.0–20.0 ml | — |
| 12 kg | 12–24 mg | 12.0–24.0 ml | — |
| 15 kg | 15–30 mg | 15.0–30.0 ml | — |
| 18 kg | 18–36 mg | 18.0–36.0 ml | — |
| 20 kg | 20–40 mg | 20.0–40.0 ml | — |
| 25 kg | 25–50 mg | 25.0–50.0 ml | — |
| 30 kg | 30–60 mg | 30.0–60.0 ml | — |
⚠️ Warnings
- • G6PD deficiency may cause dose-related hemolysis. SE: hemolytic anemia, methemoglobinemia, agranulocytosis, nephrotic syndrome, lupus erythematosus, peripheral neuropathy.
Rifampicin (Antileprosy)
Rifampicin
💊 Leprosy (MDT multi-bacillary and pauci-bacillary)
Formulation
Tablet
Standard tablet
Dose Range
10–20 mg/kg
Max Daily
N/A
Frequency
Once daily empty stomach
Max Single
600 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–100 mg | 50.0–100.0 ml | — |
| 6 kg | 60–120 mg | 60.0–120.0 ml | — |
| 7 kg | 70–140 mg | 70.0–140.0 ml | — |
| 8 kg | 80–160 mg | 80.0–160.0 ml | — |
| 9 kg | 90–180 mg | 90.0–180.0 ml | — |
| 10 kg | 100–200 mg | 100.0–200.0 ml | — |
| 12 kg | 120–240 mg | 120.0–240.0 ml | — |
| 15 kg | 150–300 mg | 150.0–300.0 ml | — |
| 18 kg | 180–360 mg | 180.0–360.0 ml | — |
| 20 kg | 200–400 mg | 200.0–400.0 ml | — |
| 25 kg | 250–500 mg | 250.0–500.0 ml | — |
| 30 kg | 300–600 mg | 300.0–600.0 ml | — |
⚠️ Warnings
- • C/I: Hepatic damage, hypersensitivity.
Mefloquine
Mefloquine
💊 P. falciparum malaria (drug resistant), prophylaxis of chloroquine-resistant malaria
Formulation
Tablet
Standard tablet
Dose Range
15–25 mg/kg
Max Daily
25 mg/kg
Frequency
As directed
Max Single
1250 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 75–125 mg | 75.0–125.0 ml | ≤ 125 mg |
| 6 kg | 90–150 mg | 90.0–150.0 ml | ≤ 150 mg |
| 7 kg | 105–175 mg | 105.0–175.0 ml | ≤ 175 mg |
| 8 kg | 120–200 mg | 120.0–200.0 ml | ≤ 200 mg |
| 9 kg | 135–225 mg | 135.0–225.0 ml | ≤ 225 mg |
| 10 kg | 150–250 mg | 150.0–250.0 ml | ≤ 250 mg |
| 12 kg | 180–300 mg | 180.0–300.0 ml | ≤ 300 mg |
| 15 kg | 225–375 mg | 225.0–375.0 ml | ≤ 375 mg |
| 18 kg | 270–450 mg | 270.0–450.0 ml | ≤ 450 mg |
| 20 kg | 300–500 mg | 300.0–500.0 ml | ≤ 500 mg |
| 25 kg | 375–625 mg | 375.0–625.0 ml | ≤ 625 mg |
| 30 kg | 450–750 mg | 450.0–750.0 ml | ≤ 750 mg |
⚠️ Warnings
- • G6PD deficiency; CNS effects
Primaquine
Primaquine
💊 Radical cure P. vivax/ovale; gametocytocidal for P. falciparum
Formulation
Tablet
Standard tablet
Dose Range
0.25–0.7 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
15 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–4 mg | 1.3–3.5 ml | — |
| 6 kg | 2–4 mg | 1.5–4.2 ml | — |
| 7 kg | 2–5 mg | 1.8–4.9 ml | — |
| 8 kg | 2–6 mg | 2.0–5.6 ml | — |
| 9 kg | 2–6 mg | 2.3–6.3 ml | — |
| 10 kg | 3–7 mg | 2.5–7.0 ml | — |
| 12 kg | 3–8 mg | 3.0–8.4 ml | — |
| 15 kg | 4–11 mg | 3.8–10.5 ml | — |
| 18 kg | 5–13 mg | 4.5–12.6 ml | — |
| 20 kg | 5–14 mg | 5.0–14.0 ml | — |
| 25 kg | 6–18 mg | 6.3–17.5 ml | — |
| 30 kg | 8–21 mg | 7.5–21.0 ml | — |
⚠️ Warnings
- • G6PD deficiency contraindicated
Pyrimethamine
Pyrimethamine
💊 Toxoplasmosis (with sulfadiazine), malaria (with sulfadoxine-pyrimethamine)
Formulation
Tablet
Standard tablet
Dose Range
1–1 mg/kg
Max Daily
1 mg/kg
Frequency
As directed
Max Single
25 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 5–5 mg | 5.0–5.0 ml | ≤ 5 mg |
| 6 kg | 6–6 mg | 6.0–6.0 ml | ≤ 6 mg |
| 7 kg | 7–7 mg | 7.0–7.0 ml | ≤ 7 mg |
| 8 kg | 8–8 mg | 8.0–8.0 ml | ≤ 8 mg |
| 9 kg | 9–9 mg | 9.0–9.0 ml | ≤ 9 mg |
| 10 kg | 10–10 mg | 10.0–10.0 ml | ≤ 10 mg |
| 12 kg | 12–12 mg | 12.0–12.0 ml | ≤ 12 mg |
| 15 kg | 15–15 mg | 15.0–15.0 ml | ≤ 15 mg |
| 18 kg | 18–18 mg | 18.0–18.0 ml | ≤ 18 mg |
| 20 kg | 20–20 mg | 20.0–20.0 ml | ≤ 20 mg |
| 25 kg | 25–25 mg | 25.0–25.0 ml | ≤ 25 mg |
| 30 kg | 30–30 mg | 30.0–30.0 ml | ≤ 30 mg |
⚠️ Warnings
- • Bone marrow suppression; give folinic acid for prolonged use
Chloroquine phosphate
Chloroquine phosphate
💊 P. vivax, P. malariae, P. ovale; chloroquine-sensitive P. falciparum; amebiasis
Formulation
Tablet
Standard tablet
Dose Range
10–10 mg/kg
Max Daily
25 mg/kg
Frequency
As directed
Max Single
600 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–50 mg | 50.0–50.0 ml | ≤ 125 mg |
| 6 kg | 60–60 mg | 60.0–60.0 ml | ≤ 150 mg |
| 7 kg | 70–70 mg | 70.0–70.0 ml | ≤ 175 mg |
| 8 kg | 80–80 mg | 80.0–80.0 ml | ≤ 200 mg |
| 9 kg | 90–90 mg | 90.0–90.0 ml | ≤ 225 mg |
| 10 kg | 100–100 mg | 100.0–100.0 ml | ≤ 250 mg |
| 12 kg | 120–120 mg | 120.0–120.0 ml | ≤ 300 mg |
| 15 kg | 150–150 mg | 150.0–150.0 ml | ≤ 375 mg |
| 18 kg | 180–180 mg | 180.0–180.0 ml | ≤ 450 mg |
| 20 kg | 200–200 mg | 200.0–200.0 ml | ≤ 500 mg |
| 25 kg | 250–250 mg | 250.0–250.0 ml | ≤ 625 mg |
| 30 kg | 300–300 mg | 300.0–300.0 ml | ≤ 750 mg |
⚠️ Warnings
- • G6PD deficiency; retinal toxicity
Lumefantrine
Lumefantrine
💊 Combined with artemether for P. falciparum malaria
Formulation
Tablet
Standard tablet
Dose Range
5–10 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
480 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 25–50 mg | 25.0–50.0 ml | — |
| 6 kg | 30–60 mg | 30.0–60.0 ml | — |
| 7 kg | 35–70 mg | 35.0–70.0 ml | — |
| 8 kg | 40–80 mg | 40.0–80.0 ml | — |
| 9 kg | 45–90 mg | 45.0–90.0 ml | — |
| 10 kg | 50–100 mg | 50.0–100.0 ml | — |
| 12 kg | 60–120 mg | 60.0–120.0 ml | — |
| 15 kg | 75–150 mg | 75.0–150.0 ml | — |
| 18 kg | 90–180 mg | 90.0–180.0 ml | — |
| 20 kg | 100–200 mg | 100.0–200.0 ml | — |
| 25 kg | 125–250 mg | 125.0–250.0 ml | — |
| 30 kg | 150–300 mg | 150.0–300.0 ml | — |
⚠️ Warnings
- • Use in combination therapy only
Quinine dihydrochloride
Quinine dihydrochloride
💊 Severe falciparum malaria
Formulation
Tablet
Standard tablet
Dose Range
10–20 mg/kg
Max Daily
30 mg/kg
Frequency
As directed
Max Single
600 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–100 mg | 50.0–100.0 ml | ≤ 150 mg |
| 6 kg | 60–120 mg | 60.0–120.0 ml | ≤ 180 mg |
| 7 kg | 70–140 mg | 70.0–140.0 ml | ≤ 210 mg |
| 8 kg | 80–160 mg | 80.0–160.0 ml | ≤ 240 mg |
| 9 kg | 90–180 mg | 90.0–180.0 ml | ≤ 270 mg |
| 10 kg | 100–200 mg | 100.0–200.0 ml | ≤ 300 mg |
| 12 kg | 120–240 mg | 120.0–240.0 ml | ≤ 360 mg |
| 15 kg | 150–300 mg | 150.0–300.0 ml | ≤ 450 mg |
| 18 kg | 180–360 mg | 180.0–360.0 ml | ≤ 540 mg |
| 20 kg | 200–400 mg | 200.0–400.0 ml | ≤ 600 mg |
| 25 kg | 250–500 mg | 250.0–500.0 ml | ≤ 750 mg |
| 30 kg | 300–600 mg | 300.0–600.0 ml | ≤ 900 mg |
⚠️ Warnings
- • Lethal hypotension if rapid IV; cinchonism; hypoglycemia; QT prolongation; G6PD deficiency; reduce dose in renal failure
Quinine sulfate
Quinine sulfate
💊 Uncomplicated chloroquine-resistant P. falciparum (preferably with tetracycline, clindamycin, or sulfadiazine)
Formulation
Tablet
Standard tablet
Dose Range
30–30 mg/kg
Max Daily
30 mg/kg
Frequency
As directed
Max Single
600 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 150–150 mg | 150.0–150.0 ml | ≤ 150 mg |
| 6 kg | 180–180 mg | 180.0–180.0 ml | ≤ 180 mg |
| 7 kg | 210–210 mg | 210.0–210.0 ml | ≤ 210 mg |
| 8 kg | 240–240 mg | 240.0–240.0 ml | ≤ 240 mg |
| 9 kg | 270–270 mg | 270.0–270.0 ml | ≤ 270 mg |
| 10 kg | 300–300 mg | 300.0–300.0 ml | ≤ 300 mg |
| 12 kg | 360–360 mg | 360.0–360.0 ml | ≤ 360 mg |
| 15 kg | 450–450 mg | 450.0–450.0 ml | ≤ 450 mg |
| 18 kg | 540–540 mg | 540.0–540.0 ml | ≤ 540 mg |
| 20 kg | 600–600 mg | 600.0–600.0 ml | ≤ 600 mg |
| 25 kg | 750–750 mg | 750.0–750.0 ml | ≤ 750 mg |
| 30 kg | 900–900 mg | 900.0–900.0 ml | ≤ 900 mg |
⚠️ Warnings
- • QT prolongation; hypoglycemia; tinnitus
Pyrimethamine + Sulfadoxine
Pyrimethamine + Sulfadoxine
💊 Chloroquine-resistant P. falciparum (in combination with artesunate)
Formulation
Tablet
Standard tablet
Dose Range
1–1 mg/kg
Max Daily
1 mg/kg
Frequency
As directed
Max Single
50 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 5–5 mg | 5.0–5.0 ml | ≤ 5 mg |
| 6 kg | 6–6 mg | 6.0–6.0 ml | ≤ 6 mg |
| 7 kg | 7–7 mg | 7.0–7.0 ml | ≤ 7 mg |
| 8 kg | 8–8 mg | 8.0–8.0 ml | ≤ 8 mg |
| 9 kg | 9–9 mg | 9.0–9.0 ml | ≤ 9 mg |
| 10 kg | 10–10 mg | 10.0–10.0 ml | ≤ 10 mg |
| 12 kg | 12–12 mg | 12.0–12.0 ml | ≤ 12 mg |
| 15 kg | 15–15 mg | 15.0–15.0 ml | ≤ 15 mg |
| 18 kg | 18–18 mg | 18.0–18.0 ml | ≤ 18 mg |
| 20 kg | 20–20 mg | 20.0–20.0 ml | ≤ 20 mg |
| 25 kg | 25–25 mg | 25.0–25.0 ml | ≤ 25 mg |
| 30 kg | 30–30 mg | 30.0–30.0 ml | ≤ 30 mg |
⚠️ Warnings
- • Not for long-term prophylaxis; Stevens-Johnson syndrome; sulfa allergy
Pyridostigmine bromide
Pyridostigmine bromide
💊 Myasthenia gravis; infants of myasthenic mothers
Formulation
Tablet
Standard tablet
Dose Range
0.05–0.15 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
60 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 0–1 mg | 0.3–0.8 ml | — |
| 6 kg | 0–1 mg | 0.3–0.9 ml | — |
| 7 kg | 0–1 mg | 0.4–1.1 ml | — |
| 8 kg | 0–1 mg | 0.4–1.2 ml | — |
| 9 kg | 0–1 mg | 0.5–1.3 ml | — |
| 10 kg | 1–2 mg | 0.5–1.5 ml | — |
| 12 kg | 1–2 mg | 0.6–1.8 ml | — |
| 15 kg | 1–2 mg | 0.8–2.3 ml | — |
| 18 kg | 1–3 mg | 0.9–2.7 ml | — |
| 20 kg | 1–3 mg | 1.0–3.0 ml | — |
| 25 kg | 1–4 mg | 1.3–3.8 ml | — |
| 30 kg | 2–5 mg | 1.5–4.5 ml | — |
⚠️ Warnings
- • Titrate dose; use atropine for muscarinic side effects
Edrophonium chloride
Edrophonium chloride
💊 Diagnosis of myasthenia gravis; reversal of non-depolarising neuromuscular blockade
Formulation
Tablet
Standard tablet
Dose Range
0.04–0.2 mg/kg
Max Daily
0.2 mg/kg
Frequency
As directed
Max Single
5 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 0–1 mg | 0.2–1.0 ml | ≤ 1 mg |
| 6 kg | 0–1 mg | 0.2–1.2 ml | ≤ 1 mg |
| 7 kg | 0–1 mg | 0.3–1.4 ml | ≤ 1 mg |
| 8 kg | 0–2 mg | 0.3–1.6 ml | ≤ 2 mg |
| 9 kg | 0–2 mg | 0.4–1.8 ml | ≤ 2 mg |
| 10 kg | 0–2 mg | 0.4–2.0 ml | ≤ 2 mg |
| 12 kg | 0–2 mg | 0.5–2.4 ml | ≤ 2 mg |
| 15 kg | 1–3 mg | 0.6–3.0 ml | ≤ 3 mg |
| 18 kg | 1–4 mg | 0.7–3.6 ml | ≤ 4 mg |
| 20 kg | 1–4 mg | 0.8–4.0 ml | ≤ 4 mg |
| 25 kg | 1–5 mg | 1.0–5.0 ml | ≤ 5 mg |
| 30 kg | 1–6 mg | 1.2–6.0 ml | ≤ 6 mg |
⚠️ Warnings
- • Keep atropine ready; may precipitate cholinergic crisis, arrhythmia, bronchospasm; contraindicated in GI/GU obstruction
Neostigmine
Neostigmine
💊 Myasthenia gravis; neonatal myasthenia; reversal of neuromuscular blockade
Formulation
Tablet
Standard tablet
Dose Range
0.01–0.04 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
2 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 0–0 mg | 0.1–0.2 ml | — |
| 6 kg | 0–0 mg | 0.1–0.2 ml | — |
| 7 kg | 0–0 mg | 0.1–0.3 ml | — |
| 8 kg | 0–0 mg | 0.1–0.3 ml | — |
| 9 kg | 0–0 mg | 0.1–0.4 ml | — |
| 10 kg | 0–0 mg | 0.1–0.4 ml | — |
| 12 kg | 0–0 mg | 0.1–0.5 ml | — |
| 15 kg | 0–1 mg | 0.1–0.6 ml | — |
| 18 kg | 0–1 mg | 0.2–0.7 ml | — |
| 20 kg | 0–1 mg | 0.2–0.8 ml | — |
| 25 kg | 0–1 mg | 0.3–1.0 ml | — |
| 30 kg | 0–1 mg | 0.3–1.2 ml | — |
⚠️ Warnings
- • Contraindicated in intestinal/urinary obstruction
Dehydroemetine dihydrochloride
Dehydroemetine dihydrochloride
💊 Amebic liver abscess, invasive amebiasis
Formulation
Tablet
Standard tablet
Dose Range
1.5–1.5 mg/kg
Max Daily
1.5 mg/kg
Frequency
As directed
Max Single
90 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 8–8 mg | 7.5–7.5 ml | ≤ 8 mg |
| 6 kg | 9–9 mg | 9.0–9.0 ml | ≤ 9 mg |
| 7 kg | 11–11 mg | 10.5–10.5 ml | ≤ 11 mg |
| 8 kg | 12–12 mg | 12.0–12.0 ml | ≤ 12 mg |
| 9 kg | 14–14 mg | 13.5–13.5 ml | ≤ 14 mg |
| 10 kg | 15–15 mg | 15.0–15.0 ml | ≤ 15 mg |
| 12 kg | 18–18 mg | 18.0–18.0 ml | ≤ 18 mg |
| 15 kg | 23–23 mg | 22.5–22.5 ml | ≤ 23 mg |
| 18 kg | 27–27 mg | 27.0–27.0 ml | ≤ 27 mg |
| 20 kg | 30–30 mg | 30.0–30.0 ml | ≤ 30 mg |
| 25 kg | 38–38 mg | 37.5–37.5 ml | ≤ 38 mg |
| 30 kg | 45–45 mg | 45.0–45.0 ml | ≤ 45 mg |
⚠️ Warnings
- • Renal and cardiac toxicity; cardiotoxic
Di-iodohydroxyquin
Di-iodohydroxyquin
💊 Asymptomatic intestinal amebiasis
Formulation
Tablet
Standard tablet
Dose Range
30–40 mg/kg
Max Daily
40 mg/kg
Frequency
As directed
Max Single
600 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 150–200 mg | 150.0–200.0 ml | ≤ 200 mg |
| 6 kg | 180–240 mg | 180.0–240.0 ml | ≤ 240 mg |
| 7 kg | 210–280 mg | 210.0–280.0 ml | ≤ 280 mg |
| 8 kg | 240–320 mg | 240.0–320.0 ml | ≤ 320 mg |
| 9 kg | 270–360 mg | 270.0–360.0 ml | ≤ 360 mg |
| 10 kg | 300–400 mg | 300.0–400.0 ml | ≤ 400 mg |
| 12 kg | 360–480 mg | 360.0–480.0 ml | ≤ 480 mg |
| 15 kg | 450–600 mg | 450.0–600.0 ml | ≤ 600 mg |
| 18 kg | 540–720 mg | 540.0–720.0 ml | ≤ 720 mg |
| 20 kg | 600–800 mg | 600.0–800.0 ml | ≤ 800 mg |
| 25 kg | 750–1000 mg | 750.0–1000.0 ml | ≤ 1000 mg |
| 30 kg | 900–1200 mg | 900.0–1200.0 ml | ≤ 1200 mg |
⚠️ Warnings
- • Iodine allergy; hepatic damage; avoid in pregnancy
Miltefosine
Miltefosine
💊 Visceral and cutaneous leishmaniasis
Formulation
Tablet
Standard tablet
Dose Range
2.5–2.5 mg/kg
Max Daily
2.5 mg/kg
Frequency
As directed
Max Single
N/A
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 13–13 mg | 12.5–12.5 ml | ≤ 13 mg |
| 6 kg | 15–15 mg | 15.0–15.0 ml | ≤ 15 mg |
| 7 kg | 18–18 mg | 17.5–17.5 ml | ≤ 18 mg |
| 8 kg | 20–20 mg | 20.0–20.0 ml | ≤ 20 mg |
| 9 kg | 23–23 mg | 22.5–22.5 ml | ≤ 23 mg |
| 10 kg | 25–25 mg | 25.0–25.0 ml | ≤ 25 mg |
| 12 kg | 30–30 mg | 30.0–30.0 ml | ≤ 30 mg |
| 15 kg | 38–38 mg | 37.5–37.5 ml | ≤ 38 mg |
| 18 kg | 45–45 mg | 45.0–45.0 ml | ≤ 45 mg |
| 20 kg | 50–50 mg | 50.0–50.0 ml | ≤ 50 mg |
| 25 kg | 63–63 mg | 62.5–62.5 ml | ≤ 63 mg |
| 30 kg | 75–75 mg | 75.0–75.0 ml | ≤ 75 mg |
⚠️ Warnings
- • Teratogenic; GI side effects; monitor renal function
Quinacrine hydrochloride
Quinacrine hydrochloride
💊 Giardiasis (course may repeat after 15 days)
Formulation
Tablet
Standard tablet
Dose Range
20–20 mg/kg
Max Daily
20 mg/kg
Frequency
As directed
Max Single
N/A
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 100–100 mg | 100.0–100.0 ml | ≤ 100 mg |
| 6 kg | 120–120 mg | 120.0–120.0 ml | ≤ 120 mg |
| 7 kg | 140–140 mg | 140.0–140.0 ml | ≤ 140 mg |
| 8 kg | 160–160 mg | 160.0–160.0 ml | ≤ 160 mg |
| 9 kg | 180–180 mg | 180.0–180.0 ml | ≤ 180 mg |
| 10 kg | 200–200 mg | 200.0–200.0 ml | ≤ 200 mg |
| 12 kg | 240–240 mg | 240.0–240.0 ml | ≤ 240 mg |
| 15 kg | 300–300 mg | 300.0–300.0 ml | ≤ 300 mg |
| 18 kg | 360–360 mg | 360.0–360.0 ml | ≤ 360 mg |
| 20 kg | 400–400 mg | 400.0–400.0 ml | ≤ 400 mg |
| 25 kg | 500–500 mg | 500.0–500.0 ml | ≤ 500 mg |
| 30 kg | 600–600 mg | 600.0–600.0 ml | ≤ 600 mg |
⚠️ Warnings
- • Yellow skin discoloration; GI upset; psychosis
Secnidazole
Secnidazole
💊 Intestinal amebiasis, giardiasis; severe invasive disease for 5 days
Formulation
Tablet
Standard tablet
Dose Range
30–30 mg/kg
Max Daily
30 mg/kg
Frequency
As directed
Max Single
2000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 150–150 mg | 150.0–150.0 ml | ≤ 150 mg |
| 6 kg | 180–180 mg | 180.0–180.0 ml | ≤ 180 mg |
| 7 kg | 210–210 mg | 210.0–210.0 ml | ≤ 210 mg |
| 8 kg | 240–240 mg | 240.0–240.0 ml | ≤ 240 mg |
| 9 kg | 270–270 mg | 270.0–270.0 ml | ≤ 270 mg |
| 10 kg | 300–300 mg | 300.0–300.0 ml | ≤ 300 mg |
| 12 kg | 360–360 mg | 360.0–360.0 ml | ≤ 360 mg |
| 15 kg | 450–450 mg | 450.0–450.0 ml | ≤ 450 mg |
| 18 kg | 540–540 mg | 540.0–540.0 ml | ≤ 540 mg |
| 20 kg | 600–600 mg | 600.0–600.0 ml | ≤ 600 mg |
| 25 kg | 750–750 mg | 750.0–750.0 ml | ≤ 750 mg |
| 30 kg | 900–900 mg | 900.0–900.0 ml | ≤ 900 mg |
⚠️ Warnings
- • Nausea, metallic taste, urticaria, cholestatic hepatitis
Sodium stibogluconate
Sodium stibogluconate
💊 Visceral and cutaneous leishmaniasis; up to 60 days for resistant cases
Formulation
Tablet
Standard tablet
Dose Range
20–20 mg/kg
Max Daily
20 mg/kg
Frequency
As directed
Max Single
850 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 100–100 mg | 100.0–100.0 ml | ≤ 100 mg |
| 6 kg | 120–120 mg | 120.0–120.0 ml | ≤ 120 mg |
| 7 kg | 140–140 mg | 140.0–140.0 ml | ≤ 140 mg |
| 8 kg | 160–160 mg | 160.0–160.0 ml | ≤ 160 mg |
| 9 kg | 180–180 mg | 180.0–180.0 ml | ≤ 180 mg |
| 10 kg | 200–200 mg | 200.0–200.0 ml | ≤ 200 mg |
| 12 kg | 240–240 mg | 240.0–240.0 ml | ≤ 240 mg |
| 15 kg | 300–300 mg | 300.0–300.0 ml | ≤ 300 mg |
| 18 kg | 360–360 mg | 360.0–360.0 ml | ≤ 360 mg |
| 20 kg | 400–400 mg | 400.0–400.0 ml | ≤ 400 mg |
| 25 kg | 500–500 mg | 500.0–500.0 ml | ≤ 500 mg |
| 30 kg | 600–600 mg | 600.0–600.0 ml | ≤ 600 mg |
⚠️ Warnings
- • Monitor QT interval; cardiotoxic; pancreatitis; arthralgia
Pentamidine isethionate
Pentamidine isethionate
💊 Antimony-resistant leishmaniasis; Pneumocystis carinii pneumonia
Formulation
Tablet
Standard tablet
Dose Range
4–4 mg/kg
Max Daily
4 mg/kg
Frequency
As directed
Max Single
300 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 20–20 mg | 20.0–20.0 ml | ≤ 20 mg |
| 6 kg | 24–24 mg | 24.0–24.0 ml | ≤ 24 mg |
| 7 kg | 28–28 mg | 28.0–28.0 ml | ≤ 28 mg |
| 8 kg | 32–32 mg | 32.0–32.0 ml | ≤ 32 mg |
| 9 kg | 36–36 mg | 36.0–36.0 ml | ≤ 36 mg |
| 10 kg | 40–40 mg | 40.0–40.0 ml | ≤ 40 mg |
| 12 kg | 48–48 mg | 48.0–48.0 ml | ≤ 48 mg |
| 15 kg | 60–60 mg | 60.0–60.0 ml | ≤ 60 mg |
| 18 kg | 72–72 mg | 72.0–72.0 ml | ≤ 72 mg |
| 20 kg | 80–80 mg | 80.0–80.0 ml | ≤ 80 mg |
| 25 kg | 100–100 mg | 100.0–100.0 ml | ≤ 100 mg |
| 30 kg | 120–120 mg | 120.0–120.0 ml | ≤ 120 mg |
⚠️ Warnings
- • Hypotension, renal damage, hypoglycemia, diabetes risk, Torsade de pointes
Tinidazole
Tinidazole
💊 Giardiasis (50 mg/kg single dose), amebiasis (60 mg/kg/day x 3 days)
Formulation
Tablet
Standard tablet
Dose Range
50–60 mg/kg
Max Daily
60 mg/kg
Frequency
As directed
Max Single
2000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 250–300 mg | 250.0–300.0 ml | ≤ 300 mg |
| 6 kg | 300–360 mg | 300.0–360.0 ml | ≤ 360 mg |
| 7 kg | 350–420 mg | 350.0–420.0 ml | ≤ 420 mg |
| 8 kg | 400–480 mg | 400.0–480.0 ml | ≤ 480 mg |
| 9 kg | 450–540 mg | 450.0–540.0 ml | ≤ 540 mg |
| 10 kg | 500–600 mg | 500.0–600.0 ml | ≤ 600 mg |
| 12 kg | 600–720 mg | 600.0–720.0 ml | ≤ 720 mg |
| 15 kg | 750–900 mg | 750.0–900.0 ml | ≤ 900 mg |
| 18 kg | 900–1080 mg | 900.0–1080.0 ml | ≤ 1080 mg |
| 20 kg | 1000–1200 mg | 1000.0–1200.0 ml | ≤ 1200 mg |
| 25 kg | 1250–1500 mg | 1250.0–1500.0 ml | ≤ 1500 mg |
| 30 kg | 1500–1800 mg | 1500.0–1800.0 ml | ≤ 1800 mg |
⚠️ Warnings
- • GI upset; metallic taste; avoid in pregnancy
Drotaverine hydrochloride
Drotaverine hydrochloride
💊 Intestinal/biliary/renal colic; abdominal pain
Formulation
Tablet
Standard tablet
Dose Range
1–2 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
80 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 5–10 mg | 5.0–10.0 ml | — |
| 6 kg | 6–12 mg | 6.0–12.0 ml | — |
| 7 kg | 7–14 mg | 7.0–14.0 ml | — |
| 8 kg | 8–16 mg | 8.0–16.0 ml | — |
| 9 kg | 9–18 mg | 9.0–18.0 ml | — |
| 10 kg | 10–20 mg | 10.0–20.0 ml | — |
| 12 kg | 12–24 mg | 12.0–24.0 ml | — |
| 15 kg | 15–30 mg | 15.0–30.0 ml | — |
| 18 kg | 18–36 mg | 18.0–36.0 ml | — |
| 20 kg | 20–40 mg | 20.0–40.0 ml | — |
| 25 kg | 25–50 mg | 25.0–50.0 ml | — |
| 30 kg | 30–60 mg | 30.0–60.0 ml | — |
⚠️ Warnings
- • Use with caution in liver/kidney impairment
Hyoscine butylbromide
Hyoscine butylbromide
💊 Intestinal/biliary colic; renal colic
Formulation
Tablet
Standard tablet
Dose Range
0.5–1 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
20 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 3–5 mg | 2.5–5.0 ml | — |
| 6 kg | 3–6 mg | 3.0–6.0 ml | — |
| 7 kg | 4–7 mg | 3.5–7.0 ml | — |
| 8 kg | 4–8 mg | 4.0–8.0 ml | — |
| 9 kg | 5–9 mg | 4.5–9.0 ml | — |
| 10 kg | 5–10 mg | 5.0–10.0 ml | — |
| 12 kg | 6–12 mg | 6.0–12.0 ml | — |
| 15 kg | 8–15 mg | 7.5–15.0 ml | — |
| 18 kg | 9–18 mg | 9.0–18.0 ml | — |
| 20 kg | 10–20 mg | 10.0–20.0 ml | — |
| 25 kg | 13–25 mg | 12.5–25.0 ml | — |
| 30 kg | 15–30 mg | 15.0–30.0 ml | — |
⚠️ Warnings
- • Contraindicated in glaucoma
Dicyclomine hydrochloride
Dicyclomine hydrochloride
💊 Infantile colic; intestinal colic; GI spasm; irritable colon
Formulation
Tablet
Standard tablet
Dose Range
0.5–1 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
20 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 3–5 mg | 2.5–5.0 ml | — |
| 6 kg | 3–6 mg | 3.0–6.0 ml | — |
| 7 kg | 4–7 mg | 3.5–7.0 ml | — |
| 8 kg | 4–8 mg | 4.0–8.0 ml | — |
| 9 kg | 5–9 mg | 4.5–9.0 ml | — |
| 10 kg | 5–10 mg | 5.0–10.0 ml | — |
| 12 kg | 6–12 mg | 6.0–12.0 ml | — |
| 15 kg | 8–15 mg | 7.5–15.0 ml | — |
| 18 kg | 9–18 mg | 9.0–18.0 ml | — |
| 20 kg | 10–20 mg | 10.0–20.0 ml | — |
| 25 kg | 13–25 mg | 12.5–25.0 ml | — |
| 30 kg | 15–30 mg | 15.0–30.0 ml | — |
⚠️ Warnings
- • Contraindicated <6 months; anticholinergic effects
Oxyphenonium bromide
Oxyphenonium bromide
💊 GI spasm; peptic ulcer adjunct
Formulation
Tablet
Standard tablet
Dose Range
0.8–0.8 mg/kg
Max Daily
0.8 mg/kg
Frequency
As directed
Max Single
5 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 4–4 mg | 4.0–4.0 ml | ≤ 4 mg |
| 6 kg | 5–5 mg | 4.8–4.8 ml | ≤ 5 mg |
| 7 kg | 6–6 mg | 5.6–5.6 ml | ≤ 6 mg |
| 8 kg | 6–6 mg | 6.4–6.4 ml | ≤ 6 mg |
| 9 kg | 7–7 mg | 7.2–7.2 ml | ≤ 7 mg |
| 10 kg | 8–8 mg | 8.0–8.0 ml | ≤ 8 mg |
| 12 kg | 10–10 mg | 9.6–9.6 ml | ≤ 10 mg |
| 15 kg | 12–12 mg | 12.0–12.0 ml | ≤ 12 mg |
| 18 kg | 14–14 mg | 14.4–14.4 ml | ≤ 14 mg |
| 20 kg | 16–16 mg | 16.0–16.0 ml | ≤ 16 mg |
| 25 kg | 20–20 mg | 20.0–20.0 ml | ≤ 20 mg |
| 30 kg | 24–24 mg | 24.0–24.0 ml | ≤ 24 mg |
⚠️ Warnings
- • Dry mouth, blurred vision, urinary retention, dizziness
Pipenzolate methyl bromide
Pipenzolate methyl bromide
💊 GI spasm in children; abdominal colic
Formulation
Tablet
Standard tablet
Dose Range
0.5–1 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
15 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 3–5 mg | 2.5–5.0 ml | — |
| 6 kg | 3–6 mg | 3.0–6.0 ml | — |
| 7 kg | 4–7 mg | 3.5–7.0 ml | — |
| 8 kg | 4–8 mg | 4.0–8.0 ml | — |
| 9 kg | 5–9 mg | 4.5–9.0 ml | — |
| 10 kg | 5–10 mg | 5.0–10.0 ml | — |
| 12 kg | 6–12 mg | 6.0–12.0 ml | — |
| 15 kg | 8–15 mg | 7.5–15.0 ml | — |
| 18 kg | 9–18 mg | 9.0–18.0 ml | — |
| 20 kg | 10–20 mg | 10.0–20.0 ml | — |
| 25 kg | 13–25 mg | 12.5–25.0 ml | — |
| 30 kg | 15–30 mg | 15.0–30.0 ml | — |
⚠️ Warnings
- • Anticholinergic side effects
Simethicone
Simethicone
💊 Antiflatulent; infant colic; bloating; gas
Formulation
Tablet
Standard tablet
Dose Range
20–40 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
125 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 100–200 mg | 100.0–200.0 ml | — |
| 6 kg | 120–240 mg | 120.0–240.0 ml | — |
| 7 kg | 140–280 mg | 140.0–280.0 ml | — |
| 8 kg | 160–320 mg | 160.0–320.0 ml | — |
| 9 kg | 180–360 mg | 180.0–360.0 ml | — |
| 10 kg | 200–400 mg | 200.0–400.0 ml | — |
| 12 kg | 240–480 mg | 240.0–480.0 ml | — |
| 15 kg | 300–600 mg | 300.0–600.0 ml | — |
| 18 kg | 360–720 mg | 360.0–720.0 ml | — |
| 20 kg | 400–800 mg | 400.0–800.0 ml | — |
| 25 kg | 500–1000 mg | 500.0–1000.0 ml | — |
| 30 kg | 600–1200 mg | 600.0–1200.0 ml | — |
⚠️ Warnings
- • Generally safe
Anti-Rh(D) immune globulin
Anti-Rh(D) immune globulin
💊 Prevention of Rh(D) sensitization; Rh-negative mothers; twin pregnancy (double dose)
Formulation
Tablet
Standard tablet
Dose Range
50–100 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
N/A
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 250–500 mg | 250.0–500.0 ml | — |
| 6 kg | 300–600 mg | 300.0–600.0 ml | — |
| 7 kg | 350–700 mg | 350.0–700.0 ml | — |
| 8 kg | 400–800 mg | 400.0–800.0 ml | — |
| 9 kg | 450–900 mg | 450.0–900.0 ml | — |
| 10 kg | 500–1000 mg | 500.0–1000.0 ml | — |
| 12 kg | 600–1200 mg | 600.0–1200.0 ml | — |
| 15 kg | 750–1500 mg | 750.0–1500.0 ml | — |
| 18 kg | 900–1800 mg | 900.0–1800.0 ml | — |
| 20 kg | 1000–2000 mg | 1000.0–2000.0 ml | — |
| 25 kg | 1250–2500 mg | 1250.0–2500.0 ml | — |
| 30 kg | 1500–3000 mg | 1500.0–3000.0 ml | — |
⚠️ Warnings
- • Must be Rh-positive baby; indirect Coombs negative; hypersensitivity
Polyvalent anti-snake venom serum
Polyvalent anti-snake venom serum
💊 Snake bite (krait, cobra, Russell's viper, saw-scaled viper); 5 vials mild, 5-15 moderate, 15-20 severe; children may need 1.5x
Formulation
Tablet
Standard tablet
Dose Range
10–50 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
N/A
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–250 mg | 50.0–250.0 ml | — |
| 6 kg | 60–300 mg | 60.0–300.0 ml | — |
| 7 kg | 70–350 mg | 70.0–350.0 ml | — |
| 8 kg | 80–400 mg | 80.0–400.0 ml | — |
| 9 kg | 90–450 mg | 90.0–450.0 ml | — |
| 10 kg | 100–500 mg | 100.0–500.0 ml | — |
| 12 kg | 120–600 mg | 120.0–600.0 ml | — |
| 15 kg | 150–750 mg | 150.0–750.0 ml | — |
| 18 kg | 180–900 mg | 180.0–900.0 ml | — |
| 20 kg | 200–1000 mg | 200.0–1000.0 ml | — |
| 25 kg | 250–1250 mg | 250.0–1250.0 ml | — |
| 30 kg | 300–1500 mg | 300.0–1500.0 ml | — |
⚠️ Warnings
- • Horse serum allergy; administer steroids/antihistamines; test intradermally first
Diphtheria antitoxin (Equine)
Diphtheria antitoxin (Equine)
💊 Diphtheria treatment: 20,000-40,000 units pharyngeal/laryngeal (<48hr); 40,000-60,000 nasopharyngeal; 80,000-120,000 extensive (>3 days with neck swelling)
Formulation
Tablet
Standard tablet
Dose Range
500–2000 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
N/A
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 2500–10000 mg | 2500.0–10000.0 ml | — |
| 6 kg | 3000–12000 mg | 3000.0–12000.0 ml | — |
| 7 kg | 3500–14000 mg | 3500.0–14000.0 ml | — |
| 8 kg | 4000–16000 mg | 4000.0–16000.0 ml | — |
| 9 kg | 4500–18000 mg | 4500.0–18000.0 ml | — |
| 10 kg | 5000–20000 mg | 5000.0–20000.0 ml | — |
| 12 kg | 6000–24000 mg | 6000.0–24000.0 ml | — |
| 15 kg | 7500–30000 mg | 7500.0–30000.0 ml | — |
| 18 kg | 9000–36000 mg | 9000.0–36000.0 ml | — |
| 20 kg | 10000–40000 mg | 10000.0–40000.0 ml | — |
| 25 kg | 12500–50000 mg | 12500.0–50000.0 ml | — |
| 30 kg | 15000–60000 mg | 15000.0–60000.0 ml | — |
⚠️ Warnings
- • Horse serum sensitivity
Human immunoglobulins (HIG)
Human immunoglobulins (HIG)
💊 Prophylaxis of viral diseases, burns, bacterial infections, primary immunodeficiency (300-400 mg/kg IM q3-4wks); measles prophylaxis (0.3 ml/kg IM within 6 days); hepatitis A (0.02-0.04 ml/kg IM within 14 days)
Formulation
Tablet
Standard tablet
Dose Range
0.3–400 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
N/A
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 2–2000 mg | 1.5–2000.0 ml | — |
| 6 kg | 2–2400 mg | 1.8–2400.0 ml | — |
| 7 kg | 2–2800 mg | 2.1–2800.0 ml | — |
| 8 kg | 2–3200 mg | 2.4–3200.0 ml | — |
| 9 kg | 3–3600 mg | 2.7–3600.0 ml | — |
| 10 kg | 3–4000 mg | 3.0–4000.0 ml | — |
| 12 kg | 4–4800 mg | 3.6–4800.0 ml | — |
| 15 kg | 5–6000 mg | 4.5–6000.0 ml | — |
| 18 kg | 5–7200 mg | 5.4–7200.0 ml | — |
| 20 kg | 6–8000 mg | 6.0–8000.0 ml | — |
| 25 kg | 8–10000 mg | 7.5–10000.0 ml | — |
| 30 kg | 9–12000 mg | 9.0–12000.0 ml | — |
⚠️ Warnings
- • No role for chickenpox, polio, mumps prophylaxis; caution in IgA deficiency
Human hepatitis B immunoglobulins (HBIG)
Human hepatitis B immunoglobulins (HBIG)
💊 Post-exposure prophylaxis (40 units/kg); neonates of HBsAg-positive mothers 0.5-1 ml within 12 hours (up to 72 hrs) with HBV vaccine
Formulation
Tablet
Standard tablet
Dose Range
0.06–0.1 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
N/A
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 0–1 mg | 0.3–0.5 ml | — |
| 6 kg | 0–1 mg | 0.4–0.6 ml | — |
| 7 kg | 0–1 mg | 0.4–0.7 ml | — |
| 8 kg | 0–1 mg | 0.5–0.8 ml | — |
| 9 kg | 1–1 mg | 0.5–0.9 ml | — |
| 10 kg | 1–1 mg | 0.6–1.0 ml | — |
| 12 kg | 1–1 mg | 0.7–1.2 ml | — |
| 15 kg | 1–2 mg | 0.9–1.5 ml | — |
| 18 kg | 1–2 mg | 1.1–1.8 ml | — |
| 20 kg | 1–2 mg | 1.2–2.0 ml | — |
| 25 kg | 2–3 mg | 1.5–2.5 ml | — |
| 30 kg | 2–3 mg | 1.8–3.0 ml | — |
⚠️ Warnings
- • Give at different site from vaccine
High dose IV immunoglobulins
High dose IV immunoglobulins
💊 Life-threatening infections, immunodeficiency, chronic ITP, Guillain-Barre syndrome, Kawasaki disease, Rh-isoimmunization; immunodeficiency 2 ml/kg q24hr; severe infection 3-5 ml/kg/day x 3 days; Kawasaki 2 g/kg single dose
Formulation
Tablet
Standard tablet
Dose Range
400–2000 mg/kg
Max Daily
2000 mg/kg
Frequency
As directed
Max Single
N/A
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 2000–10000 mg | 2000.0–10000.0 ml | ≤ 10000 mg |
| 6 kg | 2400–12000 mg | 2400.0–12000.0 ml | ≤ 12000 mg |
| 7 kg | 2800–14000 mg | 2800.0–14000.0 ml | ≤ 14000 mg |
| 8 kg | 3200–16000 mg | 3200.0–16000.0 ml | ≤ 16000 mg |
| 9 kg | 3600–18000 mg | 3600.0–18000.0 ml | ≤ 18000 mg |
| 10 kg | 4000–20000 mg | 4000.0–20000.0 ml | ≤ 20000 mg |
| 12 kg | 4800–24000 mg | 4800.0–24000.0 ml | ≤ 24000 mg |
| 15 kg | 6000–30000 mg | 6000.0–30000.0 ml | ≤ 30000 mg |
| 18 kg | 7200–36000 mg | 7200.0–36000.0 ml | ≤ 36000 mg |
| 20 kg | 8000–40000 mg | 8000.0–40000.0 ml | ≤ 40000 mg |
| 25 kg | 10000–50000 mg | 10000.0–50000.0 ml | ≤ 50000 mg |
| 30 kg | 12000–60000 mg | 12000.0–60000.0 ml | ≤ 60000 mg |
⚠️ Warnings
- • Aseptic meningitis, headache, thrombosis risk; monitor IgG levels
Human rabies specific immunoglobulins (HRIG)
Human rabies specific immunoglobulins (HRIG)
💊 Post-exposure prophylaxis for rabies (20 units/kg); infiltrate wound; rest IM in gluteal region or lateral thigh
Formulation
Tablet
Standard tablet
Dose Range
20–40 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
N/A
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 100–200 mg | 100.0–200.0 ml | — |
| 6 kg | 120–240 mg | 120.0–240.0 ml | — |
| 7 kg | 140–280 mg | 140.0–280.0 ml | — |
| 8 kg | 160–320 mg | 160.0–320.0 ml | — |
| 9 kg | 180–360 mg | 180.0–360.0 ml | — |
| 10 kg | 200–400 mg | 200.0–400.0 ml | — |
| 12 kg | 240–480 mg | 240.0–480.0 ml | — |
| 15 kg | 300–600 mg | 300.0–600.0 ml | — |
| 18 kg | 360–720 mg | 360.0–720.0 ml | — |
| 20 kg | 400–800 mg | 400.0–800.0 ml | — |
| 25 kg | 500–1000 mg | 500.0–1000.0 ml | — |
| 30 kg | 600–1200 mg | 600.0–1200.0 ml | — |
⚠️ Warnings
- • Not for previously immunized patients
Tetanus antitoxin (Equine)
Tetanus antitoxin (Equine)
💊 Prophylaxis: 3,000-5,000 units SC/IM; therapeutic: 10,000 units IM/IV; intrathecal: 250 units q24hr x 3
Formulation
Tablet
Standard tablet
Dose Range
500–2000 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
N/A
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 2500–10000 mg | 2500.0–10000.0 ml | — |
| 6 kg | 3000–12000 mg | 3000.0–12000.0 ml | — |
| 7 kg | 3500–14000 mg | 3500.0–14000.0 ml | — |
| 8 kg | 4000–16000 mg | 4000.0–16000.0 ml | — |
| 9 kg | 4500–18000 mg | 4500.0–18000.0 ml | — |
| 10 kg | 5000–20000 mg | 5000.0–20000.0 ml | — |
| 12 kg | 6000–24000 mg | 6000.0–24000.0 ml | — |
| 15 kg | 7500–30000 mg | 7500.0–30000.0 ml | — |
| 18 kg | 9000–36000 mg | 9000.0–36000.0 ml | — |
| 20 kg | 10000–40000 mg | 10000.0–40000.0 ml | — |
| 25 kg | 12500–50000 mg | 12500.0–50000.0 ml | — |
| 30 kg | 15000–60000 mg | 15000.0–60000.0 ml | — |
⚠️ Warnings
- • Horse serum reaction; test sensitivity before use
Human tetanus specific immunoglobulins (HTIG)
Human tetanus specific immunoglobulins (HTIG)
💊 Prophylaxis: 250 IU IM (>24hrs or contaminated wound: 500 IU); therapeutic: 30-300 units/kg IV; intrathecal: 250 units single dose
Formulation
Tablet
Standard tablet
Dose Range
250–500 mg/kg
Max Daily
N/A
Frequency
Single dose IM (multiple sites)
Max Single
10000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1250–2500 mg | 1250.0–2500.0 ml | — |
| 6 kg | 1500–3000 mg | 1500.0–3000.0 ml | — |
| 7 kg | 1750–3500 mg | 1750.0–3500.0 ml | — |
| 8 kg | 2000–4000 mg | 2000.0–4000.0 ml | — |
| 9 kg | 2250–4500 mg | 2250.0–4500.0 ml | — |
| 10 kg | 2500–5000 mg | 2500.0–5000.0 ml | — |
| 12 kg | 3000–6000 mg | 3000.0–6000.0 ml | — |
| 15 kg | 3750–7500 mg | 3750.0–7500.0 ml | — |
| 18 kg | 4500–9000 mg | 4500.0–9000.0 ml | — |
| 20 kg | 5000–10000 mg | 5000.0–10000.0 ml | — |
| 25 kg | 6250–12500 mg | 6250.0–12500.0 ml | — |
| 30 kg | 7500–15000 mg | 7500.0–15000.0 ml | — |
⚠️ Warnings
- • Not licensed for IV/intrathecal in US
Varicella zoster immunoglobulin (VZIG)
Varicella zoster immunoglobulin (VZIG)
💊 Post-exposure prophylaxis for varicella: 125 units/kg IM within 48-96 hours; neonates of mothers with chickenpox 5 days before to 48 hrs after delivery; immunocompromised children; preterm infants
Formulation
Tablet
Standard tablet
Dose Range
100–200 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
N/A
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 500–1000 mg | 500.0–1000.0 ml | — |
| 6 kg | 600–1200 mg | 600.0–1200.0 ml | — |
| 7 kg | 700–1400 mg | 700.0–1400.0 ml | — |
| 8 kg | 800–1600 mg | 800.0–1600.0 ml | — |
| 9 kg | 900–1800 mg | 900.0–1800.0 ml | — |
| 10 kg | 1000–2000 mg | 1000.0–2000.0 ml | — |
| 12 kg | 1200–2400 mg | 1200.0–2400.0 ml | — |
| 15 kg | 1500–3000 mg | 1500.0–3000.0 ml | — |
| 18 kg | 1800–3600 mg | 1800.0–3600.0 ml | — |
| 20 kg | 2000–4000 mg | 2000.0–4000.0 ml | — |
| 25 kg | 2500–5000 mg | 2500.0–5000.0 ml | — |
| 30 kg | 3000–6000 mg | 3000.0–6000.0 ml | — |
⚠️ Warnings
- • Not indicated if mother has herpes zoster
Capreomycin
Capreomycin
💊 MDR tuberculosis (second line)
Formulation
Tablet
Standard tablet
Dose Range
15–30 mg/kg
Max Daily
30 mg/kg
Frequency
As directed
Max Single
1000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 75–150 mg | 75.0–150.0 ml | ≤ 150 mg |
| 6 kg | 90–180 mg | 90.0–180.0 ml | ≤ 180 mg |
| 7 kg | 105–210 mg | 105.0–210.0 ml | ≤ 210 mg |
| 8 kg | 120–240 mg | 120.0–240.0 ml | ≤ 240 mg |
| 9 kg | 135–270 mg | 135.0–270.0 ml | ≤ 270 mg |
| 10 kg | 150–300 mg | 150.0–300.0 ml | ≤ 300 mg |
| 12 kg | 180–360 mg | 180.0–360.0 ml | ≤ 360 mg |
| 15 kg | 225–450 mg | 225.0–450.0 ml | ≤ 450 mg |
| 18 kg | 270–540 mg | 270.0–540.0 ml | ≤ 540 mg |
| 20 kg | 300–600 mg | 300.0–600.0 ml | ≤ 600 mg |
| 25 kg | 375–750 mg | 375.0–750.0 ml | ≤ 750 mg |
| 30 kg | 450–900 mg | 450.0–900.0 ml | ≤ 900 mg |
⚠️ Warnings
- • Ototoxicity; nephrotoxicity; hypokalemia
Cycloserine
Cycloserine
💊 MDR tuberculosis (second line, bacteriostatic)
Formulation
Tablet
Standard tablet
Dose Range
10–10 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
250 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–50 mg | 50.0–50.0 ml | — |
| 6 kg | 60–60 mg | 60.0–60.0 ml | — |
| 7 kg | 70–70 mg | 70.0–70.0 ml | — |
| 8 kg | 80–80 mg | 80.0–80.0 ml | — |
| 9 kg | 90–90 mg | 90.0–90.0 ml | — |
| 10 kg | 100–100 mg | 100.0–100.0 ml | — |
| 12 kg | 120–120 mg | 120.0–120.0 ml | — |
| 15 kg | 150–150 mg | 150.0–150.0 ml | — |
| 18 kg | 180–180 mg | 180.0–180.0 ml | — |
| 20 kg | 200–200 mg | 200.0–200.0 ml | — |
| 25 kg | 250–250 mg | 250.0–250.0 ml | — |
| 30 kg | 300–300 mg | 300.0–300.0 ml | — |
⚠️ Warnings
- • Contraindicated in epilepsy, renal failure; CNS toxicity; seizures
Ethambutol
Ethambutol
💊 Tuberculosis (first line combination); atypical mycobacteria
Formulation
Tablet
Standard tablet
Dose Range
15–25 mg/kg
Max Daily
25 mg/kg
Frequency
As directed
Max Single
1200 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 75–125 mg | 75.0–125.0 ml | ≤ 125 mg |
| 6 kg | 90–150 mg | 90.0–150.0 ml | ≤ 150 mg |
| 7 kg | 105–175 mg | 105.0–175.0 ml | ≤ 175 mg |
| 8 kg | 120–200 mg | 120.0–200.0 ml | ≤ 200 mg |
| 9 kg | 135–225 mg | 135.0–225.0 ml | ≤ 225 mg |
| 10 kg | 150–250 mg | 150.0–250.0 ml | ≤ 250 mg |
| 12 kg | 180–300 mg | 180.0–300.0 ml | ≤ 300 mg |
| 15 kg | 225–375 mg | 225.0–375.0 ml | ≤ 375 mg |
| 18 kg | 270–450 mg | 270.0–450.0 ml | ≤ 450 mg |
| 20 kg | 300–500 mg | 300.0–500.0 ml | ≤ 500 mg |
| 25 kg | 375–625 mg | 375.0–625.0 ml | ≤ 625 mg |
| 30 kg | 450–750 mg | 450.0–750.0 ml | ≤ 750 mg |
⚠️ Warnings
- • Optic neuritis; red-green color blindness; visual acuity monitoring
Ethionamide
Ethionamide
💊 MDR tuberculosis (second line)
Formulation
Tablet
Standard tablet
Dose Range
15–20 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
750 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 75–100 mg | 75.0–100.0 ml | — |
| 6 kg | 90–120 mg | 90.0–120.0 ml | — |
| 7 kg | 105–140 mg | 105.0–140.0 ml | — |
| 8 kg | 120–160 mg | 120.0–160.0 ml | — |
| 9 kg | 135–180 mg | 135.0–180.0 ml | — |
| 10 kg | 150–200 mg | 150.0–200.0 ml | — |
| 12 kg | 180–240 mg | 180.0–240.0 ml | — |
| 15 kg | 225–300 mg | 225.0–300.0 ml | — |
| 18 kg | 270–360 mg | 270.0–360.0 ml | — |
| 20 kg | 300–400 mg | 300.0–400.0 ml | — |
| 25 kg | 375–500 mg | 375.0–500.0 ml | — |
| 30 kg | 450–600 mg | 450.0–600.0 ml | — |
⚠️ Warnings
- • Hepatotoxicity; GI intolerance; hypothyroidism
Isoniazid (INH)
Isoniazid (INH)
💊 Tuberculosis (first line); prophylaxis
Formulation
Tablet
Standard tablet
Dose Range
7–14 mg/kg
Max Daily
14 mg/kg
Frequency
As directed
Max Single
300 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 35–70 mg | 35.0–70.0 ml | ≤ 70 mg |
| 6 kg | 42–84 mg | 42.0–84.0 ml | ≤ 84 mg |
| 7 kg | 49–98 mg | 49.0–98.0 ml | ≤ 98 mg |
| 8 kg | 56–112 mg | 56.0–112.0 ml | ≤ 112 mg |
| 9 kg | 63–126 mg | 63.0–126.0 ml | ≤ 126 mg |
| 10 kg | 70–140 mg | 70.0–140.0 ml | ≤ 140 mg |
| 12 kg | 84–168 mg | 84.0–168.0 ml | ≤ 168 mg |
| 15 kg | 105–210 mg | 105.0–210.0 ml | ≤ 210 mg |
| 18 kg | 126–252 mg | 126.0–252.0 ml | ≤ 252 mg |
| 20 kg | 140–280 mg | 140.0–280.0 ml | ≤ 280 mg |
| 25 kg | 175–350 mg | 175.0–350.0 ml | ≤ 350 mg |
| 30 kg | 210–420 mg | 210.0–420.0 ml | ≤ 420 mg |
⚠️ Warnings
- • Hepatotoxicity; peripheral neuropathy (pyridoxine deficiency) - give B6; lupus
Para-aminosalicylic acid (PAS)
Para-aminosalicylic acid (PAS)
💊 MDR tuberculosis (second/third line)
Formulation
Tablet
Standard tablet
Dose Range
200–400 mg/kg
Max Daily
400 mg/kg
Frequency
As directed
Max Single
4000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1000–2000 mg | 1000.0–2000.0 ml | ≤ 2000 mg |
| 6 kg | 1200–2400 mg | 1200.0–2400.0 ml | ≤ 2400 mg |
| 7 kg | 1400–2800 mg | 1400.0–2800.0 ml | ≤ 2800 mg |
| 8 kg | 1600–3200 mg | 1600.0–3200.0 ml | ≤ 3200 mg |
| 9 kg | 1800–3600 mg | 1800.0–3600.0 ml | ≤ 3600 mg |
| 10 kg | 2000–4000 mg | 2000.0–4000.0 ml | ≤ 4000 mg |
| 12 kg | 2400–4800 mg | 2400.0–4800.0 ml | ≤ 4800 mg |
| 15 kg | 3000–6000 mg | 3000.0–6000.0 ml | ≤ 6000 mg |
| 18 kg | 3600–7200 mg | 3600.0–7200.0 ml | ≤ 7200 mg |
| 20 kg | 4000–8000 mg | 4000.0–8000.0 ml | ≤ 8000 mg |
| 25 kg | 5000–10000 mg | 5000.0–10000.0 ml | ≤ 10000 mg |
| 30 kg | 6000–12000 mg | 6000.0–12000.0 ml | ≤ 12000 mg |
⚠️ Warnings
- • GI intolerance; hepatotoxicity; crystalluria; sulfa-like reactions
Prothionamide
Prothionamide
💊 MDR tuberculosis (second line)
Formulation
Tablet
Standard tablet
Dose Range
15–20 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
1000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 75–100 mg | 75.0–100.0 ml | — |
| 6 kg | 90–120 mg | 90.0–120.0 ml | — |
| 7 kg | 105–140 mg | 105.0–140.0 ml | — |
| 8 kg | 120–160 mg | 120.0–160.0 ml | — |
| 9 kg | 135–180 mg | 135.0–180.0 ml | — |
| 10 kg | 150–200 mg | 150.0–200.0 ml | — |
| 12 kg | 180–240 mg | 180.0–240.0 ml | — |
| 15 kg | 225–300 mg | 225.0–300.0 ml | — |
| 18 kg | 270–360 mg | 270.0–360.0 ml | — |
| 20 kg | 300–400 mg | 300.0–400.0 ml | — |
| 25 kg | 375–500 mg | 375.0–500.0 ml | — |
| 30 kg | 450–600 mg | 450.0–600.0 ml | — |
⚠️ Warnings
- • Hepatotoxicity; GI intolerance; hypothyroidism
Pyrazinamide
Pyrazinamide
💊 Tuberculosis (first line, intensive phase); DOTS
Formulation
Tablet
Standard tablet
Dose Range
30–40 mg/kg
Max Daily
40 mg/kg
Frequency
As directed
Max Single
2000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 150–200 mg | 150.0–200.0 ml | ≤ 200 mg |
| 6 kg | 180–240 mg | 180.0–240.0 ml | ≤ 240 mg |
| 7 kg | 210–280 mg | 210.0–280.0 ml | ≤ 280 mg |
| 8 kg | 240–320 mg | 240.0–320.0 ml | ≤ 320 mg |
| 9 kg | 270–360 mg | 270.0–360.0 ml | ≤ 360 mg |
| 10 kg | 300–400 mg | 300.0–400.0 ml | ≤ 400 mg |
| 12 kg | 360–480 mg | 360.0–480.0 ml | ≤ 480 mg |
| 15 kg | 450–600 mg | 450.0–600.0 ml | ≤ 600 mg |
| 18 kg | 540–720 mg | 540.0–720.0 ml | ≤ 720 mg |
| 20 kg | 600–800 mg | 600.0–800.0 ml | ≤ 800 mg |
| 25 kg | 750–1000 mg | 750.0–1000.0 ml | ≤ 1000 mg |
| 30 kg | 900–1200 mg | 900.0–1200.0 ml | ≤ 1200 mg |
⚠️ Warnings
- • Hepatotoxicity; hyperuricemia; arthralgia
Rifampicin
Rifampicin
💊 Tuberculosis; H. influenzae type b prophylaxis; N. meningitidis prophylaxis; cat scratch disease
Formulation
Tablet
Standard tablet
Dose Range
10–20 mg/kg
Max Daily
20 mg/kg
Frequency
As directed
Max Single
600 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–100 mg | 50.0–100.0 ml | ≤ 100 mg |
| 6 kg | 60–120 mg | 60.0–120.0 ml | ≤ 120 mg |
| 7 kg | 70–140 mg | 70.0–140.0 ml | ≤ 140 mg |
| 8 kg | 80–160 mg | 80.0–160.0 ml | ≤ 160 mg |
| 9 kg | 90–180 mg | 90.0–180.0 ml | ≤ 180 mg |
| 10 kg | 100–200 mg | 100.0–200.0 ml | ≤ 200 mg |
| 12 kg | 120–240 mg | 120.0–240.0 ml | ≤ 240 mg |
| 15 kg | 150–300 mg | 150.0–300.0 ml | ≤ 300 mg |
| 18 kg | 180–360 mg | 180.0–360.0 ml | ≤ 360 mg |
| 20 kg | 200–400 mg | 200.0–400.0 ml | ≤ 400 mg |
| 25 kg | 250–500 mg | 250.0–500.0 ml | ≤ 500 mg |
| 30 kg | 300–600 mg | 300.0–600.0 ml | ≤ 600 mg |
⚠️ Warnings
- • Hepatotoxicity; orange discoloration of secretions; many drug interactions
Aciclovir (Acyclovir)
Aciclovir (Acyclovir)
💊 Neonatal HSV (10 mg/kg IV q8h x 14-21d); HSV encephalitis (10 mg/kg IV q8h x 21d); varicella immunocompetent (80 mg/kg/d q6h x 5d); herpes zoster immunocompromised (80 mg/kg/d q8h x 7-10d)
Formulation
Tablet
Standard tablet
Dose Range
10–80 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
800 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–400 mg | 50.0–400.0 ml | — |
| 6 kg | 60–480 mg | 60.0–480.0 ml | — |
| 7 kg | 70–560 mg | 70.0–560.0 ml | — |
| 8 kg | 80–640 mg | 80.0–640.0 ml | — |
| 9 kg | 90–720 mg | 90.0–720.0 ml | — |
| 10 kg | 100–800 mg | 100.0–800.0 ml | — |
| 12 kg | 120–960 mg | 120.0–960.0 ml | — |
| 15 kg | 150–1200 mg | 150.0–1200.0 ml | — |
| 18 kg | 180–1440 mg | 180.0–1440.0 ml | — |
| 20 kg | 200–1600 mg | 200.0–1600.0 ml | — |
| 25 kg | 250–2000 mg | 250.0–2000.0 ml | — |
| 30 kg | 300–2400 mg | 300.0–2400.0 ml | — |
⚠️ Warnings
- • Renal toxicity if rapid IV; give over 1 hour; for varicella within 24h of rash onset; not indicated <2 yr for varicella
Adefovir dipivoxil
Adefovir dipivoxil
💊 Chronic lamivudine-resistant HBV
Formulation
Tablet
Standard tablet
Dose Range
0.3–0.5 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
10 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 2–3 mg | 1.5–2.5 ml | — |
| 6 kg | 2–3 mg | 1.8–3.0 ml | — |
| 7 kg | 2–4 mg | 2.1–3.5 ml | — |
| 8 kg | 2–4 mg | 2.4–4.0 ml | — |
| 9 kg | 3–5 mg | 2.7–4.5 ml | — |
| 10 kg | 3–5 mg | 3.0–5.0 ml | — |
| 12 kg | 4–6 mg | 3.6–6.0 ml | — |
| 15 kg | 5–8 mg | 4.5–7.5 ml | — |
| 18 kg | 5–9 mg | 5.4–9.0 ml | — |
| 20 kg | 6–10 mg | 6.0–10.0 ml | — |
| 25 kg | 8–13 mg | 7.5–12.5 ml | — |
| 30 kg | 9–15 mg | 9.0–15.0 ml | — |
⚠️ Warnings
- • Nephrotoxicity; lactic acidosis
Vidarabine (Adenine arabinoside)
Vidarabine (Adenine arabinoside)
💊 Neonatal HSV (15-30 mg/kg/day IV x 10-21 days)
Formulation
Tablet
Standard tablet
Dose Range
15–30 mg/kg
Max Daily
30 mg/kg
Frequency
As directed
Max Single
500 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 75–150 mg | 75.0–150.0 ml | ≤ 150 mg |
| 6 kg | 90–180 mg | 90.0–180.0 ml | ≤ 180 mg |
| 7 kg | 105–210 mg | 105.0–210.0 ml | ≤ 210 mg |
| 8 kg | 120–240 mg | 120.0–240.0 ml | ≤ 240 mg |
| 9 kg | 135–270 mg | 135.0–270.0 ml | ≤ 270 mg |
| 10 kg | 150–300 mg | 150.0–300.0 ml | ≤ 300 mg |
| 12 kg | 180–360 mg | 180.0–360.0 ml | ≤ 360 mg |
| 15 kg | 225–450 mg | 225.0–450.0 ml | ≤ 450 mg |
| 18 kg | 270–540 mg | 270.0–540.0 ml | ≤ 540 mg |
| 20 kg | 300–600 mg | 300.0–600.0 ml | ≤ 600 mg |
| 25 kg | 375–750 mg | 375.0–750.0 ml | ≤ 750 mg |
| 30 kg | 450–900 mg | 450.0–900.0 ml | ≤ 900 mg |
⚠️ Warnings
- • GI upset; tremor; bone marrow suppression
Amantadine hydrochloride
Amantadine hydrochloride
💊 Prophylaxis and treatment of influenza A; drug-induced extrapyramidal reactions
Formulation
Tablet
Standard tablet
Dose Range
4–8 mg/kg
Max Daily
8 mg/kg
Frequency
As directed
Max Single
150 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 20–40 mg | 20.0–40.0 ml | ≤ 40 mg |
| 6 kg | 24–48 mg | 24.0–48.0 ml | ≤ 48 mg |
| 7 kg | 28–56 mg | 28.0–56.0 ml | ≤ 56 mg |
| 8 kg | 32–64 mg | 32.0–64.0 ml | ≤ 64 mg |
| 9 kg | 36–72 mg | 36.0–72.0 ml | ≤ 72 mg |
| 10 kg | 40–80 mg | 40.0–80.0 ml | ≤ 80 mg |
| 12 kg | 48–96 mg | 48.0–96.0 ml | ≤ 96 mg |
| 15 kg | 60–120 mg | 60.0–120.0 ml | ≤ 120 mg |
| 18 kg | 72–144 mg | 72.0–144.0 ml | ≤ 144 mg |
| 20 kg | 80–160 mg | 80.0–160.0 ml | ≤ 160 mg |
| 25 kg | 100–200 mg | 100.0–200.0 ml | ≤ 200 mg |
| 30 kg | 120–240 mg | 120.0–240.0 ml | ≤ 240 mg |
⚠️ Warnings
- • Contraindicated in epilepsy; CNS effects; avoid in renal impairment
Foscarnet
Foscarnet
💊 CMV retinitis in AIDS (180 mg/kg/d q8h IV x 21d induction, then 90-120 mg/kg/d maintenance); acyclovir-resistant HSV/zoster in immunocompromised
Formulation
Tablet
Standard tablet
Dose Range
120–180 mg/kg
Max Daily
180 mg/kg
Frequency
As directed
Max Single
3600 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 600–900 mg | 600.0–900.0 ml | ≤ 900 mg |
| 6 kg | 720–1080 mg | 720.0–1080.0 ml | ≤ 1080 mg |
| 7 kg | 840–1260 mg | 840.0–1260.0 ml | ≤ 1260 mg |
| 8 kg | 960–1440 mg | 960.0–1440.0 ml | ≤ 1440 mg |
| 9 kg | 1080–1620 mg | 1080.0–1620.0 ml | ≤ 1620 mg |
| 10 kg | 1200–1800 mg | 1200.0–1800.0 ml | ≤ 1800 mg |
| 12 kg | 1440–2160 mg | 1440.0–2160.0 ml | ≤ 2160 mg |
| 15 kg | 1800–2700 mg | 1800.0–2700.0 ml | ≤ 2700 mg |
| 18 kg | 2160–3240 mg | 2160.0–3240.0 ml | ≤ 3240 mg |
| 20 kg | 2400–3600 mg | 2400.0–3600.0 ml | ≤ 3600 mg |
| 25 kg | 3000–4500 mg | 3000.0–4500.0 ml | ≤ 4500 mg |
| 30 kg | 3600–5400 mg | 3600.0–5400.0 ml | ≤ 5400 mg |
⚠️ Warnings
- • Nephrotoxicity; seizures; dyselectrolytemia; QT prolongation
Ganciclovir
Ganciclovir
💊 CMV retinitis/pneumonitis in immunocompromised (10 mg/kg q12h IV x 14-21d); prophylaxis CMV in transplant (10 mg/kg q12h x 7d then 5 mg/kg/d PO x 100d); severe CMV pneumonitis (30 mg/kg q8h)
Formulation
Tablet
Standard tablet
Dose Range
10–30 mg/kg
Max Daily
30 mg/kg
Frequency
As directed
Max Single
500 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–150 mg | 50.0–150.0 ml | ≤ 150 mg |
| 6 kg | 60–180 mg | 60.0–180.0 ml | ≤ 180 mg |
| 7 kg | 70–210 mg | 70.0–210.0 ml | ≤ 210 mg |
| 8 kg | 80–240 mg | 80.0–240.0 ml | ≤ 240 mg |
| 9 kg | 90–270 mg | 90.0–270.0 ml | ≤ 270 mg |
| 10 kg | 100–300 mg | 100.0–300.0 ml | ≤ 300 mg |
| 12 kg | 120–360 mg | 120.0–360.0 ml | ≤ 360 mg |
| 15 kg | 150–450 mg | 150.0–450.0 ml | ≤ 450 mg |
| 18 kg | 180–540 mg | 180.0–540.0 ml | ≤ 540 mg |
| 20 kg | 200–600 mg | 200.0–600.0 ml | ≤ 600 mg |
| 25 kg | 250–750 mg | 250.0–750.0 ml | ≤ 750 mg |
| 30 kg | 300–900 mg | 300.0–900.0 ml | ≤ 900 mg |
⚠️ Warnings
- • Bone marrow suppression; neutropenia; thrombocytopenia; nephrotoxicity
Trifluridine
Trifluridine
💊 Herpes simplex conjunctivitis/keratitis (1 drop q2h until reepithelialization, then q4h; max 5-9 drops/day)
Formulation
Tablet
Standard tablet
Dose Range
0.1–0.2 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
2 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–1 mg | 0.5–1.0 ml | — |
| 6 kg | 1–1 mg | 0.6–1.2 ml | — |
| 7 kg | 1–1 mg | 0.7–1.4 ml | — |
| 8 kg | 1–2 mg | 0.8–1.6 ml | — |
| 9 kg | 1–2 mg | 0.9–1.8 ml | — |
| 10 kg | 1–2 mg | 1.0–2.0 ml | — |
| 12 kg | 1–2 mg | 1.2–2.4 ml | — |
| 15 kg | 2–3 mg | 1.5–3.0 ml | — |
| 18 kg | 2–4 mg | 1.8–3.6 ml | — |
| 20 kg | 2–4 mg | 2.0–4.0 ml | — |
| 25 kg | 3–5 mg | 2.5–5.0 ml | — |
| 30 kg | 3–6 mg | 3.0–6.0 ml | — |
⚠️ Warnings
- • Local irritation; corneal punctate keratopathy
Valganciclovir
Valganciclovir
💊 CMV prophylaxis in post-transplant (15-18 mg/kg q6h x 100d); CMV retinitis induction (900 mg q12h x 21d, then 900 mg q24h maintenance)
Formulation
Tablet
Standard tablet
Dose Range
15–18 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
900 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 75–90 mg | 75.0–90.0 ml | — |
| 6 kg | 90–108 mg | 90.0–108.0 ml | — |
| 7 kg | 105–126 mg | 105.0–126.0 ml | — |
| 8 kg | 120–144 mg | 120.0–144.0 ml | — |
| 9 kg | 135–162 mg | 135.0–162.0 ml | — |
| 10 kg | 150–180 mg | 150.0–180.0 ml | — |
| 12 kg | 180–216 mg | 180.0–216.0 ml | — |
| 15 kg | 225–270 mg | 225.0–270.0 ml | — |
| 18 kg | 270–324 mg | 270.0–324.0 ml | — |
| 20 kg | 300–360 mg | 300.0–360.0 ml | — |
| 25 kg | 375–450 mg | 375.0–450.0 ml | — |
| 30 kg | 450–540 mg | 450.0–540.0 ml | — |
⚠️ Warnings
- • Same as ganciclovir; bone marrow suppression; teratogenic
Zanamivir
Zanamivir
💊 Treatment and prophylaxis of influenza A and B including H1N1 (>7 yr): treatment 10 mg q12h x 5d (within 48h); prophylaxis 10 mg q24h x 10 days (within 36h of exposure)
Formulation
Tablet
Standard tablet
Dose Range
0.5–1 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
10 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 3–5 mg | 2.5–5.0 ml | — |
| 6 kg | 3–6 mg | 3.0–6.0 ml | — |
| 7 kg | 4–7 mg | 3.5–7.0 ml | — |
| 8 kg | 4–8 mg | 4.0–8.0 ml | — |
| 9 kg | 5–9 mg | 4.5–9.0 ml | — |
| 10 kg | 5–10 mg | 5.0–10.0 ml | — |
| 12 kg | 6–12 mg | 6.0–12.0 ml | — |
| 15 kg | 8–15 mg | 7.5–15.0 ml | — |
| 18 kg | 9–18 mg | 9.0–18.0 ml | — |
| 20 kg | 10–20 mg | 10.0–20.0 ml | — |
| 25 kg | 13–25 mg | 12.5–25.0 ml | — |
| 30 kg | 15–30 mg | 15.0–30.0 ml | — |
⚠️ Warnings
- • Severe bronchospasm in reactive airway disease; dizziness; angioedema
Didanosine (DDI)
Didanosine (DDI)
💊 HIV infection; neonatal dose up to 90 days: 50 mg/m2 q12h; pediatric: 120 mg/m2 q12h
Formulation
Tablet
Standard tablet
Dose Range
50–120 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
200 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 250–600 mg | 250.0–600.0 ml | — |
| 6 kg | 300–720 mg | 300.0–720.0 ml | — |
| 7 kg | 350–840 mg | 350.0–840.0 ml | — |
| 8 kg | 400–960 mg | 400.0–960.0 ml | — |
| 9 kg | 450–1080 mg | 450.0–1080.0 ml | — |
| 10 kg | 500–1200 mg | 500.0–1200.0 ml | — |
| 12 kg | 600–1440 mg | 600.0–1440.0 ml | — |
| 15 kg | 750–1800 mg | 750.0–1800.0 ml | — |
| 18 kg | 900–2160 mg | 900.0–2160.0 ml | — |
| 20 kg | 1000–2400 mg | 1000.0–2400.0 ml | — |
| 25 kg | 1250–3000 mg | 1250.0–3000.0 ml | — |
| 30 kg | 1500–3600 mg | 1500.0–3600.0 ml | — |
⚠️ Warnings
- • Pancreatitis; peripheral neuropathy; optic neuritis; give 30 min before or 2 hr after meals
Efavirenz (EFV)
Efavirenz (EFV)
💊 HIV infection: 10-15 kg: 200 mg OD; 15-20 kg: 250 mg; 20-25 kg: 300 mg; 25-32.5 kg: 350 mg; 32.5-40 kg: 400 mg; >40 kg: 600 mg. Oral suspension 30% higher
Formulation
Tablet
Standard tablet
Dose Range
15–20 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
600 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 75–100 mg | 75.0–100.0 ml | — |
| 6 kg | 90–120 mg | 90.0–120.0 ml | — |
| 7 kg | 105–140 mg | 105.0–140.0 ml | — |
| 8 kg | 120–160 mg | 120.0–160.0 ml | — |
| 9 kg | 135–180 mg | 135.0–180.0 ml | — |
| 10 kg | 150–200 mg | 150.0–200.0 ml | — |
| 12 kg | 180–240 mg | 180.0–240.0 ml | — |
| 15 kg | 225–300 mg | 225.0–300.0 ml | — |
| 18 kg | 270–360 mg | 270.0–360.0 ml | — |
| 20 kg | 300–400 mg | 300.0–400.0 ml | — |
| 25 kg | 375–500 mg | 375.0–500.0 ml | — |
| 30 kg | 450–600 mg | 450.0–600.0 ml | — |
⚠️ Warnings
- • Severe CNS/psychiatric symptoms; rash; teratogenic; avoid in pregnancy
Lamivudine (3TC)
Lamivudine (3TC)
💊 HIV infection (combination therapy with zidovudine and/or other antiretrovirals); HBV infection; neonates 4 mg/kg/d q12h; children 4 mg/kg q12h
Formulation
Tablet
Standard tablet
Dose Range
4–4 mg/kg
Max Daily
4 mg/kg
Frequency
As directed
Max Single
150 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 20–20 mg | 20.0–20.0 ml | ≤ 20 mg |
| 6 kg | 24–24 mg | 24.0–24.0 ml | ≤ 24 mg |
| 7 kg | 28–28 mg | 28.0–28.0 ml | ≤ 28 mg |
| 8 kg | 32–32 mg | 32.0–32.0 ml | ≤ 32 mg |
| 9 kg | 36–36 mg | 36.0–36.0 ml | ≤ 36 mg |
| 10 kg | 40–40 mg | 40.0–40.0 ml | ≤ 40 mg |
| 12 kg | 48–48 mg | 48.0–48.0 ml | ≤ 48 mg |
| 15 kg | 60–60 mg | 60.0–60.0 ml | ≤ 60 mg |
| 18 kg | 72–72 mg | 72.0–72.0 ml | ≤ 72 mg |
| 20 kg | 80–80 mg | 80.0–80.0 ml | ≤ 80 mg |
| 25 kg | 100–100 mg | 100.0–100.0 ml | ≤ 100 mg |
| 30 kg | 120–120 mg | 120.0–120.0 ml | ≤ 120 mg |
⚠️ Warnings
- • Lactic acidosis; hepatomegaly; pancreatitis
Nevirapine (NVP)
Nevirapine (NVP)
💊 Prevention of mother-to-child HIV transmission: birth to 6 wks, <2 kg: 2 mg/kg; 2-2.5 kg: 10 mg OD; >2.5 kg: 15 mg OD. Children: once daily x 14d (induction), then half dose q12h. First line per NACO/WHO
Formulation
Tablet
Standard tablet
Dose Range
2–200 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
4000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 10–1000 mg | 10.0–1000.0 ml | — |
| 6 kg | 12–1200 mg | 12.0–1200.0 ml | — |
| 7 kg | 14–1400 mg | 14.0–1400.0 ml | — |
| 8 kg | 16–1600 mg | 16.0–1600.0 ml | — |
| 9 kg | 18–1800 mg | 18.0–1800.0 ml | — |
| 10 kg | 20–2000 mg | 20.0–2000.0 ml | — |
| 12 kg | 24–2400 mg | 24.0–2400.0 ml | — |
| 15 kg | 30–3000 mg | 30.0–3000.0 ml | — |
| 18 kg | 36–3600 mg | 36.0–3600.0 ml | — |
| 20 kg | 40–4000 mg | 40.0–4000.0 ml | — |
| 25 kg | 50–5000 mg | 50.0–5000.0 ml | — |
| 30 kg | 60–6000 mg | 60.0–6000.0 ml | — |
⚠️ Warnings
- • Skin rash; Stevens-Johnson syndrome; hepatotoxicity; do not start BD immediately
Stavudine (d4T)
Stavudine (d4T)
💊 HIV infection: 1 mg/kg/dose q12h; adolescents <60 kg: 30 mg BD; >60 kg: 40 mg BD
Formulation
Tablet
Standard tablet
Dose Range
1–1 mg/kg
Max Daily
1 mg/kg
Frequency
As directed
Max Single
30 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 5–5 mg | 5.0–5.0 ml | ≤ 5 mg |
| 6 kg | 6–6 mg | 6.0–6.0 ml | ≤ 6 mg |
| 7 kg | 7–7 mg | 7.0–7.0 ml | ≤ 7 mg |
| 8 kg | 8–8 mg | 8.0–8.0 ml | ≤ 8 mg |
| 9 kg | 9–9 mg | 9.0–9.0 ml | ≤ 9 mg |
| 10 kg | 10–10 mg | 10.0–10.0 ml | ≤ 10 mg |
| 12 kg | 12–12 mg | 12.0–12.0 ml | ≤ 12 mg |
| 15 kg | 15–15 mg | 15.0–15.0 ml | ≤ 15 mg |
| 18 kg | 18–18 mg | 18.0–18.0 ml | ≤ 18 mg |
| 20 kg | 20–20 mg | 20.0–20.0 ml | ≤ 20 mg |
| 25 kg | 25–25 mg | 25.0–25.0 ml | ≤ 25 mg |
| 30 kg | 30–30 mg | 30.0–30.0 ml | ≤ 30 mg |
⚠️ Warnings
- • Peripheral neuropathy; pancreatitis; lactic acidosis; lipodystrophy
Tenofovir
Tenofovir
💊 First line ART for adults and pregnant women; children >10 yr: 300 mg OD
Formulation
Tablet
Standard tablet
Dose Range
6–8 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
300 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 30–40 mg | 30.0–40.0 ml | — |
| 6 kg | 36–48 mg | 36.0–48.0 ml | — |
| 7 kg | 42–56 mg | 42.0–56.0 ml | — |
| 8 kg | 48–64 mg | 48.0–64.0 ml | — |
| 9 kg | 54–72 mg | 54.0–72.0 ml | — |
| 10 kg | 60–80 mg | 60.0–80.0 ml | — |
| 12 kg | 72–96 mg | 72.0–96.0 ml | — |
| 15 kg | 90–120 mg | 90.0–120.0 ml | — |
| 18 kg | 108–144 mg | 108.0–144.0 ml | — |
| 20 kg | 120–160 mg | 120.0–160.0 ml | — |
| 25 kg | 150–200 mg | 150.0–200.0 ml | — |
| 30 kg | 180–240 mg | 180.0–240.0 ml | — |
⚠️ Warnings
- • Nephrotoxicity; hypophosphatemia; lactic acidosis; do not use in renal impairment
Zalicitabine (DDC)
Zalicitabine (DDC)
💊 HIV infection: pediatric 0.01 mg/kg q8h; adolescents 0.75 mg q8h (1 hr before or 2 hr after meals)
Formulation
Tablet
Standard tablet
Dose Range
0.01–0.01 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
0.75 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 0–0 mg | 0.1–0.1 ml | — |
| 6 kg | 0–0 mg | 0.1–0.1 ml | — |
| 7 kg | 0–0 mg | 0.1–0.1 ml | — |
| 8 kg | 0–0 mg | 0.1–0.1 ml | — |
| 9 kg | 0–0 mg | 0.1–0.1 ml | — |
| 10 kg | 0–0 mg | 0.1–0.1 ml | — |
| 12 kg | 0–0 mg | 0.1–0.1 ml | — |
| 15 kg | 0–0 mg | 0.1–0.1 ml | — |
| 18 kg | 0–0 mg | 0.2–0.2 ml | — |
| 20 kg | 0–0 mg | 0.2–0.2 ml | — |
| 25 kg | 0–0 mg | 0.3–0.3 ml | — |
| 30 kg | 0–0 mg | 0.3–0.3 ml | — |
⚠️ Warnings
- • Peripheral neuropathy; pancreatitis
Zidovudine (ZDV, AZT)
Zidovudine (ZDV, AZT)
💊 HIV infection; premature infants: 1.5 mg/kg IV or 2 mg/kg PO q8-12h; infants <3 mo: 2 mg/kg PO q6h; pediatric oral: 90-180 mg/m2 q6-8h
Formulation
Tablet
Standard tablet
Dose Range
1.5–180 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
3000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 8–900 mg | 7.5–900.0 ml | — |
| 6 kg | 9–1080 mg | 9.0–1080.0 ml | — |
| 7 kg | 11–1260 mg | 10.5–1260.0 ml | — |
| 8 kg | 12–1440 mg | 12.0–1440.0 ml | — |
| 9 kg | 14–1620 mg | 13.5–1620.0 ml | — |
| 10 kg | 15–1800 mg | 15.0–1800.0 ml | — |
| 12 kg | 18–2160 mg | 18.0–2160.0 ml | — |
| 15 kg | 23–2700 mg | 22.5–2700.0 ml | — |
| 18 kg | 27–3240 mg | 27.0–3240.0 ml | — |
| 20 kg | 30–3600 mg | 30.0–3600.0 ml | — |
| 25 kg | 38–4500 mg | 37.5–4500.0 ml | — |
| 30 kg | 45–5400 mg | 45.0–5400.0 ml | — |
⚠️ Warnings
- • Bone marrow suppression; anemia; neutropenia; myopathy; GI upset
Isosorbide Dinitrate
Isosorbide Dinitrate
💊 Angina pectoris, Congestive cardiac failure
Formulation
Tablet
Standard tablet
Dose Range
0.1–0.1 mg/kg
Max Daily
2 mg/kg
Frequency
As directed
Max Single
10 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–1 mg | 0.5–0.5 ml | ≤ 10 mg |
| 6 kg | 1–1 mg | 0.6–0.6 ml | ≤ 12 mg |
| 7 kg | 1–1 mg | 0.7–0.7 ml | ≤ 14 mg |
| 8 kg | 1–1 mg | 0.8–0.8 ml | ≤ 16 mg |
| 9 kg | 1–1 mg | 0.9–0.9 ml | ≤ 18 mg |
| 10 kg | 1–1 mg | 1.0–1.0 ml | ≤ 20 mg |
| 12 kg | 1–1 mg | 1.2–1.2 ml | ≤ 24 mg |
| 15 kg | 2–2 mg | 1.5–1.5 ml | ≤ 30 mg |
| 18 kg | 2–2 mg | 1.8–1.8 ml | ≤ 36 mg |
| 20 kg | 2–2 mg | 2.0–2.0 ml | ≤ 40 mg |
| 25 kg | 3–3 mg | 2.5–2.5 ml | ≤ 50 mg |
| 30 kg | 3–3 mg | 3.0–3.0 ml | ≤ 60 mg |
⚠️ Warnings
- • Not recommended in children; adult dose 5-10 mg sublingual
Isoxsuprine Hydrochloride
Isoxsuprine Hydrochloride
💊 Vasospastic conditions
Formulation
Tablet
Standard tablet
Dose Range
0.5–1 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
10 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 3–5 mg | 2.5–5.0 ml | — |
| 6 kg | 3–6 mg | 3.0–6.0 ml | — |
| 7 kg | 4–7 mg | 3.5–7.0 ml | — |
| 8 kg | 4–8 mg | 4.0–8.0 ml | — |
| 9 kg | 5–9 mg | 4.5–9.0 ml | — |
| 10 kg | 5–10 mg | 5.0–10.0 ml | — |
| 12 kg | 6–12 mg | 6.0–12.0 ml | — |
| 15 kg | 8–15 mg | 7.5–15.0 ml | — |
| 18 kg | 9–18 mg | 9.0–18.0 ml | — |
| 20 kg | 10–20 mg | 10.0–20.0 ml | — |
| 25 kg | 13–25 mg | 12.5–25.0 ml | — |
| 30 kg | 15–30 mg | 15.0–30.0 ml | — |
⚠️ Warnings
- • Not recommended in children
Nifedipine
Nifedipine
💊 Hypertension, Vasodilation
Formulation
Tablet
Standard tablet
Dose Range
0.6–0.9 mg/kg
Max Daily
0.9 mg/kg
Frequency
As directed
Max Single
10 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 3–5 mg | 3.0–4.5 ml | ≤ 5 mg |
| 6 kg | 4–5 mg | 3.6–5.4 ml | ≤ 5 mg |
| 7 kg | 4–6 mg | 4.2–6.3 ml | ≤ 6 mg |
| 8 kg | 5–7 mg | 4.8–7.2 ml | ≤ 7 mg |
| 9 kg | 5–8 mg | 5.4–8.1 ml | ≤ 8 mg |
| 10 kg | 6–9 mg | 6.0–9.0 ml | ≤ 9 mg |
| 12 kg | 7–11 mg | 7.2–10.8 ml | ≤ 11 mg |
| 15 kg | 9–14 mg | 9.0–13.5 ml | ≤ 14 mg |
| 18 kg | 11–16 mg | 10.8–16.2 ml | ≤ 16 mg |
| 20 kg | 12–18 mg | 12.0–18.0 ml | ≤ 18 mg |
| 25 kg | 15–23 mg | 15.0–22.5 ml | ≤ 23 mg |
| 30 kg | 18–27 mg | 18.0–27.0 ml | ≤ 27 mg |
⚠️ Warnings
- • Contraindicated in cardiogenic shock
Tolazoline Hydrochloride
Tolazoline Hydrochloride
💊 Pulmonary arterial hypertension in newborns with RDS
Formulation
Tablet
Standard tablet
Dose Range
1–2 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
40 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 5–10 mg | 5.0–10.0 ml | — |
| 6 kg | 6–12 mg | 6.0–12.0 ml | — |
| 7 kg | 7–14 mg | 7.0–14.0 ml | — |
| 8 kg | 8–16 mg | 8.0–16.0 ml | — |
| 9 kg | 9–18 mg | 9.0–18.0 ml | — |
| 10 kg | 10–20 mg | 10.0–20.0 ml | — |
| 12 kg | 12–24 mg | 12.0–24.0 ml | — |
| 15 kg | 15–30 mg | 15.0–30.0 ml | — |
| 18 kg | 18–36 mg | 18.0–36.0 ml | — |
| 20 kg | 20–40 mg | 20.0–40.0 ml | — |
| 25 kg | 25–50 mg | 25.0–50.0 ml | — |
| 30 kg | 30–60 mg | 30.0–60.0 ml | — |
⚠️ Warnings
- • Hypotension
- • GI bleed
- • Thrombocytopenia
- • Oliguria
Alfacalcidol (1-alpha-hydroxycholecalciferol)
Alfacalcidol (1-alpha-hydroxycholecalciferol)
💊 Renal rickets, Hypoparathyroidism, Hypocalcemia, Vitamin D resistant rickets, Osteomalacia
Formulation
Tablet
Standard tablet
Dose Range
0.04–0.08 mg/kg
Max Daily
0.08 mg/kg
Frequency
As directed
Max Single
2 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 0–0 mg | 0.2–0.4 ml | ≤ 0 mg |
| 6 kg | 0–0 mg | 0.2–0.5 ml | ≤ 0 mg |
| 7 kg | 0–1 mg | 0.3–0.6 ml | ≤ 1 mg |
| 8 kg | 0–1 mg | 0.3–0.6 ml | ≤ 1 mg |
| 9 kg | 0–1 mg | 0.4–0.7 ml | ≤ 1 mg |
| 10 kg | 0–1 mg | 0.4–0.8 ml | ≤ 1 mg |
| 12 kg | 0–1 mg | 0.5–1.0 ml | ≤ 1 mg |
| 15 kg | 1–1 mg | 0.6–1.2 ml | ≤ 1 mg |
| 18 kg | 1–1 mg | 0.7–1.4 ml | ≤ 1 mg |
| 20 kg | 1–2 mg | 0.8–1.6 ml | ≤ 2 mg |
| 25 kg | 1–2 mg | 1.0–2.0 ml | ≤ 2 mg |
| 30 kg | 1–2 mg | 1.2–2.4 ml | ≤ 2 mg |
⚠️ Warnings
- • Overdosage risk
Folic Acid
Folic Acid
💊 Megaloblastic anemia, Hemolytic anemia, Tropical sprue, Neural tube defect prophylaxis
Formulation
Tablet
Standard tablet
Dose Range
0.1–0.5 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
5 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–3 mg | 0.5–2.5 ml | — |
| 6 kg | 1–3 mg | 0.6–3.0 ml | — |
| 7 kg | 1–4 mg | 0.7–3.5 ml | — |
| 8 kg | 1–4 mg | 0.8–4.0 ml | — |
| 9 kg | 1–5 mg | 0.9–4.5 ml | — |
| 10 kg | 1–5 mg | 1.0–5.0 ml | — |
| 12 kg | 1–6 mg | 1.2–6.0 ml | — |
| 15 kg | 2–8 mg | 1.5–7.5 ml | — |
| 18 kg | 2–9 mg | 1.8–9.0 ml | — |
| 20 kg | 2–10 mg | 2.0–10.0 ml | — |
| 25 kg | 3–13 mg | 2.5–12.5 ml | — |
| 30 kg | 3–15 mg | 3.0–15.0 ml | — |
⚠️ Warnings
- • Masks B12 deficiency if given alone
Iron (Oral)
Iron (Oral)
💊 Iron deficiency anemia, Prophylaxis against anemia
Formulation
Tablet
Standard tablet
Dose Range
1–6 mg/kg
Max Daily
6 mg/kg
Frequency
As directed
Max Single
100 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 5–30 mg | 5.0–30.0 ml | ≤ 30 mg |
| 6 kg | 6–36 mg | 6.0–36.0 ml | ≤ 36 mg |
| 7 kg | 7–42 mg | 7.0–42.0 ml | ≤ 42 mg |
| 8 kg | 8–48 mg | 8.0–48.0 ml | ≤ 48 mg |
| 9 kg | 9–54 mg | 9.0–54.0 ml | ≤ 54 mg |
| 10 kg | 10–60 mg | 10.0–60.0 ml | ≤ 60 mg |
| 12 kg | 12–72 mg | 12.0–72.0 ml | ≤ 72 mg |
| 15 kg | 15–90 mg | 15.0–90.0 ml | ≤ 90 mg |
| 18 kg | 18–108 mg | 18.0–108.0 ml | ≤ 108 mg |
| 20 kg | 20–120 mg | 20.0–120.0 ml | ≤ 120 mg |
| 25 kg | 25–150 mg | 25.0–150.0 ml | ≤ 150 mg |
| 30 kg | 30–180 mg | 30.0–180.0 ml | ≤ 180 mg |
⚠️ Warnings
- • Give between meals for treatment; parenteral IM = 4 x weight x Hb deficit
Vitamin B1 (Thiamine)
Vitamin B1 (Thiamine)
💊 Beriberi, Neuropathy, Inborn errors of metabolism
Formulation
Tablet
Standard tablet
Dose Range
0.5–1 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
50 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 3–5 mg | 2.5–5.0 ml | — |
| 6 kg | 3–6 mg | 3.0–6.0 ml | — |
| 7 kg | 4–7 mg | 3.5–7.0 ml | — |
| 8 kg | 4–8 mg | 4.0–8.0 ml | — |
| 9 kg | 5–9 mg | 4.5–9.0 ml | — |
| 10 kg | 5–10 mg | 5.0–10.0 ml | — |
| 12 kg | 6–12 mg | 6.0–12.0 ml | — |
| 15 kg | 8–15 mg | 7.5–15.0 ml | — |
| 18 kg | 9–18 mg | 9.0–18.0 ml | — |
| 20 kg | 10–20 mg | 10.0–20.0 ml | — |
| 25 kg | 13–25 mg | 12.5–25.0 ml | — |
| 30 kg | 15–30 mg | 15.0–30.0 ml | — |
⚠️ Warnings
- • Give 25 mg IV slowly for cardiomyopathy collapse
Vitamin B12 (Cyanocobalamin)
Vitamin B12 (Cyanocobalamin)
💊 Megaloblastic anemia
Formulation
Tablet
Standard tablet
Dose Range
0.5–1 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
100 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 3–5 mg | 2.5–5.0 ml | — |
| 6 kg | 3–6 mg | 3.0–6.0 ml | — |
| 7 kg | 4–7 mg | 3.5–7.0 ml | — |
| 8 kg | 4–8 mg | 4.0–8.0 ml | — |
| 9 kg | 5–9 mg | 4.5–9.0 ml | — |
| 10 kg | 5–10 mg | 5.0–10.0 ml | — |
| 12 kg | 6–12 mg | 6.0–12.0 ml | — |
| 15 kg | 8–15 mg | 7.5–15.0 ml | — |
| 18 kg | 9–18 mg | 9.0–18.0 ml | — |
| 20 kg | 10–20 mg | 10.0–20.0 ml | — |
| 25 kg | 13–25 mg | 12.5–25.0 ml | — |
| 30 kg | 15–30 mg | 15.0–30.0 ml | — |
⚠️ Warnings
- • Monitor iron and folic acid stores; watch for hypokalemia
Vitamin C (Ascorbic Acid)
Vitamin C (Ascorbic Acid)
💊 Scurvy, Methemoglobinemia
Formulation
Tablet
Standard tablet
Dose Range
2–5 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
500 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 10–25 mg | 10.0–25.0 ml | — |
| 6 kg | 12–30 mg | 12.0–30.0 ml | — |
| 7 kg | 14–35 mg | 14.0–35.0 ml | — |
| 8 kg | 16–40 mg | 16.0–40.0 ml | — |
| 9 kg | 18–45 mg | 18.0–45.0 ml | — |
| 10 kg | 20–50 mg | 20.0–50.0 ml | — |
| 12 kg | 24–60 mg | 24.0–60.0 ml | — |
| 15 kg | 30–75 mg | 30.0–75.0 ml | — |
| 18 kg | 36–90 mg | 36.0–90.0 ml | — |
| 20 kg | 40–100 mg | 40.0–100.0 ml | — |
| 25 kg | 50–125 mg | 50.0–125.0 ml | — |
| 30 kg | 60–150 mg | 60.0–150.0 ml | — |
Vitamin D3 (Cholecalciferol)
Vitamin D3 (Cholecalciferol)
💊 Rickets, Osteomalacia, Vitamin D deficiency
Formulation
Tablet
Standard tablet
Dose Range
0.025–0.1 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
50000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 0–1 mg | 0.1–0.5 ml | — |
| 6 kg | 0–1 mg | 0.2–0.6 ml | — |
| 7 kg | 0–1 mg | 0.2–0.7 ml | — |
| 8 kg | 0–1 mg | 0.2–0.8 ml | — |
| 9 kg | 0–1 mg | 0.2–0.9 ml | — |
| 10 kg | 0–1 mg | 0.3–1.0 ml | — |
| 12 kg | 0–1 mg | 0.3–1.2 ml | — |
| 15 kg | 0–2 mg | 0.4–1.5 ml | — |
| 18 kg | 0–2 mg | 0.5–1.8 ml | — |
| 20 kg | 1–2 mg | 0.5–2.0 ml | — |
| 25 kg | 1–3 mg | 0.6–2.5 ml | — |
| 30 kg | 1–3 mg | 0.8–3.0 ml | — |
⚠️ Warnings
- • Overdose may cause pseudotumor cerebri, hydrocephalus, nephrocalcinosis
Vitamin E (Tocopherol)
Vitamin E (Tocopherol)
💊 Prevention of anemia of prematurity, Sickle cell anemia, Beta-thalassemia, Cystic fibrosis
Formulation
Tablet
Standard tablet
Dose Range
1–1 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
750 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 5–5 mg | 5.0–5.0 ml | — |
| 6 kg | 6–6 mg | 6.0–6.0 ml | — |
| 7 kg | 7–7 mg | 7.0–7.0 ml | — |
| 8 kg | 8–8 mg | 8.0–8.0 ml | — |
| 9 kg | 9–9 mg | 9.0–9.0 ml | — |
| 10 kg | 10–10 mg | 10.0–10.0 ml | — |
| 12 kg | 12–12 mg | 12.0–12.0 ml | — |
| 15 kg | 15–15 mg | 15.0–15.0 ml | — |
| 18 kg | 18–18 mg | 18.0–18.0 ml | — |
| 20 kg | 20–20 mg | 20.0–20.0 ml | — |
| 25 kg | 25–25 mg | 25.0–25.0 ml | — |
| 30 kg | 30–30 mg | 30.0–30.0 ml | — |
Vitamin K (Phytomenadione)
Vitamin K (Phytomenadione)
💊 Hemorrhagic disease of newborn, Bleeding due to liver disorder, Vitamin K-dependent clotting factor deficiency
Formulation
Tablet
Standard tablet
Dose Range
1–5 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
10 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 5–25 mg | 5.0–25.0 ml | — |
| 6 kg | 6–30 mg | 6.0–30.0 ml | — |
| 7 kg | 7–35 mg | 7.0–35.0 ml | — |
| 8 kg | 8–40 mg | 8.0–40.0 ml | — |
| 9 kg | 9–45 mg | 9.0–45.0 ml | — |
| 10 kg | 10–50 mg | 10.0–50.0 ml | — |
| 12 kg | 12–60 mg | 12.0–60.0 ml | — |
| 15 kg | 15–75 mg | 15.0–75.0 ml | — |
| 18 kg | 18–90 mg | 18.0–90.0 ml | — |
| 20 kg | 20–100 mg | 20.0–100.0 ml | — |
| 25 kg | 25–125 mg | 25.0–125.0 ml | — |
| 30 kg | 30–150 mg | 30.0–150.0 ml | — |
Acetazolamide
Acetazolamide
💊 Diuretic, Hydrocephalus, Glaucoma, Epilepsy, Congestive heart failure
Formulation
Tablet
Standard tablet
Dose Range
5–10 mg/kg
Max Daily
30 mg/kg
Frequency
As directed
Max Single
500 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 25–50 mg | 25.0–50.0 ml | ≤ 150 mg |
| 6 kg | 30–60 mg | 30.0–60.0 ml | ≤ 180 mg |
| 7 kg | 35–70 mg | 35.0–70.0 ml | ≤ 210 mg |
| 8 kg | 40–80 mg | 40.0–80.0 ml | ≤ 240 mg |
| 9 kg | 45–90 mg | 45.0–90.0 ml | ≤ 270 mg |
| 10 kg | 50–100 mg | 50.0–100.0 ml | ≤ 300 mg |
| 12 kg | 60–120 mg | 60.0–120.0 ml | ≤ 360 mg |
| 15 kg | 75–150 mg | 75.0–150.0 ml | ≤ 450 mg |
| 18 kg | 90–180 mg | 90.0–180.0 ml | ≤ 540 mg |
| 20 kg | 100–200 mg | 100.0–200.0 ml | ≤ 600 mg |
| 25 kg | 125–250 mg | 125.0–250.0 ml | ≤ 750 mg |
| 30 kg | 150–300 mg | 150.0–300.0 ml | ≤ 900 mg |
⚠️ Warnings
- • Contraindicated in Na/K depletion, hepatic/renal dysfunction
Albumin (Human)
Albumin (Human)
💊 Hypoproteinemia, Hypovolemia, Shock, Cerebral edema, Nephrotic syndrome, Neonatal jaundice
Formulation
Tablet
Standard tablet
Dose Range
0.5–1 mg/kg
Max Daily
6 mg/kg
Frequency
As directed
Max Single
N/A
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 3–5 mg | 2.5–5.0 ml | ≤ 30 mg |
| 6 kg | 3–6 mg | 3.0–6.0 ml | ≤ 36 mg |
| 7 kg | 4–7 mg | 3.5–7.0 ml | ≤ 42 mg |
| 8 kg | 4–8 mg | 4.0–8.0 ml | ≤ 48 mg |
| 9 kg | 5–9 mg | 4.5–9.0 ml | ≤ 54 mg |
| 10 kg | 5–10 mg | 5.0–10.0 ml | ≤ 60 mg |
| 12 kg | 6–12 mg | 6.0–12.0 ml | ≤ 72 mg |
| 15 kg | 8–15 mg | 7.5–15.0 ml | ≤ 90 mg |
| 18 kg | 9–18 mg | 9.0–18.0 ml | ≤ 108 mg |
| 20 kg | 10–20 mg | 10.0–20.0 ml | ≤ 120 mg |
| 25 kg | 13–25 mg | 12.5–25.0 ml | ≤ 150 mg |
| 30 kg | 15–30 mg | 15.0–30.0 ml | ≤ 180 mg |
⚠️ Warnings
- • Contraindicated in CHF and severe anemia; max 6 g/kg/24hr
Allopurinol
Allopurinol
💊 Gout, Lesch-Nyhan syndrome, Adjuvant in leukemia/malignancy chemotherapy, Duchenne's muscular dystrophy
Formulation
Tablet
Standard tablet
Dose Range
10–10 mg/kg
Max Daily
10 mg/kg
Frequency
As directed
Max Single
600 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–50 mg | 50.0–50.0 ml | ≤ 50 mg |
| 6 kg | 60–60 mg | 60.0–60.0 ml | ≤ 60 mg |
| 7 kg | 70–70 mg | 70.0–70.0 ml | ≤ 70 mg |
| 8 kg | 80–80 mg | 80.0–80.0 ml | ≤ 80 mg |
| 9 kg | 90–90 mg | 90.0–90.0 ml | ≤ 90 mg |
| 10 kg | 100–100 mg | 100.0–100.0 ml | ≤ 100 mg |
| 12 kg | 120–120 mg | 120.0–120.0 ml | ≤ 120 mg |
| 15 kg | 150–150 mg | 150.0–150.0 ml | ≤ 150 mg |
| 18 kg | 180–180 mg | 180.0–180.0 ml | ≤ 180 mg |
| 20 kg | 200–200 mg | 200.0–200.0 ml | ≤ 200 mg |
| 25 kg | 250–250 mg | 250.0–250.0 ml | ≤ 250 mg |
| 30 kg | 300–300 mg | 300.0–300.0 ml | ≤ 300 mg |
⚠️ Warnings
- • Reduce dose by 25% if given with azathioprine
Amphetamine-d (Dextroamphetamine)
Amphetamine-d (Dextroamphetamine)
💊 ADHD
Formulation
Tablet
Standard tablet
Dose Range
0.15–0.5 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
40 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–3 mg | 0.8–2.5 ml | — |
| 6 kg | 1–3 mg | 0.9–3.0 ml | — |
| 7 kg | 1–4 mg | 1.1–3.5 ml | — |
| 8 kg | 1–4 mg | 1.2–4.0 ml | — |
| 9 kg | 1–5 mg | 1.3–4.5 ml | — |
| 10 kg | 2–5 mg | 1.5–5.0 ml | — |
| 12 kg | 2–6 mg | 1.8–6.0 ml | — |
| 15 kg | 2–8 mg | 2.3–7.5 ml | — |
| 18 kg | 3–9 mg | 2.7–9.0 ml | — |
| 20 kg | 3–10 mg | 3.0–10.0 ml | — |
| 25 kg | 4–13 mg | 3.8–12.5 ml | — |
| 30 kg | 5–15 mg | 4.5–15.0 ml | — |
⚠️ Warnings
- • Age 3-5 yr: start 2.5 mg/day; >6 yr: start 5 mg once or twice daily
Atorvastatin
Atorvastatin
💊 Hypercholesterolemia, Lipid lowering
Formulation
Tablet
Standard tablet
Dose Range
0.2–0.5 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
20 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–3 mg | 1.0–2.5 ml | — |
| 6 kg | 1–3 mg | 1.2–3.0 ml | — |
| 7 kg | 1–4 mg | 1.4–3.5 ml | — |
| 8 kg | 2–4 mg | 1.6–4.0 ml | — |
| 9 kg | 2–5 mg | 1.8–4.5 ml | — |
| 10 kg | 2–5 mg | 2.0–5.0 ml | — |
| 12 kg | 2–6 mg | 2.4–6.0 ml | — |
| 15 kg | 3–8 mg | 3.0–7.5 ml | — |
| 18 kg | 4–9 mg | 3.6–9.0 ml | — |
| 20 kg | 4–10 mg | 4.0–10.0 ml | — |
| 25 kg | 5–13 mg | 5.0–12.5 ml | — |
| 30 kg | 6–15 mg | 6.0–15.0 ml | — |
⚠️ Warnings
- • Only for children above 10 years; max 20 mg/day in children
Atovaquone
Atovaquone
💊 Pneumocystis carinii pneumonia (alternative to co-trimoxazole)
Formulation
Tablet
Standard tablet
Dose Range
30–40 mg/kg
Max Daily
40 mg/kg
Frequency
As directed
Max Single
750 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 150–200 mg | 150.0–200.0 ml | ≤ 200 mg |
| 6 kg | 180–240 mg | 180.0–240.0 ml | ≤ 240 mg |
| 7 kg | 210–280 mg | 210.0–280.0 ml | ≤ 280 mg |
| 8 kg | 240–320 mg | 240.0–320.0 ml | ≤ 320 mg |
| 9 kg | 270–360 mg | 270.0–360.0 ml | ≤ 360 mg |
| 10 kg | 300–400 mg | 300.0–400.0 ml | ≤ 400 mg |
| 12 kg | 360–480 mg | 360.0–480.0 ml | ≤ 480 mg |
| 15 kg | 450–600 mg | 450.0–600.0 ml | ≤ 600 mg |
| 18 kg | 540–720 mg | 540.0–720.0 ml | ≤ 720 mg |
| 20 kg | 600–800 mg | 600.0–800.0 ml | ≤ 800 mg |
| 25 kg | 750–1000 mg | 750.0–1000.0 ml | ≤ 1000 mg |
| 30 kg | 900–1200 mg | 900.0–1200.0 ml | ≤ 1200 mg |
⚠️ Warnings
- • Administer with food
Azathioprine
Azathioprine
💊 Renal transplant rejection prevention, Rheumatoid arthritis, SLE, Steroid-resistant nephrotic syndrome
Formulation
Tablet
Standard tablet
Dose Range
1–5 mg/kg
Max Daily
5 mg/kg
Frequency
As directed
Max Single
100 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 5–25 mg | 5.0–25.0 ml | ≤ 25 mg |
| 6 kg | 6–30 mg | 6.0–30.0 ml | ≤ 30 mg |
| 7 kg | 7–35 mg | 7.0–35.0 ml | ≤ 35 mg |
| 8 kg | 8–40 mg | 8.0–40.0 ml | ≤ 40 mg |
| 9 kg | 9–45 mg | 9.0–45.0 ml | ≤ 45 mg |
| 10 kg | 10–50 mg | 10.0–50.0 ml | ≤ 50 mg |
| 12 kg | 12–60 mg | 12.0–60.0 ml | ≤ 60 mg |
| 15 kg | 15–75 mg | 15.0–75.0 ml | ≤ 75 mg |
| 18 kg | 18–90 mg | 18.0–90.0 ml | ≤ 90 mg |
| 20 kg | 20–100 mg | 20.0–100.0 ml | ≤ 100 mg |
| 25 kg | 25–125 mg | 25.0–125.0 ml | ≤ 125 mg |
| 30 kg | 30–150 mg | 30.0–150.0 ml | ≤ 150 mg |
⚠️ Warnings
- • Leukopenia
- • Thrombocytopenia
- • Hepatotoxicity; reduce dose 25% if with allopurinol
Baclofen
Baclofen
💊 Muscle spasticity (spinal or cerebral origin)
Formulation
Tablet
Standard tablet
Dose Range
0.75–2 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
60 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 4–10 mg | 3.8–10.0 ml | — |
| 6 kg | 5–12 mg | 4.5–12.0 ml | — |
| 7 kg | 5–14 mg | 5.3–14.0 ml | — |
| 8 kg | 6–16 mg | 6.0–16.0 ml | — |
| 9 kg | 7–18 mg | 6.8–18.0 ml | — |
| 10 kg | 8–20 mg | 7.5–20.0 ml | — |
| 12 kg | 9–24 mg | 9.0–24.0 ml | — |
| 15 kg | 11–30 mg | 11.3–30.0 ml | — |
| 18 kg | 14–36 mg | 13.5–36.0 ml | — |
| 20 kg | 15–40 mg | 15.0–40.0 ml | — |
| 25 kg | 19–50 mg | 18.8–50.0 ml | — |
| 30 kg | 23–60 mg | 22.5–60.0 ml | — |
⚠️ Warnings
- • Max dose: <8 yr 40 mg/day; >8 yr 60 mg/day
Betahistine Dihydrochloride
Betahistine Dihydrochloride
💊 Vertigo, Tinnitus, Meniere's disease
Formulation
Tablet
Standard tablet
Dose Range
0.1–0.3 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
16 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–2 mg | 0.5–1.5 ml | — |
| 6 kg | 1–2 mg | 0.6–1.8 ml | — |
| 7 kg | 1–2 mg | 0.7–2.1 ml | — |
| 8 kg | 1–2 mg | 0.8–2.4 ml | — |
| 9 kg | 1–3 mg | 0.9–2.7 ml | — |
| 10 kg | 1–3 mg | 1.0–3.0 ml | — |
| 12 kg | 1–4 mg | 1.2–3.6 ml | — |
| 15 kg | 2–5 mg | 1.5–4.5 ml | — |
| 18 kg | 2–5 mg | 1.8–5.4 ml | — |
| 20 kg | 2–6 mg | 2.0–6.0 ml | — |
| 25 kg | 3–8 mg | 2.5–7.5 ml | — |
| 30 kg | 3–9 mg | 3.0–9.0 ml | — |
⚠️ Warnings
- • Avoid below 12 years of age
Caffeine Citrate
Caffeine Citrate
💊 Apnea of prematurity
Formulation
Tablet
Standard tablet
Dose Range
5–5 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
25 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 25–25 mg | 25.0–25.0 ml | — |
| 6 kg | 30–30 mg | 30.0–30.0 ml | — |
| 7 kg | 35–35 mg | 35.0–35.0 ml | — |
| 8 kg | 40–40 mg | 40.0–40.0 ml | — |
| 9 kg | 45–45 mg | 45.0–45.0 ml | — |
| 10 kg | 50–50 mg | 50.0–50.0 ml | — |
| 12 kg | 60–60 mg | 60.0–60.0 ml | — |
| 15 kg | 75–75 mg | 75.0–75.0 ml | — |
| 18 kg | 90–90 mg | 90.0–90.0 ml | — |
| 20 kg | 100–100 mg | 100.0–100.0 ml | — |
| 25 kg | 125–125 mg | 125.0–125.0 ml | — |
| 30 kg | 150–150 mg | 150.0–150.0 ml | — |
⚠️ Warnings
- • Stop if HR >180/min; do not mix with sodium bicarbonate or aminophylline
Calcium Gluconate
Calcium Gluconate
💊 Symptomatic hypocalcemia, Hyperkalemia, Cardiac arrest
Formulation
Tablet
Standard tablet
Dose Range
1–2 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
2200 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 5–10 mg | 5.0–10.0 ml | — |
| 6 kg | 6–12 mg | 6.0–12.0 ml | — |
| 7 kg | 7–14 mg | 7.0–14.0 ml | — |
| 8 kg | 8–16 mg | 8.0–16.0 ml | — |
| 9 kg | 9–18 mg | 9.0–18.0 ml | — |
| 10 kg | 10–20 mg | 10.0–20.0 ml | — |
| 12 kg | 12–24 mg | 12.0–24.0 ml | — |
| 15 kg | 15–30 mg | 15.0–30.0 ml | — |
| 18 kg | 18–36 mg | 18.0–36.0 ml | — |
| 20 kg | 20–40 mg | 20.0–40.0 ml | — |
| 25 kg | 25–50 mg | 25.0–50.0 ml | — |
| 30 kg | 30–60 mg | 30.0–60.0 ml | — |
⚠️ Warnings
- • Never give IV to digitalized patient; monitor HR; do not mix with sodium bicarbonate; IV leakage may cause tissue necrosis
Carnitine, Levo
Carnitine, Levo
💊 Myopathy, Cardiomyopathy, Primary/secondary carnitine deficiency, Rett syndrome, TPN supplement, Valproate therapy supplement
Formulation
Tablet
Standard tablet
Dose Range
50–100 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
3000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 250–500 mg | 250.0–500.0 ml | — |
| 6 kg | 300–600 mg | 300.0–600.0 ml | — |
| 7 kg | 350–700 mg | 350.0–700.0 ml | — |
| 8 kg | 400–800 mg | 400.0–800.0 ml | — |
| 9 kg | 450–900 mg | 450.0–900.0 ml | — |
| 10 kg | 500–1000 mg | 500.0–1000.0 ml | — |
| 12 kg | 600–1200 mg | 600.0–1200.0 ml | — |
| 15 kg | 750–1500 mg | 750.0–1500.0 ml | — |
| 18 kg | 900–1800 mg | 900.0–1800.0 ml | — |
| 20 kg | 1000–2000 mg | 1000.0–2000.0 ml | — |
| 25 kg | 1250–2500 mg | 1250.0–2500.0 ml | — |
| 30 kg | 1500–3000 mg | 1500.0–3000.0 ml | — |
⚠️ Warnings
- • Max 3 g/day oral; max IV dose 1 g
Cholestyramine
Cholestyramine
💊 Hypercholesterolemia, Pruritus in liver disease
Formulation
Tablet
Standard tablet
Dose Range
250–500 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
8000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1250–2500 mg | 1250.0–2500.0 ml | — |
| 6 kg | 1500–3000 mg | 1500.0–3000.0 ml | — |
| 7 kg | 1750–3500 mg | 1750.0–3500.0 ml | — |
| 8 kg | 2000–4000 mg | 2000.0–4000.0 ml | — |
| 9 kg | 2250–4500 mg | 2250.0–4500.0 ml | — |
| 10 kg | 2500–5000 mg | 2500.0–5000.0 ml | — |
| 12 kg | 3000–6000 mg | 3000.0–6000.0 ml | — |
| 15 kg | 3750–7500 mg | 3750.0–7500.0 ml | — |
| 18 kg | 4500–9000 mg | 4500.0–9000.0 ml | — |
| 20 kg | 5000–10000 mg | 5000.0–10000.0 ml | — |
| 25 kg | 6250–12500 mg | 6250.0–12500.0 ml | — |
| 30 kg | 7500–15000 mg | 7500.0–15000.0 ml | — |
⚠️ Warnings
- • Constipation; fat-soluble vitamin deficiency; avoid other oral medications 2 hr before/after
Cimetidine
Cimetidine
💊 Duodenal ulcer, Reflux esophagitis, Acute peptic ulcer
Formulation
Tablet
Standard tablet
Dose Range
20–29 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
800 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 100–145 mg | 100.0–145.0 ml | — |
| 6 kg | 120–174 mg | 120.0–174.0 ml | — |
| 7 kg | 140–203 mg | 140.0–203.0 ml | — |
| 8 kg | 160–232 mg | 160.0–232.0 ml | — |
| 9 kg | 180–261 mg | 180.0–261.0 ml | — |
| 10 kg | 200–290 mg | 200.0–290.0 ml | — |
| 12 kg | 240–348 mg | 240.0–348.0 ml | — |
| 15 kg | 300–435 mg | 300.0–435.0 ml | — |
| 18 kg | 360–522 mg | 360.0–522.0 ml | — |
| 20 kg | 400–580 mg | 400.0–580.0 ml | — |
| 25 kg | 500–725 mg | 500.0–725.0 ml | — |
| 30 kg | 600–870 mg | 600.0–870.0 ml | — |
⚠️ Warnings
- • Limited experience in children
Cinnarizine
Cinnarizine
💊 Motion sickness, Vertigo
Formulation
Tablet
Standard tablet
Dose Range
0.5–1 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
25 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 3–5 mg | 2.5–5.0 ml | — |
| 6 kg | 3–6 mg | 3.0–6.0 ml | — |
| 7 kg | 4–7 mg | 3.5–7.0 ml | — |
| 8 kg | 4–8 mg | 4.0–8.0 ml | — |
| 9 kg | 5–9 mg | 4.5–9.0 ml | — |
| 10 kg | 5–10 mg | 5.0–10.0 ml | — |
| 12 kg | 6–12 mg | 6.0–12.0 ml | — |
| 15 kg | 8–15 mg | 7.5–15.0 ml | — |
| 18 kg | 9–18 mg | 9.0–18.0 ml | — |
| 20 kg | 10–20 mg | 10.0–20.0 ml | — |
| 25 kg | 13–25 mg | 12.5–25.0 ml | — |
| 30 kg | 15–30 mg | 15.0–30.0 ml | — |
Cyclosporin
Cyclosporin
💊 Renal transplant rejection prevention, Autoimmune disorders
Formulation
Tablet
Standard tablet
Dose Range
2–15 mg/kg
Max Daily
15 mg/kg
Frequency
As directed
Max Single
200 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 10–75 mg | 10.0–75.0 ml | ≤ 75 mg |
| 6 kg | 12–90 mg | 12.0–90.0 ml | ≤ 90 mg |
| 7 kg | 14–105 mg | 14.0–105.0 ml | ≤ 105 mg |
| 8 kg | 16–120 mg | 16.0–120.0 ml | ≤ 120 mg |
| 9 kg | 18–135 mg | 18.0–135.0 ml | ≤ 135 mg |
| 10 kg | 20–150 mg | 20.0–150.0 ml | ≤ 150 mg |
| 12 kg | 24–180 mg | 24.0–180.0 ml | ≤ 180 mg |
| 15 kg | 30–225 mg | 30.0–225.0 ml | ≤ 225 mg |
| 18 kg | 36–270 mg | 36.0–270.0 ml | ≤ 270 mg |
| 20 kg | 40–300 mg | 40.0–300.0 ml | ≤ 300 mg |
| 25 kg | 50–375 mg | 50.0–375.0 ml | ≤ 375 mg |
| 30 kg | 60–450 mg | 60.0–450.0 ml | ≤ 450 mg |
⚠️ Warnings
- • Nephrotoxicity
- • Tremors
- • Hypertension
- • Hyperlipidemia
- • Gingival hyperplasia
- • Hirsutism
d-Penicillamine
d-Penicillamine
💊 Heavy metal poisoning, Cystinuria, Rheumatoid arthritis, Wilson's disease
Formulation
Tablet
Standard tablet
Dose Range
20–40 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
500 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 100–200 mg | 100.0–200.0 ml | — |
| 6 kg | 120–240 mg | 120.0–240.0 ml | — |
| 7 kg | 140–280 mg | 140.0–280.0 ml | — |
| 8 kg | 160–320 mg | 160.0–320.0 ml | — |
| 9 kg | 180–360 mg | 180.0–360.0 ml | — |
| 10 kg | 200–400 mg | 200.0–400.0 ml | — |
| 12 kg | 240–480 mg | 240.0–480.0 ml | — |
| 15 kg | 300–600 mg | 300.0–600.0 ml | — |
| 18 kg | 360–720 mg | 360.0–720.0 ml | — |
| 20 kg | 400–800 mg | 400.0–800.0 ml | — |
| 25 kg | 500–1000 mg | 500.0–1000.0 ml | — |
| 30 kg | 600–1200 mg | 600.0–1200.0 ml | — |
⚠️ Warnings
- • Requires vitamin B6 supplement 25 mg/day and zinc
Deferasirox
Deferasirox
💊 Iron overload from chronic hemolytic anemia, Blood transfusions
Formulation
Tablet
Standard tablet
Dose Range
20–30 mg/kg
Max Daily
30 mg/kg
Frequency
As directed
Max Single
360 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 100–150 mg | 100.0–150.0 ml | ≤ 150 mg |
| 6 kg | 120–180 mg | 120.0–180.0 ml | ≤ 180 mg |
| 7 kg | 140–210 mg | 140.0–210.0 ml | ≤ 210 mg |
| 8 kg | 160–240 mg | 160.0–240.0 ml | ≤ 240 mg |
| 9 kg | 180–270 mg | 180.0–270.0 ml | ≤ 270 mg |
| 10 kg | 200–300 mg | 200.0–300.0 ml | ≤ 300 mg |
| 12 kg | 240–360 mg | 240.0–360.0 ml | ≤ 360 mg |
| 15 kg | 300–450 mg | 300.0–450.0 ml | ≤ 450 mg |
| 18 kg | 360–540 mg | 360.0–540.0 ml | ≤ 540 mg |
| 20 kg | 400–600 mg | 400.0–600.0 ml | ≤ 600 mg |
| 25 kg | 500–750 mg | 500.0–750.0 ml | ≤ 750 mg |
| 30 kg | 600–900 mg | 600.0–900.0 ml | ≤ 900 mg |
⚠️ Warnings
- • Not approved below 2 years; maintain serum ferritin below 500 ng/ml
Deferiprone
Deferiprone
💊 Transfusion hemosiderosis in thalassemia, Hemolytic anemia, Acute iron poisoning
Formulation
Tablet
Standard tablet
Dose Range
50–100 mg/kg
Max Daily
100 mg/kg
Frequency
As directed
Max Single
1500 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 250–500 mg | 250.0–500.0 ml | ≤ 500 mg |
| 6 kg | 300–600 mg | 300.0–600.0 ml | ≤ 600 mg |
| 7 kg | 350–700 mg | 350.0–700.0 ml | ≤ 700 mg |
| 8 kg | 400–800 mg | 400.0–800.0 ml | ≤ 800 mg |
| 9 kg | 450–900 mg | 450.0–900.0 ml | ≤ 900 mg |
| 10 kg | 500–1000 mg | 500.0–1000.0 ml | ≤ 1000 mg |
| 12 kg | 600–1200 mg | 600.0–1200.0 ml | ≤ 1200 mg |
| 15 kg | 750–1500 mg | 750.0–1500.0 ml | ≤ 1500 mg |
| 18 kg | 900–1800 mg | 900.0–1800.0 ml | ≤ 1800 mg |
| 20 kg | 1000–2000 mg | 1000.0–2000.0 ml | ≤ 2000 mg |
| 25 kg | 1250–2500 mg | 1250.0–2500.0 ml | ≤ 2500 mg |
| 30 kg | 1500–3000 mg | 1500.0–3000.0 ml | ≤ 3000 mg |
Desferrioxamine (Deferoxamine)
Desferrioxamine (Deferoxamine)
💊 Acute iron intoxication, Chronic iron overload
Formulation
Tablet
Standard tablet
Dose Range
20–40 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
6000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 100–200 mg | 100.0–200.0 ml | — |
| 6 kg | 120–240 mg | 120.0–240.0 ml | — |
| 7 kg | 140–280 mg | 140.0–280.0 ml | — |
| 8 kg | 160–320 mg | 160.0–320.0 ml | — |
| 9 kg | 180–360 mg | 180.0–360.0 ml | — |
| 10 kg | 200–400 mg | 200.0–400.0 ml | — |
| 12 kg | 240–480 mg | 240.0–480.0 ml | — |
| 15 kg | 300–600 mg | 300.0–600.0 ml | — |
| 18 kg | 360–720 mg | 360.0–720.0 ml | — |
| 20 kg | 400–800 mg | 400.0–800.0 ml | — |
| 25 kg | 500–1000 mg | 500.0–1000.0 ml | — |
| 30 kg | 600–1200 mg | 600.0–1200.0 ml | — |
⚠️ Warnings
- • Excreted iron imparts reddish color to urine; contraindicated in acute renal failure unless hemodialysis
Dextran-40
Dextran-40
💊 Prevention of deep vein thrombosis, Shock, Cerebrovascular accident
Formulation
Tablet
Standard tablet
Dose Range
10–20 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
N/A
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–100 mg | 50.0–100.0 ml | — |
| 6 kg | 60–120 mg | 60.0–120.0 ml | — |
| 7 kg | 70–140 mg | 70.0–140.0 ml | — |
| 8 kg | 80–160 mg | 80.0–160.0 ml | — |
| 9 kg | 90–180 mg | 90.0–180.0 ml | — |
| 10 kg | 100–200 mg | 100.0–200.0 ml | — |
| 12 kg | 120–240 mg | 120.0–240.0 ml | — |
| 15 kg | 150–300 mg | 150.0–300.0 ml | — |
| 18 kg | 180–360 mg | 180.0–360.0 ml | — |
| 20 kg | 200–400 mg | 200.0–400.0 ml | — |
| 25 kg | 250–500 mg | 250.0–500.0 ml | — |
| 30 kg | 300–600 mg | 300.0–600.0 ml | — |
⚠️ Warnings
- • Contraindicated in fluid overload
Dextromethorphan
Dextromethorphan
💊 Antitussive, Nonketotic hyperglycinemia
Formulation
Tablet
Standard tablet
Dose Range
1–2 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
60 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 5–10 mg | 5.0–10.0 ml | — |
| 6 kg | 6–12 mg | 6.0–12.0 ml | — |
| 7 kg | 7–14 mg | 7.0–14.0 ml | — |
| 8 kg | 8–16 mg | 8.0–16.0 ml | — |
| 9 kg | 9–18 mg | 9.0–18.0 ml | — |
| 10 kg | 10–20 mg | 10.0–20.0 ml | — |
| 12 kg | 12–24 mg | 12.0–24.0 ml | — |
| 15 kg | 15–30 mg | 15.0–30.0 ml | — |
| 18 kg | 18–36 mg | 18.0–36.0 ml | — |
| 20 kg | 20–40 mg | 20.0–40.0 ml | — |
| 25 kg | 25–50 mg | 25.0–50.0 ml | — |
| 30 kg | 30–60 mg | 30.0–60.0 ml | — |
Doxapram Hydrochloride
Doxapram Hydrochloride
💊 Apnea of prematurity unresponsive to theophylline
Formulation
Tablet
Standard tablet
Dose Range
0.5–2.5 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
100 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 3–13 mg | 2.5–12.5 ml | — |
| 6 kg | 3–15 mg | 3.0–15.0 ml | — |
| 7 kg | 4–18 mg | 3.5–17.5 ml | — |
| 8 kg | 4–20 mg | 4.0–20.0 ml | — |
| 9 kg | 5–23 mg | 4.5–22.5 ml | — |
| 10 kg | 5–25 mg | 5.0–25.0 ml | — |
| 12 kg | 6–30 mg | 6.0–30.0 ml | — |
| 15 kg | 8–38 mg | 7.5–37.5 ml | — |
| 18 kg | 9–45 mg | 9.0–45.0 ml | — |
| 20 kg | 10–50 mg | 10.0–50.0 ml | — |
| 25 kg | 13–63 mg | 12.5–62.5 ml | — |
| 30 kg | 15–75 mg | 15.0–75.0 ml | — |
⚠️ Warnings
- • Contraindicated in seizure disorder, hypertension, head injury, acute asthma; do not mix with sodium bicarbonate or aminophylline
Erythropoietin (rHu-EPO)
Erythropoietin (rHu-EPO)
💊 Anemia of chronic renal failure, Anemia of prematurity
Formulation
Tablet
Standard tablet
Dose Range
50–500 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
N/A
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 250–2500 mg | 250.0–2500.0 ml | — |
| 6 kg | 300–3000 mg | 300.0–3000.0 ml | — |
| 7 kg | 350–3500 mg | 350.0–3500.0 ml | — |
| 8 kg | 400–4000 mg | 400.0–4000.0 ml | — |
| 9 kg | 450–4500 mg | 450.0–4500.0 ml | — |
| 10 kg | 500–5000 mg | 500.0–5000.0 ml | — |
| 12 kg | 600–6000 mg | 600.0–6000.0 ml | — |
| 15 kg | 750–7500 mg | 750.0–7500.0 ml | — |
| 18 kg | 900–9000 mg | 900.0–9000.0 ml | — |
| 20 kg | 1000–10000 mg | 1000.0–10000.0 ml | — |
| 25 kg | 1250–12500 mg | 1250.0–12500.0 ml | — |
| 30 kg | 1500–15000 mg | 1500.0–15000.0 ml | — |
⚠️ Warnings
- • Provide iron supplements 2-3 mg/kg/day
Famotidine
Famotidine
💊 Peptic ulcer, GERD
Formulation
Tablet
Standard tablet
Dose Range
0.4–0.4 mg/kg
Max Daily
0.4 mg/kg
Frequency
As directed
Max Single
40 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 2–2 mg | 2.0–2.0 ml | ≤ 2 mg |
| 6 kg | 2–2 mg | 2.4–2.4 ml | ≤ 2 mg |
| 7 kg | 3–3 mg | 2.8–2.8 ml | ≤ 3 mg |
| 8 kg | 3–3 mg | 3.2–3.2 ml | ≤ 3 mg |
| 9 kg | 4–4 mg | 3.6–3.6 ml | ≤ 4 mg |
| 10 kg | 4–4 mg | 4.0–4.0 ml | ≤ 4 mg |
| 12 kg | 5–5 mg | 4.8–4.8 ml | ≤ 5 mg |
| 15 kg | 6–6 mg | 6.0–6.0 ml | ≤ 6 mg |
| 18 kg | 7–7 mg | 7.2–7.2 ml | ≤ 7 mg |
| 20 kg | 8–8 mg | 8.0–8.0 ml | ≤ 8 mg |
| 25 kg | 10–10 mg | 10.0–10.0 ml | ≤ 10 mg |
| 30 kg | 12–12 mg | 12.0–12.0 ml | ≤ 12 mg |
Flunarizine
Flunarizine
💊 Migraine prophylaxis
Formulation
Tablet
Standard tablet
Dose Range
0.05–0.1 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
10 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 0–1 mg | 0.3–0.5 ml | — |
| 6 kg | 0–1 mg | 0.3–0.6 ml | — |
| 7 kg | 0–1 mg | 0.4–0.7 ml | — |
| 8 kg | 0–1 mg | 0.4–0.8 ml | — |
| 9 kg | 0–1 mg | 0.5–0.9 ml | — |
| 10 kg | 1–1 mg | 0.5–1.0 ml | — |
| 12 kg | 1–1 mg | 0.6–1.2 ml | — |
| 15 kg | 1–2 mg | 0.8–1.5 ml | — |
| 18 kg | 1–2 mg | 0.9–1.8 ml | — |
| 20 kg | 1–2 mg | 1.0–2.0 ml | — |
| 25 kg | 1–3 mg | 1.3–2.5 ml | — |
| 30 kg | 2–3 mg | 1.5–3.0 ml | — |
⚠️ Warnings
- • Only above 5 years; sedation, dry mouth, nausea, weight gain
Gamma Benzene Hexachloride (Lindane)
Gamma Benzene Hexachloride (Lindane)
💊 Scabies, Pediculosis (head lice)
Formulation
Tablet
Standard tablet
Dose Range
10–20 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
N/A
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–100 mg | 50.0–100.0 ml | — |
| 6 kg | 60–120 mg | 60.0–120.0 ml | — |
| 7 kg | 70–140 mg | 70.0–140.0 ml | — |
| 8 kg | 80–160 mg | 80.0–160.0 ml | — |
| 9 kg | 90–180 mg | 90.0–180.0 ml | — |
| 10 kg | 100–200 mg | 100.0–200.0 ml | — |
| 12 kg | 120–240 mg | 120.0–240.0 ml | — |
| 15 kg | 150–300 mg | 150.0–300.0 ml | — |
| 18 kg | 180–360 mg | 180.0–360.0 ml | — |
| 20 kg | 200–400 mg | 200.0–400.0 ml | — |
| 25 kg | 250–500 mg | 250.0–500.0 ml | — |
| 30 kg | 300–600 mg | 300.0–600.0 ml | — |
⚠️ Warnings
- • Repeat after one week if needed; avoid contact with eyes
Glucagon
Glucagon
💊 Insulin-induced hypoglycemia, Drug-induced hypoglycemia, Intractable hypoglycemia in large-for-dates babies
Formulation
Tablet
Standard tablet
Dose Range
0.02–0.1 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
1 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 0–1 mg | 0.1–0.5 ml | — |
| 6 kg | 0–1 mg | 0.1–0.6 ml | — |
| 7 kg | 0–1 mg | 0.1–0.7 ml | — |
| 8 kg | 0–1 mg | 0.2–0.8 ml | — |
| 9 kg | 0–1 mg | 0.2–0.9 ml | — |
| 10 kg | 0–1 mg | 0.2–1.0 ml | — |
| 12 kg | 0–1 mg | 0.2–1.2 ml | — |
| 15 kg | 0–2 mg | 0.3–1.5 ml | — |
| 18 kg | 0–2 mg | 0.4–1.8 ml | — |
| 20 kg | 0–2 mg | 0.4–2.0 ml | — |
| 25 kg | 1–3 mg | 0.5–2.5 ml | — |
| 30 kg | 1–3 mg | 0.6–3.0 ml | — |
G-CSF (Filgrastim) / GM-CSF (Sargramostim)
G-CSF (Filgrastim) / GM-CSF (Sargramostim)
💊 Neutropenia from cytotoxic therapy, Post bone marrow transplant, Congenital/idiopathic neutropenia, HIV-associated neutropenia, Sepsis-related neutropenia
Formulation
Tablet
Standard tablet
Dose Range
5–10 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
N/A
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 25–50 mg | 25.0–50.0 ml | — |
| 6 kg | 30–60 mg | 30.0–60.0 ml | — |
| 7 kg | 35–70 mg | 35.0–70.0 ml | — |
| 8 kg | 40–80 mg | 40.0–80.0 ml | — |
| 9 kg | 45–90 mg | 45.0–90.0 ml | — |
| 10 kg | 50–100 mg | 50.0–100.0 ml | — |
| 12 kg | 60–120 mg | 60.0–120.0 ml | — |
| 15 kg | 75–150 mg | 75.0–150.0 ml | — |
| 18 kg | 90–180 mg | 90.0–180.0 ml | — |
| 20 kg | 100–200 mg | 100.0–200.0 ml | — |
| 25 kg | 125–250 mg | 125.0–250.0 ml | — |
| 30 kg | 150–300 mg | 150.0–300.0 ml | — |
⚠️ Warnings
- • Do not give 14 days before or 24 hours after cytotoxic chemotherapy
Lactulose
Lactulose
💊 Hepatic coma, Constipation
Formulation
Tablet
Standard tablet
Dose Range
1–2 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
30 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 5–10 mg | 5.0–10.0 ml | — |
| 6 kg | 6–12 mg | 6.0–12.0 ml | — |
| 7 kg | 7–14 mg | 7.0–14.0 ml | — |
| 8 kg | 8–16 mg | 8.0–16.0 ml | — |
| 9 kg | 9–18 mg | 9.0–18.0 ml | — |
| 10 kg | 10–20 mg | 10.0–20.0 ml | — |
| 12 kg | 12–24 mg | 12.0–24.0 ml | — |
| 15 kg | 15–30 mg | 15.0–30.0 ml | — |
| 18 kg | 18–36 mg | 18.0–36.0 ml | — |
| 20 kg | 20–40 mg | 20.0–40.0 ml | — |
| 25 kg | 25–50 mg | 25.0–50.0 ml | — |
| 30 kg | 30–60 mg | 30.0–60.0 ml | — |
⚠️ Warnings
- • Dehydration, hypernatremia, hypokalemia; contraindicated in low galactose diet, diabetes
Lansoprazole
Lansoprazole
💊 Gastroesophageal reflux disease (GERD)
Formulation
Tablet
Standard tablet
Dose Range
1–1 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
30 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 5–5 mg | 5.0–5.0 ml | — |
| 6 kg | 6–6 mg | 6.0–6.0 ml | — |
| 7 kg | 7–7 mg | 7.0–7.0 ml | — |
| 8 kg | 8–8 mg | 8.0–8.0 ml | — |
| 9 kg | 9–9 mg | 9.0–9.0 ml | — |
| 10 kg | 10–10 mg | 10.0–10.0 ml | — |
| 12 kg | 12–12 mg | 12.0–12.0 ml | — |
| 15 kg | 15–15 mg | 15.0–15.0 ml | — |
| 18 kg | 18–18 mg | 18.0–18.0 ml | — |
| 20 kg | 20–20 mg | 20.0–20.0 ml | — |
| 25 kg | 25–25 mg | 25.0–25.0 ml | — |
| 30 kg | 30–30 mg | 30.0–30.0 ml | — |
Magnesium Sulfate
Magnesium Sulfate
💊 Hypomagnesemia, Asthma (severe)
Formulation
Tablet
Standard tablet
Dose Range
100–100 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
4000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 500–500 mg | 500.0–500.0 ml | — |
| 6 kg | 600–600 mg | 600.0–600.0 ml | — |
| 7 kg | 700–700 mg | 700.0–700.0 ml | — |
| 8 kg | 800–800 mg | 800.0–800.0 ml | — |
| 9 kg | 900–900 mg | 900.0–900.0 ml | — |
| 10 kg | 1000–1000 mg | 1000.0–1000.0 ml | — |
| 12 kg | 1200–1200 mg | 1200.0–1200.0 ml | — |
| 15 kg | 1500–1500 mg | 1500.0–1500.0 ml | — |
| 18 kg | 1800–1800 mg | 1800.0–1800.0 ml | — |
| 20 kg | 2000–2000 mg | 2000.0–2000.0 ml | — |
| 25 kg | 2500–2500 mg | 2500.0–2500.0 ml | — |
| 30 kg | 3000–3000 mg | 3000.0–3000.0 ml | — |
Mannitol (20%)
Mannitol (20%)
💊 Increased intracranial pressure, Cerebral edema, Oliguria/renal failure prevention, Hyponatremia
Formulation
Tablet
Standard tablet
Dose Range
0.5–3 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
2000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 3–15 mg | 2.5–15.0 ml | — |
| 6 kg | 3–18 mg | 3.0–18.0 ml | — |
| 7 kg | 4–21 mg | 3.5–21.0 ml | — |
| 8 kg | 4–24 mg | 4.0–24.0 ml | — |
| 9 kg | 5–27 mg | 4.5–27.0 ml | — |
| 10 kg | 5–30 mg | 5.0–30.0 ml | — |
| 12 kg | 6–36 mg | 6.0–36.0 ml | — |
| 15 kg | 8–45 mg | 7.5–45.0 ml | — |
| 18 kg | 9–54 mg | 9.0–54.0 ml | — |
| 20 kg | 10–60 mg | 10.0–60.0 ml | — |
| 25 kg | 13–75 mg | 12.5–75.0 ml | — |
| 30 kg | 15–90 mg | 15.0–90.0 ml | — |
⚠️ Warnings
- • Administer rapidly over 30-60 min for brain edema
Methotrexate
Methotrexate
💊 Malignant disorders, Juvenile rheumatoid arthritis
Formulation
Tablet
Standard tablet
Dose Range
0.1–0.5 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
25 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–3 mg | 0.5–2.5 ml | — |
| 6 kg | 1–3 mg | 0.6–3.0 ml | — |
| 7 kg | 1–4 mg | 0.7–3.5 ml | — |
| 8 kg | 1–4 mg | 0.8–4.0 ml | — |
| 9 kg | 1–5 mg | 0.9–4.5 ml | — |
| 10 kg | 1–5 mg | 1.0–5.0 ml | — |
| 12 kg | 1–6 mg | 1.2–6.0 ml | — |
| 15 kg | 2–8 mg | 1.5–7.5 ml | — |
| 18 kg | 2–9 mg | 1.8–9.0 ml | — |
| 20 kg | 2–10 mg | 2.0–10.0 ml | — |
| 25 kg | 3–13 mg | 2.5–12.5 ml | — |
| 30 kg | 3–15 mg | 3.0–15.0 ml | — |
⚠️ Warnings
- • Bone marrow suppression
- • Hepatic dysfunction
Methylphenidate Hydrochloride
Methylphenidate Hydrochloride
💊 ADHD, Narcolepsy, Pain management
Formulation
Tablet
Standard tablet
Dose Range
0.3–1 mg/kg
Max Daily
2 mg/kg
Frequency
As directed
Max Single
60 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 2–5 mg | 1.5–5.0 ml | ≤ 10 mg |
| 6 kg | 2–6 mg | 1.8–6.0 ml | ≤ 12 mg |
| 7 kg | 2–7 mg | 2.1–7.0 ml | ≤ 14 mg |
| 8 kg | 2–8 mg | 2.4–8.0 ml | ≤ 16 mg |
| 9 kg | 3–9 mg | 2.7–9.0 ml | ≤ 18 mg |
| 10 kg | 3–10 mg | 3.0–10.0 ml | ≤ 20 mg |
| 12 kg | 4–12 mg | 3.6–12.0 ml | ≤ 24 mg |
| 15 kg | 5–15 mg | 4.5–15.0 ml | ≤ 30 mg |
| 18 kg | 5–18 mg | 5.4–18.0 ml | ≤ 36 mg |
| 20 kg | 6–20 mg | 6.0–20.0 ml | ≤ 40 mg |
| 25 kg | 8–25 mg | 7.5–25.0 ml | ≤ 50 mg |
| 30 kg | 9–30 mg | 9.0–30.0 ml | ≤ 60 mg |
⚠️ Warnings
- • Avoid below 6 years; avoid in glaucoma; avoid with MAO inhibitors
Modafinil
Modafinil
💊 Sleep disorders, Narcolepsy
Formulation
Tablet
Standard tablet
Dose Range
2–5 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
200 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 10–25 mg | 10.0–25.0 ml | — |
| 6 kg | 12–30 mg | 12.0–30.0 ml | — |
| 7 kg | 14–35 mg | 14.0–35.0 ml | — |
| 8 kg | 16–40 mg | 16.0–40.0 ml | — |
| 9 kg | 18–45 mg | 18.0–45.0 ml | — |
| 10 kg | 20–50 mg | 20.0–50.0 ml | — |
| 12 kg | 24–60 mg | 24.0–60.0 ml | — |
| 15 kg | 30–75 mg | 30.0–75.0 ml | — |
| 18 kg | 36–90 mg | 36.0–90.0 ml | — |
| 20 kg | 40–100 mg | 40.0–100.0 ml | — |
| 25 kg | 50–125 mg | 50.0–125.0 ml | — |
| 30 kg | 60–150 mg | 60.0–150.0 ml | — |
⚠️ Warnings
- • Severe skin reactions
- • Psychiatric reactions
- • Tremors
- • Tachycardia; not below 17 years
Pancuronium Bromide
Pancuronium Bromide
💊 Neuromuscular blockade
Formulation
Tablet
Standard tablet
Dose Range
0.04–0.1 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
8 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 0–1 mg | 0.2–0.5 ml | — |
| 6 kg | 0–1 mg | 0.2–0.6 ml | — |
| 7 kg | 0–1 mg | 0.3–0.7 ml | — |
| 8 kg | 0–1 mg | 0.3–0.8 ml | — |
| 9 kg | 0–1 mg | 0.4–0.9 ml | — |
| 10 kg | 0–1 mg | 0.4–1.0 ml | — |
| 12 kg | 0–1 mg | 0.5–1.2 ml | — |
| 15 kg | 1–2 mg | 0.6–1.5 ml | — |
| 18 kg | 1–2 mg | 0.7–1.8 ml | — |
| 20 kg | 1–2 mg | 0.8–2.0 ml | — |
| 25 kg | 1–3 mg | 1.0–2.5 ml | — |
| 30 kg | 1–3 mg | 1.2–3.0 ml | — |
⚠️ Warnings
- • May cause hypertension and increased cerebral blood flow; reverse with IV atropine 0.02 mg/kg
Pemoline
Pemoline
💊 ADHD
Formulation
Tablet
Standard tablet
Dose Range
1–3 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
40 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 5–15 mg | 5.0–15.0 ml | — |
| 6 kg | 6–18 mg | 6.0–18.0 ml | — |
| 7 kg | 7–21 mg | 7.0–21.0 ml | — |
| 8 kg | 8–24 mg | 8.0–24.0 ml | — |
| 9 kg | 9–27 mg | 9.0–27.0 ml | — |
| 10 kg | 10–30 mg | 10.0–30.0 ml | — |
| 12 kg | 12–36 mg | 12.0–36.0 ml | — |
| 15 kg | 15–45 mg | 15.0–45.0 ml | — |
| 18 kg | 18–54 mg | 18.0–54.0 ml | — |
| 20 kg | 20–60 mg | 20.0–60.0 ml | — |
| 25 kg | 25–75 mg | 25.0–75.0 ml | — |
| 30 kg | 30–90 mg | 30.0–90.0 ml | — |
Permethrin
Permethrin
💊 Scabies, Head lice (pediculosis)
Formulation
Tablet
Standard tablet
Dose Range
5–10 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
N/A
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 25–50 mg | 25.0–50.0 ml | — |
| 6 kg | 30–60 mg | 30.0–60.0 ml | — |
| 7 kg | 35–70 mg | 35.0–70.0 ml | — |
| 8 kg | 40–80 mg | 40.0–80.0 ml | — |
| 9 kg | 45–90 mg | 45.0–90.0 ml | — |
| 10 kg | 50–100 mg | 50.0–100.0 ml | — |
| 12 kg | 60–120 mg | 60.0–120.0 ml | — |
| 15 kg | 75–150 mg | 75.0–150.0 ml | — |
| 18 kg | 90–180 mg | 90.0–180.0 ml | — |
| 20 kg | 100–200 mg | 100.0–200.0 ml | — |
| 25 kg | 125–250 mg | 125.0–250.0 ml | — |
| 30 kg | 150–300 mg | 150.0–300.0 ml | — |
⚠️ Warnings
- • Treat all contacts simultaneously
Piracetam
Piracetam
💊 Psychomotor retardation, Learning problems, Adjunct in cortical myoclonus
Formulation
Tablet
Standard tablet
Dose Range
40–40 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
2400 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 200–200 mg | 200.0–200.0 ml | — |
| 6 kg | 240–240 mg | 240.0–240.0 ml | — |
| 7 kg | 280–280 mg | 280.0–280.0 ml | — |
| 8 kg | 320–320 mg | 320.0–320.0 ml | — |
| 9 kg | 360–360 mg | 360.0–360.0 ml | — |
| 10 kg | 400–400 mg | 400.0–400.0 ml | — |
| 12 kg | 480–480 mg | 480.0–480.0 ml | — |
| 15 kg | 600–600 mg | 600.0–600.0 ml | — |
| 18 kg | 720–720 mg | 720.0–720.0 ml | — |
| 20 kg | 800–800 mg | 800.0–800.0 ml | — |
| 25 kg | 1000–1000 mg | 1000.0–1000.0 ml | — |
| 30 kg | 1200–1200 mg | 1200.0–1200.0 ml | — |
⚠️ Warnings
- • Reduce dose to half once desired effect achieved
Polyethylene Glycol (PEG)
Polyethylene Glycol (PEG)
💊 Constipation (osmotic laxative)
Formulation
Tablet
Standard tablet
Dose Range
0.75–1.5 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
20000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 4–8 mg | 3.8–7.5 ml | — |
| 6 kg | 5–9 mg | 4.5–9.0 ml | — |
| 7 kg | 5–11 mg | 5.3–10.5 ml | — |
| 8 kg | 6–12 mg | 6.0–12.0 ml | — |
| 9 kg | 7–14 mg | 6.8–13.5 ml | — |
| 10 kg | 8–15 mg | 7.5–15.0 ml | — |
| 12 kg | 9–18 mg | 9.0–18.0 ml | — |
| 15 kg | 11–23 mg | 11.3–22.5 ml | — |
| 18 kg | 14–27 mg | 13.5–27.0 ml | — |
| 20 kg | 15–30 mg | 15.0–30.0 ml | — |
| 25 kg | 19–38 mg | 18.8–37.5 ml | — |
| 30 kg | 23–45 mg | 22.5–45.0 ml | — |
Potassium Chloride
Potassium Chloride
💊 Hypokalemia
Formulation
Tablet
Standard tablet
Dose Range
1–2 mg/kg
Max Daily
2 mg/kg
Frequency
As directed
Max Single
20 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 5–10 mg | 5.0–10.0 ml | ≤ 10 mg |
| 6 kg | 6–12 mg | 6.0–12.0 ml | ≤ 12 mg |
| 7 kg | 7–14 mg | 7.0–14.0 ml | ≤ 14 mg |
| 8 kg | 8–16 mg | 8.0–16.0 ml | ≤ 16 mg |
| 9 kg | 9–18 mg | 9.0–18.0 ml | ≤ 18 mg |
| 10 kg | 10–20 mg | 10.0–20.0 ml | ≤ 20 mg |
| 12 kg | 12–24 mg | 12.0–24.0 ml | ≤ 24 mg |
| 15 kg | 15–30 mg | 15.0–30.0 ml | ≤ 30 mg |
| 18 kg | 18–36 mg | 18.0–36.0 ml | ≤ 36 mg |
| 20 kg | 20–40 mg | 20.0–40.0 ml | ≤ 40 mg |
| 25 kg | 25–50 mg | 25.0–50.0 ml | ≤ 50 mg |
| 30 kg | 30–60 mg | 30.0–60.0 ml | ≤ 60 mg |
⚠️ Warnings
- • Administer only when urine flow is established
Probenecid
Probenecid
💊 Gout, Increases penicillin blood levels
Formulation
Tablet
Standard tablet
Dose Range
25–40 mg/kg
Max Daily
40 mg/kg
Frequency
As directed
Max Single
500 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 125–200 mg | 125.0–200.0 ml | ≤ 200 mg |
| 6 kg | 150–240 mg | 150.0–240.0 ml | ≤ 240 mg |
| 7 kg | 175–280 mg | 175.0–280.0 ml | ≤ 280 mg |
| 8 kg | 200–320 mg | 200.0–320.0 ml | ≤ 320 mg |
| 9 kg | 225–360 mg | 225.0–360.0 ml | ≤ 360 mg |
| 10 kg | 250–400 mg | 250.0–400.0 ml | ≤ 400 mg |
| 12 kg | 300–480 mg | 300.0–480.0 ml | ≤ 480 mg |
| 15 kg | 375–600 mg | 375.0–600.0 ml | ≤ 600 mg |
| 18 kg | 450–720 mg | 450.0–720.0 ml | ≤ 720 mg |
| 20 kg | 500–800 mg | 500.0–800.0 ml | ≤ 800 mg |
| 25 kg | 625–1000 mg | 625.0–1000.0 ml | ≤ 1000 mg |
| 30 kg | 750–1200 mg | 750.0–1200.0 ml | ≤ 1200 mg |
Prostaglandin E1 (Alprostadil)
Prostaglandin E1 (Alprostadil)
💊 Ductus-dependent congenital heart diseases
Formulation
Tablet
Standard tablet
Dose Range
0.01–0.4 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
N/A
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 0–2 mg | 0.1–2.0 ml | — |
| 6 kg | 0–2 mg | 0.1–2.4 ml | — |
| 7 kg | 0–3 mg | 0.1–2.8 ml | — |
| 8 kg | 0–3 mg | 0.1–3.2 ml | — |
| 9 kg | 0–4 mg | 0.1–3.6 ml | — |
| 10 kg | 0–4 mg | 0.1–4.0 ml | — |
| 12 kg | 0–5 mg | 0.1–4.8 ml | — |
| 15 kg | 0–6 mg | 0.1–6.0 ml | — |
| 18 kg | 0–7 mg | 0.2–7.2 ml | — |
| 20 kg | 0–8 mg | 0.2–8.0 ml | — |
| 25 kg | 0–10 mg | 0.3–10.0 ml | — |
| 30 kg | 0–12 mg | 0.3–12.0 ml | — |
⚠️ Warnings
- • Apnea
- • Flushing
- • Hypotension
- • Seizure-like activity
- • Platelet aggregation defect
Pyritinol Hydrochloride
Pyritinol Hydrochloride
💊 Cognitive enhancement
Formulation
Tablet
Standard tablet
Dose Range
2–4 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
200 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 10–20 mg | 10.0–20.0 ml | — |
| 6 kg | 12–24 mg | 12.0–24.0 ml | — |
| 7 kg | 14–28 mg | 14.0–28.0 ml | — |
| 8 kg | 16–32 mg | 16.0–32.0 ml | — |
| 9 kg | 18–36 mg | 18.0–36.0 ml | — |
| 10 kg | 20–40 mg | 20.0–40.0 ml | — |
| 12 kg | 24–48 mg | 24.0–48.0 ml | — |
| 15 kg | 30–60 mg | 30.0–60.0 ml | — |
| 18 kg | 36–72 mg | 36.0–72.0 ml | — |
| 20 kg | 40–80 mg | 40.0–80.0 ml | — |
| 25 kg | 50–100 mg | 50.0–100.0 ml | — |
| 30 kg | 60–120 mg | 60.0–120.0 ml | — |
Racecadotril
Racecadotril
💊 Acute diarrhea (antisecretory)
Formulation
Tablet
Standard tablet
Dose Range
1.5–1.5 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
100 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 8–8 mg | 7.5–7.5 ml | — |
| 6 kg | 9–9 mg | 9.0–9.0 ml | — |
| 7 kg | 11–11 mg | 10.5–10.5 ml | — |
| 8 kg | 12–12 mg | 12.0–12.0 ml | — |
| 9 kg | 14–14 mg | 13.5–13.5 ml | — |
| 10 kg | 15–15 mg | 15.0–15.0 ml | — |
| 12 kg | 18–18 mg | 18.0–18.0 ml | — |
| 15 kg | 23–23 mg | 22.5–22.5 ml | — |
| 18 kg | 27–27 mg | 27.0–27.0 ml | — |
| 20 kg | 30–30 mg | 30.0–30.0 ml | — |
| 25 kg | 38–38 mg | 37.5–37.5 ml | — |
| 30 kg | 45–45 mg | 45.0–45.0 ml | — |
Rituximab
Rituximab
💊 Severe autoimmune disorders
Formulation
Tablet
Standard tablet
Dose Range
3–5 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
600 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 15–25 mg | 15.0–25.0 ml | — |
| 6 kg | 18–30 mg | 18.0–30.0 ml | — |
| 7 kg | 21–35 mg | 21.0–35.0 ml | — |
| 8 kg | 24–40 mg | 24.0–40.0 ml | — |
| 9 kg | 27–45 mg | 27.0–45.0 ml | — |
| 10 kg | 30–50 mg | 30.0–50.0 ml | — |
| 12 kg | 36–60 mg | 36.0–60.0 ml | — |
| 15 kg | 45–75 mg | 45.0–75.0 ml | — |
| 18 kg | 54–90 mg | 54.0–90.0 ml | — |
| 20 kg | 60–100 mg | 60.0–100.0 ml | — |
| 25 kg | 75–125 mg | 75.0–125.0 ml | — |
| 30 kg | 90–150 mg | 90.0–150.0 ml | — |
Sildenafil
Sildenafil
💊 Persistent pulmonary hypertension, Vasodilation
Formulation
Tablet
Standard tablet
Dose Range
0.5–2 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
100 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 3–10 mg | 2.5–10.0 ml | — |
| 6 kg | 3–12 mg | 3.0–12.0 ml | — |
| 7 kg | 4–14 mg | 3.5–14.0 ml | — |
| 8 kg | 4–16 mg | 4.0–16.0 ml | — |
| 9 kg | 5–18 mg | 4.5–18.0 ml | — |
| 10 kg | 5–20 mg | 5.0–20.0 ml | — |
| 12 kg | 6–24 mg | 6.0–24.0 ml | — |
| 15 kg | 8–30 mg | 7.5–30.0 ml | — |
| 18 kg | 9–36 mg | 9.0–36.0 ml | — |
| 20 kg | 10–40 mg | 10.0–40.0 ml | — |
| 25 kg | 13–50 mg | 12.5–50.0 ml | — |
| 30 kg | 15–60 mg | 15.0–60.0 ml | — |
Sodium Bicarbonate
Sodium Bicarbonate
💊 Metabolic acidosis, Prolonged resuscitation
Formulation
Tablet
Standard tablet
Dose Range
1–2 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
50 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 5–10 mg | 5.0–10.0 ml | — |
| 6 kg | 6–12 mg | 6.0–12.0 ml | — |
| 7 kg | 7–14 mg | 7.0–14.0 ml | — |
| 8 kg | 8–16 mg | 8.0–16.0 ml | — |
| 9 kg | 9–18 mg | 9.0–18.0 ml | — |
| 10 kg | 10–20 mg | 10.0–20.0 ml | — |
| 12 kg | 12–24 mg | 12.0–24.0 ml | — |
| 15 kg | 15–30 mg | 15.0–30.0 ml | — |
| 18 kg | 18–36 mg | 18.0–36.0 ml | — |
| 20 kg | 20–40 mg | 20.0–40.0 ml | — |
| 25 kg | 25–50 mg | 25.0–50.0 ml | — |
| 30 kg | 30–60 mg | 30.0–60.0 ml | — |
⚠️ Warnings
- • Avoid bolus in newborns; dilute with equal distilled water or double volume 5% dextrose; ensure adequate ventilation
Ursodeoxycholic Acid
Ursodeoxycholic Acid
💊 Cholestasis, Biliary disorders, Liver disease
Formulation
Tablet
Standard tablet
Dose Range
10–15 mg/kg
Max Daily
15 mg/kg
Frequency
As directed
Max Single
500 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 50–75 mg | 50.0–75.0 ml | ≤ 75 mg |
| 6 kg | 60–90 mg | 60.0–90.0 ml | ≤ 90 mg |
| 7 kg | 70–105 mg | 70.0–105.0 ml | ≤ 105 mg |
| 8 kg | 80–120 mg | 80.0–120.0 ml | ≤ 120 mg |
| 9 kg | 90–135 mg | 90.0–135.0 ml | ≤ 135 mg |
| 10 kg | 100–150 mg | 100.0–150.0 ml | ≤ 150 mg |
| 12 kg | 120–180 mg | 120.0–180.0 ml | ≤ 180 mg |
| 15 kg | 150–225 mg | 150.0–225.0 ml | ≤ 225 mg |
| 18 kg | 180–270 mg | 180.0–270.0 ml | ≤ 270 mg |
| 20 kg | 200–300 mg | 200.0–300.0 ml | ≤ 300 mg |
| 25 kg | 250–375 mg | 250.0–375.0 ml | ≤ 375 mg |
| 30 kg | 300–450 mg | 300.0–450.0 ml | ≤ 450 mg |
⚠️ Warnings
- • Contraindicated in severe hepatic dysfunction, complete biliary obstruction; diarrhea, itching
Furosemide
Furosemide
💊 Edema, Congestive heart failure, Pulmonary edema
Formulation
Tablet
Standard tablet
Dose Range
1–2 mg/kg
Max Daily
6 mg/kg
Frequency
As directed
Max Single
40 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 5–10 mg | 5.0–10.0 ml | ≤ 30 mg |
| 6 kg | 6–12 mg | 6.0–12.0 ml | ≤ 36 mg |
| 7 kg | 7–14 mg | 7.0–14.0 ml | ≤ 42 mg |
| 8 kg | 8–16 mg | 8.0–16.0 ml | ≤ 48 mg |
| 9 kg | 9–18 mg | 9.0–18.0 ml | ≤ 54 mg |
| 10 kg | 10–20 mg | 10.0–20.0 ml | ≤ 60 mg |
| 12 kg | 12–24 mg | 12.0–24.0 ml | ≤ 72 mg |
| 15 kg | 15–30 mg | 15.0–30.0 ml | ≤ 90 mg |
| 18 kg | 18–36 mg | 18.0–36.0 ml | ≤ 108 mg |
| 20 kg | 20–40 mg | 20.0–40.0 ml | ≤ 120 mg |
| 25 kg | 25–50 mg | 25.0–50.0 ml | ≤ 150 mg |
| 30 kg | 30–60 mg | 30.0–60.0 ml | ≤ 180 mg |
⚠️ Warnings
- • Monitor electrolytes
Hydrocortisone Sodium Succinate
Hydrocortisone Sodium Succinate
💊 Status asthmaticus, Endotoxic shock, Adrenal insufficiency
Formulation
Tablet
Standard tablet
Dose Range
25–50 mg/kg
Max Daily
150 mg/kg
Frequency
As directed
Max Single
500 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 125–250 mg | 125.0–250.0 ml | ≤ 750 mg |
| 6 kg | 150–300 mg | 150.0–300.0 ml | ≤ 900 mg |
| 7 kg | 175–350 mg | 175.0–350.0 ml | ≤ 1050 mg |
| 8 kg | 200–400 mg | 200.0–400.0 ml | ≤ 1200 mg |
| 9 kg | 225–450 mg | 225.0–450.0 ml | ≤ 1350 mg |
| 10 kg | 250–500 mg | 250.0–500.0 ml | ≤ 1500 mg |
| 12 kg | 300–600 mg | 300.0–600.0 ml | ≤ 1800 mg |
| 15 kg | 375–750 mg | 375.0–750.0 ml | ≤ 2250 mg |
| 18 kg | 450–900 mg | 450.0–900.0 ml | ≤ 2700 mg |
| 20 kg | 500–1000 mg | 500.0–1000.0 ml | ≤ 3000 mg |
| 25 kg | 625–1250 mg | 625.0–1250.0 ml | ≤ 3750 mg |
| 30 kg | 750–1500 mg | 750.0–1500.0 ml | ≤ 4500 mg |
Ketamine
Ketamine
💊 Emergency anesthesia, Procedural sedation
Formulation
Tablet
Standard tablet
Dose Range
0.5–5 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
500 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 3–25 mg | 2.5–25.0 ml | — |
| 6 kg | 3–30 mg | 3.0–30.0 ml | — |
| 7 kg | 4–35 mg | 3.5–35.0 ml | — |
| 8 kg | 4–40 mg | 4.0–40.0 ml | — |
| 9 kg | 5–45 mg | 4.5–45.0 ml | — |
| 10 kg | 5–50 mg | 5.0–50.0 ml | — |
| 12 kg | 6–60 mg | 6.0–60.0 ml | — |
| 15 kg | 8–75 mg | 7.5–75.0 ml | — |
| 18 kg | 9–90 mg | 9.0–90.0 ml | — |
| 20 kg | 10–100 mg | 10.0–100.0 ml | — |
| 25 kg | 13–125 mg | 12.5–125.0 ml | — |
| 30 kg | 15–150 mg | 15.0–150.0 ml | — |
⚠️ Warnings
- • Give slowly IV to avoid respiratory depression
Morphine Sulfate
Morphine Sulfate
💊 Pain management, Emergency analgesia
Formulation
Tablet
Standard tablet
Dose Range
0.1–0.2 mg/kg
Max Daily
N/A
Frequency
As directed
Max Single
15 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–1 mg | 0.5–1.0 ml | — |
| 6 kg | 1–1 mg | 0.6–1.2 ml | — |
| 7 kg | 1–1 mg | 0.7–1.4 ml | — |
| 8 kg | 1–2 mg | 0.8–1.6 ml | — |
| 9 kg | 1–2 mg | 0.9–1.8 ml | — |
| 10 kg | 1–2 mg | 1.0–2.0 ml | — |
| 12 kg | 1–2 mg | 1.2–2.4 ml | — |
| 15 kg | 2–3 mg | 1.5–3.0 ml | — |
| 18 kg | 2–4 mg | 1.8–3.6 ml | — |
| 20 kg | 2–4 mg | 2.0–4.0 ml | — |
| 25 kg | 3–5 mg | 2.5–5.0 ml | — |
| 30 kg | 3–6 mg | 3.0–6.0 ml | — |
⚠️ Warnings
- • Respiratory depression; naloxone available for reversal
Peppermint Oil
Peppermint Oil
💊 Irritable bowel syndrome, functional abdominal pain, flatulence
Formulation
Capsule
Enteric coated capsule
Dose Range
0.2–0.4 mg/kg
Max Daily
N/A
Frequency
TDS
Max Single
10 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–2 mg | 5.0–10.0 ml | — |
| 6 kg | 1–2 mg | 6.0–12.0 ml | — |
| 7 kg | 1–3 mg | 7.0–14.0 ml | — |
| 8 kg | 2–3 mg | 8.0–16.0 ml | — |
| 9 kg | 2–4 mg | 9.0–18.0 ml | — |
| 10 kg | 2–4 mg | 10.0–20.0 ml | — |
| 12 kg | 2–5 mg | 12.0–24.0 ml | — |
| 15 kg | 3–6 mg | 15.0–30.0 ml | — |
| 18 kg | 4–7 mg | 18.0–36.0 ml | — |
| 20 kg | 4–8 mg | 20.0–40.0 ml | — |
| 25 kg | 5–10 mg | 25.0–50.0 ml | — |
| 30 kg | 6–12 mg | 30.0–60.0 ml | — |
⚠️ Warnings
- • Do not use in children < 2 years
- • Avoid in GERD
Mebeverine
Mebeverine Hydrochloride
💊 Functional abdominal pain, irritable bowel syndrome, intestinal colic
Formulation
Tablet
135mg tablet
Dose Range
2–4 mg/kg
Max Daily
N/A
Frequency
BD
Max Single
200 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 10–20 mg | 0.1–0.1 ml | — |
| 6 kg | 12–24 mg | 0.1–0.2 ml | — |
| 7 kg | 14–28 mg | 0.1–0.2 ml | — |
| 8 kg | 16–32 mg | 0.1–0.2 ml | — |
| 9 kg | 18–36 mg | 0.1–0.3 ml | — |
| 10 kg | 20–40 mg | 0.1–0.3 ml | — |
| 12 kg | 24–48 mg | 0.2–0.4 ml | — |
| 15 kg | 30–60 mg | 0.2–0.4 ml | — |
| 18 kg | 36–72 mg | 0.3–0.5 ml | — |
| 20 kg | 40–80 mg | 0.3–0.6 ml | — |
| 25 kg | 50–100 mg | 0.4–0.7 ml | — |
| 30 kg | 60–120 mg | 0.4–0.9 ml | — |
⚠️ Warnings
- • Not for children < 3 years
Omeprazole
Omeprazole
💊 GERD, peptic ulcer, H. pylori eradication
Formulation
Capsule
10mg/20mg capsules
Dose Range
0.5–1 mg/kg
Max Daily
N/A
Frequency
OD-BD
Max Single
40 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 3–5 mg | 0.3–0.5 ml | — |
| 6 kg | 3–6 mg | 0.3–0.6 ml | — |
| 7 kg | 4–7 mg | 0.3–0.7 ml | — |
| 8 kg | 4–8 mg | 0.4–0.8 ml | — |
| 9 kg | 5–9 mg | 0.5–0.9 ml | — |
| 10 kg | 5–10 mg | 0.5–1.0 ml | — |
| 12 kg | 6–12 mg | 0.6–1.2 ml | — |
| 15 kg | 8–15 mg | 0.8–1.5 ml | — |
| 18 kg | 9–18 mg | 0.9–1.8 ml | — |
| 20 kg | 10–20 mg | 1.0–2.0 ml | — |
| 25 kg | 13–25 mg | 1.3–2.5 ml | — |
| 30 kg | 15–30 mg | 1.5–3.0 ml | — |
⚠️ Warnings
- • May affect absorption of other drugs
Pantoprazole
Pantoprazole Sodium
💊 GERD, peptic ulcer, erosive esophagitis
Formulation
Tablet
20mg/40mg tablets
Dose Range
0.5–1 mg/kg
Max Daily
N/A
Frequency
OD
Max Single
40 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 3–5 mg | 0.1–0.3 ml | — |
| 6 kg | 3–6 mg | 0.1–0.3 ml | — |
| 7 kg | 4–7 mg | 0.2–0.3 ml | — |
| 8 kg | 4–8 mg | 0.2–0.4 ml | — |
| 9 kg | 5–9 mg | 0.2–0.5 ml | — |
| 10 kg | 5–10 mg | 0.3–0.5 ml | — |
| 12 kg | 6–12 mg | 0.3–0.6 ml | — |
| 15 kg | 8–15 mg | 0.4–0.8 ml | — |
| 18 kg | 9–18 mg | 0.5–0.9 ml | — |
| 20 kg | 10–20 mg | 0.5–1.0 ml | — |
| 25 kg | 13–25 mg | 0.6–1.3 ml | — |
| 30 kg | 15–30 mg | 0.8–1.5 ml | — |
⚠️ Warnings
- • May affect absorption of atazanavir
Ticarcillin with Clavulanic Acid
Ticarcillin/Clavulanate
💊 Beta-lactamase producing enterobacteriaceae, serious gram-negative infections
Formulation
Injection
200mg ticarcillin + 3.4mg clavulanic acid per ml
Dose Range
50–75 mg/kg
Max Daily
N/A
Frequency
QID (q6h)
Max Single
3000 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 250–375 mg | 1.3–1.9 ml | — |
| 6 kg | 300–450 mg | 1.5–2.3 ml | — |
| 7 kg | 350–525 mg | 1.8–2.6 ml | — |
| 8 kg | 400–600 mg | 2.0–3.0 ml | — |
| 9 kg | 450–675 mg | 2.3–3.4 ml | — |
| 10 kg | 500–750 mg | 2.5–3.8 ml | — |
| 12 kg | 600–900 mg | 3.0–4.5 ml | — |
| 15 kg | 750–1125 mg | 3.8–5.6 ml | — |
| 18 kg | 900–1350 mg | 4.5–6.8 ml | — |
| 20 kg | 1000–1500 mg | 5.0–7.5 ml | — |
| 25 kg | 1250–1875 mg | 6.3–9.4 ml | — |
| 30 kg | 1500–2250 mg | 7.5–11.3 ml | — |
⚠️ Warnings
- • Penicillin allergy cross-reactivity
- • Monitor for superinfection
Oxymetazoline
Oxymetazoline Hydrochloride
💊 Nasal congestion, allergic rhinitis
Formulation
Nasal Drops/Spray
0.025%/0.05% nasal drops
Dose Range
0.025–0.05 mg/kg
Max Daily
N/A
Frequency
BD-TDS nasal
Max Single
0.1 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 0–0 mg | 0.3–0.5 ml | — |
| 6 kg | 0–0 mg | 0.3–0.6 ml | — |
| 7 kg | 0–0 mg | 0.4–0.7 ml | — |
| 8 kg | 0–0 mg | 0.4–0.8 ml | — |
| 9 kg | 0–0 mg | 0.5–0.9 ml | — |
| 10 kg | 0–1 mg | 0.5–1.0 ml | — |
| 12 kg | 0–1 mg | 0.6–1.2 ml | — |
| 15 kg | 0–1 mg | 0.8–1.5 ml | — |
| 18 kg | 0–1 mg | 0.9–1.8 ml | — |
| 20 kg | 1–1 mg | 1.0–2.0 ml | — |
| 25 kg | 1–1 mg | 1.3–2.5 ml | — |
| 30 kg | 1–2 mg | 1.5–3.0 ml | — |
⚠️ Warnings
- • Not for children < 3 years
- • Max 3 days use
Xylometazoline
Xylometazoline Hydrochloride
💊 Nasal congestion, allergic rhinitis, sinusitis
Formulation
Nasal Drops/Spray
0.025%/0.05% nasal drops
Dose Range
0.025–0.05 mg/kg
Max Daily
N/A
Frequency
BD-TDS nasal
Max Single
0.1 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 0–0 mg | 0.3–0.5 ml | — |
| 6 kg | 0–0 mg | 0.3–0.6 ml | — |
| 7 kg | 0–0 mg | 0.4–0.7 ml | — |
| 8 kg | 0–0 mg | 0.4–0.8 ml | — |
| 9 kg | 0–0 mg | 0.5–0.9 ml | — |
| 10 kg | 0–1 mg | 0.5–1.0 ml | — |
| 12 kg | 0–1 mg | 0.6–1.2 ml | — |
| 15 kg | 0–1 mg | 0.8–1.5 ml | — |
| 18 kg | 0–1 mg | 0.9–1.8 ml | — |
| 20 kg | 1–1 mg | 1.0–2.0 ml | — |
| 25 kg | 1–1 mg | 1.3–2.5 ml | — |
| 30 kg | 1–2 mg | 1.5–3.0 ml | — |
⚠️ Warnings
- • Not for children < 3 years
- • Max 3 days use
Phenylephrine
Phenylephrine Hydrochloride
💊 Hypotension, nasal congestion, mydriasis
Formulation
Nasal Drops
0.25%/0.5% nasal drops
Dose Range
0.1–0.15 mg/kg
Max Daily
N/A
Frequency
Q4h PRN
Max Single
5 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–1 mg | 0.5–0.8 ml | — |
| 6 kg | 1–1 mg | 0.6–0.9 ml | — |
| 7 kg | 1–1 mg | 0.7–1.1 ml | — |
| 8 kg | 1–1 mg | 0.8–1.2 ml | — |
| 9 kg | 1–1 mg | 0.9–1.3 ml | — |
| 10 kg | 1–2 mg | 1.0–1.5 ml | — |
| 12 kg | 1–2 mg | 1.2–1.8 ml | — |
| 15 kg | 2–2 mg | 1.5–2.3 ml | — |
| 18 kg | 2–3 mg | 1.8–2.7 ml | — |
| 20 kg | 2–3 mg | 2.0–3.0 ml | — |
| 25 kg | 3–4 mg | 2.5–3.8 ml | — |
| 30 kg | 3–5 mg | 3.0–4.5 ml | — |
⚠️ Warnings
- • May cause hypertension
- • Avoid in hyperthyroidism
Naphazoline
Naphazoline Nitrate
💊 Nasal congestion, eye redness/irritation
Formulation
Nasal Drops
0.05% nasal drops
Dose Range
0.01–0.02 mg/kg
Max Daily
N/A
Frequency
Q6h PRN
Max Single
0.05 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 0–0 mg | 0.1–0.2 ml | — |
| 6 kg | 0–0 mg | 0.1–0.2 ml | — |
| 7 kg | 0–0 mg | 0.1–0.3 ml | — |
| 8 kg | 0–0 mg | 0.2–0.3 ml | — |
| 9 kg | 0–0 mg | 0.2–0.4 ml | — |
| 10 kg | 0–0 mg | 0.2–0.4 ml | — |
| 12 kg | 0–0 mg | 0.2–0.5 ml | — |
| 15 kg | 0–0 mg | 0.3–0.6 ml | — |
| 18 kg | 0–0 mg | 0.4–0.7 ml | — |
| 20 kg | 0–0 mg | 0.4–0.8 ml | — |
| 25 kg | 0–1 mg | 0.5–1.0 ml | — |
| 30 kg | 0–1 mg | 0.6–1.2 ml | — |
⚠️ Warnings
- • Not for children < 5 years
- • Avoid in glaucoma
Olopatadine
Olopatadine Hydrochloride
💊 Allergic rhinitis, allergic conjunctivitis
Formulation
Nasal Spray
0.665% nasal spray (5.3mg/ml)
Dose Range
0.1–0.15 mg/kg
Max Daily
N/A
Frequency
BD
Max Single
10 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–1 mg | 0.8–1.1 ml | — |
| 6 kg | 1–1 mg | 0.9–1.4 ml | — |
| 7 kg | 1–1 mg | 1.1–1.6 ml | — |
| 8 kg | 1–1 mg | 1.2–1.8 ml | — |
| 9 kg | 1–1 mg | 1.4–2.0 ml | — |
| 10 kg | 1–2 mg | 1.5–2.3 ml | — |
| 12 kg | 1–2 mg | 1.8–2.7 ml | — |
| 15 kg | 2–2 mg | 2.3–3.4 ml | — |
| 18 kg | 2–3 mg | 2.7–4.1 ml | — |
| 20 kg | 2–3 mg | 3.0–4.5 ml | — |
| 25 kg | 3–4 mg | 3.8–5.6 ml | — |
| 30 kg | 3–5 mg | 4.5–6.8 ml | — |
⚠️ Warnings
- • Not for children < 3 years
Azelastine
Azelastine Hydrochloride
💊 Allergic rhinitis, allergic conjunctivitis
Formulation
Nasal Spray
0.1% nasal spray (0.5mg/spray)
Dose Range
0.1–0.15 mg/kg
Max Daily
N/A
Frequency
BD
Max Single
0.14 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–1 mg | 1.0–1.5 ml | — |
| 6 kg | 1–1 mg | 1.2–1.8 ml | — |
| 7 kg | 1–1 mg | 1.4–2.1 ml | — |
| 8 kg | 1–1 mg | 1.6–2.4 ml | — |
| 9 kg | 1–1 mg | 1.8–2.7 ml | — |
| 10 kg | 1–2 mg | 2.0–3.0 ml | — |
| 12 kg | 1–2 mg | 2.4–3.6 ml | — |
| 15 kg | 2–2 mg | 3.0–4.5 ml | — |
| 18 kg | 2–3 mg | 3.6–5.4 ml | — |
| 20 kg | 2–3 mg | 4.0–6.0 ml | — |
| 25 kg | 3–4 mg | 5.0–7.5 ml | — |
| 30 kg | 3–5 mg | 6.0–9.0 ml | — |
⚠️ Warnings
- • Not for children < 3 years
Cromolyn Sodium
Cromolyn Sodium
💊 Asthma prophylaxis, allergic rhinitis, mastocytosis
Formulation
Inhaler
20mg per puff
Dose Range
1–2 mg/kg
Max Daily
N/A
Frequency
QID
Max Single
20 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 5–10 mg | 0.3–0.5 ml | — |
| 6 kg | 6–12 mg | 0.3–0.6 ml | — |
| 7 kg | 7–14 mg | 0.3–0.7 ml | — |
| 8 kg | 8–16 mg | 0.4–0.8 ml | — |
| 9 kg | 9–18 mg | 0.5–0.9 ml | — |
| 10 kg | 10–20 mg | 0.5–1.0 ml | — |
| 12 kg | 12–24 mg | 0.6–1.2 ml | — |
| 15 kg | 15–30 mg | 0.8–1.5 ml | — |
| 18 kg | 18–36 mg | 0.9–1.8 ml | — |
| 20 kg | 20–40 mg | 1.0–2.0 ml | — |
| 25 kg | 25–50 mg | 1.3–2.5 ml | — |
| 30 kg | 30–60 mg | 1.5–3.0 ml | — |
⚠️ Warnings
- • Not for acute asthma attacks
Montelukast
Montelukast Sodium
💊 Asthma prophylaxis, allergic rhinitis, exercise-induced bronchospasm
Formulation
Chewable Tablet
4mg/5mg chewable tablets
Dose Range
0.1–0.5 mg/kg
Max Daily
N/A
Frequency
OD at bedtime
Max Single
10 mg
| Weight | Dose (mg) | Dose (ml) | Daily Max |
|---|---|---|---|
| 5 kg | 1–3 mg | 0.1–0.6 ml | — |
| 6 kg | 1–3 mg | 0.2–0.8 ml | — |
| 7 kg | 1–4 mg | 0.2–0.9 ml | — |
| 8 kg | 1–4 mg | 0.2–1.0 ml | — |
| 9 kg | 1–5 mg | 0.2–1.1 ml | — |
| 10 kg | 1–5 mg | 0.3–1.3 ml | — |
| 12 kg | 1–6 mg | 0.3–1.5 ml | — |
| 15 kg | 2–8 mg | 0.4–1.9 ml | — |
| 18 kg | 2–9 mg | 0.5–2.3 ml | — |
| 20 kg | 2–10 mg | 0.5–2.5 ml | — |
| 25 kg | 3–13 mg | 0.6–3.1 ml | — |
| 30 kg | 3–15 mg | 0.8–3.8 ml | — |
⚠️ Warnings
- • Not for acute asthma attacks
- • Monitor for neuropsychiatric effects
💡 Tip: Use the DoseCare Calculator for interactive dose calculations based on your child's exact weight.
DoseCare is a decision support tool only. Always consult a healthcare professional before administering medication to children.